@prefix np: <http://www.nanopub.org/nschema#>.
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix sio: <http://semanticscience.org/resource/> .
@prefix ncit: <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#> .
@prefix chear: <http://hadatac.org/ont/chear#> .
@prefix uberon: <http://purl.obolibrary.org/obo/UBERON_> .
@prefix pr: <http://purl.obolibrary.org/obo/PR_>.
@prefix hasco: <http://hadatac.org/ont/hasco#> .
@prefix uo: <http://purl.obolibrary.org/obo/UO_> . 
@prefix cst: <http://idea.rpi.edu/ontologies/cancer_staging_terms.owl#>.
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix hp: <http://purl.obolibrary.org/obo/HP_> .
@prefix dron: <http://purl.obolibrary.org/obo/DRON_> .
@prefix chebi: <http://purl.obolibrary.org/obo/CHEBI> .
@prefix db: <https://www.drugbank.ca/drugs/> .
@prefix civic-kb: <http://idea.rpi.edu/heals/kb/civic#>.
@prefix uniprot: <http://www.uniprot.org/uniprot/> .
@prefix doid: <http://purl.obolibrary.org/obo/DOID_> .
@prefix efo: <http://www.ebi.ac.uk/efo/EFO_> .


civic-kb:head-explicit_entry { 
	civic-kb:nanoPub-explicit_entry	rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-explicit_entry ;
		np:hasProvenance civic-kb:provenance-explicit_entry ;
		np:hasPublicationInfo civic-kb:pubInfo-explicit_entry .
}

civic-kb:assertion-explicit_entry {
	civic-kb:Drugs	rdf:type	owl:Class ;
		rdfs:subClassOf sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string .

	civic-kb:Status	rdf:type	owl:Class ;
		rdfs:subClassOf sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string .

	civic-kb:Evidence_ID	rdf:type	owl:Class ;
		rdfs:subClassOf sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string .

	civic-kb:Gene	rdf:type	owl:Class ;
		rdfs:subClassOf sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string .

	civic-kb:Variant	rdf:type	owl:Class ;
		rdfs:subClassOf ncit:C97927 ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string .

	civic-kb:Description	rdf:type	owl:Class ;
		rdfs:subClassOf sio:Description ;
		sio:isAttributeOf civic-kb:evidence ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease	rdf:type	owl:Class ;
		rdfs:subClassOf sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string .

	civic-kb:Evidence_Level	rdf:type	owl:Class ;
		rdfs:subClassOf ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string .

	civic-kb:Evidence_Type	rdf:type	owl:Class ;
		rdfs:subClassOf	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string .

	civic-kb:Evidence_Direction	rdf:type	owl:Class ;
		rdfs:subClassOf	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string .

	civic-kb:Clinical_Significance	rdf:type	owl:Class ;
		rdfs:subClassOf	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string .

	civic-kb:Variant_Origin	rdf:type	owl:Class ;
		rdfs:subClassOf ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating	rdf:type	owl:Class ;
		rdfs:subClassOf ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string .

}

civic-kb:provenance-explicit_entry {
	civic-kb:assertion-explicit_entry	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom civic-kb:evidence .

	civic-kb:Status
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-explicit_entry {
	civic-kb:nanoPub-explicit_entry	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime .
	civic-kb:Drugs	hasco:hasPosition	"1"^^xsd:integer .
	civic-kb:Status	hasco:hasPosition	"2"^^xsd:integer .
	civic-kb:Evidence_ID	hasco:hasPosition	"3"^^xsd:integer .
	civic-kb:Gene	hasco:hasPosition	"4"^^xsd:integer .
	civic-kb:Variant	hasco:hasPosition	"5"^^xsd:integer .
	civic-kb:Description	hasco:hasPosition	"6"^^xsd:integer .
	civic-kb:Disease	hasco:hasPosition	"7"^^xsd:integer .
	civic-kb:Evidence_Level	hasco:hasPosition	"8"^^xsd:integer .
	civic-kb:Evidence_Type	hasco:hasPosition	"9"^^xsd:integer .
	civic-kb:Evidence_Direction	hasco:hasPosition	"10"^^xsd:integer .
	civic-kb:Clinical_Significance	hasco:hasPosition	"11"^^xsd:integer .
	civic-kb:Variant_Origin	hasco:hasPosition	"12"^^xsd:integer .
	civic-kb:Trust_Rating	hasco:hasPosition	"13"^^xsd:integer .
}

civic-kb:head-virtual_entry { 
	civic-kb:nanoPub-virtual_entry	rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-virtual_entry ;
		np:hasProvenance civic-kb:provenance-virtual_entry ;
		np:hasPublicationInfo civic-kb:pubInfo-virtual_entry .
}

civic-kb:assertion-virtual_entry {
	civic-kb:evidence	rdf:type	owl:Class ;
		rdfs:label "evidence" ;
		rdfs:subClassOf ncit:C43583 .

}

civic-kb:provenance-virtual_entry {
	civic-kb:assertion-virtual_entry	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:evidence
		prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-virtual_entry {
	civic-kb:nanoPub-virtual_entry	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime .
}

civic-kb:head-160be83fef619821258b34df29bf9644 {
	civic-kb:nanoPub-160be83fef619821258b34df29bf9644
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-160be83fef619821258b34df29bf9644 ;
		np:hasProvenance civic-kb:provenance-160be83fef619821258b34df29bf9644 ;
		np:hasPublicationInfo civic-kb:pubInfo-160be83fef619821258b34df29bf9644 .
}

civic-kb:assertion-160be83fef619821258b34df29bf9644 {
	civic-kb:Drugs-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-160be83fef619821258b34df29bf9644 ;
		rdf:type	chebi:41774 ;
		rdf:type	db:DB00675 ;
		rdfs:label	"Tamoxifen"^^xsd:string ;
		sio:hasValue	"Tamoxifen"^^xsd:string .

	civic-kb:Status-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-160be83fef619821258b34df29bf9644 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-160be83fef619821258b34df29bf9644 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"858"^^xsd:integer .

	civic-kb:Gene-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18021 ;
		rdf:type	uniprot:P24385 ;
		rdfs:label	"CCND1 Gene"^^xsd:string ;
		sio:hasValue	"CCND1"^^xsd:string .

	civic-kb:Variant-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-160be83fef619821258b34df29bf9644 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In this retrospective analysis, CCND1 amplification was analyzed in 442 patients. No interaction with treatment was observed."^^xsd:string .

	civic-kb:Disease-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-160be83fef619821258b34df29bf9644 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-160be83fef619821258b34df29bf9644 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-160be83fef619821258b34df29bf9644 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-160be83fef619821258b34df29bf9644 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-160be83fef619821258b34df29bf9644 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-160be83fef619821258b34df29bf9644 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-160be83fef619821258b34df29bf9644	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-160be83fef619821258b34df29bf9644 .

}

civic-kb:provenance-160be83fef619821258b34df29bf9644 {
	civic-kb:assertion-160be83fef619821258b34df29bf9644 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-160be83fef619821258b34df29bf9644 .

	civic-kb:Status-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-160be83fef619821258b34df29bf9644	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-160be83fef619821258b34df29bf9644 {
	civic-kb:nanoPub-160be83fef619821258b34df29bf9644 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-160be83fef619821258b34df29bf9644
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-a8272523cad524d9478dbdba0d0c90a0 {
	civic-kb:nanoPub-a8272523cad524d9478dbdba0d0c90a0
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-a8272523cad524d9478dbdba0d0c90a0 ;
		np:hasProvenance civic-kb:provenance-a8272523cad524d9478dbdba0d0c90a0 ;
		np:hasPublicationInfo civic-kb:pubInfo-a8272523cad524d9478dbdba0d0c90a0 .
}

civic-kb:assertion-a8272523cad524d9478dbdba0d0c90a0 {
	civic-kb:Drugs-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a8272523cad524d9478dbdba0d0c90a0 ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib (PD0332991)"^^xsd:string .

	civic-kb:Status-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-a8272523cad524d9478dbdba0d0c90a0 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-a8272523cad524d9478dbdba0d0c90a0 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1562"^^xsd:integer .

	civic-kb:Gene-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18021 ;
		rdf:type	uniprot:P24385 ;
		rdfs:label	"CCND1 Gene"^^xsd:string ;
		sio:hasValue	"CCND1"^^xsd:string .

	civic-kb:Variant-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-a8272523cad524d9478dbdba0d0c90a0 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A panel of 47 breast cancer cell lines was tested for sensitivty/resistance to CDK4/6 inhibitor Palbociclib (PD0332991),  where IC50 below 150nM was sensitive, and above 1000nM resistant. Cyclin D1 had higher expression levels in sensitive cell lines."^^xsd:string .

	civic-kb:Disease-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a8272523cad524d9478dbdba0d0c90a0 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-a8272523cad524d9478dbdba0d0c90a0 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a8272523cad524d9478dbdba0d0c90a0 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a8272523cad524d9478dbdba0d0c90a0 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-a8272523cad524d9478dbdba0d0c90a0 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-a8272523cad524d9478dbdba0d0c90a0 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-a8272523cad524d9478dbdba0d0c90a0	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-a8272523cad524d9478dbdba0d0c90a0 .

}

civic-kb:provenance-a8272523cad524d9478dbdba0d0c90a0 {
	civic-kb:assertion-a8272523cad524d9478dbdba0d0c90a0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-a8272523cad524d9478dbdba0d0c90a0 .

	civic-kb:Status-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-a8272523cad524d9478dbdba0d0c90a0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-a8272523cad524d9478dbdba0d0c90a0 {
	civic-kb:nanoPub-a8272523cad524d9478dbdba0d0c90a0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-a8272523cad524d9478dbdba0d0c90a0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-852f8b8d7f8f8ff321682f0c4b574a90 {
	civic-kb:nanoPub-852f8b8d7f8f8ff321682f0c4b574a90
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-852f8b8d7f8f8ff321682f0c4b574a90 ;
		np:hasProvenance civic-kb:provenance-852f8b8d7f8f8ff321682f0c4b574a90 ;
		np:hasPublicationInfo civic-kb:pubInfo-852f8b8d7f8f8ff321682f0c4b574a90 .
}

civic-kb:assertion-852f8b8d7f8f8ff321682f0c4b574a90 {
	civic-kb:Drugs-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-852f8b8d7f8f8ff321682f0c4b574a90 ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-852f8b8d7f8f8ff321682f0c4b574a90 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-852f8b8d7f8f8ff321682f0c4b574a90 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1967"^^xsd:integer .

	civic-kb:Gene-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C20174 ;
		rdf:type	uniprot:Q02297 ;
		rdfs:label	"NRG1 Gene"^^xsd:string ;
		sio:hasValue	"NRG1"^^xsd:string .

	civic-kb:Variant-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-852f8b8d7f8f8ff321682f0c4b574a90 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Reactivation of EGFR, HER2 and HER3 occurred within 24 hours of lapatinib treatment in breast cancer cell lines, This was associated with increased expression of NRG1 in cells treated with lapatinib."^^xsd:string .

	civic-kb:Disease-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-852f8b8d7f8f8ff321682f0c4b574a90 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-852f8b8d7f8f8ff321682f0c4b574a90 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-852f8b8d7f8f8ff321682f0c4b574a90 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-852f8b8d7f8f8ff321682f0c4b574a90 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-852f8b8d7f8f8ff321682f0c4b574a90 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-852f8b8d7f8f8ff321682f0c4b574a90 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-852f8b8d7f8f8ff321682f0c4b574a90	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-852f8b8d7f8f8ff321682f0c4b574a90 .

}

civic-kb:provenance-852f8b8d7f8f8ff321682f0c4b574a90 {
	civic-kb:assertion-852f8b8d7f8f8ff321682f0c4b574a90 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-852f8b8d7f8f8ff321682f0c4b574a90 .

	civic-kb:Status-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-852f8b8d7f8f8ff321682f0c4b574a90	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-852f8b8d7f8f8ff321682f0c4b574a90 {
	civic-kb:nanoPub-852f8b8d7f8f8ff321682f0c4b574a90 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-852f8b8d7f8f8ff321682f0c4b574a90
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-1c4343735087f0cd4bb2e844951695e4 {
	civic-kb:nanoPub-1c4343735087f0cd4bb2e844951695e4
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-1c4343735087f0cd4bb2e844951695e4 ;
		np:hasProvenance civic-kb:provenance-1c4343735087f0cd4bb2e844951695e4 ;
		np:hasPublicationInfo civic-kb:pubInfo-1c4343735087f0cd4bb2e844951695e4 .
}

civic-kb:assertion-1c4343735087f0cd4bb2e844951695e4 {
	civic-kb:Drugs-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1c4343735087f0cd4bb2e844951695e4 ;
		rdf:type	dron:00018972 ;
		rdf:type	db:DB00947 ;
		rdfs:label	"Fulvestrant"^^xsd:string ;
		sio:hasValue	"Fulvestrant"^^xsd:string .

	civic-kb:Status-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-1c4343735087f0cd4bb2e844951695e4 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-1c4343735087f0cd4bb2e844951695e4 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"901"^^xsd:integer .

	civic-kb:Gene-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C28675 ;
		rdf:type	uniprot:P01033 ;
		rdfs:label	"TIMP1 Gene"^^xsd:string ;
		sio:hasValue	"TIMP1"^^xsd:string .

	civic-kb:Variant-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-1c4343735087f0cd4bb2e844951695e4 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"TIMP1 overexpression was associated with resistance to fulvestrant in breast cancer cell lines."^^xsd:string .

	civic-kb:Disease-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1c4343735087f0cd4bb2e844951695e4 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-1c4343735087f0cd4bb2e844951695e4 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1c4343735087f0cd4bb2e844951695e4 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1c4343735087f0cd4bb2e844951695e4 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-1c4343735087f0cd4bb2e844951695e4 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-1c4343735087f0cd4bb2e844951695e4 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-1c4343735087f0cd4bb2e844951695e4	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-1c4343735087f0cd4bb2e844951695e4 .

}

civic-kb:provenance-1c4343735087f0cd4bb2e844951695e4 {
	civic-kb:assertion-1c4343735087f0cd4bb2e844951695e4 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-1c4343735087f0cd4bb2e844951695e4 .

	civic-kb:Status-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-1c4343735087f0cd4bb2e844951695e4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-1c4343735087f0cd4bb2e844951695e4 {
	civic-kb:nanoPub-1c4343735087f0cd4bb2e844951695e4 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-1c4343735087f0cd4bb2e844951695e4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-1fa2be44eb3fc7850056078fd1fb0d39 {
	civic-kb:nanoPub-1fa2be44eb3fc7850056078fd1fb0d39
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-1fa2be44eb3fc7850056078fd1fb0d39 ;
		np:hasProvenance civic-kb:provenance-1fa2be44eb3fc7850056078fd1fb0d39 ;
		np:hasPublicationInfo civic-kb:pubInfo-1fa2be44eb3fc7850056078fd1fb0d39 .
}

civic-kb:assertion-1fa2be44eb3fc7850056078fd1fb0d39 {
	civic-kb:Drugs-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1fa2be44eb3fc7850056078fd1fb0d39 ;
		rdf:type	chebi:45863 ;
		rdf:type	db:DB01229 ;
		rdfs:label	"Paclitaxel"^^xsd:string ;
		sio:hasValue	"Paclitaxel"^^xsd:string .

	civic-kb:Status-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-1fa2be44eb3fc7850056078fd1fb0d39 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-1fa2be44eb3fc7850056078fd1fb0d39 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"927"^^xsd:integer .

	civic-kb:Gene-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C28675 ;
		rdf:type	uniprot:P01033 ;
		rdfs:label	"TIMP1 Gene"^^xsd:string ;
		sio:hasValue	"TIMP1"^^xsd:string .

	civic-kb:Variant-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-1fa2be44eb3fc7850056078fd1fb0d39 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"High expression of TIMP-1 was assessed by IHC in 99 primary breast cancers that had not spread beyond the breast after 6 postoperative courses of paclitaxel-based chemotherapy. High TIMP1 levels were associated with worse 5-year disease free survival (71.1%) than low levels (88.5 %; P = 0.020). High TIMP-1 levels were also associated with worse 5-year overall survival (78.9 %) than low levels (96.7 %; P = 0.004)."^^xsd:string .

	civic-kb:Disease-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1fa2be44eb3fc7850056078fd1fb0d39 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-1fa2be44eb3fc7850056078fd1fb0d39 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1fa2be44eb3fc7850056078fd1fb0d39 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1fa2be44eb3fc7850056078fd1fb0d39 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-1fa2be44eb3fc7850056078fd1fb0d39 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-1fa2be44eb3fc7850056078fd1fb0d39 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-1fa2be44eb3fc7850056078fd1fb0d39	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-1fa2be44eb3fc7850056078fd1fb0d39 .

}

civic-kb:provenance-1fa2be44eb3fc7850056078fd1fb0d39 {
	civic-kb:assertion-1fa2be44eb3fc7850056078fd1fb0d39 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-1fa2be44eb3fc7850056078fd1fb0d39 .

	civic-kb:Status-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-1fa2be44eb3fc7850056078fd1fb0d39	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-1fa2be44eb3fc7850056078fd1fb0d39 {
	civic-kb:nanoPub-1fa2be44eb3fc7850056078fd1fb0d39 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-1fa2be44eb3fc7850056078fd1fb0d39
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-98809e3037cdddaf1f6ed3bbd159c395 {
	civic-kb:nanoPub-98809e3037cdddaf1f6ed3bbd159c395
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-98809e3037cdddaf1f6ed3bbd159c395 ;
		np:hasProvenance civic-kb:provenance-98809e3037cdddaf1f6ed3bbd159c395 ;
		np:hasPublicationInfo civic-kb:pubInfo-98809e3037cdddaf1f6ed3bbd159c395 .
}

civic-kb:assertion-98809e3037cdddaf1f6ed3bbd159c395 {
	civic-kb:Drugs-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-98809e3037cdddaf1f6ed3bbd159c395 .

	civic-kb:Status-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-98809e3037cdddaf1f6ed3bbd159c395 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-98809e3037cdddaf1f6ed3bbd159c395 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1084"^^xsd:integer .

	civic-kb:Gene-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38552 ;
		rdf:type	uniprot:P12318 ;
		rdfs:label	"FCGR2A Gene"^^xsd:string ;
		sio:hasValue	"FCGR2A"^^xsd:string .

	civic-kb:Variant-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H167R"^^xsd:string .

	civic-kb:Description-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-98809e3037cdddaf1f6ed3bbd159c395 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A total of 57 women with HER2-positive metastatic breast cancer were analyzed after taxane plus trastuzumab chemotherapy. FCGR2A H131R carriers did not have a significantly different response rate, progression-free survival, or overall survival."^^xsd:string .

	civic-kb:Disease-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-98809e3037cdddaf1f6ed3bbd159c395 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-98809e3037cdddaf1f6ed3bbd159c395 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-98809e3037cdddaf1f6ed3bbd159c395 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-98809e3037cdddaf1f6ed3bbd159c395 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string .

	civic-kb:Variant_Origin-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-98809e3037cdddaf1f6ed3bbd159c395 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Polymorphism"^^xsd:string .

	civic-kb:Trust_Rating-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-98809e3037cdddaf1f6ed3bbd159c395 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-98809e3037cdddaf1f6ed3bbd159c395	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-98809e3037cdddaf1f6ed3bbd159c395 .

}

civic-kb:provenance-98809e3037cdddaf1f6ed3bbd159c395 {
	civic-kb:assertion-98809e3037cdddaf1f6ed3bbd159c395 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-98809e3037cdddaf1f6ed3bbd159c395 .

	civic-kb:Status-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-98809e3037cdddaf1f6ed3bbd159c395	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-98809e3037cdddaf1f6ed3bbd159c395 {
	civic-kb:nanoPub-98809e3037cdddaf1f6ed3bbd159c395 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-98809e3037cdddaf1f6ed3bbd159c395
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8f89b039f9f9cb44a3081bd8a6b6a5cd {
	civic-kb:nanoPub-8f89b039f9f9cb44a3081bd8a6b6a5cd
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8f89b039f9f9cb44a3081bd8a6b6a5cd ;
		np:hasProvenance civic-kb:provenance-8f89b039f9f9cb44a3081bd8a6b6a5cd ;
		np:hasPublicationInfo civic-kb:pubInfo-8f89b039f9f9cb44a3081bd8a6b6a5cd .
}

civic-kb:assertion-8f89b039f9f9cb44a3081bd8a6b6a5cd {
	civic-kb:Drugs-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8f89b039f9f9cb44a3081bd8a6b6a5cd .

	civic-kb:Status-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8f89b039f9f9cb44a3081bd8a6b6a5cd ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8f89b039f9f9cb44a3081bd8a6b6a5cd ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1088"^^xsd:integer .

	civic-kb:Gene-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38552 ;
		rdf:type	uniprot:P12318 ;
		rdfs:label	"FCGR2A Gene"^^xsd:string ;
		sio:hasValue	"FCGR2A"^^xsd:string .

	civic-kb:Variant-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H167R"^^xsd:string .

	civic-kb:Description-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8f89b039f9f9cb44a3081bd8a6b6a5cd ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"1325 HER2-positive breast cancer patients treated with trastuzumab and chemotherapy from the N9831 clinical trial were analyzed. There was no statistical difference in disease-free survival between trastuzumab-treated patients who had the FCGR2A 131 H/H high-affinity genotype and patients without that genotype."^^xsd:string .

	civic-kb:Disease-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8f89b039f9f9cb44a3081bd8a6b6a5cd ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8f89b039f9f9cb44a3081bd8a6b6a5cd ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8f89b039f9f9cb44a3081bd8a6b6a5cd ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8f89b039f9f9cb44a3081bd8a6b6a5cd ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string .

	civic-kb:Variant_Origin-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8f89b039f9f9cb44a3081bd8a6b6a5cd ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Polymorphism"^^xsd:string .

	civic-kb:Trust_Rating-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8f89b039f9f9cb44a3081bd8a6b6a5cd ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-8f89b039f9f9cb44a3081bd8a6b6a5cd	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8f89b039f9f9cb44a3081bd8a6b6a5cd .

}

civic-kb:provenance-8f89b039f9f9cb44a3081bd8a6b6a5cd {
	civic-kb:assertion-8f89b039f9f9cb44a3081bd8a6b6a5cd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8f89b039f9f9cb44a3081bd8a6b6a5cd .

	civic-kb:Status-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-8f89b039f9f9cb44a3081bd8a6b6a5cd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8f89b039f9f9cb44a3081bd8a6b6a5cd {
	civic-kb:nanoPub-8f89b039f9f9cb44a3081bd8a6b6a5cd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8f89b039f9f9cb44a3081bd8a6b6a5cd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ebec715e62228aa5c47cbf8608c9dac8 {
	civic-kb:nanoPub-ebec715e62228aa5c47cbf8608c9dac8
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ebec715e62228aa5c47cbf8608c9dac8 ;
		np:hasProvenance civic-kb:provenance-ebec715e62228aa5c47cbf8608c9dac8 ;
		np:hasPublicationInfo civic-kb:pubInfo-ebec715e62228aa5c47cbf8608c9dac8 .
}

civic-kb:assertion-ebec715e62228aa5c47cbf8608c9dac8 {
	civic-kb:Drugs-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ebec715e62228aa5c47cbf8608c9dac8 ;
		rdf:type	chebi:41774 ;
		rdf:type	db:DB00675 ;
		rdfs:label	"Tamoxifen"^^xsd:string ;
		sio:hasValue	"Tamoxifen"^^xsd:string .

	civic-kb:Status-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ebec715e62228aa5c47cbf8608c9dac8 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ebec715e62228aa5c47cbf8608c9dac8 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3036"^^xsd:integer .

	civic-kb:Gene-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L3 Domain Mutation"^^xsd:string .

	civic-kb:Description-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ebec715e62228aa5c47cbf8608c9dac8 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a study 202 breast cancer patients undergoing first line tamoxifen treatment, 65 patients had mutations in TP53. Among the p53 wild type population a 66% response rate was reported, where response was considered as complete response, partial response or stable disease. In a patient subgroup with mutations in the p53 L3 domain which interatcts with zinc, 2 of 13 (15%) of patients responded to tamoxifen."^^xsd:string .

	civic-kb:Disease-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ebec715e62228aa5c47cbf8608c9dac8 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ebec715e62228aa5c47cbf8608c9dac8 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ebec715e62228aa5c47cbf8608c9dac8 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ebec715e62228aa5c47cbf8608c9dac8 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ebec715e62228aa5c47cbf8608c9dac8 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ebec715e62228aa5c47cbf8608c9dac8 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-ebec715e62228aa5c47cbf8608c9dac8	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ebec715e62228aa5c47cbf8608c9dac8 .

}

civic-kb:provenance-ebec715e62228aa5c47cbf8608c9dac8 {
	civic-kb:assertion-ebec715e62228aa5c47cbf8608c9dac8 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ebec715e62228aa5c47cbf8608c9dac8 .

	civic-kb:Status-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ebec715e62228aa5c47cbf8608c9dac8	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ebec715e62228aa5c47cbf8608c9dac8 {
	civic-kb:nanoPub-ebec715e62228aa5c47cbf8608c9dac8 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ebec715e62228aa5c47cbf8608c9dac8
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d04592e84be7b8c0c1697918b638a739 {
	civic-kb:nanoPub-d04592e84be7b8c0c1697918b638a739
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d04592e84be7b8c0c1697918b638a739 ;
		np:hasProvenance civic-kb:provenance-d04592e84be7b8c0c1697918b638a739 ;
		np:hasPublicationInfo civic-kb:pubInfo-d04592e84be7b8c0c1697918b638a739 .
}

civic-kb:assertion-d04592e84be7b8c0c1697918b638a739 {
	civic-kb:Drugs-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d04592e84be7b8c0c1697918b638a739 ;
		rdf:type	db:DB12015 ;
		rdfs:label	"Alpelisib"^^xsd:string ;
		sio:hasValue	"BYL719 (Alpelisib)"^^xsd:string .

	civic-kb:Status-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d04592e84be7b8c0c1697918b638a739 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d04592e84be7b8c0c1697918b638a739 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"264"^^xsd:integer .

	civic-kb:Gene-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18250 ;
		rdf:type	uniprot:P11802 ;
		rdfs:label	"CDK4 Gene"^^xsd:string ;
		sio:hasValue	"CDK4"^^xsd:string .

	civic-kb:Variant-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d04592e84be7b8c0c1697918b638a739 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In mouse xenograft studies of PIK3CA mutant breast cancers, the combination of PI3K and CDK4/6 inhibitors overcomes intrinsic and adaptive resistance leading to tumor regressions."^^xsd:string .

	civic-kb:Disease-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d04592e84be7b8c0c1697918b638a739 ;
		rdf:type	efo:1000649 ;
		rdf:type	doid:0060075 ;
		rdfs:label	"Estrogen-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d04592e84be7b8c0c1697918b638a739 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d04592e84be7b8c0c1697918b638a739 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d04592e84be7b8c0c1697918b638a739 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d04592e84be7b8c0c1697918b638a739 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d04592e84be7b8c0c1697918b638a739 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-d04592e84be7b8c0c1697918b638a739	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d04592e84be7b8c0c1697918b638a739 .

}

civic-kb:provenance-d04592e84be7b8c0c1697918b638a739 {
	civic-kb:assertion-d04592e84be7b8c0c1697918b638a739 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d04592e84be7b8c0c1697918b638a739 .

	civic-kb:Status-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-d04592e84be7b8c0c1697918b638a739	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d04592e84be7b8c0c1697918b638a739 {
	civic-kb:nanoPub-d04592e84be7b8c0c1697918b638a739 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d04592e84be7b8c0c1697918b638a739
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-39d839636f552b22e4953547f15d2d00 {
	civic-kb:nanoPub-39d839636f552b22e4953547f15d2d00
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-39d839636f552b22e4953547f15d2d00 ;
		np:hasProvenance civic-kb:provenance-39d839636f552b22e4953547f15d2d00 ;
		np:hasPublicationInfo civic-kb:pubInfo-39d839636f552b22e4953547f15d2d00 .
}

civic-kb:assertion-39d839636f552b22e4953547f15d2d00 {
	civic-kb:Drugs-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-39d839636f552b22e4953547f15d2d00 ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib (PD0332991)"^^xsd:string .

	civic-kb:Status-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-39d839636f552b22e4953547f15d2d00 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"rejected"^^xsd:string .

	civic-kb:Evidence_ID-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-39d839636f552b22e4953547f15d2d00 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"345"^^xsd:integer .

	civic-kb:Gene-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18250 ;
		rdf:type	uniprot:P11802 ;
		rdfs:label	"CDK4 Gene"^^xsd:string ;
		sio:hasValue	"CDK4"^^xsd:string .

	civic-kb:Variant-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-39d839636f552b22e4953547f15d2d00 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Palbociclib has been shown to dramatically improve progression-free survival by over 18 months in patients with ER+ Breast Cancer."^^xsd:string .

	civic-kb:Disease-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-39d839636f552b22e4953547f15d2d00 ;
		rdf:type	efo:1000649 ;
		rdf:type	doid:0060075 ;
		rdfs:label	"Estrogen-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-39d839636f552b22e4953547f15d2d00 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-39d839636f552b22e4953547f15d2d00 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-39d839636f552b22e4953547f15d2d00 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-39d839636f552b22e4953547f15d2d00 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-39d839636f552b22e4953547f15d2d00 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-39d839636f552b22e4953547f15d2d00	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-39d839636f552b22e4953547f15d2d00 .

}

civic-kb:provenance-39d839636f552b22e4953547f15d2d00 {
	civic-kb:assertion-39d839636f552b22e4953547f15d2d00 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-39d839636f552b22e4953547f15d2d00 .

	civic-kb:Status-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-39d839636f552b22e4953547f15d2d00	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-39d839636f552b22e4953547f15d2d00 {
	civic-kb:nanoPub-39d839636f552b22e4953547f15d2d00 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-39d839636f552b22e4953547f15d2d00
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f53496c40e6bb5203313c126664eb188 {
	civic-kb:nanoPub-f53496c40e6bb5203313c126664eb188
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f53496c40e6bb5203313c126664eb188 ;
		np:hasProvenance civic-kb:provenance-f53496c40e6bb5203313c126664eb188 ;
		np:hasPublicationInfo civic-kb:pubInfo-f53496c40e6bb5203313c126664eb188 .
}

civic-kb:assertion-f53496c40e6bb5203313c126664eb188 {
	civic-kb:Drugs-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f53496c40e6bb5203313c126664eb188 ;
		sio:hasValue	"Neratinib, Lapatinib"^^xsd:string .

	civic-kb:Status-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f53496c40e6bb5203313c126664eb188 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f53496c40e6bb5203313c126664eb188 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"281"^^xsd:integer .

	civic-kb:Gene-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"DEL 755-759"^^xsd:string .

	civic-kb:Description-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f53496c40e6bb5203313c126664eb188 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In MCF10A cell lines retrovirally transduced with wildtype or mutant ERBB2, cells expressing the in-frame deletion of amino acids 755-759 were shown to be sensitive to neratinib."^^xsd:string .

	civic-kb:Disease-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f53496c40e6bb5203313c126664eb188 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f53496c40e6bb5203313c126664eb188 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f53496c40e6bb5203313c126664eb188 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f53496c40e6bb5203313c126664eb188 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f53496c40e6bb5203313c126664eb188 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f53496c40e6bb5203313c126664eb188 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-f53496c40e6bb5203313c126664eb188	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f53496c40e6bb5203313c126664eb188 .

}

civic-kb:provenance-f53496c40e6bb5203313c126664eb188 {
	civic-kb:assertion-f53496c40e6bb5203313c126664eb188 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f53496c40e6bb5203313c126664eb188 .

	civic-kb:Status-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-f53496c40e6bb5203313c126664eb188	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f53496c40e6bb5203313c126664eb188 {
	civic-kb:nanoPub-f53496c40e6bb5203313c126664eb188 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f53496c40e6bb5203313c126664eb188
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-7dcf3cea2ebeb7e438cf41535ccdfa48 {
	civic-kb:nanoPub-7dcf3cea2ebeb7e438cf41535ccdfa48
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-7dcf3cea2ebeb7e438cf41535ccdfa48 ;
		np:hasProvenance civic-kb:provenance-7dcf3cea2ebeb7e438cf41535ccdfa48 ;
		np:hasPublicationInfo civic-kb:pubInfo-7dcf3cea2ebeb7e438cf41535ccdfa48 .
}

civic-kb:assertion-7dcf3cea2ebeb7e438cf41535ccdfa48 {
	civic-kb:Drugs-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7dcf3cea2ebeb7e438cf41535ccdfa48 .

	civic-kb:Status-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-7dcf3cea2ebeb7e438cf41535ccdfa48 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-7dcf3cea2ebeb7e438cf41535ccdfa48 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1075"^^xsd:integer .

	civic-kb:Gene-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17966 ;
		rdf:type	uniprot:P08183 ;
		rdfs:label	"ABCB1 Gene"^^xsd:string ;
		sio:hasValue	"ABCB1"^^xsd:string .

	civic-kb:Variant-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"S893A/T"^^xsd:string .

	civic-kb:Description-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-7dcf3cea2ebeb7e438cf41535ccdfa48 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A total of 57 women with HER2-positive metastatic breast cancer were analyzed after taxane plus trastuzumab chemotherapy. ABCB1 G2677T carriers had a longer progression-free survival (p = 0.037) along with a tendency toward a longer overall survival (p = 0.057)."^^xsd:string .

	civic-kb:Disease-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7dcf3cea2ebeb7e438cf41535ccdfa48 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-7dcf3cea2ebeb7e438cf41535ccdfa48 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7dcf3cea2ebeb7e438cf41535ccdfa48 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7dcf3cea2ebeb7e438cf41535ccdfa48 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Better Outcome"^^xsd:string .

	civic-kb:Variant_Origin-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-7dcf3cea2ebeb7e438cf41535ccdfa48 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Polymorphism"^^xsd:string .

	civic-kb:Trust_Rating-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-7dcf3cea2ebeb7e438cf41535ccdfa48 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-7dcf3cea2ebeb7e438cf41535ccdfa48	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-7dcf3cea2ebeb7e438cf41535ccdfa48 .

}

civic-kb:provenance-7dcf3cea2ebeb7e438cf41535ccdfa48 {
	civic-kb:assertion-7dcf3cea2ebeb7e438cf41535ccdfa48 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-7dcf3cea2ebeb7e438cf41535ccdfa48 .

	civic-kb:Status-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-7dcf3cea2ebeb7e438cf41535ccdfa48	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-7dcf3cea2ebeb7e438cf41535ccdfa48 {
	civic-kb:nanoPub-7dcf3cea2ebeb7e438cf41535ccdfa48 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-7dcf3cea2ebeb7e438cf41535ccdfa48
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2fa5b1471253b4607a0f9fd52c065a9d {
	civic-kb:nanoPub-2fa5b1471253b4607a0f9fd52c065a9d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2fa5b1471253b4607a0f9fd52c065a9d ;
		np:hasProvenance civic-kb:provenance-2fa5b1471253b4607a0f9fd52c065a9d ;
		np:hasPublicationInfo civic-kb:pubInfo-2fa5b1471253b4607a0f9fd52c065a9d .
}

civic-kb:assertion-2fa5b1471253b4607a0f9fd52c065a9d {
	civic-kb:Drugs-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2fa5b1471253b4607a0f9fd52c065a9d .

	civic-kb:Status-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2fa5b1471253b4607a0f9fd52c065a9d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2fa5b1471253b4607a0f9fd52c065a9d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1085"^^xsd:integer .

	civic-kb:Gene-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38558 ;
		rdf:type	uniprot:P08637 ;
		rdfs:label	"FCGR3A Gene"^^xsd:string ;
		sio:hasValue	"FCGR3A"^^xsd:string .

	civic-kb:Variant-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"F212V"^^xsd:string .

	civic-kb:Description-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2fa5b1471253b4607a0f9fd52c065a9d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A total of 57 women with HER2-positive metastatic breast cancer were analyzed after taxane plus trastuzumab chemotherapy. FCGR3A V158F carriers did not have a significantly different response rate, progression-free survival, or overall survival."^^xsd:string .

	civic-kb:Disease-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2fa5b1471253b4607a0f9fd52c065a9d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2fa5b1471253b4607a0f9fd52c065a9d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2fa5b1471253b4607a0f9fd52c065a9d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2fa5b1471253b4607a0f9fd52c065a9d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string .

	civic-kb:Variant_Origin-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2fa5b1471253b4607a0f9fd52c065a9d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Polymorphism"^^xsd:string .

	civic-kb:Trust_Rating-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2fa5b1471253b4607a0f9fd52c065a9d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-2fa5b1471253b4607a0f9fd52c065a9d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2fa5b1471253b4607a0f9fd52c065a9d .

}

civic-kb:provenance-2fa5b1471253b4607a0f9fd52c065a9d {
	civic-kb:assertion-2fa5b1471253b4607a0f9fd52c065a9d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2fa5b1471253b4607a0f9fd52c065a9d .

	civic-kb:Status-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-2fa5b1471253b4607a0f9fd52c065a9d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2fa5b1471253b4607a0f9fd52c065a9d {
	civic-kb:nanoPub-2fa5b1471253b4607a0f9fd52c065a9d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2fa5b1471253b4607a0f9fd52c065a9d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c89cea41a9c7ada845ab1d4cef32501c {
	civic-kb:nanoPub-c89cea41a9c7ada845ab1d4cef32501c
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c89cea41a9c7ada845ab1d4cef32501c ;
		np:hasProvenance civic-kb:provenance-c89cea41a9c7ada845ab1d4cef32501c ;
		np:hasPublicationInfo civic-kb:pubInfo-c89cea41a9c7ada845ab1d4cef32501c .
}

civic-kb:assertion-c89cea41a9c7ada845ab1d4cef32501c {
	civic-kb:Drugs-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c89cea41a9c7ada845ab1d4cef32501c ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c89cea41a9c7ada845ab1d4cef32501c ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c89cea41a9c7ada845ab1d4cef32501c ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1087"^^xsd:integer .

	civic-kb:Gene-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38558 ;
		rdf:type	uniprot:P08637 ;
		rdfs:label	"FCGR3A Gene"^^xsd:string ;
		sio:hasValue	"FCGR3A"^^xsd:string .

	civic-kb:Variant-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"F212V"^^xsd:string .

	civic-kb:Description-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c89cea41a9c7ada845ab1d4cef32501c ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"1325 HER2-positive breast cancer patients treated with trastuzumab and chemotherapy from the N9831 clinical trial were analyzed. There was no statistically significant difference in disease-free survival between trastuzumab-treated patients who had the FCGR3A 158 V/V high-affinity genotype and patients without that genotype (V/F and F/F)."^^xsd:string .

	civic-kb:Disease-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c89cea41a9c7ada845ab1d4cef32501c ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c89cea41a9c7ada845ab1d4cef32501c ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c89cea41a9c7ada845ab1d4cef32501c ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c89cea41a9c7ada845ab1d4cef32501c ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string .

	civic-kb:Variant_Origin-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c89cea41a9c7ada845ab1d4cef32501c ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Polymorphism"^^xsd:string .

	civic-kb:Trust_Rating-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c89cea41a9c7ada845ab1d4cef32501c ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-c89cea41a9c7ada845ab1d4cef32501c	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c89cea41a9c7ada845ab1d4cef32501c .

}

civic-kb:provenance-c89cea41a9c7ada845ab1d4cef32501c {
	civic-kb:assertion-c89cea41a9c7ada845ab1d4cef32501c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c89cea41a9c7ada845ab1d4cef32501c .

	civic-kb:Status-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-c89cea41a9c7ada845ab1d4cef32501c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c89cea41a9c7ada845ab1d4cef32501c {
	civic-kb:nanoPub-c89cea41a9c7ada845ab1d4cef32501c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c89cea41a9c7ada845ab1d4cef32501c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-0fe6dd53986578fac1d60f564d0c6a20 {
	civic-kb:nanoPub-0fe6dd53986578fac1d60f564d0c6a20
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-0fe6dd53986578fac1d60f564d0c6a20 ;
		np:hasProvenance civic-kb:provenance-0fe6dd53986578fac1d60f564d0c6a20 ;
		np:hasPublicationInfo civic-kb:pubInfo-0fe6dd53986578fac1d60f564d0c6a20 .
}

civic-kb:assertion-0fe6dd53986578fac1d60f564d0c6a20 {
	civic-kb:Drugs-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-0fe6dd53986578fac1d60f564d0c6a20 .

	civic-kb:Status-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-0fe6dd53986578fac1d60f564d0c6a20 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-0fe6dd53986578fac1d60f564d0c6a20 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1086"^^xsd:integer .

	civic-kb:Gene-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38554 ;
		rdf:type	uniprot:P31994 ;
		rdfs:label	"FCGR2B Gene"^^xsd:string ;
		sio:hasValue	"FCGR2B"^^xsd:string .

	civic-kb:Variant-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"I232T"^^xsd:string .

	civic-kb:Description-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-0fe6dd53986578fac1d60f564d0c6a20 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"1325 HER2-positive breast cancer patients treated with trastuzumab and chemotherapy from the N9831 clinical trial were analyzed. There was a difference in disease-free survival for FCGR2B I232T, with I/I patients deriving benefit from trastuzumab (p<0.001) compared to the T carriers who did not (p=0.81). The interaction between FCGR2B genotype and treatment was statistically significant (p=0.03)."^^xsd:string .

	civic-kb:Disease-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-0fe6dd53986578fac1d60f564d0c6a20 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-0fe6dd53986578fac1d60f564d0c6a20 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-0fe6dd53986578fac1d60f564d0c6a20 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-0fe6dd53986578fac1d60f564d0c6a20 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-0fe6dd53986578fac1d60f564d0c6a20 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Polymorphism"^^xsd:string .

	civic-kb:Trust_Rating-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-0fe6dd53986578fac1d60f564d0c6a20 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-0fe6dd53986578fac1d60f564d0c6a20	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-0fe6dd53986578fac1d60f564d0c6a20 .

}

civic-kb:provenance-0fe6dd53986578fac1d60f564d0c6a20 {
	civic-kb:assertion-0fe6dd53986578fac1d60f564d0c6a20 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-0fe6dd53986578fac1d60f564d0c6a20 .

	civic-kb:Status-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-0fe6dd53986578fac1d60f564d0c6a20	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-0fe6dd53986578fac1d60f564d0c6a20 {
	civic-kb:nanoPub-0fe6dd53986578fac1d60f564d0c6a20 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-0fe6dd53986578fac1d60f564d0c6a20
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-e3cabb8c1d2d7bae2edd116bf71ae44a {
	civic-kb:nanoPub-e3cabb8c1d2d7bae2edd116bf71ae44a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-e3cabb8c1d2d7bae2edd116bf71ae44a ;
		np:hasProvenance civic-kb:provenance-e3cabb8c1d2d7bae2edd116bf71ae44a ;
		np:hasPublicationInfo civic-kb:pubInfo-e3cabb8c1d2d7bae2edd116bf71ae44a .
}

civic-kb:assertion-e3cabb8c1d2d7bae2edd116bf71ae44a {
	civic-kb:Drugs-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-e3cabb8c1d2d7bae2edd116bf71ae44a .

	civic-kb:Status-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-e3cabb8c1d2d7bae2edd116bf71ae44a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-e3cabb8c1d2d7bae2edd116bf71ae44a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1111"^^xsd:integer .

	civic-kb:Gene-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C116930 ;
		rdf:type	uniprot:O75771 ;
		rdfs:label	"RAD51D Gene"^^xsd:string ;
		sio:hasValue	"RAD51D"^^xsd:string .

	civic-kb:Variant-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R186*"^^xsd:string .

	civic-kb:Description-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-e3cabb8c1d2d7bae2edd116bf71ae44a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A healthy, 36-year-old woman presented with a palpable right breast mass upon biopsy determined to be high-grade, triple negative invasive ductal carcinoma. Her family history was notable for multiple relatives on her maternal side with breast cancer, including a distant male relative with breast cancer. Multigene panel testing with an 18-gene panel revealed a germline truncating pathogenic mutation in RAD51D (p.R186X; c. 556C>T)."^^xsd:string .

	civic-kb:Disease-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-e3cabb8c1d2d7bae2edd116bf71ae44a ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-e3cabb8c1d2d7bae2edd116bf71ae44a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-e3cabb8c1d2d7bae2edd116bf71ae44a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predisposing"^^xsd:string .

	civic-kb:Evidence_Direction-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-e3cabb8c1d2d7bae2edd116bf71ae44a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string .

	civic-kb:Variant_Origin-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-e3cabb8c1d2d7bae2edd116bf71ae44a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-e3cabb8c1d2d7bae2edd116bf71ae44a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-e3cabb8c1d2d7bae2edd116bf71ae44a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-e3cabb8c1d2d7bae2edd116bf71ae44a .

}

civic-kb:provenance-e3cabb8c1d2d7bae2edd116bf71ae44a {
	civic-kb:assertion-e3cabb8c1d2d7bae2edd116bf71ae44a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-e3cabb8c1d2d7bae2edd116bf71ae44a .

	civic-kb:Status-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-e3cabb8c1d2d7bae2edd116bf71ae44a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-e3cabb8c1d2d7bae2edd116bf71ae44a {
	civic-kb:nanoPub-e3cabb8c1d2d7bae2edd116bf71ae44a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-e3cabb8c1d2d7bae2edd116bf71ae44a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2a2e94142036500b20367e8ed6526225 {
	civic-kb:nanoPub-2a2e94142036500b20367e8ed6526225
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2a2e94142036500b20367e8ed6526225 ;
		np:hasProvenance civic-kb:provenance-2a2e94142036500b20367e8ed6526225 ;
		np:hasPublicationInfo civic-kb:pubInfo-2a2e94142036500b20367e8ed6526225 .
}

civic-kb:assertion-2a2e94142036500b20367e8ed6526225 {
	civic-kb:Drugs-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2a2e94142036500b20367e8ed6526225 ;
		rdf:type	db:DB11760 ;
		rdfs:label	"Talazoparib"^^xsd:string ;
		sio:hasValue	"Talazoparib"^^xsd:string .

	civic-kb:Status-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2a2e94142036500b20367e8ed6526225 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2a2e94142036500b20367e8ed6526225 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4834"^^xsd:integer .

	civic-kb:Gene-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C122750 ;
		rdf:type	uniprot:P55036 ;
		rdfs:label	"PSMD4 Gene"^^xsd:string ;
		sio:hasValue	"PSMD4"^^xsd:string .

	civic-kb:Variant-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2a2e94142036500b20367e8ed6526225 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Current randomized Phase III trials of PARPi in metastatic breast cancer are limited to patients with BRCA1/2 mutations, no biomarker of PARPi beyond BRCA status is available. we created a cell line (HCC1187/TALRES) resistant to the PARP1 inhibitor talazoparib. Herein we show by array-CGH that HCC1187/TALRES has a selective loss of the proteasome ubiquitin receptor PSMD4 amplicon resulting in significant down-regulation of PSMD4. Conversely, we find that breast cancer cell lines that have copy number gain or amplification for PSMD4 are significantly more sensitive to talazoparib. We provide evidence that PSMD4 is a proteasomal amplification target in breast cancer that PSMD4 amplification confers sensitivity to PARP inhibition, and that PSMD4 amplification is lost in the process of acquiring resistance to PARPi."^^xsd:string .

	civic-kb:Disease-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2a2e94142036500b20367e8ed6526225 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2a2e94142036500b20367e8ed6526225 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2a2e94142036500b20367e8ed6526225 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2a2e94142036500b20367e8ed6526225 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2a2e94142036500b20367e8ed6526225 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2a2e94142036500b20367e8ed6526225 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-2a2e94142036500b20367e8ed6526225	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2a2e94142036500b20367e8ed6526225 .

}

civic-kb:provenance-2a2e94142036500b20367e8ed6526225 {
	civic-kb:assertion-2a2e94142036500b20367e8ed6526225 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2a2e94142036500b20367e8ed6526225 .

	civic-kb:Status-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-2a2e94142036500b20367e8ed6526225	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2a2e94142036500b20367e8ed6526225 {
	civic-kb:nanoPub-2a2e94142036500b20367e8ed6526225 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2a2e94142036500b20367e8ed6526225
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ac84cb5d57536e29370ead210834b4e5 {
	civic-kb:nanoPub-ac84cb5d57536e29370ead210834b4e5
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ac84cb5d57536e29370ead210834b4e5 ;
		np:hasProvenance civic-kb:provenance-ac84cb5d57536e29370ead210834b4e5 ;
		np:hasPublicationInfo civic-kb:pubInfo-ac84cb5d57536e29370ead210834b4e5 .
}

civic-kb:assertion-ac84cb5d57536e29370ead210834b4e5 {
	civic-kb:Drugs-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ac84cb5d57536e29370ead210834b4e5 ;
		rdf:type	db:DB12001 ;
		rdfs:label	"Abemaciclib"^^xsd:string ;
		sio:hasValue	"Abemaciclib"^^xsd:string .

	civic-kb:Status-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ac84cb5d57536e29370ead210834b4e5 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ac84cb5d57536e29370ead210834b4e5 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4843"^^xsd:integer .

	civic-kb:Gene-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C97384 ;
		rdf:type	uniprot:Q00534 ;
		rdfs:label	"CDK6 Gene"^^xsd:string ;
		sio:hasValue	"CDK6"^^xsd:string .

	civic-kb:Variant-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ac84cb5d57536e29370ead210834b4e5 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Inhibitors of CDK4/6 complex have advanced in clinic and have shown significant activity, particularly against tumors driven by the estrogen receptor (ER). Consecutively resistance to these agents has emerged.  After prolonged exposure to the selective and potent CDK4/6 inhibitor Acemaciclib (LY2835219) clones emerged and several were found to harbor amplification of the CDK6 kinase. Amplification of CDK6 resulted in a marked increase in CDK6 expression and reduced response of the CDK4/6 target, phospho-Rb (pRb), to CDK4/6 inhibitors. Knockdown of CDK6 restored drug sensitivity, while enforced overexpression of CDK6 was sufficient to mediate drug resistance. Furthermore, CDK6 amplification lead to reduced expression of the ER and progesterone receptor (PR), and diminished responsiveness to ER antagonism. The reduced ER/PR expression after CDK4/6 inhibitor resistance was additionally observed in tumor biopsy specimens from patients treated with these drugs. Alternative mechanisms of resistance to CDK4/6 inhibitors such as loss of pRb and cyclin E1 overexpression also exhibited decreased hormone responsiveness."^^xsd:string .

	civic-kb:Disease-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ac84cb5d57536e29370ead210834b4e5 ;
		rdf:type	efo:1000649 ;
		rdf:type	doid:0060075 ;
		rdfs:label	"Estrogen-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ac84cb5d57536e29370ead210834b4e5 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ac84cb5d57536e29370ead210834b4e5 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ac84cb5d57536e29370ead210834b4e5 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ac84cb5d57536e29370ead210834b4e5 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ac84cb5d57536e29370ead210834b4e5 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-ac84cb5d57536e29370ead210834b4e5	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ac84cb5d57536e29370ead210834b4e5 .

}

civic-kb:provenance-ac84cb5d57536e29370ead210834b4e5 {
	civic-kb:assertion-ac84cb5d57536e29370ead210834b4e5 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ac84cb5d57536e29370ead210834b4e5 .

	civic-kb:Status-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ac84cb5d57536e29370ead210834b4e5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ac84cb5d57536e29370ead210834b4e5 {
	civic-kb:nanoPub-ac84cb5d57536e29370ead210834b4e5 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ac84cb5d57536e29370ead210834b4e5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c69ec6fb85b16dc84f25d6c0092f5b49 {
	civic-kb:nanoPub-c69ec6fb85b16dc84f25d6c0092f5b49
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c69ec6fb85b16dc84f25d6c0092f5b49 ;
		np:hasProvenance civic-kb:provenance-c69ec6fb85b16dc84f25d6c0092f5b49 ;
		np:hasPublicationInfo civic-kb:pubInfo-c69ec6fb85b16dc84f25d6c0092f5b49 .
}

civic-kb:assertion-c69ec6fb85b16dc84f25d6c0092f5b49 {
	civic-kb:Drugs-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c69ec6fb85b16dc84f25d6c0092f5b49 .

	civic-kb:Status-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c69ec6fb85b16dc84f25d6c0092f5b49 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c69ec6fb85b16dc84f25d6c0092f5b49 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"5918"^^xsd:integer .

	civic-kb:Gene-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C104620 ;
		rdf:type	uniprot:P18627 ;
		rdfs:label	"LAG3 Gene"^^xsd:string ;
		sio:hasValue	"LAG3"^^xsd:string .

	civic-kb:Variant-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c69ec6fb85b16dc84f25d6c0092f5b49 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"LAG-3+ iTILs are enriched in estrogen receptor-negative breast cancers and represent an independent favorable prognostic factor."^^xsd:string .

	civic-kb:Disease-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c69ec6fb85b16dc84f25d6c0092f5b49 ;
		rdf:type	efo:1000650 ;
		rdf:type	doid:0060076 ;
		rdfs:label	"Estrogen-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c69ec6fb85b16dc84f25d6c0092f5b49 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c69ec6fb85b16dc84f25d6c0092f5b49 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c69ec6fb85b16dc84f25d6c0092f5b49 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Better Outcome"^^xsd:string .

	civic-kb:Variant_Origin-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c69ec6fb85b16dc84f25d6c0092f5b49 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c69ec6fb85b16dc84f25d6c0092f5b49 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-c69ec6fb85b16dc84f25d6c0092f5b49	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c69ec6fb85b16dc84f25d6c0092f5b49 .

}

civic-kb:provenance-c69ec6fb85b16dc84f25d6c0092f5b49 {
	civic-kb:assertion-c69ec6fb85b16dc84f25d6c0092f5b49 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c69ec6fb85b16dc84f25d6c0092f5b49 .

	civic-kb:Status-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-c69ec6fb85b16dc84f25d6c0092f5b49	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c69ec6fb85b16dc84f25d6c0092f5b49 {
	civic-kb:nanoPub-c69ec6fb85b16dc84f25d6c0092f5b49 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c69ec6fb85b16dc84f25d6c0092f5b49
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-6897bff33cf0038200ea5f2544f5dd1b {
	civic-kb:nanoPub-6897bff33cf0038200ea5f2544f5dd1b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-6897bff33cf0038200ea5f2544f5dd1b ;
		np:hasProvenance civic-kb:provenance-6897bff33cf0038200ea5f2544f5dd1b ;
		np:hasPublicationInfo civic-kb:pubInfo-6897bff33cf0038200ea5f2544f5dd1b .
}

civic-kb:assertion-6897bff33cf0038200ea5f2544f5dd1b {
	civic-kb:Drugs-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6897bff33cf0038200ea5f2544f5dd1b ;
		sio:hasValue	"CX-5461, CX-3543"^^xsd:string .

	civic-kb:Status-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-6897bff33cf0038200ea5f2544f5dd1b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-6897bff33cf0038200ea5f2544f5dd1b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1924"^^xsd:integer .

	civic-kb:Gene-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17965 ;
		rdf:type	uniprot:P38398 ;
		rdfs:label	"BRCA1 Gene"^^xsd:string ;
		sio:hasValue	"BRCA1"^^xsd:string .

	civic-kb:Variant-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss of Function"^^xsd:string ;
		sio:hasValue	"LOSS-OF-FUNCTION"^^xsd:string .

	civic-kb:Description-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-6897bff33cf0038200ea5f2544f5dd1b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The authors show that in the CX-5461 and CX-3543, G-quadruplex stabilizing agents, demonstrate specific toxicity against BRCA deficient breast cancer derived cells and polyclonal patient-derived xenograft models. Xenografts harbored both a germline BRCA and a somatic BRCA mutation leading to disruption of both. The BRCA and NHEJ pathways are required for the repair of CX-5461 and CX-3543-induced DNA damage and failure to do so leads to lethality."^^xsd:string .

	civic-kb:Disease-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6897bff33cf0038200ea5f2544f5dd1b ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-6897bff33cf0038200ea5f2544f5dd1b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6897bff33cf0038200ea5f2544f5dd1b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6897bff33cf0038200ea5f2544f5dd1b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-6897bff33cf0038200ea5f2544f5dd1b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Unknown"^^xsd:string .

	civic-kb:Trust_Rating-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-6897bff33cf0038200ea5f2544f5dd1b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-6897bff33cf0038200ea5f2544f5dd1b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-6897bff33cf0038200ea5f2544f5dd1b .

}

civic-kb:provenance-6897bff33cf0038200ea5f2544f5dd1b {
	civic-kb:assertion-6897bff33cf0038200ea5f2544f5dd1b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-6897bff33cf0038200ea5f2544f5dd1b .

	civic-kb:Status-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-6897bff33cf0038200ea5f2544f5dd1b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-6897bff33cf0038200ea5f2544f5dd1b {
	civic-kb:nanoPub-6897bff33cf0038200ea5f2544f5dd1b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-6897bff33cf0038200ea5f2544f5dd1b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-82c027211a85ffe6152c3b4d8434a1c2 {
	civic-kb:nanoPub-82c027211a85ffe6152c3b4d8434a1c2
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-82c027211a85ffe6152c3b4d8434a1c2 ;
		np:hasProvenance civic-kb:provenance-82c027211a85ffe6152c3b4d8434a1c2 ;
		np:hasPublicationInfo civic-kb:pubInfo-82c027211a85ffe6152c3b4d8434a1c2 .
}

civic-kb:assertion-82c027211a85ffe6152c3b4d8434a1c2 {
	civic-kb:Drugs-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-82c027211a85ffe6152c3b4d8434a1c2 ;
		rdf:type	db:DB11760 ;
		rdfs:label	"Talazoparib"^^xsd:string ;
		sio:hasValue	"Talazoparib"^^xsd:string .

	civic-kb:Status-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-82c027211a85ffe6152c3b4d8434a1c2 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-82c027211a85ffe6152c3b4d8434a1c2 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4838"^^xsd:integer .

	civic-kb:Gene-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17965 ;
		rdf:type	uniprot:P38398 ;
		rdfs:label	"BRCA1 Gene"^^xsd:string ;
		sio:hasValue	"BRCA1"^^xsd:string .

	civic-kb:Variant-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss of Function"^^xsd:string ;
		sio:hasValue	"LOSS-OF-FUNCTION"^^xsd:string .

	civic-kb:Description-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-82c027211a85ffe6152c3b4d8434a1c2 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In part 2 of a two-part dose-escalation phase I trial (NCT01286987), 71 patients with Ewings sarcoma, breast, ovarian, small cell lung, or pancreatic cancers received 1.0 mg/day talazoparib treatment. Of patients with BRCA mutation-associated breast and ovarian cancers, confirmed responses were observed in 7 of 14 (50%) and 5 of 12 (42%) patients, respectively."^^xsd:string .

	civic-kb:Disease-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-82c027211a85ffe6152c3b4d8434a1c2 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-82c027211a85ffe6152c3b4d8434a1c2 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-82c027211a85ffe6152c3b4d8434a1c2 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-82c027211a85ffe6152c3b4d8434a1c2 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-82c027211a85ffe6152c3b4d8434a1c2 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-82c027211a85ffe6152c3b4d8434a1c2 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-82c027211a85ffe6152c3b4d8434a1c2	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-82c027211a85ffe6152c3b4d8434a1c2 .

}

civic-kb:provenance-82c027211a85ffe6152c3b4d8434a1c2 {
	civic-kb:assertion-82c027211a85ffe6152c3b4d8434a1c2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-82c027211a85ffe6152c3b4d8434a1c2 .

	civic-kb:Status-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-82c027211a85ffe6152c3b4d8434a1c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-82c027211a85ffe6152c3b4d8434a1c2 {
	civic-kb:nanoPub-82c027211a85ffe6152c3b4d8434a1c2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-82c027211a85ffe6152c3b4d8434a1c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2f3a816ff2a7cd71191ce17206bc990a {
	civic-kb:nanoPub-2f3a816ff2a7cd71191ce17206bc990a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2f3a816ff2a7cd71191ce17206bc990a ;
		np:hasProvenance civic-kb:provenance-2f3a816ff2a7cd71191ce17206bc990a ;
		np:hasPublicationInfo civic-kb:pubInfo-2f3a816ff2a7cd71191ce17206bc990a .
}

civic-kb:assertion-2f3a816ff2a7cd71191ce17206bc990a {
	civic-kb:Drugs-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2f3a816ff2a7cd71191ce17206bc990a ;
		rdf:type	dron:00730843 ;
		rdf:type	db:DB09074 ;
		rdfs:label	"Olaparib"^^xsd:string ;
		sio:hasValue	"Olaparib"^^xsd:string .

	civic-kb:Status-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2f3a816ff2a7cd71191ce17206bc990a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2f3a816ff2a7cd71191ce17206bc990a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"5815"^^xsd:integer .

	civic-kb:Gene-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17965 ;
		rdf:type	uniprot:P38398 ;
		rdfs:label	"BRCA1 Gene"^^xsd:string ;
		sio:hasValue	"BRCA1"^^xsd:string .

	civic-kb:Variant-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss of Function"^^xsd:string ;
		sio:hasValue	"LOSS-OF-FUNCTION"^^xsd:string .

	civic-kb:Description-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2f3a816ff2a7cd71191ce17206bc990a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"302 patients (234 with progression events) with HER2-negative metastatic breast cancer and with a confirmed deleterious or suspected deleterious germline BRCA mutation (164 BRCA1, 129 BRCA2) had significantly improved progression-free survival and better response rate to olaparib (PARP inhibitor) than standard therapy (7.0 mo vs 4.2 mo, hazard ratio 0.58, 95% CI 0.43-0.8) in this randomized phase 3 trial (NCT02000622). For BRCA1 patients specifically, the hazard ratio was 0.54, 95% CI 0.37-0.79)."^^xsd:string .

	civic-kb:Disease-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2f3a816ff2a7cd71191ce17206bc990a ;
		rdf:type	doid:0060080 ;
		rdfs:label	"Her2-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2f3a816ff2a7cd71191ce17206bc990a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2f3a816ff2a7cd71191ce17206bc990a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2f3a816ff2a7cd71191ce17206bc990a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2f3a816ff2a7cd71191ce17206bc990a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2f3a816ff2a7cd71191ce17206bc990a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-2f3a816ff2a7cd71191ce17206bc990a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2f3a816ff2a7cd71191ce17206bc990a .

}

civic-kb:provenance-2f3a816ff2a7cd71191ce17206bc990a {
	civic-kb:assertion-2f3a816ff2a7cd71191ce17206bc990a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2f3a816ff2a7cd71191ce17206bc990a .

	civic-kb:Status-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-2f3a816ff2a7cd71191ce17206bc990a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2f3a816ff2a7cd71191ce17206bc990a {
	civic-kb:nanoPub-2f3a816ff2a7cd71191ce17206bc990a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2f3a816ff2a7cd71191ce17206bc990a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-99434980677652e1f560b28f51c519f6 {
	civic-kb:nanoPub-99434980677652e1f560b28f51c519f6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-99434980677652e1f560b28f51c519f6 ;
		np:hasProvenance civic-kb:provenance-99434980677652e1f560b28f51c519f6 ;
		np:hasPublicationInfo civic-kb:pubInfo-99434980677652e1f560b28f51c519f6 .
}

civic-kb:assertion-99434980677652e1f560b28f51c519f6 {
	civic-kb:Drugs-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-99434980677652e1f560b28f51c519f6 ;
		rdf:type	chebi:41774 ;
		rdf:type	db:DB00675 ;
		rdfs:label	"Tamoxifen"^^xsd:string ;
		sio:hasValue	"Tamoxifen"^^xsd:string .

	civic-kb:Status-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-99434980677652e1f560b28f51c519f6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-99434980677652e1f560b28f51c519f6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1959"^^xsd:integer .

	civic-kb:Gene-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C24838 ;
		rdf:type	uniprot:O14965 ;
		rdfs:label	"AURKA Gene"^^xsd:string ;
		sio:hasValue	"AURKA"^^xsd:string .

	civic-kb:Variant-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-99434980677652e1f560b28f51c519f6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-99434980677652e1f560b28f51c519f6 ;
		rdf:type	efo:1000649 ;
		rdf:type	doid:0060075 ;
		rdfs:label	"Estrogen-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-99434980677652e1f560b28f51c519f6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-99434980677652e1f560b28f51c519f6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-99434980677652e1f560b28f51c519f6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-99434980677652e1f560b28f51c519f6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-99434980677652e1f560b28f51c519f6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-99434980677652e1f560b28f51c519f6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-99434980677652e1f560b28f51c519f6 .

}

civic-kb:provenance-99434980677652e1f560b28f51c519f6 {
	civic-kb:assertion-99434980677652e1f560b28f51c519f6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-99434980677652e1f560b28f51c519f6 .

	civic-kb:Status-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-99434980677652e1f560b28f51c519f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-99434980677652e1f560b28f51c519f6 {
	civic-kb:nanoPub-99434980677652e1f560b28f51c519f6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-99434980677652e1f560b28f51c519f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-eb9ffd9330c6886977ac8fd641c0dba6 {
	civic-kb:nanoPub-eb9ffd9330c6886977ac8fd641c0dba6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-eb9ffd9330c6886977ac8fd641c0dba6 ;
		np:hasProvenance civic-kb:provenance-eb9ffd9330c6886977ac8fd641c0dba6 ;
		np:hasPublicationInfo civic-kb:pubInfo-eb9ffd9330c6886977ac8fd641c0dba6 .
}

civic-kb:assertion-eb9ffd9330c6886977ac8fd641c0dba6 {
	civic-kb:Drugs-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-eb9ffd9330c6886977ac8fd641c0dba6 ;
		rdf:type	db:DB00997 ;
		rdfs:label	"Doxorubicin"^^xsd:string ;
		sio:hasValue	"Doxorubicin"^^xsd:string .

	civic-kb:Status-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-eb9ffd9330c6886977ac8fd641c0dba6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-eb9ffd9330c6886977ac8fd641c0dba6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"851"^^xsd:integer .

	civic-kb:Gene-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-eb9ffd9330c6886977ac8fd641c0dba6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In this preclinical study, MMTV-Wnt1 mammary tumors with mutant TP53 showed a better clinical response to chemotherapy (doxorubicin) than TP53 wild-type tumors. This was mediated by wild-type TP53-induced cell-arrest under chemotherapy even in the context of heterozygous TP53 point mutations or absence of p21. Thus the status of both TP53 alleles should be assessed because even one copy of wild-type TP53 may contribute to poor response to chemotherapy."^^xsd:string .

	civic-kb:Disease-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-eb9ffd9330c6886977ac8fd641c0dba6 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-eb9ffd9330c6886977ac8fd641c0dba6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-eb9ffd9330c6886977ac8fd641c0dba6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-eb9ffd9330c6886977ac8fd641c0dba6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-eb9ffd9330c6886977ac8fd641c0dba6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-eb9ffd9330c6886977ac8fd641c0dba6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-eb9ffd9330c6886977ac8fd641c0dba6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-eb9ffd9330c6886977ac8fd641c0dba6 .

}

civic-kb:provenance-eb9ffd9330c6886977ac8fd641c0dba6 {
	civic-kb:assertion-eb9ffd9330c6886977ac8fd641c0dba6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-eb9ffd9330c6886977ac8fd641c0dba6 .

	civic-kb:Status-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-eb9ffd9330c6886977ac8fd641c0dba6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-eb9ffd9330c6886977ac8fd641c0dba6 {
	civic-kb:nanoPub-eb9ffd9330c6886977ac8fd641c0dba6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-eb9ffd9330c6886977ac8fd641c0dba6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-b95f0652392e3d92e3a720ad2810a2ff {
	civic-kb:nanoPub-b95f0652392e3d92e3a720ad2810a2ff
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-b95f0652392e3d92e3a720ad2810a2ff ;
		np:hasProvenance civic-kb:provenance-b95f0652392e3d92e3a720ad2810a2ff ;
		np:hasPublicationInfo civic-kb:pubInfo-b95f0652392e3d92e3a720ad2810a2ff .
}

civic-kb:assertion-b95f0652392e3d92e3a720ad2810a2ff {
	civic-kb:Drugs-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b95f0652392e3d92e3a720ad2810a2ff ;
		rdf:type	chebi:41774 ;
		rdf:type	db:DB00675 ;
		rdfs:label	"Tamoxifen"^^xsd:string ;
		sio:hasValue	"Tamoxifen"^^xsd:string .

	civic-kb:Status-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-b95f0652392e3d92e3a720ad2810a2ff ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-b95f0652392e3d92e3a720ad2810a2ff ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2784"^^xsd:integer .

	civic-kb:Gene-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-b95f0652392e3d92e3a720ad2810a2ff ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a study 202 breast cancer patients undergoing tamoxifen treatment, a higher frequency of wildtype TP53 patients responded to treatment compared to those with mutations in TP53 (66% wild-type vs. 31%, odds ratio (OR):0.22, 95CI:0.12-0.42, P<0.0001, univariate analysis; OR:0.29, 95% CI:0.12-0.42, P=0.0014, multivariate analysis). The median survival after start of therapy was shorter in patients with mutations in TP53 than for patients with wild-type TP53 (20mo vs. 29mo, HR:1.99,95% CI:1.43-2.75, P<0.001). Breast cancer patients with TP53 mutations also had a decrease in progression-free survival (HR:2.61, 95% CI:1.90-3.6, P<0.001)."^^xsd:string .

	civic-kb:Disease-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b95f0652392e3d92e3a720ad2810a2ff ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-b95f0652392e3d92e3a720ad2810a2ff ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b95f0652392e3d92e3a720ad2810a2ff ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b95f0652392e3d92e3a720ad2810a2ff ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-b95f0652392e3d92e3a720ad2810a2ff ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-b95f0652392e3d92e3a720ad2810a2ff ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"1"^^xsd:integer .

	civic-kb:evidence-b95f0652392e3d92e3a720ad2810a2ff	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-b95f0652392e3d92e3a720ad2810a2ff .

}

civic-kb:provenance-b95f0652392e3d92e3a720ad2810a2ff {
	civic-kb:assertion-b95f0652392e3d92e3a720ad2810a2ff prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-b95f0652392e3d92e3a720ad2810a2ff .

	civic-kb:Status-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-b95f0652392e3d92e3a720ad2810a2ff	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-b95f0652392e3d92e3a720ad2810a2ff {
	civic-kb:nanoPub-b95f0652392e3d92e3a720ad2810a2ff prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-b95f0652392e3d92e3a720ad2810a2ff
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ca0c68c4a12f6f5ed5e37983bb33854e {
	civic-kb:nanoPub-ca0c68c4a12f6f5ed5e37983bb33854e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ca0c68c4a12f6f5ed5e37983bb33854e ;
		np:hasProvenance civic-kb:provenance-ca0c68c4a12f6f5ed5e37983bb33854e ;
		np:hasPublicationInfo civic-kb:pubInfo-ca0c68c4a12f6f5ed5e37983bb33854e .
}

civic-kb:assertion-ca0c68c4a12f6f5ed5e37983bb33854e {
	civic-kb:Drugs-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ca0c68c4a12f6f5ed5e37983bb33854e ;
		rdf:type	db:DB11828 ;
		rdfs:label	"Neratinib"^^xsd:string ;
		sio:hasValue	"Neratinib"^^xsd:string .

	civic-kb:Status-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ca0c68c4a12f6f5ed5e37983bb33854e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ca0c68c4a12f6f5ed5e37983bb33854e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"282"^^xsd:integer .

	civic-kb:Gene-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"G309A"^^xsd:string .

	civic-kb:Description-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ca0c68c4a12f6f5ed5e37983bb33854e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In MCF10A cell lines, the G309A mutation was shown to be sensitive to neratinib."^^xsd:string .

	civic-kb:Disease-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ca0c68c4a12f6f5ed5e37983bb33854e ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ca0c68c4a12f6f5ed5e37983bb33854e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ca0c68c4a12f6f5ed5e37983bb33854e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ca0c68c4a12f6f5ed5e37983bb33854e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ca0c68c4a12f6f5ed5e37983bb33854e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ca0c68c4a12f6f5ed5e37983bb33854e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-ca0c68c4a12f6f5ed5e37983bb33854e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ca0c68c4a12f6f5ed5e37983bb33854e .

}

civic-kb:provenance-ca0c68c4a12f6f5ed5e37983bb33854e {
	civic-kb:assertion-ca0c68c4a12f6f5ed5e37983bb33854e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ca0c68c4a12f6f5ed5e37983bb33854e .

	civic-kb:Status-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ca0c68c4a12f6f5ed5e37983bb33854e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ca0c68c4a12f6f5ed5e37983bb33854e {
	civic-kb:nanoPub-ca0c68c4a12f6f5ed5e37983bb33854e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ca0c68c4a12f6f5ed5e37983bb33854e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-fa8f70e4652b5eb5eef3951a61a3db8e {
	civic-kb:nanoPub-fa8f70e4652b5eb5eef3951a61a3db8e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-fa8f70e4652b5eb5eef3951a61a3db8e ;
		np:hasProvenance civic-kb:provenance-fa8f70e4652b5eb5eef3951a61a3db8e ;
		np:hasPublicationInfo civic-kb:pubInfo-fa8f70e4652b5eb5eef3951a61a3db8e .
}

civic-kb:assertion-fa8f70e4652b5eb5eef3951a61a3db8e {
	civic-kb:Drugs-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fa8f70e4652b5eb5eef3951a61a3db8e ;
		rdf:type	db:DB11828 ;
		rdfs:label	"Neratinib"^^xsd:string ;
		sio:hasValue	"Neratinib"^^xsd:string .

	civic-kb:Status-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-fa8f70e4652b5eb5eef3951a61a3db8e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-fa8f70e4652b5eb5eef3951a61a3db8e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"287"^^xsd:integer .

	civic-kb:Gene-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R896C"^^xsd:string .

	civic-kb:Description-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-fa8f70e4652b5eb5eef3951a61a3db8e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In MCF10A cell lines, the R896C mutation was shown to be sensitive to neratinib."^^xsd:string .

	civic-kb:Disease-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fa8f70e4652b5eb5eef3951a61a3db8e ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-fa8f70e4652b5eb5eef3951a61a3db8e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fa8f70e4652b5eb5eef3951a61a3db8e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fa8f70e4652b5eb5eef3951a61a3db8e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-fa8f70e4652b5eb5eef3951a61a3db8e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-fa8f70e4652b5eb5eef3951a61a3db8e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-fa8f70e4652b5eb5eef3951a61a3db8e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-fa8f70e4652b5eb5eef3951a61a3db8e .

}

civic-kb:provenance-fa8f70e4652b5eb5eef3951a61a3db8e {
	civic-kb:assertion-fa8f70e4652b5eb5eef3951a61a3db8e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-fa8f70e4652b5eb5eef3951a61a3db8e .

	civic-kb:Status-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-fa8f70e4652b5eb5eef3951a61a3db8e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-fa8f70e4652b5eb5eef3951a61a3db8e {
	civic-kb:nanoPub-fa8f70e4652b5eb5eef3951a61a3db8e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-fa8f70e4652b5eb5eef3951a61a3db8e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d4570b3bf0c822a4ee230aeb4f089ad9 {
	civic-kb:nanoPub-d4570b3bf0c822a4ee230aeb4f089ad9
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		np:hasProvenance civic-kb:provenance-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		np:hasPublicationInfo civic-kb:pubInfo-d4570b3bf0c822a4ee230aeb4f089ad9 .
}

civic-kb:assertion-d4570b3bf0c822a4ee230aeb4f089ad9 {
	civic-kb:Drugs-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		sio:hasValue	"Aminoglutethimide, Tamoxifen"^^xsd:string .

	civic-kb:Status-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"823"^^xsd:integer .

	civic-kb:Gene-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C101769 ;
		rdf:type	uniprot:Q07654 ;
		rdfs:label	"TFF3 Gene"^^xsd:string ;
		sio:hasValue	"TFF3"^^xsd:string .

	civic-kb:Variant-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"TFF3 expression was assessed by IHC in 75 patients, 187 patients were identified for the validation cohort. TFF3 expression was associated with response to endocrine therapy (tamoxifen, aminoglutethimide or oophorectomy) and outperformed ER, PR and TFF1 as biomarkers."^^xsd:string .

	civic-kb:Disease-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d4570b3bf0c822a4ee230aeb4f089ad9 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-d4570b3bf0c822a4ee230aeb4f089ad9	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d4570b3bf0c822a4ee230aeb4f089ad9 .

}

civic-kb:provenance-d4570b3bf0c822a4ee230aeb4f089ad9 {
	civic-kb:assertion-d4570b3bf0c822a4ee230aeb4f089ad9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d4570b3bf0c822a4ee230aeb4f089ad9 .

	civic-kb:Status-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-d4570b3bf0c822a4ee230aeb4f089ad9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d4570b3bf0c822a4ee230aeb4f089ad9 {
	civic-kb:nanoPub-d4570b3bf0c822a4ee230aeb4f089ad9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d4570b3bf0c822a4ee230aeb4f089ad9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-479f5225393db9d93b8043ef81c7c897 {
	civic-kb:nanoPub-479f5225393db9d93b8043ef81c7c897
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-479f5225393db9d93b8043ef81c7c897 ;
		np:hasProvenance civic-kb:provenance-479f5225393db9d93b8043ef81c7c897 ;
		np:hasPublicationInfo civic-kb:pubInfo-479f5225393db9d93b8043ef81c7c897 .
}

civic-kb:assertion-479f5225393db9d93b8043ef81c7c897 {
	civic-kb:Drugs-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-479f5225393db9d93b8043ef81c7c897 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-479f5225393db9d93b8043ef81c7c897 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-479f5225393db9d93b8043ef81c7c897 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"867"^^xsd:integer .

	civic-kb:Gene-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18388 ;
		rdf:type	uniprot:Q15303 ;
		rdfs:label	"ERBB4 Gene"^^xsd:string ;
		sio:hasValue	"ERBB4"^^xsd:string .

	civic-kb:Variant-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"NUCLEAR TRANSLOCATION"^^xsd:string .

	civic-kb:Description-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-479f5225393db9d93b8043ef81c7c897 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"HER4 nuclear translocation was identified as a mediator of trastuzumab resistance in HER2 positive breast cancer cell lines. Increased nuclear staining was also identified in xenograft and patient samples after trastuzumab treatment."^^xsd:string .

	civic-kb:Disease-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-479f5225393db9d93b8043ef81c7c897 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-479f5225393db9d93b8043ef81c7c897 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-479f5225393db9d93b8043ef81c7c897 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-479f5225393db9d93b8043ef81c7c897 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-479f5225393db9d93b8043ef81c7c897 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-479f5225393db9d93b8043ef81c7c897 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-479f5225393db9d93b8043ef81c7c897	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-479f5225393db9d93b8043ef81c7c897 .

}

civic-kb:provenance-479f5225393db9d93b8043ef81c7c897 {
	civic-kb:assertion-479f5225393db9d93b8043ef81c7c897 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-479f5225393db9d93b8043ef81c7c897 .

	civic-kb:Status-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-479f5225393db9d93b8043ef81c7c897	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-479f5225393db9d93b8043ef81c7c897 {
	civic-kb:nanoPub-479f5225393db9d93b8043ef81c7c897 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-479f5225393db9d93b8043ef81c7c897
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ad370e060d0f86b72676f4835107b205 {
	civic-kb:nanoPub-ad370e060d0f86b72676f4835107b205
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ad370e060d0f86b72676f4835107b205 ;
		np:hasProvenance civic-kb:provenance-ad370e060d0f86b72676f4835107b205 ;
		np:hasPublicationInfo civic-kb:pubInfo-ad370e060d0f86b72676f4835107b205 .
}

civic-kb:assertion-ad370e060d0f86b72676f4835107b205 {
	civic-kb:Drugs-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ad370e060d0f86b72676f4835107b205 ;
		rdf:type	chebi:41774 ;
		rdf:type	db:DB00675 ;
		rdfs:label	"Tamoxifen"^^xsd:string ;
		sio:hasValue	"Tamoxifen"^^xsd:string .

	civic-kb:Status-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ad370e060d0f86b72676f4835107b205 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ad370e060d0f86b72676f4835107b205 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"891"^^xsd:integer .

	civic-kb:Gene-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C20755 ;
		rdf:type	uniprot:O95994 ;
		rdfs:label	"AGR2 Gene"^^xsd:string ;
		sio:hasValue	"AGR2"^^xsd:string .

	civic-kb:Variant-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ad370e060d0f86b72676f4835107b205 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"mRNA expression of AGR2 in 61 patients with tamoxifen treated postmenopausal breast cancer was determined by qRT-PCR and was inversely associated with treatment response and progression free survival (p= 0.0011, p = 0.0366 respectively). AGR2 protein expression as assessed by IHC was not significantly associated with treatment outcome."^^xsd:string .

	civic-kb:Disease-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ad370e060d0f86b72676f4835107b205 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ad370e060d0f86b72676f4835107b205 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ad370e060d0f86b72676f4835107b205 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ad370e060d0f86b72676f4835107b205 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ad370e060d0f86b72676f4835107b205 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ad370e060d0f86b72676f4835107b205 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"1"^^xsd:integer .

	civic-kb:evidence-ad370e060d0f86b72676f4835107b205	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ad370e060d0f86b72676f4835107b205 .

}

civic-kb:provenance-ad370e060d0f86b72676f4835107b205 {
	civic-kb:assertion-ad370e060d0f86b72676f4835107b205 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ad370e060d0f86b72676f4835107b205 .

	civic-kb:Status-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ad370e060d0f86b72676f4835107b205	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ad370e060d0f86b72676f4835107b205 {
	civic-kb:nanoPub-ad370e060d0f86b72676f4835107b205 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ad370e060d0f86b72676f4835107b205
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-981fc7a03d5109a01d2ebf673eec52c3 {
	civic-kb:nanoPub-981fc7a03d5109a01d2ebf673eec52c3
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-981fc7a03d5109a01d2ebf673eec52c3 ;
		np:hasProvenance civic-kb:provenance-981fc7a03d5109a01d2ebf673eec52c3 ;
		np:hasPublicationInfo civic-kb:pubInfo-981fc7a03d5109a01d2ebf673eec52c3 .
}

civic-kb:assertion-981fc7a03d5109a01d2ebf673eec52c3 {
	civic-kb:Drugs-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-981fc7a03d5109a01d2ebf673eec52c3 ;
		rdf:type	db:DB13051 ;
		rdfs:label	"CH5132799"^^xsd:string ;
		sio:hasValue	"CH5132799"^^xsd:string .

	civic-kb:Status-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-981fc7a03d5109a01d2ebf673eec52c3 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-981fc7a03d5109a01d2ebf673eec52c3 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"314"^^xsd:integer .

	civic-kb:Gene-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-981fc7a03d5109a01d2ebf673eec52c3 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with H1047R mutation showed increased sensitivity to CH5132799 than cells with wild-type PIK3CA gene."^^xsd:string .

	civic-kb:Disease-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-981fc7a03d5109a01d2ebf673eec52c3 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-981fc7a03d5109a01d2ebf673eec52c3 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-981fc7a03d5109a01d2ebf673eec52c3 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-981fc7a03d5109a01d2ebf673eec52c3 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-981fc7a03d5109a01d2ebf673eec52c3 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-981fc7a03d5109a01d2ebf673eec52c3 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-981fc7a03d5109a01d2ebf673eec52c3	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-981fc7a03d5109a01d2ebf673eec52c3 .

}

civic-kb:provenance-981fc7a03d5109a01d2ebf673eec52c3 {
	civic-kb:assertion-981fc7a03d5109a01d2ebf673eec52c3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-981fc7a03d5109a01d2ebf673eec52c3 .

	civic-kb:Status-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-981fc7a03d5109a01d2ebf673eec52c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-981fc7a03d5109a01d2ebf673eec52c3 {
	civic-kb:nanoPub-981fc7a03d5109a01d2ebf673eec52c3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-981fc7a03d5109a01d2ebf673eec52c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-b036fab7a6e10c0d07480ee318f934da {
	civic-kb:nanoPub-b036fab7a6e10c0d07480ee318f934da
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-b036fab7a6e10c0d07480ee318f934da ;
		np:hasProvenance civic-kb:provenance-b036fab7a6e10c0d07480ee318f934da ;
		np:hasPublicationInfo civic-kb:pubInfo-b036fab7a6e10c0d07480ee318f934da .
}

civic-kb:assertion-b036fab7a6e10c0d07480ee318f934da {
	civic-kb:Drugs-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b036fab7a6e10c0d07480ee318f934da ;
		sio:hasValue	"AZD5363, Trastuzumab"^^xsd:string .

	civic-kb:Status-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-b036fab7a6e10c0d07480ee318f934da ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-b036fab7a6e10c0d07480ee318f934da ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1505"^^xsd:integer .

	civic-kb:Gene-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-b036fab7a6e10c0d07480ee318f934da ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Tumor xenografts in mice were established with the KPL4 HER2 positive breast cancer cell line with PIK3CA H1047R mutation. KPL4 has suboptimal responses to trastuzumab and lapatinib. Xengraft treatment with trastuzumab and AZD5363 monotherapy induced moderate growth inhibition which was significant for AZD5363, but co-treatment with trastuzumab and AZD5363 induced significant tumor regression and enhanced growth delay upon removal of treatment."^^xsd:string .

	civic-kb:Disease-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b036fab7a6e10c0d07480ee318f934da ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-b036fab7a6e10c0d07480ee318f934da ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b036fab7a6e10c0d07480ee318f934da ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b036fab7a6e10c0d07480ee318f934da ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-b036fab7a6e10c0d07480ee318f934da ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-b036fab7a6e10c0d07480ee318f934da ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-b036fab7a6e10c0d07480ee318f934da	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-b036fab7a6e10c0d07480ee318f934da .

}

civic-kb:provenance-b036fab7a6e10c0d07480ee318f934da {
	civic-kb:assertion-b036fab7a6e10c0d07480ee318f934da prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-b036fab7a6e10c0d07480ee318f934da .

	civic-kb:Status-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-b036fab7a6e10c0d07480ee318f934da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-b036fab7a6e10c0d07480ee318f934da {
	civic-kb:nanoPub-b036fab7a6e10c0d07480ee318f934da prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-b036fab7a6e10c0d07480ee318f934da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2a02d430475da39227f3efd8b4a1e21c {
	civic-kb:nanoPub-2a02d430475da39227f3efd8b4a1e21c
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2a02d430475da39227f3efd8b4a1e21c ;
		np:hasProvenance civic-kb:provenance-2a02d430475da39227f3efd8b4a1e21c ;
		np:hasPublicationInfo civic-kb:pubInfo-2a02d430475da39227f3efd8b4a1e21c .
}

civic-kb:assertion-2a02d430475da39227f3efd8b4a1e21c {
	civic-kb:Drugs-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2a02d430475da39227f3efd8b4a1e21c ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2a02d430475da39227f3efd8b4a1e21c ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2a02d430475da39227f3efd8b4a1e21c ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2096"^^xsd:integer .

	civic-kb:Gene-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2a02d430475da39227f3efd8b4a1e21c ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines (n=54, P=0.005)."^^xsd:string .

	civic-kb:Disease-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2a02d430475da39227f3efd8b4a1e21c ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2a02d430475da39227f3efd8b4a1e21c ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2a02d430475da39227f3efd8b4a1e21c ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2a02d430475da39227f3efd8b4a1e21c ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2a02d430475da39227f3efd8b4a1e21c ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2a02d430475da39227f3efd8b4a1e21c ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-2a02d430475da39227f3efd8b4a1e21c	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2a02d430475da39227f3efd8b4a1e21c .

}

civic-kb:provenance-2a02d430475da39227f3efd8b4a1e21c {
	civic-kb:assertion-2a02d430475da39227f3efd8b4a1e21c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2a02d430475da39227f3efd8b4a1e21c .

	civic-kb:Status-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-2a02d430475da39227f3efd8b4a1e21c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2a02d430475da39227f3efd8b4a1e21c {
	civic-kb:nanoPub-2a02d430475da39227f3efd8b4a1e21c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2a02d430475da39227f3efd8b4a1e21c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d9f11c9b67ec55272326b51c05afd6fd {
	civic-kb:nanoPub-d9f11c9b67ec55272326b51c05afd6fd
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d9f11c9b67ec55272326b51c05afd6fd ;
		np:hasProvenance civic-kb:provenance-d9f11c9b67ec55272326b51c05afd6fd ;
		np:hasPublicationInfo civic-kb:pubInfo-d9f11c9b67ec55272326b51c05afd6fd .
}

civic-kb:assertion-d9f11c9b67ec55272326b51c05afd6fd {
	civic-kb:Drugs-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d9f11c9b67ec55272326b51c05afd6fd ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d9f11c9b67ec55272326b51c05afd6fd ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d9f11c9b67ec55272326b51c05afd6fd ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2101"^^xsd:integer .

	civic-kb:Gene-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d9f11c9b67ec55272326b51c05afd6fd ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In unilateral breast cancer patients, PIK3CA mutation was associated with improved local recurrence-free survival."^^xsd:string .

	civic-kb:Disease-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d9f11c9b67ec55272326b51c05afd6fd ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d9f11c9b67ec55272326b51c05afd6fd ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d9f11c9b67ec55272326b51c05afd6fd ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d9f11c9b67ec55272326b51c05afd6fd ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d9f11c9b67ec55272326b51c05afd6fd ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d9f11c9b67ec55272326b51c05afd6fd ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-d9f11c9b67ec55272326b51c05afd6fd	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d9f11c9b67ec55272326b51c05afd6fd .

}

civic-kb:provenance-d9f11c9b67ec55272326b51c05afd6fd {
	civic-kb:assertion-d9f11c9b67ec55272326b51c05afd6fd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d9f11c9b67ec55272326b51c05afd6fd .

	civic-kb:Status-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-d9f11c9b67ec55272326b51c05afd6fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d9f11c9b67ec55272326b51c05afd6fd {
	civic-kb:nanoPub-d9f11c9b67ec55272326b51c05afd6fd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d9f11c9b67ec55272326b51c05afd6fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-57be120cf010698ce3fe1f67026997fd {
	civic-kb:nanoPub-57be120cf010698ce3fe1f67026997fd
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-57be120cf010698ce3fe1f67026997fd ;
		np:hasProvenance civic-kb:provenance-57be120cf010698ce3fe1f67026997fd ;
		np:hasPublicationInfo civic-kb:pubInfo-57be120cf010698ce3fe1f67026997fd .
}

civic-kb:assertion-57be120cf010698ce3fe1f67026997fd {
	civic-kb:Drugs-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-57be120cf010698ce3fe1f67026997fd ;
		sio:hasValue	"AZD5363, Lapatinib"^^xsd:string .

	civic-kb:Status-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-57be120cf010698ce3fe1f67026997fd ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-57be120cf010698ce3fe1f67026997fd ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1506"^^xsd:integer .

	civic-kb:Gene-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-57be120cf010698ce3fe1f67026997fd ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The HER2 breast cancer cell line KPL4 with PIK3CA H1047R shows sub-optimal responses to trastuzumab and lapatinib, and was used to establish mouse xenografts. Treatment of mice with monotherapy of AZD5363 or lapatinib alone induced growth inhibition (37%, not significant; 65%, P = 0.004), but treatment with AZD5363 and lapatinib together induced significant tumor regression (109%, P < 0.0001) as well as delayed tumor regrowth after removal of therapy."^^xsd:string .

	civic-kb:Disease-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-57be120cf010698ce3fe1f67026997fd ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-57be120cf010698ce3fe1f67026997fd ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-57be120cf010698ce3fe1f67026997fd ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-57be120cf010698ce3fe1f67026997fd ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-57be120cf010698ce3fe1f67026997fd ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-57be120cf010698ce3fe1f67026997fd ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-57be120cf010698ce3fe1f67026997fd	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-57be120cf010698ce3fe1f67026997fd .

}

civic-kb:provenance-57be120cf010698ce3fe1f67026997fd {
	civic-kb:assertion-57be120cf010698ce3fe1f67026997fd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-57be120cf010698ce3fe1f67026997fd .

	civic-kb:Status-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-57be120cf010698ce3fe1f67026997fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-57be120cf010698ce3fe1f67026997fd {
	civic-kb:nanoPub-57be120cf010698ce3fe1f67026997fd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-57be120cf010698ce3fe1f67026997fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-7fb683b4ea8cbaaf7d00dbcbe09a9330 {
	civic-kb:nanoPub-7fb683b4ea8cbaaf7d00dbcbe09a9330
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		np:hasProvenance civic-kb:provenance-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		np:hasPublicationInfo civic-kb:pubInfo-7fb683b4ea8cbaaf7d00dbcbe09a9330 .
}

civic-kb:assertion-7fb683b4ea8cbaaf7d00dbcbe09a9330 {
	civic-kb:Drugs-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		sio:hasValue	"Everolimus, Fulvestrant"^^xsd:string .

	civic-kb:Status-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1623"^^xsd:integer .

	civic-kb:Gene-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Case report of a 44-year-old patient with recurrent HER2-positive breast cancer. The primary tumor was HR positive; however, the metastatic tumor was HR negative. The patient was resistant to classical chemotherapeutic agents and anti-HER2 treatment. Thus, the combination of everolimus and fulvestrant was administered. The patient experienced stable disease and PFS of 10 months. Genetic testing of pleural effusion after disease progression revealed a PIK3CA H1047R gene mutation but was positive for PTEN expression (IHC)."^^xsd:string .

	civic-kb:Disease-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-7fb683b4ea8cbaaf7d00dbcbe09a9330 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-7fb683b4ea8cbaaf7d00dbcbe09a9330	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-7fb683b4ea8cbaaf7d00dbcbe09a9330 .

}

civic-kb:provenance-7fb683b4ea8cbaaf7d00dbcbe09a9330 {
	civic-kb:assertion-7fb683b4ea8cbaaf7d00dbcbe09a9330 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-7fb683b4ea8cbaaf7d00dbcbe09a9330 .

	civic-kb:Status-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-7fb683b4ea8cbaaf7d00dbcbe09a9330	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-7fb683b4ea8cbaaf7d00dbcbe09a9330 {
	civic-kb:nanoPub-7fb683b4ea8cbaaf7d00dbcbe09a9330 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-7fb683b4ea8cbaaf7d00dbcbe09a9330
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-da879633b18cc033eb19754c8de376e9 {
	civic-kb:nanoPub-da879633b18cc033eb19754c8de376e9
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-da879633b18cc033eb19754c8de376e9 ;
		np:hasProvenance civic-kb:provenance-da879633b18cc033eb19754c8de376e9 ;
		np:hasPublicationInfo civic-kb:pubInfo-da879633b18cc033eb19754c8de376e9 .
}

civic-kb:assertion-da879633b18cc033eb19754c8de376e9 {
	civic-kb:Drugs-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-da879633b18cc033eb19754c8de376e9 ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-da879633b18cc033eb19754c8de376e9 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-da879633b18cc033eb19754c8de376e9 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2097"^^xsd:integer .

	civic-kb:Gene-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-da879633b18cc033eb19754c8de376e9 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-da879633b18cc033eb19754c8de376e9 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-da879633b18cc033eb19754c8de376e9 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-da879633b18cc033eb19754c8de376e9 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-da879633b18cc033eb19754c8de376e9 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-da879633b18cc033eb19754c8de376e9 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-da879633b18cc033eb19754c8de376e9 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-da879633b18cc033eb19754c8de376e9	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-da879633b18cc033eb19754c8de376e9 .

}

civic-kb:provenance-da879633b18cc033eb19754c8de376e9 {
	civic-kb:assertion-da879633b18cc033eb19754c8de376e9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-da879633b18cc033eb19754c8de376e9 .

	civic-kb:Status-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-da879633b18cc033eb19754c8de376e9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-da879633b18cc033eb19754c8de376e9 {
	civic-kb:nanoPub-da879633b18cc033eb19754c8de376e9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-da879633b18cc033eb19754c8de376e9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-dd5aaac2584070476d0a360e3f54648d {
	civic-kb:nanoPub-dd5aaac2584070476d0a360e3f54648d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-dd5aaac2584070476d0a360e3f54648d ;
		np:hasProvenance civic-kb:provenance-dd5aaac2584070476d0a360e3f54648d ;
		np:hasPublicationInfo civic-kb:pubInfo-dd5aaac2584070476d0a360e3f54648d .
}

civic-kb:assertion-dd5aaac2584070476d0a360e3f54648d {
	civic-kb:Drugs-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-dd5aaac2584070476d0a360e3f54648d ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-dd5aaac2584070476d0a360e3f54648d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-dd5aaac2584070476d0a360e3f54648d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2100"^^xsd:integer .

	civic-kb:Gene-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-dd5aaac2584070476d0a360e3f54648d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In Japanese invasive breast cancer patients, PIK3CA mutation was associated with improved relapse-free survival."^^xsd:string .

	civic-kb:Disease-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-dd5aaac2584070476d0a360e3f54648d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-dd5aaac2584070476d0a360e3f54648d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-dd5aaac2584070476d0a360e3f54648d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-dd5aaac2584070476d0a360e3f54648d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-dd5aaac2584070476d0a360e3f54648d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-dd5aaac2584070476d0a360e3f54648d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-dd5aaac2584070476d0a360e3f54648d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-dd5aaac2584070476d0a360e3f54648d .

}

civic-kb:provenance-dd5aaac2584070476d0a360e3f54648d {
	civic-kb:assertion-dd5aaac2584070476d0a360e3f54648d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-dd5aaac2584070476d0a360e3f54648d .

	civic-kb:Status-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-dd5aaac2584070476d0a360e3f54648d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-dd5aaac2584070476d0a360e3f54648d {
	civic-kb:nanoPub-dd5aaac2584070476d0a360e3f54648d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-dd5aaac2584070476d0a360e3f54648d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-7c6ed41e7dca48d1207041fd2c397eba {
	civic-kb:nanoPub-7c6ed41e7dca48d1207041fd2c397eba
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-7c6ed41e7dca48d1207041fd2c397eba ;
		np:hasProvenance civic-kb:provenance-7c6ed41e7dca48d1207041fd2c397eba ;
		np:hasPublicationInfo civic-kb:pubInfo-7c6ed41e7dca48d1207041fd2c397eba .
}

civic-kb:assertion-7c6ed41e7dca48d1207041fd2c397eba {
	civic-kb:Drugs-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7c6ed41e7dca48d1207041fd2c397eba ;
		rdf:type	dron:00730818 ;
		rdf:type	db:DB05773 ;
		rdfs:label	"Ado-trastuzumab Emtansine"^^xsd:string ;
		sio:hasValue	"Ado-trastuzumab Emtansine"^^xsd:string .

	civic-kb:Status-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-7c6ed41e7dca48d1207041fd2c397eba ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-7c6ed41e7dca48d1207041fd2c397eba ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2103"^^xsd:integer .

	civic-kb:Gene-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-7c6ed41e7dca48d1207041fd2c397eba ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase 3 clinical trial (NCT00829166), metastatic breast cancer patients with PIK3CA mutation (n=40), including patients with PIK3CA H1047R, treated with ado-trastuzumab were associated with improved median progression free survival (10.9 vs. 9.8 months), as compared to patients with wild-type PIK3CA (n=93). Further, the patients harboring PIK3CA mutations (n=79) were associated with a decrease in disease progression (ado-trastuzumab relative to standard chemotherapy; HR:0.45; 95% CI:0.25-0.82), as compared to patients with wild-type PIK3CA (n=180; HR:0.74; 95% CI:0.50-1.10). In an in vitro study, HCC1954 and KPL-4 cell lines expressing PIK3CA H1047R mutation was associated with increased sensitivity to ado-trastuzumab emtansine treatment compared to trastuzumab treated HCC1954 and KPL-4 cells. Sensitivity was determined by assessing cell viability. Further, in an in vivo study, KPL-4 xenografts expressing PIK3CA H1047R were reportedly sensitive to ado-trastuzumab emtansine, as assessed by tumor growth."^^xsd:string .

	civic-kb:Disease-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7c6ed41e7dca48d1207041fd2c397eba ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-7c6ed41e7dca48d1207041fd2c397eba ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7c6ed41e7dca48d1207041fd2c397eba ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7c6ed41e7dca48d1207041fd2c397eba ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-7c6ed41e7dca48d1207041fd2c397eba ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-7c6ed41e7dca48d1207041fd2c397eba ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-7c6ed41e7dca48d1207041fd2c397eba	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-7c6ed41e7dca48d1207041fd2c397eba .

}

civic-kb:provenance-7c6ed41e7dca48d1207041fd2c397eba {
	civic-kb:assertion-7c6ed41e7dca48d1207041fd2c397eba prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-7c6ed41e7dca48d1207041fd2c397eba .

	civic-kb:Status-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-7c6ed41e7dca48d1207041fd2c397eba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-7c6ed41e7dca48d1207041fd2c397eba {
	civic-kb:nanoPub-7c6ed41e7dca48d1207041fd2c397eba prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-7c6ed41e7dca48d1207041fd2c397eba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-fbccb58144a4ef9894e7711a053a8138 {
	civic-kb:nanoPub-fbccb58144a4ef9894e7711a053a8138
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-fbccb58144a4ef9894e7711a053a8138 ;
		np:hasProvenance civic-kb:provenance-fbccb58144a4ef9894e7711a053a8138 ;
		np:hasPublicationInfo civic-kb:pubInfo-fbccb58144a4ef9894e7711a053a8138 .
}

civic-kb:assertion-fbccb58144a4ef9894e7711a053a8138 {
	civic-kb:Drugs-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fbccb58144a4ef9894e7711a053a8138 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-fbccb58144a4ef9894e7711a053a8138 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-fbccb58144a4ef9894e7711a053a8138 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2098"^^xsd:integer .

	civic-kb:Gene-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-fbccb58144a4ef9894e7711a053a8138 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In HER2-positive metastic breast cancer patients treated with trastuzumab-based therapy, the presence of a PIK3CA mutation was associated with an increased risk of progression (HR:2.50, 95% CI:1.35-4.61, P=0.003, univariate analysis; HR:1.86, 95% CI:1.13-3.05, P=0.014, multivariate analysis) and reduced time to progression (HR:2.50, 95% CI:1.35-4.61, P=0.003) compared to wildtype PIK3CA."^^xsd:string .

	civic-kb:Disease-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fbccb58144a4ef9894e7711a053a8138 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-fbccb58144a4ef9894e7711a053a8138 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fbccb58144a4ef9894e7711a053a8138 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fbccb58144a4ef9894e7711a053a8138 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-fbccb58144a4ef9894e7711a053a8138 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-fbccb58144a4ef9894e7711a053a8138 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-fbccb58144a4ef9894e7711a053a8138	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-fbccb58144a4ef9894e7711a053a8138 .

}

civic-kb:provenance-fbccb58144a4ef9894e7711a053a8138 {
	civic-kb:assertion-fbccb58144a4ef9894e7711a053a8138 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-fbccb58144a4ef9894e7711a053a8138 .

	civic-kb:Status-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-fbccb58144a4ef9894e7711a053a8138	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-fbccb58144a4ef9894e7711a053a8138 {
	civic-kb:nanoPub-fbccb58144a4ef9894e7711a053a8138 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-fbccb58144a4ef9894e7711a053a8138
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-24cbc753210c172829ebf3832d6e94f0 {
	civic-kb:nanoPub-24cbc753210c172829ebf3832d6e94f0
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-24cbc753210c172829ebf3832d6e94f0 ;
		np:hasProvenance civic-kb:provenance-24cbc753210c172829ebf3832d6e94f0 ;
		np:hasPublicationInfo civic-kb:pubInfo-24cbc753210c172829ebf3832d6e94f0 .
}

civic-kb:assertion-24cbc753210c172829ebf3832d6e94f0 {
	civic-kb:Drugs-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-24cbc753210c172829ebf3832d6e94f0 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-24cbc753210c172829ebf3832d6e94f0 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"rejected"^^xsd:string .

	civic-kb:Evidence_ID-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-24cbc753210c172829ebf3832d6e94f0 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2099"^^xsd:integer .

	civic-kb:Gene-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-24cbc753210c172829ebf3832d6e94f0 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In primary invasive breast cancer patients, PIK3CA mutation was associated with improved overall survival compared to wildtype PIK3CA. PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-24cbc753210c172829ebf3832d6e94f0 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-24cbc753210c172829ebf3832d6e94f0 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-24cbc753210c172829ebf3832d6e94f0 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-24cbc753210c172829ebf3832d6e94f0 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-24cbc753210c172829ebf3832d6e94f0 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-24cbc753210c172829ebf3832d6e94f0 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-24cbc753210c172829ebf3832d6e94f0	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-24cbc753210c172829ebf3832d6e94f0 .

}

civic-kb:provenance-24cbc753210c172829ebf3832d6e94f0 {
	civic-kb:assertion-24cbc753210c172829ebf3832d6e94f0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-24cbc753210c172829ebf3832d6e94f0 .

	civic-kb:Status-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-24cbc753210c172829ebf3832d6e94f0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-24cbc753210c172829ebf3832d6e94f0 {
	civic-kb:nanoPub-24cbc753210c172829ebf3832d6e94f0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-24cbc753210c172829ebf3832d6e94f0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-687cffe4ddcc7f9b40870c1ae51f2276 {
	civic-kb:nanoPub-687cffe4ddcc7f9b40870c1ae51f2276
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-687cffe4ddcc7f9b40870c1ae51f2276 ;
		np:hasProvenance civic-kb:provenance-687cffe4ddcc7f9b40870c1ae51f2276 ;
		np:hasPublicationInfo civic-kb:pubInfo-687cffe4ddcc7f9b40870c1ae51f2276 .
}

civic-kb:assertion-687cffe4ddcc7f9b40870c1ae51f2276 {
	civic-kb:Drugs-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-687cffe4ddcc7f9b40870c1ae51f2276 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-687cffe4ddcc7f9b40870c1ae51f2276 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-687cffe4ddcc7f9b40870c1ae51f2276 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2102"^^xsd:integer .

	civic-kb:Gene-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"H1047R"^^xsd:string .

	civic-kb:Description-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-687cffe4ddcc7f9b40870c1ae51f2276 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor, GDC-0941 (pictilisib), as compared to wildtype PIK3CA cell lines."^^xsd:string .

	civic-kb:Disease-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-687cffe4ddcc7f9b40870c1ae51f2276 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-687cffe4ddcc7f9b40870c1ae51f2276 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-687cffe4ddcc7f9b40870c1ae51f2276 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-687cffe4ddcc7f9b40870c1ae51f2276 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-687cffe4ddcc7f9b40870c1ae51f2276 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-687cffe4ddcc7f9b40870c1ae51f2276 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-687cffe4ddcc7f9b40870c1ae51f2276	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-687cffe4ddcc7f9b40870c1ae51f2276 .

}

civic-kb:provenance-687cffe4ddcc7f9b40870c1ae51f2276 {
	civic-kb:assertion-687cffe4ddcc7f9b40870c1ae51f2276 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-687cffe4ddcc7f9b40870c1ae51f2276 .

	civic-kb:Status-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-687cffe4ddcc7f9b40870c1ae51f2276	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-687cffe4ddcc7f9b40870c1ae51f2276 {
	civic-kb:nanoPub-687cffe4ddcc7f9b40870c1ae51f2276 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-687cffe4ddcc7f9b40870c1ae51f2276
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-727ee43b9b3fcfa781196bc970fb4541 {
	civic-kb:nanoPub-727ee43b9b3fcfa781196bc970fb4541
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-727ee43b9b3fcfa781196bc970fb4541 ;
		np:hasProvenance civic-kb:provenance-727ee43b9b3fcfa781196bc970fb4541 ;
		np:hasPublicationInfo civic-kb:pubInfo-727ee43b9b3fcfa781196bc970fb4541 .
}

civic-kb:assertion-727ee43b9b3fcfa781196bc970fb4541 {
	civic-kb:Drugs-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-727ee43b9b3fcfa781196bc970fb4541 ;
		rdfs:label	"MTOR Inhibitors"^^xsd:string ;
		sio:hasValue	"MTOR Inhibitors"^^xsd:string .

	civic-kb:Status-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-727ee43b9b3fcfa781196bc970fb4541 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-727ee43b9b3fcfa781196bc970fb4541 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"317"^^xsd:integer .

	civic-kb:Gene-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R233*"^^xsd:string .

	civic-kb:Description-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-727ee43b9b3fcfa781196bc970fb4541 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Cells with PTEN deficiency have been shown to exhibit slowed growth in reponse to PI3K-mTOR inhibitors."^^xsd:string .

	civic-kb:Disease-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-727ee43b9b3fcfa781196bc970fb4541 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-727ee43b9b3fcfa781196bc970fb4541 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-727ee43b9b3fcfa781196bc970fb4541 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-727ee43b9b3fcfa781196bc970fb4541 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-727ee43b9b3fcfa781196bc970fb4541 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-727ee43b9b3fcfa781196bc970fb4541 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-727ee43b9b3fcfa781196bc970fb4541	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-727ee43b9b3fcfa781196bc970fb4541 .

}

civic-kb:provenance-727ee43b9b3fcfa781196bc970fb4541 {
	civic-kb:assertion-727ee43b9b3fcfa781196bc970fb4541 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-727ee43b9b3fcfa781196bc970fb4541 .

	civic-kb:Status-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-727ee43b9b3fcfa781196bc970fb4541	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-727ee43b9b3fcfa781196bc970fb4541 {
	civic-kb:nanoPub-727ee43b9b3fcfa781196bc970fb4541 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-727ee43b9b3fcfa781196bc970fb4541
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-0c0d9df1d13b04f9d376d686d6f39f13 {
	civic-kb:nanoPub-0c0d9df1d13b04f9d376d686d6f39f13
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-0c0d9df1d13b04f9d376d686d6f39f13 ;
		np:hasProvenance civic-kb:provenance-0c0d9df1d13b04f9d376d686d6f39f13 ;
		np:hasPublicationInfo civic-kb:pubInfo-0c0d9df1d13b04f9d376d686d6f39f13 .
}

civic-kb:assertion-0c0d9df1d13b04f9d376d686d6f39f13 {
	civic-kb:Drugs-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-0c0d9df1d13b04f9d376d686d6f39f13 ;
		rdfs:label	"Spliceostatin A"^^xsd:string ;
		sio:hasValue	"Spliceostatin A"^^xsd:string .

	civic-kb:Status-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-0c0d9df1d13b04f9d376d686d6f39f13 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-0c0d9df1d13b04f9d376d686d6f39f13 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1418"^^xsd:integer .

	civic-kb:Gene-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C98284 ;
		rdf:type	uniprot:O75533 ;
		rdfs:label	"SF3B1 Gene"^^xsd:string ;
		sio:hasValue	"SF3B1"^^xsd:string .

	civic-kb:Variant-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"K666N"^^xsd:string .

	civic-kb:Description-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-0c0d9df1d13b04f9d376d686d6f39f13 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Mutations in SF3B1 were identified in 21/936 ER positive vs. 1/289 ER negative breast cancers. Mutation was recurrent (K700E in 74% or K666Q or K666E in another 9% of tumors). Treatment of two SF3B1 mutant cell lines (pancreatic and endometrial with K700 and K666 mutation, respectively) and six wild-type controls showed that mutant cell lines were significantly more sensitive to spliceostatin A (SF3b complex inhibitor)."^^xsd:string .

	civic-kb:Disease-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-0c0d9df1d13b04f9d376d686d6f39f13 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-0c0d9df1d13b04f9d376d686d6f39f13 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-0c0d9df1d13b04f9d376d686d6f39f13 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-0c0d9df1d13b04f9d376d686d6f39f13 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-0c0d9df1d13b04f9d376d686d6f39f13 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-0c0d9df1d13b04f9d376d686d6f39f13 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-0c0d9df1d13b04f9d376d686d6f39f13	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-0c0d9df1d13b04f9d376d686d6f39f13 .

}

civic-kb:provenance-0c0d9df1d13b04f9d376d686d6f39f13 {
	civic-kb:assertion-0c0d9df1d13b04f9d376d686d6f39f13 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-0c0d9df1d13b04f9d376d686d6f39f13 .

	civic-kb:Status-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-0c0d9df1d13b04f9d376d686d6f39f13	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-0c0d9df1d13b04f9d376d686d6f39f13 {
	civic-kb:nanoPub-0c0d9df1d13b04f9d376d686d6f39f13 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-0c0d9df1d13b04f9d376d686d6f39f13
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-98a80647a387c1386eda827cce9c22dd {
	civic-kb:nanoPub-98a80647a387c1386eda827cce9c22dd
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-98a80647a387c1386eda827cce9c22dd ;
		np:hasProvenance civic-kb:provenance-98a80647a387c1386eda827cce9c22dd ;
		np:hasPublicationInfo civic-kb:pubInfo-98a80647a387c1386eda827cce9c22dd .
}

civic-kb:assertion-98a80647a387c1386eda827cce9c22dd {
	civic-kb:Drugs-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-98a80647a387c1386eda827cce9c22dd .

	civic-kb:Status-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-98a80647a387c1386eda827cce9c22dd ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-98a80647a387c1386eda827cce9c22dd ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"391"^^xsd:integer .

	civic-kb:Gene-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R248Q"^^xsd:string .

	civic-kb:Description-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-98a80647a387c1386eda827cce9c22dd ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In breast cancer patients harboring TP53 mutation, mutations in DNA contact regions such as R248 are prognostic for a worse relapse-free survival compared to other non-silent mutations in TP53."^^xsd:string .

	civic-kb:Disease-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-98a80647a387c1386eda827cce9c22dd ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-98a80647a387c1386eda827cce9c22dd ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-98a80647a387c1386eda827cce9c22dd ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-98a80647a387c1386eda827cce9c22dd ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-98a80647a387c1386eda827cce9c22dd ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-98a80647a387c1386eda827cce9c22dd ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-98a80647a387c1386eda827cce9c22dd	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-98a80647a387c1386eda827cce9c22dd .

}

civic-kb:provenance-98a80647a387c1386eda827cce9c22dd {
	civic-kb:assertion-98a80647a387c1386eda827cce9c22dd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-98a80647a387c1386eda827cce9c22dd .

	civic-kb:Status-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-98a80647a387c1386eda827cce9c22dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-98a80647a387c1386eda827cce9c22dd {
	civic-kb:nanoPub-98a80647a387c1386eda827cce9c22dd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-98a80647a387c1386eda827cce9c22dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-1f7837b2093a6ac7a6b02cf31557e2bf {
	civic-kb:nanoPub-1f7837b2093a6ac7a6b02cf31557e2bf
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-1f7837b2093a6ac7a6b02cf31557e2bf ;
		np:hasProvenance civic-kb:provenance-1f7837b2093a6ac7a6b02cf31557e2bf ;
		np:hasPublicationInfo civic-kb:pubInfo-1f7837b2093a6ac7a6b02cf31557e2bf .
}

civic-kb:assertion-1f7837b2093a6ac7a6b02cf31557e2bf {
	civic-kb:Drugs-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1f7837b2093a6ac7a6b02cf31557e2bf .

	civic-kb:Status-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-1f7837b2093a6ac7a6b02cf31557e2bf ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-1f7837b2093a6ac7a6b02cf31557e2bf ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"390"^^xsd:integer .

	civic-kb:Gene-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R248Q"^^xsd:string .

	civic-kb:Description-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-1f7837b2093a6ac7a6b02cf31557e2bf ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer patients who harbor a R248Q mutation (N=18) have worse overall survival than those with wild type TP53 (N=1460), but have better prognosis than those with a R248W mutation (N=8)."^^xsd:string .

	civic-kb:Disease-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1f7837b2093a6ac7a6b02cf31557e2bf ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-1f7837b2093a6ac7a6b02cf31557e2bf ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1f7837b2093a6ac7a6b02cf31557e2bf ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1f7837b2093a6ac7a6b02cf31557e2bf ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-1f7837b2093a6ac7a6b02cf31557e2bf ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-1f7837b2093a6ac7a6b02cf31557e2bf ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-1f7837b2093a6ac7a6b02cf31557e2bf	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-1f7837b2093a6ac7a6b02cf31557e2bf .

}

civic-kb:provenance-1f7837b2093a6ac7a6b02cf31557e2bf {
	civic-kb:assertion-1f7837b2093a6ac7a6b02cf31557e2bf prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-1f7837b2093a6ac7a6b02cf31557e2bf .

	civic-kb:Status-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-1f7837b2093a6ac7a6b02cf31557e2bf	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-1f7837b2093a6ac7a6b02cf31557e2bf {
	civic-kb:nanoPub-1f7837b2093a6ac7a6b02cf31557e2bf prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-1f7837b2093a6ac7a6b02cf31557e2bf
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ba14818daa89c35ccb5a2bd4573ce356 {
	civic-kb:nanoPub-ba14818daa89c35ccb5a2bd4573ce356
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ba14818daa89c35ccb5a2bd4573ce356 ;
		np:hasProvenance civic-kb:provenance-ba14818daa89c35ccb5a2bd4573ce356 ;
		np:hasPublicationInfo civic-kb:pubInfo-ba14818daa89c35ccb5a2bd4573ce356 .
}

civic-kb:assertion-ba14818daa89c35ccb5a2bd4573ce356 {
	civic-kb:Drugs-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ba14818daa89c35ccb5a2bd4573ce356 .

	civic-kb:Status-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ba14818daa89c35ccb5a2bd4573ce356 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ba14818daa89c35ccb5a2bd4573ce356 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"392"^^xsd:integer .

	civic-kb:Gene-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R248W"^^xsd:string .

	civic-kb:Description-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ba14818daa89c35ccb5a2bd4573ce356 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In breast cancer patients harboring R248W mutation, the prognosis is worse than any other hotspot TP53 mutation, as well as worse than patients with wild type TP53."^^xsd:string .

	civic-kb:Disease-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ba14818daa89c35ccb5a2bd4573ce356 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ba14818daa89c35ccb5a2bd4573ce356 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ba14818daa89c35ccb5a2bd4573ce356 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ba14818daa89c35ccb5a2bd4573ce356 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ba14818daa89c35ccb5a2bd4573ce356 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ba14818daa89c35ccb5a2bd4573ce356 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-ba14818daa89c35ccb5a2bd4573ce356	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ba14818daa89c35ccb5a2bd4573ce356 .

}

civic-kb:provenance-ba14818daa89c35ccb5a2bd4573ce356 {
	civic-kb:assertion-ba14818daa89c35ccb5a2bd4573ce356 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ba14818daa89c35ccb5a2bd4573ce356 .

	civic-kb:Status-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ba14818daa89c35ccb5a2bd4573ce356	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ba14818daa89c35ccb5a2bd4573ce356 {
	civic-kb:nanoPub-ba14818daa89c35ccb5a2bd4573ce356 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ba14818daa89c35ccb5a2bd4573ce356
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-53666226cac782177bd84f829105273b {
	civic-kb:nanoPub-53666226cac782177bd84f829105273b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-53666226cac782177bd84f829105273b ;
		np:hasProvenance civic-kb:provenance-53666226cac782177bd84f829105273b ;
		np:hasPublicationInfo civic-kb:pubInfo-53666226cac782177bd84f829105273b .
}

civic-kb:assertion-53666226cac782177bd84f829105273b {
	civic-kb:Drugs-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-53666226cac782177bd84f829105273b .

	civic-kb:Status-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-53666226cac782177bd84f829105273b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-53666226cac782177bd84f829105273b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"393"^^xsd:integer .

	civic-kb:Gene-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R249"^^xsd:string .

	civic-kb:Description-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-53666226cac782177bd84f829105273b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In breast cancer patients harboring TP53 mutation, mutations in conserved regions such as R249 are prognostic for a worse overall survival compared to those harboring wild-type TP53."^^xsd:string .

	civic-kb:Disease-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-53666226cac782177bd84f829105273b ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-53666226cac782177bd84f829105273b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-53666226cac782177bd84f829105273b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-53666226cac782177bd84f829105273b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-53666226cac782177bd84f829105273b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-53666226cac782177bd84f829105273b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-53666226cac782177bd84f829105273b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-53666226cac782177bd84f829105273b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-53666226cac782177bd84f829105273b .

}

civic-kb:provenance-53666226cac782177bd84f829105273b {
	civic-kb:assertion-53666226cac782177bd84f829105273b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-53666226cac782177bd84f829105273b .

	civic-kb:Status-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-53666226cac782177bd84f829105273b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-53666226cac782177bd84f829105273b {
	civic-kb:nanoPub-53666226cac782177bd84f829105273b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-53666226cac782177bd84f829105273b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-a9e34c79bea001d3f9e0a9272ca9ca15 {
	civic-kb:nanoPub-a9e34c79bea001d3f9e0a9272ca9ca15
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		np:hasProvenance civic-kb:provenance-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		np:hasPublicationInfo civic-kb:pubInfo-a9e34c79bea001d3f9e0a9272ca9ca15 .
}

civic-kb:assertion-a9e34c79bea001d3f9e0a9272ca9ca15 {
	civic-kb:Drugs-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		rdf:type	db:DB00997 ;
		rdfs:label	"Doxorubicin"^^xsd:string ;
		sio:hasValue	"Doxorubicin"^^xsd:string .

	civic-kb:Status-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"399"^^xsd:integer .

	civic-kb:Gene-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R249"^^xsd:string .

	civic-kb:Description-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast tumors with R175H or R249 mutations are more responsive to doxorubicin than breast tumors with wild type TP53."^^xsd:string .

	civic-kb:Disease-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-a9e34c79bea001d3f9e0a9272ca9ca15 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-a9e34c79bea001d3f9e0a9272ca9ca15	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-a9e34c79bea001d3f9e0a9272ca9ca15 .

}

civic-kb:provenance-a9e34c79bea001d3f9e0a9272ca9ca15 {
	civic-kb:assertion-a9e34c79bea001d3f9e0a9272ca9ca15 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-a9e34c79bea001d3f9e0a9272ca9ca15 .

	civic-kb:Status-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-a9e34c79bea001d3f9e0a9272ca9ca15	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-a9e34c79bea001d3f9e0a9272ca9ca15 {
	civic-kb:nanoPub-a9e34c79bea001d3f9e0a9272ca9ca15 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-a9e34c79bea001d3f9e0a9272ca9ca15
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-83cc3d6521b3e9bd92a51ad471aeb0f9 {
	civic-kb:nanoPub-83cc3d6521b3e9bd92a51ad471aeb0f9
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-83cc3d6521b3e9bd92a51ad471aeb0f9 ;
		np:hasProvenance civic-kb:provenance-83cc3d6521b3e9bd92a51ad471aeb0f9 ;
		np:hasPublicationInfo civic-kb:pubInfo-83cc3d6521b3e9bd92a51ad471aeb0f9 .
}

civic-kb:assertion-83cc3d6521b3e9bd92a51ad471aeb0f9 {
	civic-kb:Drugs-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-83cc3d6521b3e9bd92a51ad471aeb0f9 .

	civic-kb:Status-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-83cc3d6521b3e9bd92a51ad471aeb0f9 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-83cc3d6521b3e9bd92a51ad471aeb0f9 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1302"^^xsd:integer .

	civic-kb:Gene-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"P72R"^^xsd:string .

	civic-kb:Description-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-83cc3d6521b3e9bd92a51ad471aeb0f9 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-83cc3d6521b3e9bd92a51ad471aeb0f9 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-83cc3d6521b3e9bd92a51ad471aeb0f9 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-83cc3d6521b3e9bd92a51ad471aeb0f9 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predisposing"^^xsd:string .

	civic-kb:Evidence_Direction-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-83cc3d6521b3e9bd92a51ad471aeb0f9 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Positive"^^xsd:string .

	civic-kb:Variant_Origin-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-83cc3d6521b3e9bd92a51ad471aeb0f9 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Polymorphism"^^xsd:string .

	civic-kb:Trust_Rating-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-83cc3d6521b3e9bd92a51ad471aeb0f9 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-83cc3d6521b3e9bd92a51ad471aeb0f9	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-83cc3d6521b3e9bd92a51ad471aeb0f9 .

}

civic-kb:provenance-83cc3d6521b3e9bd92a51ad471aeb0f9 {
	civic-kb:assertion-83cc3d6521b3e9bd92a51ad471aeb0f9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-83cc3d6521b3e9bd92a51ad471aeb0f9 .

	civic-kb:Status-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-83cc3d6521b3e9bd92a51ad471aeb0f9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-83cc3d6521b3e9bd92a51ad471aeb0f9 {
	civic-kb:nanoPub-83cc3d6521b3e9bd92a51ad471aeb0f9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-83cc3d6521b3e9bd92a51ad471aeb0f9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-635ea0632cbc26c42829fcdb6dd816c3 {
	civic-kb:nanoPub-635ea0632cbc26c42829fcdb6dd816c3
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-635ea0632cbc26c42829fcdb6dd816c3 ;
		np:hasProvenance civic-kb:provenance-635ea0632cbc26c42829fcdb6dd816c3 ;
		np:hasPublicationInfo civic-kb:pubInfo-635ea0632cbc26c42829fcdb6dd816c3 .
}

civic-kb:assertion-635ea0632cbc26c42829fcdb6dd816c3 {
	civic-kb:Drugs-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-635ea0632cbc26c42829fcdb6dd816c3 .

	civic-kb:Status-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-635ea0632cbc26c42829fcdb6dd816c3 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-635ea0632cbc26c42829fcdb6dd816c3 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"395"^^xsd:integer .

	civic-kb:Gene-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R273C"^^xsd:string .

	civic-kb:Description-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-635ea0632cbc26c42829fcdb6dd816c3 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer patients who harbor R273C mutation have worse overall survival than those with wild type TP53, but have better prognosis than those with R248W mutation."^^xsd:string .

	civic-kb:Disease-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-635ea0632cbc26c42829fcdb6dd816c3 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-635ea0632cbc26c42829fcdb6dd816c3 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-635ea0632cbc26c42829fcdb6dd816c3 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-635ea0632cbc26c42829fcdb6dd816c3 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-635ea0632cbc26c42829fcdb6dd816c3 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-635ea0632cbc26c42829fcdb6dd816c3 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-635ea0632cbc26c42829fcdb6dd816c3	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-635ea0632cbc26c42829fcdb6dd816c3 .

}

civic-kb:provenance-635ea0632cbc26c42829fcdb6dd816c3 {
	civic-kb:assertion-635ea0632cbc26c42829fcdb6dd816c3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-635ea0632cbc26c42829fcdb6dd816c3 .

	civic-kb:Status-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-635ea0632cbc26c42829fcdb6dd816c3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-635ea0632cbc26c42829fcdb6dd816c3 {
	civic-kb:nanoPub-635ea0632cbc26c42829fcdb6dd816c3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-635ea0632cbc26c42829fcdb6dd816c3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f233af58d597a607ed0ae84dd0e1091f {
	civic-kb:nanoPub-f233af58d597a607ed0ae84dd0e1091f
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f233af58d597a607ed0ae84dd0e1091f ;
		np:hasProvenance civic-kb:provenance-f233af58d597a607ed0ae84dd0e1091f ;
		np:hasPublicationInfo civic-kb:pubInfo-f233af58d597a607ed0ae84dd0e1091f .
}

civic-kb:assertion-f233af58d597a607ed0ae84dd0e1091f {
	civic-kb:Drugs-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f233af58d597a607ed0ae84dd0e1091f .

	civic-kb:Status-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f233af58d597a607ed0ae84dd0e1091f ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f233af58d597a607ed0ae84dd0e1091f ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"396"^^xsd:integer .

	civic-kb:Gene-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R273C"^^xsd:string .

	civic-kb:Description-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f233af58d597a607ed0ae84dd0e1091f ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In breast cancer patients  harboring TP53 mutation, mutations in DNA contact regions such as R273 are prognostic for a worse relapse-free survival compared to other non-silent mutations in TP53."^^xsd:string .

	civic-kb:Disease-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f233af58d597a607ed0ae84dd0e1091f ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f233af58d597a607ed0ae84dd0e1091f ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f233af58d597a607ed0ae84dd0e1091f ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f233af58d597a607ed0ae84dd0e1091f ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f233af58d597a607ed0ae84dd0e1091f ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f233af58d597a607ed0ae84dd0e1091f ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-f233af58d597a607ed0ae84dd0e1091f	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f233af58d597a607ed0ae84dd0e1091f .

}

civic-kb:provenance-f233af58d597a607ed0ae84dd0e1091f {
	civic-kb:assertion-f233af58d597a607ed0ae84dd0e1091f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f233af58d597a607ed0ae84dd0e1091f .

	civic-kb:Status-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-f233af58d597a607ed0ae84dd0e1091f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f233af58d597a607ed0ae84dd0e1091f {
	civic-kb:nanoPub-f233af58d597a607ed0ae84dd0e1091f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f233af58d597a607ed0ae84dd0e1091f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-1a5be98aea5e518177160148df8e6df3 {
	civic-kb:nanoPub-1a5be98aea5e518177160148df8e6df3
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-1a5be98aea5e518177160148df8e6df3 ;
		np:hasProvenance civic-kb:provenance-1a5be98aea5e518177160148df8e6df3 ;
		np:hasPublicationInfo civic-kb:pubInfo-1a5be98aea5e518177160148df8e6df3 .
}

civic-kb:assertion-1a5be98aea5e518177160148df8e6df3 {
	civic-kb:Drugs-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1a5be98aea5e518177160148df8e6df3 .

	civic-kb:Status-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-1a5be98aea5e518177160148df8e6df3 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-1a5be98aea5e518177160148df8e6df3 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1076"^^xsd:integer .

	civic-kb:Gene-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17966 ;
		rdf:type	uniprot:P08183 ;
		rdfs:label	"ABCB1 Gene"^^xsd:string ;
		sio:hasValue	"ABCB1"^^xsd:string .

	civic-kb:Variant-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"I1145I"^^xsd:string .

	civic-kb:Description-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-1a5be98aea5e518177160148df8e6df3 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A total of 57 women with HER2-positive metastatic breast cancer were analyzed after taxane plus trastuzumab chemotherapy. ABCB1 C3435T carriers had a longer progression-free survival (p = 0.039) along with a tendency toward a longer overall survival (p = 0.093)."^^xsd:string .

	civic-kb:Disease-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1a5be98aea5e518177160148df8e6df3 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-1a5be98aea5e518177160148df8e6df3 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1a5be98aea5e518177160148df8e6df3 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1a5be98aea5e518177160148df8e6df3 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Better Outcome"^^xsd:string .

	civic-kb:Variant_Origin-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-1a5be98aea5e518177160148df8e6df3 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Polymorphism"^^xsd:string .

	civic-kb:Trust_Rating-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-1a5be98aea5e518177160148df8e6df3 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-1a5be98aea5e518177160148df8e6df3	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-1a5be98aea5e518177160148df8e6df3 .

}

civic-kb:provenance-1a5be98aea5e518177160148df8e6df3 {
	civic-kb:assertion-1a5be98aea5e518177160148df8e6df3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-1a5be98aea5e518177160148df8e6df3 .

	civic-kb:Status-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-1a5be98aea5e518177160148df8e6df3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-1a5be98aea5e518177160148df8e6df3 {
	civic-kb:nanoPub-1a5be98aea5e518177160148df8e6df3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-1a5be98aea5e518177160148df8e6df3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-beaef61ca990cf9e264d7417d49bccad {
	civic-kb:nanoPub-beaef61ca990cf9e264d7417d49bccad
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-beaef61ca990cf9e264d7417d49bccad ;
		np:hasProvenance civic-kb:provenance-beaef61ca990cf9e264d7417d49bccad ;
		np:hasPublicationInfo civic-kb:pubInfo-beaef61ca990cf9e264d7417d49bccad .
}

civic-kb:assertion-beaef61ca990cf9e264d7417d49bccad {
	civic-kb:Drugs-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-beaef61ca990cf9e264d7417d49bccad ;
		rdf:type	chebi:41774 ;
		rdf:type	db:DB00675 ;
		rdfs:label	"Tamoxifen"^^xsd:string ;
		sio:hasValue	"Tamoxifen"^^xsd:string .

	civic-kb:Status-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-beaef61ca990cf9e264d7417d49bccad ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-beaef61ca990cf9e264d7417d49bccad ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"857"^^xsd:integer .

	civic-kb:Gene-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C49129 ;
		rdf:type	uniprot:Q96T23 ;
		rdfs:label	"RSF1 Gene"^^xsd:string ;
		sio:hasValue	"RSF1"^^xsd:string .

	civic-kb:Variant-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-beaef61ca990cf9e264d7417d49bccad ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In retrospective study, 413 patients were assessed for RSF1 amplification. 28 patients with RSF1 amplification did not show a benefit from adjuvant tamoxifen compared to placebo (12 treated vs 16 placebo). 381 patients without amplification did show a benefit compared to placebo (187 treated vs 194 placebo)."^^xsd:string .

	civic-kb:Disease-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-beaef61ca990cf9e264d7417d49bccad ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-beaef61ca990cf9e264d7417d49bccad ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-beaef61ca990cf9e264d7417d49bccad ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-beaef61ca990cf9e264d7417d49bccad ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-beaef61ca990cf9e264d7417d49bccad ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-beaef61ca990cf9e264d7417d49bccad ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-beaef61ca990cf9e264d7417d49bccad	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-beaef61ca990cf9e264d7417d49bccad .

}

civic-kb:provenance-beaef61ca990cf9e264d7417d49bccad {
	civic-kb:assertion-beaef61ca990cf9e264d7417d49bccad prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-beaef61ca990cf9e264d7417d49bccad .

	civic-kb:Status-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-beaef61ca990cf9e264d7417d49bccad	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-beaef61ca990cf9e264d7417d49bccad {
	civic-kb:nanoPub-beaef61ca990cf9e264d7417d49bccad prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-beaef61ca990cf9e264d7417d49bccad
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2b2cba1a8ecc34c0f14f33cc7306814d {
	civic-kb:nanoPub-2b2cba1a8ecc34c0f14f33cc7306814d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2b2cba1a8ecc34c0f14f33cc7306814d ;
		np:hasProvenance civic-kb:provenance-2b2cba1a8ecc34c0f14f33cc7306814d ;
		np:hasPublicationInfo civic-kb:pubInfo-2b2cba1a8ecc34c0f14f33cc7306814d .
}

civic-kb:assertion-2b2cba1a8ecc34c0f14f33cc7306814d {
	civic-kb:Drugs-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2b2cba1a8ecc34c0f14f33cc7306814d ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2b2cba1a8ecc34c0f14f33cc7306814d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2b2cba1a8ecc34c0f14f33cc7306814d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"869"^^xsd:integer .

	civic-kb:Gene-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18388 ;
		rdf:type	uniprot:Q15303 ;
		rdfs:label	"ERBB4 Gene"^^xsd:string ;
		sio:hasValue	"ERBB4"^^xsd:string .

	civic-kb:Variant-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2b2cba1a8ecc34c0f14f33cc7306814d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"ERBB4 protein expression was identified in breast cancer cell lines with acquired lapatinib resistance. Genetic ablation of ERBB4 (not ERBB1-3) led to apoptosis in trastuzumab- and lapatinib resistant cells, probably through a decrease in the PI3K/Akt pathway."^^xsd:string .

	civic-kb:Disease-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2b2cba1a8ecc34c0f14f33cc7306814d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2b2cba1a8ecc34c0f14f33cc7306814d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2b2cba1a8ecc34c0f14f33cc7306814d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2b2cba1a8ecc34c0f14f33cc7306814d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2b2cba1a8ecc34c0f14f33cc7306814d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2b2cba1a8ecc34c0f14f33cc7306814d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-2b2cba1a8ecc34c0f14f33cc7306814d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2b2cba1a8ecc34c0f14f33cc7306814d .

}

civic-kb:provenance-2b2cba1a8ecc34c0f14f33cc7306814d {
	civic-kb:assertion-2b2cba1a8ecc34c0f14f33cc7306814d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2b2cba1a8ecc34c0f14f33cc7306814d .

	civic-kb:Status-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-2b2cba1a8ecc34c0f14f33cc7306814d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2b2cba1a8ecc34c0f14f33cc7306814d {
	civic-kb:nanoPub-2b2cba1a8ecc34c0f14f33cc7306814d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2b2cba1a8ecc34c0f14f33cc7306814d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f6dff1432a6957e274c4c63531f9ac2d {
	civic-kb:nanoPub-f6dff1432a6957e274c4c63531f9ac2d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f6dff1432a6957e274c4c63531f9ac2d ;
		np:hasProvenance civic-kb:provenance-f6dff1432a6957e274c4c63531f9ac2d ;
		np:hasPublicationInfo civic-kb:pubInfo-f6dff1432a6957e274c4c63531f9ac2d .
}

civic-kb:assertion-f6dff1432a6957e274c4c63531f9ac2d {
	civic-kb:Drugs-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f6dff1432a6957e274c4c63531f9ac2d .

	civic-kb:Status-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f6dff1432a6957e274c4c63531f9ac2d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f6dff1432a6957e274c4c63531f9ac2d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1961"^^xsd:integer .

	civic-kb:Gene-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18388 ;
		rdf:type	uniprot:Q15303 ;
		rdfs:label	"ERBB4 Gene"^^xsd:string ;
		sio:hasValue	"ERBB4"^^xsd:string .

	civic-kb:Variant-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f6dff1432a6957e274c4c63531f9ac2d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f6dff1432a6957e274c4c63531f9ac2d ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f6dff1432a6957e274c4c63531f9ac2d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f6dff1432a6957e274c4c63531f9ac2d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f6dff1432a6957e274c4c63531f9ac2d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Positive"^^xsd:string .

	civic-kb:Variant_Origin-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f6dff1432a6957e274c4c63531f9ac2d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f6dff1432a6957e274c4c63531f9ac2d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-f6dff1432a6957e274c4c63531f9ac2d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f6dff1432a6957e274c4c63531f9ac2d .

}

civic-kb:provenance-f6dff1432a6957e274c4c63531f9ac2d {
	civic-kb:assertion-f6dff1432a6957e274c4c63531f9ac2d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f6dff1432a6957e274c4c63531f9ac2d .

	civic-kb:Status-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-f6dff1432a6957e274c4c63531f9ac2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f6dff1432a6957e274c4c63531f9ac2d {
	civic-kb:nanoPub-f6dff1432a6957e274c4c63531f9ac2d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f6dff1432a6957e274c4c63531f9ac2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2ced2704e17737f064c3b45a572e3b3d {
	civic-kb:nanoPub-2ced2704e17737f064c3b45a572e3b3d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2ced2704e17737f064c3b45a572e3b3d ;
		np:hasProvenance civic-kb:provenance-2ced2704e17737f064c3b45a572e3b3d ;
		np:hasPublicationInfo civic-kb:pubInfo-2ced2704e17737f064c3b45a572e3b3d .
}

civic-kb:assertion-2ced2704e17737f064c3b45a572e3b3d {
	civic-kb:Drugs-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2ced2704e17737f064c3b45a572e3b3d ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2ced2704e17737f064c3b45a572e3b3d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2ced2704e17737f064c3b45a572e3b3d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"868"^^xsd:integer .

	civic-kb:Gene-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18388 ;
		rdf:type	uniprot:Q15303 ;
		rdfs:label	"ERBB4 Gene"^^xsd:string ;
		sio:hasValue	"ERBB4"^^xsd:string .

	civic-kb:Variant-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2ced2704e17737f064c3b45a572e3b3d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"siRNA knockdown of HER4 or inhibition with neratinib enhanced trastuzumab response in breast cancer cell lines."^^xsd:string .

	civic-kb:Disease-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2ced2704e17737f064c3b45a572e3b3d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2ced2704e17737f064c3b45a572e3b3d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2ced2704e17737f064c3b45a572e3b3d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2ced2704e17737f064c3b45a572e3b3d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2ced2704e17737f064c3b45a572e3b3d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2ced2704e17737f064c3b45a572e3b3d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-2ced2704e17737f064c3b45a572e3b3d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2ced2704e17737f064c3b45a572e3b3d .

}

civic-kb:provenance-2ced2704e17737f064c3b45a572e3b3d {
	civic-kb:assertion-2ced2704e17737f064c3b45a572e3b3d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2ced2704e17737f064c3b45a572e3b3d .

	civic-kb:Status-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-2ced2704e17737f064c3b45a572e3b3d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2ced2704e17737f064c3b45a572e3b3d {
	civic-kb:nanoPub-2ced2704e17737f064c3b45a572e3b3d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2ced2704e17737f064c3b45a572e3b3d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-45e44bc30cd2db2c8c47d33757e4b342 {
	civic-kb:nanoPub-45e44bc30cd2db2c8c47d33757e4b342
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-45e44bc30cd2db2c8c47d33757e4b342 ;
		np:hasProvenance civic-kb:provenance-45e44bc30cd2db2c8c47d33757e4b342 ;
		np:hasPublicationInfo civic-kb:pubInfo-45e44bc30cd2db2c8c47d33757e4b342 .
}

civic-kb:assertion-45e44bc30cd2db2c8c47d33757e4b342 {
	civic-kb:Drugs-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-45e44bc30cd2db2c8c47d33757e4b342 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-45e44bc30cd2db2c8c47d33757e4b342 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-45e44bc30cd2db2c8c47d33757e4b342 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"645"^^xsd:integer .

	civic-kb:Gene-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss"^^xsd:string ;
		sio:hasValue	"LOSS"^^xsd:string .

	civic-kb:Description-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-45e44bc30cd2db2c8c47d33757e4b342 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PTEN loss is associated with loss of sensitivity to the HER2-antibody trastuzumab in breast cancer in smaller trials, a phase III trial (NCCTG N9831) did not show an effect of PTEN on disease-free survival."^^xsd:string .

	civic-kb:Disease-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-45e44bc30cd2db2c8c47d33757e4b342 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-45e44bc30cd2db2c8c47d33757e4b342 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-45e44bc30cd2db2c8c47d33757e4b342 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-45e44bc30cd2db2c8c47d33757e4b342 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-45e44bc30cd2db2c8c47d33757e4b342 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-45e44bc30cd2db2c8c47d33757e4b342 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"1"^^xsd:integer .

	civic-kb:evidence-45e44bc30cd2db2c8c47d33757e4b342	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-45e44bc30cd2db2c8c47d33757e4b342 .

}

civic-kb:provenance-45e44bc30cd2db2c8c47d33757e4b342 {
	civic-kb:assertion-45e44bc30cd2db2c8c47d33757e4b342 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-45e44bc30cd2db2c8c47d33757e4b342 .

	civic-kb:Status-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-45e44bc30cd2db2c8c47d33757e4b342	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-45e44bc30cd2db2c8c47d33757e4b342 {
	civic-kb:nanoPub-45e44bc30cd2db2c8c47d33757e4b342 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-45e44bc30cd2db2c8c47d33757e4b342
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-87a333712ae8a25f26b6e8ecf9334ce4 {
	civic-kb:nanoPub-87a333712ae8a25f26b6e8ecf9334ce4
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-87a333712ae8a25f26b6e8ecf9334ce4 ;
		np:hasProvenance civic-kb:provenance-87a333712ae8a25f26b6e8ecf9334ce4 ;
		np:hasPublicationInfo civic-kb:pubInfo-87a333712ae8a25f26b6e8ecf9334ce4 .
}

civic-kb:assertion-87a333712ae8a25f26b6e8ecf9334ce4 {
	civic-kb:Drugs-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-87a333712ae8a25f26b6e8ecf9334ce4 ;
		rdfs:label	"AZD-8186"^^xsd:string ;
		sio:hasValue	"AZD8186"^^xsd:string .

	civic-kb:Status-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-87a333712ae8a25f26b6e8ecf9334ce4 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-87a333712ae8a25f26b6e8ecf9334ce4 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"711"^^xsd:integer .

	civic-kb:Gene-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss"^^xsd:string ;
		sio:hasValue	"LOSS"^^xsd:string .

	civic-kb:Description-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-87a333712ae8a25f26b6e8ecf9334ce4 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast and prostate cancer cell lines responsive to AZD8186 were enriched for PTEN deficiency."^^xsd:string .

	civic-kb:Disease-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-87a333712ae8a25f26b6e8ecf9334ce4 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-87a333712ae8a25f26b6e8ecf9334ce4 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-87a333712ae8a25f26b6e8ecf9334ce4 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-87a333712ae8a25f26b6e8ecf9334ce4 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-87a333712ae8a25f26b6e8ecf9334ce4 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-87a333712ae8a25f26b6e8ecf9334ce4 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-87a333712ae8a25f26b6e8ecf9334ce4	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-87a333712ae8a25f26b6e8ecf9334ce4 .

}

civic-kb:provenance-87a333712ae8a25f26b6e8ecf9334ce4 {
	civic-kb:assertion-87a333712ae8a25f26b6e8ecf9334ce4 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-87a333712ae8a25f26b6e8ecf9334ce4 .

	civic-kb:Status-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-87a333712ae8a25f26b6e8ecf9334ce4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-87a333712ae8a25f26b6e8ecf9334ce4 {
	civic-kb:nanoPub-87a333712ae8a25f26b6e8ecf9334ce4 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-87a333712ae8a25f26b6e8ecf9334ce4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-93b8e8aa4b3754bea7991babb9cdfccc {
	civic-kb:nanoPub-93b8e8aa4b3754bea7991babb9cdfccc
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-93b8e8aa4b3754bea7991babb9cdfccc ;
		np:hasProvenance civic-kb:provenance-93b8e8aa4b3754bea7991babb9cdfccc ;
		np:hasPublicationInfo civic-kb:pubInfo-93b8e8aa4b3754bea7991babb9cdfccc .
}

civic-kb:assertion-93b8e8aa4b3754bea7991babb9cdfccc {
	civic-kb:Drugs-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-93b8e8aa4b3754bea7991babb9cdfccc ;
		rdf:type	db:DB12015 ;
		rdfs:label	"Alpelisib"^^xsd:string ;
		sio:hasValue	"BYL719 (Alpelisib)"^^xsd:string .

	civic-kb:Status-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-93b8e8aa4b3754bea7991babb9cdfccc ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-93b8e8aa4b3754bea7991babb9cdfccc ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"716"^^xsd:integer .

	civic-kb:Gene-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss"^^xsd:string ;
		sio:hasValue	"LOSS"^^xsd:string .

	civic-kb:Description-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-93b8e8aa4b3754bea7991babb9cdfccc ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A case report described a responder to PI3K inhibitor BYL719 for a tumor with PIK3CA E542K mutation. After partial response for 9.5 months, resistance developed. Sequencing in this and other patients as well as preclinical models showed loss of PTEN as the probable mechanism of resistance."^^xsd:string .

	civic-kb:Disease-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-93b8e8aa4b3754bea7991babb9cdfccc ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-93b8e8aa4b3754bea7991babb9cdfccc ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-93b8e8aa4b3754bea7991babb9cdfccc ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-93b8e8aa4b3754bea7991babb9cdfccc ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-93b8e8aa4b3754bea7991babb9cdfccc ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-93b8e8aa4b3754bea7991babb9cdfccc ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-93b8e8aa4b3754bea7991babb9cdfccc	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-93b8e8aa4b3754bea7991babb9cdfccc .

}

civic-kb:provenance-93b8e8aa4b3754bea7991babb9cdfccc {
	civic-kb:assertion-93b8e8aa4b3754bea7991babb9cdfccc prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-93b8e8aa4b3754bea7991babb9cdfccc .

	civic-kb:Status-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-93b8e8aa4b3754bea7991babb9cdfccc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-93b8e8aa4b3754bea7991babb9cdfccc {
	civic-kb:nanoPub-93b8e8aa4b3754bea7991babb9cdfccc prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-93b8e8aa4b3754bea7991babb9cdfccc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-14b0d11d43f2fd94f5ba2a39a1656e12 {
	civic-kb:nanoPub-14b0d11d43f2fd94f5ba2a39a1656e12
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		np:hasProvenance civic-kb:provenance-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		np:hasPublicationInfo civic-kb:pubInfo-14b0d11d43f2fd94f5ba2a39a1656e12 .
}

civic-kb:assertion-14b0d11d43f2fd94f5ba2a39a1656e12 {
	civic-kb:Drugs-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1385"^^xsd:integer .

	civic-kb:Gene-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss"^^xsd:string ;
		sio:hasValue	"LOSS"^^xsd:string .

	civic-kb:Description-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A subgroup of HER2-positive breast cancer patients that received first-line trastuzumab treatment were assessed for PTEN loss via IHC of FFPE samples. 46 samples showed PTEN loss while 41 did not, and PTEN loss alone was found to be significantly associated with resistance to trastuzumab (p=0.028) and shorter overall survival (p=0.008)."^^xsd:string .

	civic-kb:Disease-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-14b0d11d43f2fd94f5ba2a39a1656e12 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-14b0d11d43f2fd94f5ba2a39a1656e12	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-14b0d11d43f2fd94f5ba2a39a1656e12 .

}

civic-kb:provenance-14b0d11d43f2fd94f5ba2a39a1656e12 {
	civic-kb:assertion-14b0d11d43f2fd94f5ba2a39a1656e12 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-14b0d11d43f2fd94f5ba2a39a1656e12 .

	civic-kb:Status-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-14b0d11d43f2fd94f5ba2a39a1656e12	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-14b0d11d43f2fd94f5ba2a39a1656e12 {
	civic-kb:nanoPub-14b0d11d43f2fd94f5ba2a39a1656e12 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-14b0d11d43f2fd94f5ba2a39a1656e12
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f664a45fabefc067f157777272dd1740 {
	civic-kb:nanoPub-f664a45fabefc067f157777272dd1740
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f664a45fabefc067f157777272dd1740 ;
		np:hasProvenance civic-kb:provenance-f664a45fabefc067f157777272dd1740 ;
		np:hasPublicationInfo civic-kb:pubInfo-f664a45fabefc067f157777272dd1740 .
}

civic-kb:assertion-f664a45fabefc067f157777272dd1740 {
	civic-kb:Drugs-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f664a45fabefc067f157777272dd1740 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f664a45fabefc067f157777272dd1740 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f664a45fabefc067f157777272dd1740 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1383"^^xsd:integer .

	civic-kb:Gene-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss"^^xsd:string ;
		sio:hasValue	"LOSS"^^xsd:string .

	civic-kb:Description-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f664a45fabefc067f157777272dd1740 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A large-scale RNAi genetic sereen in HER2 overexpressing breast cancer cell line BT-474 was performed to discover genes whose loss induced trastuzumab resistance. The most prominently enriched gene in trastuzumab resistant populations was PTEN. Subsequent knockdown of PTEN in BT-474 cells increased cell survival when treated with trastuzumab, and growth curves showed partial restoration of proliferation in PTEN knockdown BT-474 cells treated with trastuzumab."^^xsd:string .

	civic-kb:Disease-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f664a45fabefc067f157777272dd1740 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f664a45fabefc067f157777272dd1740 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f664a45fabefc067f157777272dd1740 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f664a45fabefc067f157777272dd1740 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f664a45fabefc067f157777272dd1740 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f664a45fabefc067f157777272dd1740 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-f664a45fabefc067f157777272dd1740	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f664a45fabefc067f157777272dd1740 .

}

civic-kb:provenance-f664a45fabefc067f157777272dd1740 {
	civic-kb:assertion-f664a45fabefc067f157777272dd1740 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f664a45fabefc067f157777272dd1740 .

	civic-kb:Status-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-f664a45fabefc067f157777272dd1740	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f664a45fabefc067f157777272dd1740 {
	civic-kb:nanoPub-f664a45fabefc067f157777272dd1740 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f664a45fabefc067f157777272dd1740
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-a01c58bb684e8763836f58bede4b5368 {
	civic-kb:nanoPub-a01c58bb684e8763836f58bede4b5368
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-a01c58bb684e8763836f58bede4b5368 ;
		np:hasProvenance civic-kb:provenance-a01c58bb684e8763836f58bede4b5368 ;
		np:hasPublicationInfo civic-kb:pubInfo-a01c58bb684e8763836f58bede4b5368 .
}

civic-kb:assertion-a01c58bb684e8763836f58bede4b5368 {
	civic-kb:Drugs-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a01c58bb684e8763836f58bede4b5368 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-a01c58bb684e8763836f58bede4b5368 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-a01c58bb684e8763836f58bede4b5368 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1386"^^xsd:integer .

	civic-kb:Gene-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss"^^xsd:string ;
		sio:hasValue	"LOSS"^^xsd:string .

	civic-kb:Description-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-a01c58bb684e8763836f58bede4b5368 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"While some reports indicate PTEN loss is associated with resistance to trastuzumab, in a subgroup of HER2 breast cancer FFPE samples from patients receiving trastuzumab as later line therapy (second or greater line therapy), with 25 PTEN loss and and 25 normal samples, no association was seen between trastuzumab response and PTEN status (p=1.000) or overall survival and PTEN status (p=0.863)."^^xsd:string .

	civic-kb:Disease-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a01c58bb684e8763836f58bede4b5368 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-a01c58bb684e8763836f58bede4b5368 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a01c58bb684e8763836f58bede4b5368 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a01c58bb684e8763836f58bede4b5368 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-a01c58bb684e8763836f58bede4b5368 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-a01c58bb684e8763836f58bede4b5368 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-a01c58bb684e8763836f58bede4b5368	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-a01c58bb684e8763836f58bede4b5368 .

}

civic-kb:provenance-a01c58bb684e8763836f58bede4b5368 {
	civic-kb:assertion-a01c58bb684e8763836f58bede4b5368 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-a01c58bb684e8763836f58bede4b5368 .

	civic-kb:Status-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-a01c58bb684e8763836f58bede4b5368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-a01c58bb684e8763836f58bede4b5368 {
	civic-kb:nanoPub-a01c58bb684e8763836f58bede4b5368 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-a01c58bb684e8763836f58bede4b5368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-67bb9f77784acfe7a8516bcc041a7640 {
	civic-kb:nanoPub-67bb9f77784acfe7a8516bcc041a7640
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-67bb9f77784acfe7a8516bcc041a7640 ;
		np:hasProvenance civic-kb:provenance-67bb9f77784acfe7a8516bcc041a7640 ;
		np:hasPublicationInfo civic-kb:pubInfo-67bb9f77784acfe7a8516bcc041a7640 .
}

civic-kb:assertion-67bb9f77784acfe7a8516bcc041a7640 {
	civic-kb:Drugs-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-67bb9f77784acfe7a8516bcc041a7640 ;
		rdf:type	dron:00018224 ;
		rdf:type	db:DB01590 ;
		rdfs:label	"Everolimus"^^xsd:string ;
		sio:hasValue	"Everolimus"^^xsd:string .

	civic-kb:Status-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-67bb9f77784acfe7a8516bcc041a7640 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-67bb9f77784acfe7a8516bcc041a7640 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1297"^^xsd:integer .

	civic-kb:Gene-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss"^^xsd:string ;
		sio:hasValue	"LOSS"^^xsd:string .

	civic-kb:Description-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-67bb9f77784acfe7a8516bcc041a7640 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Archival tumor samples from 549 patients from the BOLERO-1 and -3 trials were analyzed for alterations in the PI3K pathway using next-generation sequencing, immunohistochemistry (IHC) and Sanger sequencing. In the BOLERO trials, patients with HER2-overexpressing advanced breast cancer were treated with trastuzumab, chemotherapy and randomized to receive either everolimus or placebo. In the pooled analysis of both trials, patients with PTEN loss (as defined by IHC staining intensity and proportion of positive tumor cells) had a longer progression-free survival with everolimus compared to placebo (HR 0.54 (95%CI 0.31 to 0.96, P=0.04) whereas patients with PTEN normal status had a hazard ration of 1.00 (95%CI 0.8 to 1.26, P=0.97).
The same was found when PI3K mutations, PTEN loss and AKT E17K mutations were combined and analyzed as hyperactive PI3K pathway. Patients with PI3K hyperactive pathway had a hazard ratio of 0.67 (95%CI 0.48 to 0.93, P=0.02) compared to HR 1.19 (95%CI 0.87 to 1.62, P=0.28) in patients with PI3K normal pathway. These trends were independently confirmed in both trials but only pooled results showed consistent statistical significance."^^xsd:string .

	civic-kb:Disease-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-67bb9f77784acfe7a8516bcc041a7640 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-67bb9f77784acfe7a8516bcc041a7640 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-67bb9f77784acfe7a8516bcc041a7640 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-67bb9f77784acfe7a8516bcc041a7640 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-67bb9f77784acfe7a8516bcc041a7640 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-67bb9f77784acfe7a8516bcc041a7640 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-67bb9f77784acfe7a8516bcc041a7640	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-67bb9f77784acfe7a8516bcc041a7640 .

}

civic-kb:provenance-67bb9f77784acfe7a8516bcc041a7640 {
	civic-kb:assertion-67bb9f77784acfe7a8516bcc041a7640 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-67bb9f77784acfe7a8516bcc041a7640 .

	civic-kb:Status-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-67bb9f77784acfe7a8516bcc041a7640	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-67bb9f77784acfe7a8516bcc041a7640 {
	civic-kb:nanoPub-67bb9f77784acfe7a8516bcc041a7640 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-67bb9f77784acfe7a8516bcc041a7640
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-18c50b575e2f9e425d7af83659d2e7dc {
	civic-kb:nanoPub-18c50b575e2f9e425d7af83659d2e7dc
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-18c50b575e2f9e425d7af83659d2e7dc ;
		np:hasProvenance civic-kb:provenance-18c50b575e2f9e425d7af83659d2e7dc ;
		np:hasPublicationInfo civic-kb:pubInfo-18c50b575e2f9e425d7af83659d2e7dc .
}

civic-kb:assertion-18c50b575e2f9e425d7af83659d2e7dc {
	civic-kb:Drugs-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-18c50b575e2f9e425d7af83659d2e7dc ;
		sio:hasValue	"Trastuzumab, LY294002"^^xsd:string .

	civic-kb:Status-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-18c50b575e2f9e425d7af83659d2e7dc ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-18c50b575e2f9e425d7af83659d2e7dc ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1455"^^xsd:integer .

	civic-kb:Gene-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss"^^xsd:string ;
		sio:hasValue	"LOSS"^^xsd:string .

	civic-kb:Description-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-18c50b575e2f9e425d7af83659d2e7dc ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Knockdown of PTEN in trastuzumab sensitive HER2 breast cancer BT474 cells induced trastuzumab resistance. PTEN null cells treated with PI3K inhibitor LY294002 also did not show substantial inhibition, but co-treatment with trastuzumab and LY294002 induced growth inhibition comparable to trastuzumab alone in normal BT474 cells. BT474 mouse xenograft tumors were injected with PTEN antisense (AS) oligonucleotides and this resulted in trastuzumab resitance. Co-treatment of PTEN AS tumor mice with LY294002 and trastuzumab inhibited tumor growth in comparison to PTEN AS tumors treated with trastuzumab or LY294002 alone."^^xsd:string .

	civic-kb:Disease-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-18c50b575e2f9e425d7af83659d2e7dc ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-18c50b575e2f9e425d7af83659d2e7dc ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-18c50b575e2f9e425d7af83659d2e7dc ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-18c50b575e2f9e425d7af83659d2e7dc ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-18c50b575e2f9e425d7af83659d2e7dc ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-18c50b575e2f9e425d7af83659d2e7dc ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-18c50b575e2f9e425d7af83659d2e7dc	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-18c50b575e2f9e425d7af83659d2e7dc .

}

civic-kb:provenance-18c50b575e2f9e425d7af83659d2e7dc {
	civic-kb:assertion-18c50b575e2f9e425d7af83659d2e7dc prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-18c50b575e2f9e425d7af83659d2e7dc .

	civic-kb:Status-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-18c50b575e2f9e425d7af83659d2e7dc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-18c50b575e2f9e425d7af83659d2e7dc {
	civic-kb:nanoPub-18c50b575e2f9e425d7af83659d2e7dc prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-18c50b575e2f9e425d7af83659d2e7dc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-960cab6990f2ce6b39b0cf959882880b {
	civic-kb:nanoPub-960cab6990f2ce6b39b0cf959882880b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-960cab6990f2ce6b39b0cf959882880b ;
		np:hasProvenance civic-kb:provenance-960cab6990f2ce6b39b0cf959882880b ;
		np:hasPublicationInfo civic-kb:pubInfo-960cab6990f2ce6b39b0cf959882880b .
}

civic-kb:assertion-960cab6990f2ce6b39b0cf959882880b {
	civic-kb:Drugs-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-960cab6990f2ce6b39b0cf959882880b ;
		sio:hasValue	"Everolimus, PP242"^^xsd:string .

	civic-kb:Status-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-960cab6990f2ce6b39b0cf959882880b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-960cab6990f2ce6b39b0cf959882880b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1611"^^xsd:integer .

	civic-kb:Gene-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss"^^xsd:string ;
		sio:hasValue	"LOSS"^^xsd:string .

	civic-kb:Description-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-960cab6990f2ce6b39b0cf959882880b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a panel of 31 breast cancer cell lines, 11 had loss of PTEN function. Cells were tested for sensitivity to mTORC1 inhibitor everolimus and mTORC1/2 inhibitor PP242, and no significant correlation was found between PTEN status and sensitivity to mTORC inhibition."^^xsd:string .

	civic-kb:Disease-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-960cab6990f2ce6b39b0cf959882880b ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-960cab6990f2ce6b39b0cf959882880b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-960cab6990f2ce6b39b0cf959882880b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-960cab6990f2ce6b39b0cf959882880b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-960cab6990f2ce6b39b0cf959882880b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-960cab6990f2ce6b39b0cf959882880b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-960cab6990f2ce6b39b0cf959882880b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-960cab6990f2ce6b39b0cf959882880b .

}

civic-kb:provenance-960cab6990f2ce6b39b0cf959882880b {
	civic-kb:assertion-960cab6990f2ce6b39b0cf959882880b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-960cab6990f2ce6b39b0cf959882880b .

	civic-kb:Status-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-960cab6990f2ce6b39b0cf959882880b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-960cab6990f2ce6b39b0cf959882880b {
	civic-kb:nanoPub-960cab6990f2ce6b39b0cf959882880b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-960cab6990f2ce6b39b0cf959882880b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d56bb5b3ebe5e4bc5d9a9625684593a1 {
	civic-kb:nanoPub-d56bb5b3ebe5e4bc5d9a9625684593a1
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		np:hasProvenance civic-kb:provenance-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		np:hasPublicationInfo civic-kb:pubInfo-d56bb5b3ebe5e4bc5d9a9625684593a1 .
}

civic-kb:assertion-d56bb5b3ebe5e4bc5d9a9625684593a1 {
	civic-kb:Drugs-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		rdf:type	dron:00013476 ;
		rdf:type	db:DB00877 ;
		rdfs:label	"Sirolimus"^^xsd:string ;
		sio:hasValue	"Rapamycin (Sirolimus)"^^xsd:string .

	civic-kb:Status-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"311"^^xsd:integer .

	civic-kb:Gene-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E542K"^^xsd:string .

	civic-kb:Description-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Rapamycin inhibits transformation induced by mutation in PIK3CA."^^xsd:string .

	civic-kb:Disease-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d56bb5b3ebe5e4bc5d9a9625684593a1 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-d56bb5b3ebe5e4bc5d9a9625684593a1	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d56bb5b3ebe5e4bc5d9a9625684593a1 .

}

civic-kb:provenance-d56bb5b3ebe5e4bc5d9a9625684593a1 {
	civic-kb:assertion-d56bb5b3ebe5e4bc5d9a9625684593a1 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d56bb5b3ebe5e4bc5d9a9625684593a1 .

	civic-kb:Status-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-d56bb5b3ebe5e4bc5d9a9625684593a1	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d56bb5b3ebe5e4bc5d9a9625684593a1 {
	civic-kb:nanoPub-d56bb5b3ebe5e4bc5d9a9625684593a1 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d56bb5b3ebe5e4bc5d9a9625684593a1
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c26477313718e6cb6fac435b73201e99 {
	civic-kb:nanoPub-c26477313718e6cb6fac435b73201e99
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c26477313718e6cb6fac435b73201e99 ;
		np:hasProvenance civic-kb:provenance-c26477313718e6cb6fac435b73201e99 ;
		np:hasPublicationInfo civic-kb:pubInfo-c26477313718e6cb6fac435b73201e99 .
}

civic-kb:assertion-c26477313718e6cb6fac435b73201e99 {
	civic-kb:Drugs-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c26477313718e6cb6fac435b73201e99 ;
		rdf:type	db:DB13051 ;
		rdfs:label	"CH5132799"^^xsd:string ;
		sio:hasValue	"CH5132799"^^xsd:string .

	civic-kb:Status-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c26477313718e6cb6fac435b73201e99 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c26477313718e6cb6fac435b73201e99 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"310"^^xsd:integer .

	civic-kb:Gene-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E542K"^^xsd:string .

	civic-kb:Description-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c26477313718e6cb6fac435b73201e99 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with E542K/E545K mutations showed increased sensitivity to CH5132799 than cells with wild-type PIK3CA gene."^^xsd:string .

	civic-kb:Disease-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c26477313718e6cb6fac435b73201e99 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c26477313718e6cb6fac435b73201e99 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c26477313718e6cb6fac435b73201e99 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c26477313718e6cb6fac435b73201e99 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c26477313718e6cb6fac435b73201e99 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c26477313718e6cb6fac435b73201e99 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-c26477313718e6cb6fac435b73201e99	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c26477313718e6cb6fac435b73201e99 .

}

civic-kb:provenance-c26477313718e6cb6fac435b73201e99 {
	civic-kb:assertion-c26477313718e6cb6fac435b73201e99 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c26477313718e6cb6fac435b73201e99 .

	civic-kb:Status-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-c26477313718e6cb6fac435b73201e99	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c26477313718e6cb6fac435b73201e99 {
	civic-kb:nanoPub-c26477313718e6cb6fac435b73201e99 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c26477313718e6cb6fac435b73201e99
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-bc1f00fe14c2a98e5b1820c0cfc3d851 {
	civic-kb:nanoPub-bc1f00fe14c2a98e5b1820c0cfc3d851
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		np:hasProvenance civic-kb:provenance-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		np:hasPublicationInfo civic-kb:pubInfo-bc1f00fe14c2a98e5b1820c0cfc3d851 .
}

civic-kb:assertion-bc1f00fe14c2a98e5b1820c0cfc3d851 {
	civic-kb:Drugs-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2022"^^xsd:integer .

	civic-kb:Gene-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E542K"^^xsd:string .

	civic-kb:Description-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines (n=54, P=0.005)."^^xsd:string .

	civic-kb:Disease-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-bc1f00fe14c2a98e5b1820c0cfc3d851 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-bc1f00fe14c2a98e5b1820c0cfc3d851	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-bc1f00fe14c2a98e5b1820c0cfc3d851 .

}

civic-kb:provenance-bc1f00fe14c2a98e5b1820c0cfc3d851 {
	civic-kb:assertion-bc1f00fe14c2a98e5b1820c0cfc3d851 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-bc1f00fe14c2a98e5b1820c0cfc3d851 .

	civic-kb:Status-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-bc1f00fe14c2a98e5b1820c0cfc3d851	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-bc1f00fe14c2a98e5b1820c0cfc3d851 {
	civic-kb:nanoPub-bc1f00fe14c2a98e5b1820c0cfc3d851 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-bc1f00fe14c2a98e5b1820c0cfc3d851
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-0958fc4150f86d14c29b99861730dcbd {
	civic-kb:nanoPub-0958fc4150f86d14c29b99861730dcbd
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-0958fc4150f86d14c29b99861730dcbd ;
		np:hasProvenance civic-kb:provenance-0958fc4150f86d14c29b99861730dcbd ;
		np:hasPublicationInfo civic-kb:pubInfo-0958fc4150f86d14c29b99861730dcbd .
}

civic-kb:assertion-0958fc4150f86d14c29b99861730dcbd {
	civic-kb:Drugs-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-0958fc4150f86d14c29b99861730dcbd ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-0958fc4150f86d14c29b99861730dcbd ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-0958fc4150f86d14c29b99861730dcbd ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2026"^^xsd:integer .

	civic-kb:Gene-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E542K"^^xsd:string .

	civic-kb:Description-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-0958fc4150f86d14c29b99861730dcbd ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines."^^xsd:string .

	civic-kb:Disease-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-0958fc4150f86d14c29b99861730dcbd ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-0958fc4150f86d14c29b99861730dcbd ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-0958fc4150f86d14c29b99861730dcbd ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-0958fc4150f86d14c29b99861730dcbd ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-0958fc4150f86d14c29b99861730dcbd ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-0958fc4150f86d14c29b99861730dcbd ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-0958fc4150f86d14c29b99861730dcbd	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-0958fc4150f86d14c29b99861730dcbd .

}

civic-kb:provenance-0958fc4150f86d14c29b99861730dcbd {
	civic-kb:assertion-0958fc4150f86d14c29b99861730dcbd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-0958fc4150f86d14c29b99861730dcbd .

	civic-kb:Status-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-0958fc4150f86d14c29b99861730dcbd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-0958fc4150f86d14c29b99861730dcbd {
	civic-kb:nanoPub-0958fc4150f86d14c29b99861730dcbd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-0958fc4150f86d14c29b99861730dcbd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ff4e541bc8b89da88521f168c677afaa {
	civic-kb:nanoPub-ff4e541bc8b89da88521f168c677afaa
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ff4e541bc8b89da88521f168c677afaa ;
		np:hasProvenance civic-kb:provenance-ff4e541bc8b89da88521f168c677afaa ;
		np:hasPublicationInfo civic-kb:pubInfo-ff4e541bc8b89da88521f168c677afaa .
}

civic-kb:assertion-ff4e541bc8b89da88521f168c677afaa {
	civic-kb:Drugs-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ff4e541bc8b89da88521f168c677afaa ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ff4e541bc8b89da88521f168c677afaa ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ff4e541bc8b89da88521f168c677afaa ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2025"^^xsd:integer .

	civic-kb:Gene-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E542K"^^xsd:string .

	civic-kb:Description-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ff4e541bc8b89da88521f168c677afaa ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ff4e541bc8b89da88521f168c677afaa ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ff4e541bc8b89da88521f168c677afaa ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ff4e541bc8b89da88521f168c677afaa ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ff4e541bc8b89da88521f168c677afaa ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ff4e541bc8b89da88521f168c677afaa ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ff4e541bc8b89da88521f168c677afaa ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-ff4e541bc8b89da88521f168c677afaa	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ff4e541bc8b89da88521f168c677afaa .

}

civic-kb:provenance-ff4e541bc8b89da88521f168c677afaa {
	civic-kb:assertion-ff4e541bc8b89da88521f168c677afaa prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ff4e541bc8b89da88521f168c677afaa .

	civic-kb:Status-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ff4e541bc8b89da88521f168c677afaa	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ff4e541bc8b89da88521f168c677afaa {
	civic-kb:nanoPub-ff4e541bc8b89da88521f168c677afaa prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ff4e541bc8b89da88521f168c677afaa
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-3f0f98f9a30e9b17f3e8af7c651ba76a {
	civic-kb:nanoPub-3f0f98f9a30e9b17f3e8af7c651ba76a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		np:hasProvenance civic-kb:provenance-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		np:hasPublicationInfo civic-kb:pubInfo-3f0f98f9a30e9b17f3e8af7c651ba76a .
}

civic-kb:assertion-3f0f98f9a30e9b17f3e8af7c651ba76a {
	civic-kb:Drugs-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2023"^^xsd:integer .

	civic-kb:Gene-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E542K"^^xsd:string .

	civic-kb:Description-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-3f0f98f9a30e9b17f3e8af7c651ba76a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-3f0f98f9a30e9b17f3e8af7c651ba76a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-3f0f98f9a30e9b17f3e8af7c651ba76a .

}

civic-kb:provenance-3f0f98f9a30e9b17f3e8af7c651ba76a {
	civic-kb:assertion-3f0f98f9a30e9b17f3e8af7c651ba76a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-3f0f98f9a30e9b17f3e8af7c651ba76a .

	civic-kb:Status-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-3f0f98f9a30e9b17f3e8af7c651ba76a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-3f0f98f9a30e9b17f3e8af7c651ba76a {
	civic-kb:nanoPub-3f0f98f9a30e9b17f3e8af7c651ba76a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-3f0f98f9a30e9b17f3e8af7c651ba76a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-a9074a0fd668861bdffb45b995a62033 {
	civic-kb:nanoPub-a9074a0fd668861bdffb45b995a62033
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-a9074a0fd668861bdffb45b995a62033 ;
		np:hasProvenance civic-kb:provenance-a9074a0fd668861bdffb45b995a62033 ;
		np:hasPublicationInfo civic-kb:pubInfo-a9074a0fd668861bdffb45b995a62033 .
}

civic-kb:assertion-a9074a0fd668861bdffb45b995a62033 {
	civic-kb:Drugs-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a9074a0fd668861bdffb45b995a62033 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-a9074a0fd668861bdffb45b995a62033 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-a9074a0fd668861bdffb45b995a62033 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2024"^^xsd:integer .

	civic-kb:Gene-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E542K"^^xsd:string .

	civic-kb:Description-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-a9074a0fd668861bdffb45b995a62033 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In HER2-positive metastic breast cancer patients treated with trastuzumab-based therapy, the presence of a PIK3CA mutation was associated with an increased risk of progression (HR:2.50, 95% CI:1.35-4.61, P=0.003, univariate analysis; HR:1.86, 95% CI:1.13-3.05, P=0.014, multivariate analysis) and reduced time to progression (HR:2.50, 95% CI:1.35-4.61, P=0.003) compared to wildtype PIK3CA."^^xsd:string .

	civic-kb:Disease-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a9074a0fd668861bdffb45b995a62033 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-a9074a0fd668861bdffb45b995a62033 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a9074a0fd668861bdffb45b995a62033 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a9074a0fd668861bdffb45b995a62033 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-a9074a0fd668861bdffb45b995a62033 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-a9074a0fd668861bdffb45b995a62033 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-a9074a0fd668861bdffb45b995a62033	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-a9074a0fd668861bdffb45b995a62033 .

}

civic-kb:provenance-a9074a0fd668861bdffb45b995a62033 {
	civic-kb:assertion-a9074a0fd668861bdffb45b995a62033 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-a9074a0fd668861bdffb45b995a62033 .

	civic-kb:Status-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-a9074a0fd668861bdffb45b995a62033	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-a9074a0fd668861bdffb45b995a62033 {
	civic-kb:nanoPub-a9074a0fd668861bdffb45b995a62033 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-a9074a0fd668861bdffb45b995a62033
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c310de2760b03f9d3b8394dfa2077585 {
	civic-kb:nanoPub-c310de2760b03f9d3b8394dfa2077585
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c310de2760b03f9d3b8394dfa2077585 ;
		np:hasProvenance civic-kb:provenance-c310de2760b03f9d3b8394dfa2077585 ;
		np:hasPublicationInfo civic-kb:pubInfo-c310de2760b03f9d3b8394dfa2077585 .
}

civic-kb:assertion-c310de2760b03f9d3b8394dfa2077585 {
	civic-kb:Drugs-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c310de2760b03f9d3b8394dfa2077585 ;
		sio:hasValue	"Cisplatin, Carboplatin"^^xsd:string .

	civic-kb:Status-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c310de2760b03f9d3b8394dfa2077585 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c310de2760b03f9d3b8394dfa2077585 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1684"^^xsd:integer .

	civic-kb:Gene-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17965 ;
		rdf:type	uniprot:P38398 ;
		rdfs:label	"BRCA1 Gene"^^xsd:string ;
		sio:hasValue	"BRCA1"^^xsd:string .

	civic-kb:Variant-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c310de2760b03f9d3b8394dfa2077585 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In an evaluation of 77 patients, those who had BRCA1/2 germline mutations (n=11) had an increase response rate to cisplatin when compared to those without germline mutations (54.5% versus 19.7%; P=0.022) although progression free survival and overall survival was not significantly different."^^xsd:string .

	civic-kb:Disease-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c310de2760b03f9d3b8394dfa2077585 ;
		rdf:type	efo:0005537 ;
		rdf:type	ncit:C71428 ;
		rdf:type	doid:60081 ;
		rdfs:label	"Triple-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Triple-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c310de2760b03f9d3b8394dfa2077585 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c310de2760b03f9d3b8394dfa2077585 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c310de2760b03f9d3b8394dfa2077585 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c310de2760b03f9d3b8394dfa2077585 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c310de2760b03f9d3b8394dfa2077585 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-c310de2760b03f9d3b8394dfa2077585	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c310de2760b03f9d3b8394dfa2077585 .

}

civic-kb:provenance-c310de2760b03f9d3b8394dfa2077585 {
	civic-kb:assertion-c310de2760b03f9d3b8394dfa2077585 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c310de2760b03f9d3b8394dfa2077585 .

	civic-kb:Status-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-c310de2760b03f9d3b8394dfa2077585	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c310de2760b03f9d3b8394dfa2077585 {
	civic-kb:nanoPub-c310de2760b03f9d3b8394dfa2077585 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c310de2760b03f9d3b8394dfa2077585
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-4fcb248c6c2960dc0063e9fc09e1fece {
	civic-kb:nanoPub-4fcb248c6c2960dc0063e9fc09e1fece
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-4fcb248c6c2960dc0063e9fc09e1fece ;
		np:hasProvenance civic-kb:provenance-4fcb248c6c2960dc0063e9fc09e1fece ;
		np:hasPublicationInfo civic-kb:pubInfo-4fcb248c6c2960dc0063e9fc09e1fece .
}

civic-kb:assertion-4fcb248c6c2960dc0063e9fc09e1fece {
	civic-kb:Drugs-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4fcb248c6c2960dc0063e9fc09e1fece ;
		rdf:type	dron:00730843 ;
		rdf:type	db:DB09074 ;
		rdfs:label	"Olaparib"^^xsd:string ;
		sio:hasValue	"Olaparib"^^xsd:string .

	civic-kb:Status-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-4fcb248c6c2960dc0063e9fc09e1fece ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-4fcb248c6c2960dc0063e9fc09e1fece ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1775"^^xsd:integer .

	civic-kb:Gene-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17965 ;
		rdf:type	uniprot:P38398 ;
		rdfs:label	"BRCA1 Gene"^^xsd:string ;
		sio:hasValue	"BRCA1"^^xsd:string .

	civic-kb:Variant-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-4fcb248c6c2960dc0063e9fc09e1fece ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a study of 26 patients with breast cancer, 10 patients were BRCA-positive and 16 patients were BRCA-negative.  Regardless of BRCA status, none showed objective response when treated with olaparib."^^xsd:string .

	civic-kb:Disease-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4fcb248c6c2960dc0063e9fc09e1fece ;
		rdf:type	efo:0005537 ;
		rdf:type	ncit:C71428 ;
		rdf:type	doid:60081 ;
		rdfs:label	"Triple-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Triple-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-4fcb248c6c2960dc0063e9fc09e1fece ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4fcb248c6c2960dc0063e9fc09e1fece ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4fcb248c6c2960dc0063e9fc09e1fece ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-4fcb248c6c2960dc0063e9fc09e1fece ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-4fcb248c6c2960dc0063e9fc09e1fece ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-4fcb248c6c2960dc0063e9fc09e1fece	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-4fcb248c6c2960dc0063e9fc09e1fece .

}

civic-kb:provenance-4fcb248c6c2960dc0063e9fc09e1fece {
	civic-kb:assertion-4fcb248c6c2960dc0063e9fc09e1fece prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-4fcb248c6c2960dc0063e9fc09e1fece .

	civic-kb:Status-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-4fcb248c6c2960dc0063e9fc09e1fece	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-4fcb248c6c2960dc0063e9fc09e1fece {
	civic-kb:nanoPub-4fcb248c6c2960dc0063e9fc09e1fece prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-4fcb248c6c2960dc0063e9fc09e1fece
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-716f7c70227e1b4699d6893393af4420 {
	civic-kb:nanoPub-716f7c70227e1b4699d6893393af4420
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-716f7c70227e1b4699d6893393af4420 ;
		np:hasProvenance civic-kb:provenance-716f7c70227e1b4699d6893393af4420 ;
		np:hasPublicationInfo civic-kb:pubInfo-716f7c70227e1b4699d6893393af4420 .
}

civic-kb:assertion-716f7c70227e1b4699d6893393af4420 {
	civic-kb:Drugs-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-716f7c70227e1b4699d6893393af4420 ;
		rdf:type	dron:00730843 ;
		rdf:type	db:DB09074 ;
		rdfs:label	"Olaparib"^^xsd:string ;
		sio:hasValue	"Olaparib"^^xsd:string .

	civic-kb:Status-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-716f7c70227e1b4699d6893393af4420 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-716f7c70227e1b4699d6893393af4420 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"5830"^^xsd:integer .

	civic-kb:Gene-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17965 ;
		rdf:type	uniprot:P38398 ;
		rdfs:label	"BRCA1 Gene"^^xsd:string ;
		sio:hasValue	"BRCA1"^^xsd:string .

	civic-kb:Variant-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-716f7c70227e1b4699d6893393af4420 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-716f7c70227e1b4699d6893393af4420 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-716f7c70227e1b4699d6893393af4420 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-716f7c70227e1b4699d6893393af4420 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-716f7c70227e1b4699d6893393af4420 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-716f7c70227e1b4699d6893393af4420 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-716f7c70227e1b4699d6893393af4420 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-716f7c70227e1b4699d6893393af4420	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-716f7c70227e1b4699d6893393af4420 .

}

civic-kb:provenance-716f7c70227e1b4699d6893393af4420 {
	civic-kb:assertion-716f7c70227e1b4699d6893393af4420 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-716f7c70227e1b4699d6893393af4420 .

	civic-kb:Status-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-716f7c70227e1b4699d6893393af4420	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-716f7c70227e1b4699d6893393af4420 {
	civic-kb:nanoPub-716f7c70227e1b4699d6893393af4420 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-716f7c70227e1b4699d6893393af4420
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-015c0723a6017f05aa6d65d73949e77f {
	civic-kb:nanoPub-015c0723a6017f05aa6d65d73949e77f
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-015c0723a6017f05aa6d65d73949e77f ;
		np:hasProvenance civic-kb:provenance-015c0723a6017f05aa6d65d73949e77f ;
		np:hasPublicationInfo civic-kb:pubInfo-015c0723a6017f05aa6d65d73949e77f .
}

civic-kb:assertion-015c0723a6017f05aa6d65d73949e77f {
	civic-kb:Drugs-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-015c0723a6017f05aa6d65d73949e77f ;
		sio:hasValue	"Cisplatin, Carboplatin"^^xsd:string .

	civic-kb:Status-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-015c0723a6017f05aa6d65d73949e77f ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-015c0723a6017f05aa6d65d73949e77f ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1685"^^xsd:integer .

	civic-kb:Gene-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18120 ;
		rdf:type	uniprot:P51587 ;
		rdfs:label	"BRCA2 Gene"^^xsd:string ;
		sio:hasValue	"BRCA2"^^xsd:string .

	civic-kb:Variant-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-015c0723a6017f05aa6d65d73949e77f ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In an evaluation of 77 patients, those who had BRCA1/2 germline mutations (n=11) had an increase response rate to cisplatin when compared to those without germline mutations (54.5% versus 19.7%; P=0.022) although progression free survival and overall survival was not significantly different."^^xsd:string .

	civic-kb:Disease-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-015c0723a6017f05aa6d65d73949e77f ;
		rdf:type	efo:0005537 ;
		rdf:type	ncit:C71428 ;
		rdf:type	doid:60081 ;
		rdfs:label	"Triple-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Triple-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-015c0723a6017f05aa6d65d73949e77f ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-015c0723a6017f05aa6d65d73949e77f ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-015c0723a6017f05aa6d65d73949e77f ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-015c0723a6017f05aa6d65d73949e77f ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-015c0723a6017f05aa6d65d73949e77f ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-015c0723a6017f05aa6d65d73949e77f	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-015c0723a6017f05aa6d65d73949e77f .

}

civic-kb:provenance-015c0723a6017f05aa6d65d73949e77f {
	civic-kb:assertion-015c0723a6017f05aa6d65d73949e77f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-015c0723a6017f05aa6d65d73949e77f .

	civic-kb:Status-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-015c0723a6017f05aa6d65d73949e77f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-015c0723a6017f05aa6d65d73949e77f {
	civic-kb:nanoPub-015c0723a6017f05aa6d65d73949e77f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-015c0723a6017f05aa6d65d73949e77f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-323160ae4cded55ad8f09719defde44b {
	civic-kb:nanoPub-323160ae4cded55ad8f09719defde44b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-323160ae4cded55ad8f09719defde44b ;
		np:hasProvenance civic-kb:provenance-323160ae4cded55ad8f09719defde44b ;
		np:hasPublicationInfo civic-kb:pubInfo-323160ae4cded55ad8f09719defde44b .
}

civic-kb:assertion-323160ae4cded55ad8f09719defde44b {
	civic-kb:Drugs-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-323160ae4cded55ad8f09719defde44b ;
		rdf:type	dron:00730843 ;
		rdf:type	db:DB09074 ;
		rdfs:label	"Olaparib"^^xsd:string ;
		sio:hasValue	"Olaparib"^^xsd:string .

	civic-kb:Status-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-323160ae4cded55ad8f09719defde44b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-323160ae4cded55ad8f09719defde44b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1776"^^xsd:integer .

	civic-kb:Gene-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18120 ;
		rdf:type	uniprot:P51587 ;
		rdfs:label	"BRCA2 Gene"^^xsd:string ;
		sio:hasValue	"BRCA2"^^xsd:string .

	civic-kb:Variant-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-323160ae4cded55ad8f09719defde44b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a study of 26 patients with breast cancer, 10 patients were BRCA-positive and 16 patients were BRCA-negative.  Regardless of BRCA status, none showed objective response when treated with olaparib."^^xsd:string .

	civic-kb:Disease-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-323160ae4cded55ad8f09719defde44b ;
		rdf:type	efo:0005537 ;
		rdf:type	ncit:C71428 ;
		rdf:type	doid:60081 ;
		rdfs:label	"Triple-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Triple-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-323160ae4cded55ad8f09719defde44b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-323160ae4cded55ad8f09719defde44b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-323160ae4cded55ad8f09719defde44b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-323160ae4cded55ad8f09719defde44b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-323160ae4cded55ad8f09719defde44b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-323160ae4cded55ad8f09719defde44b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-323160ae4cded55ad8f09719defde44b .

}

civic-kb:provenance-323160ae4cded55ad8f09719defde44b {
	civic-kb:assertion-323160ae4cded55ad8f09719defde44b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-323160ae4cded55ad8f09719defde44b .

	civic-kb:Status-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-323160ae4cded55ad8f09719defde44b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-323160ae4cded55ad8f09719defde44b {
	civic-kb:nanoPub-323160ae4cded55ad8f09719defde44b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-323160ae4cded55ad8f09719defde44b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-9dc48f6e6bf53970b240d85115fb690f {
	civic-kb:nanoPub-9dc48f6e6bf53970b240d85115fb690f
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-9dc48f6e6bf53970b240d85115fb690f ;
		np:hasProvenance civic-kb:provenance-9dc48f6e6bf53970b240d85115fb690f ;
		np:hasPublicationInfo civic-kb:pubInfo-9dc48f6e6bf53970b240d85115fb690f .
}

civic-kb:assertion-9dc48f6e6bf53970b240d85115fb690f {
	civic-kb:Drugs-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9dc48f6e6bf53970b240d85115fb690f ;
		rdf:type	dron:00730843 ;
		rdf:type	db:DB09074 ;
		rdfs:label	"Olaparib"^^xsd:string ;
		sio:hasValue	"Olaparib"^^xsd:string .

	civic-kb:Status-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-9dc48f6e6bf53970b240d85115fb690f ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-9dc48f6e6bf53970b240d85115fb690f ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"5831"^^xsd:integer .

	civic-kb:Gene-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18120 ;
		rdf:type	uniprot:P51587 ;
		rdfs:label	"BRCA2 Gene"^^xsd:string ;
		sio:hasValue	"BRCA2"^^xsd:string .

	civic-kb:Variant-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-9dc48f6e6bf53970b240d85115fb690f ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9dc48f6e6bf53970b240d85115fb690f ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-9dc48f6e6bf53970b240d85115fb690f ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9dc48f6e6bf53970b240d85115fb690f ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9dc48f6e6bf53970b240d85115fb690f ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-9dc48f6e6bf53970b240d85115fb690f ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-9dc48f6e6bf53970b240d85115fb690f ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-9dc48f6e6bf53970b240d85115fb690f	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-9dc48f6e6bf53970b240d85115fb690f .

}

civic-kb:provenance-9dc48f6e6bf53970b240d85115fb690f {
	civic-kb:assertion-9dc48f6e6bf53970b240d85115fb690f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-9dc48f6e6bf53970b240d85115fb690f .

	civic-kb:Status-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-9dc48f6e6bf53970b240d85115fb690f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-9dc48f6e6bf53970b240d85115fb690f {
	civic-kb:nanoPub-9dc48f6e6bf53970b240d85115fb690f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-9dc48f6e6bf53970b240d85115fb690f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-80247b2ba0f4143f0778db7a6ff3ab4f {
	civic-kb:nanoPub-80247b2ba0f4143f0778db7a6ff3ab4f
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-80247b2ba0f4143f0778db7a6ff3ab4f ;
		np:hasProvenance civic-kb:provenance-80247b2ba0f4143f0778db7a6ff3ab4f ;
		np:hasPublicationInfo civic-kb:pubInfo-80247b2ba0f4143f0778db7a6ff3ab4f .
}

civic-kb:assertion-80247b2ba0f4143f0778db7a6ff3ab4f {
	civic-kb:Drugs-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-80247b2ba0f4143f0778db7a6ff3ab4f ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib (PD0332991)"^^xsd:string .

	civic-kb:Status-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-80247b2ba0f4143f0778db7a6ff3ab4f ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-80247b2ba0f4143f0778db7a6ff3ab4f ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1629"^^xsd:integer .

	civic-kb:Gene-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21412 ;
		rdf:type	uniprot:P24864 ;
		rdfs:label	"CCNE1 Gene"^^xsd:string ;
		sio:hasValue	"CCNE1"^^xsd:string .

	civic-kb:Variant-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-80247b2ba0f4143f0778db7a6ff3ab4f ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-80247b2ba0f4143f0778db7a6ff3ab4f ;
		rdf:type	efo:1000649 ;
		rdf:type	doid:0060075 ;
		rdfs:label	"Estrogen-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-80247b2ba0f4143f0778db7a6ff3ab4f ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-80247b2ba0f4143f0778db7a6ff3ab4f ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-80247b2ba0f4143f0778db7a6ff3ab4f ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-80247b2ba0f4143f0778db7a6ff3ab4f ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-80247b2ba0f4143f0778db7a6ff3ab4f ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-80247b2ba0f4143f0778db7a6ff3ab4f	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-80247b2ba0f4143f0778db7a6ff3ab4f .

}

civic-kb:provenance-80247b2ba0f4143f0778db7a6ff3ab4f {
	civic-kb:assertion-80247b2ba0f4143f0778db7a6ff3ab4f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-80247b2ba0f4143f0778db7a6ff3ab4f .

	civic-kb:Status-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-80247b2ba0f4143f0778db7a6ff3ab4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-80247b2ba0f4143f0778db7a6ff3ab4f {
	civic-kb:nanoPub-80247b2ba0f4143f0778db7a6ff3ab4f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-80247b2ba0f4143f0778db7a6ff3ab4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-6616ac464f38439c822e543ace608cb4 {
	civic-kb:nanoPub-6616ac464f38439c822e543ace608cb4
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-6616ac464f38439c822e543ace608cb4 ;
		np:hasProvenance civic-kb:provenance-6616ac464f38439c822e543ace608cb4 ;
		np:hasPublicationInfo civic-kb:pubInfo-6616ac464f38439c822e543ace608cb4 .
}

civic-kb:assertion-6616ac464f38439c822e543ace608cb4 {
	civic-kb:Drugs-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6616ac464f38439c822e543ace608cb4 .

	civic-kb:Status-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-6616ac464f38439c822e543ace608cb4 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-6616ac464f38439c822e543ace608cb4 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"492"^^xsd:integer .

	civic-kb:Gene-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C20699 ;
		rdf:type	uniprot:Q9Y6Q9 ;
		rdfs:label	"NCOA3 Gene"^^xsd:string ;
		sio:hasValue	"NCOA3"^^xsd:string .

	civic-kb:Variant-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-6616ac464f38439c822e543ace608cb4 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In patients with breast cancer, those with amplification of NCOA3 had shorter disease-specific survival."^^xsd:string .

	civic-kb:Disease-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6616ac464f38439c822e543ace608cb4 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-6616ac464f38439c822e543ace608cb4 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6616ac464f38439c822e543ace608cb4 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6616ac464f38439c822e543ace608cb4 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-6616ac464f38439c822e543ace608cb4 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-6616ac464f38439c822e543ace608cb4 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-6616ac464f38439c822e543ace608cb4	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-6616ac464f38439c822e543ace608cb4 .

}

civic-kb:provenance-6616ac464f38439c822e543ace608cb4 {
	civic-kb:assertion-6616ac464f38439c822e543ace608cb4 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-6616ac464f38439c822e543ace608cb4 .

	civic-kb:Status-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-6616ac464f38439c822e543ace608cb4	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-6616ac464f38439c822e543ace608cb4 {
	civic-kb:nanoPub-6616ac464f38439c822e543ace608cb4 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-6616ac464f38439c822e543ace608cb4
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-6007f02c6263b03db15fdfc692239f46 {
	civic-kb:nanoPub-6007f02c6263b03db15fdfc692239f46
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-6007f02c6263b03db15fdfc692239f46 ;
		np:hasProvenance civic-kb:provenance-6007f02c6263b03db15fdfc692239f46 ;
		np:hasPublicationInfo civic-kb:pubInfo-6007f02c6263b03db15fdfc692239f46 .
}

civic-kb:assertion-6007f02c6263b03db15fdfc692239f46 {
	civic-kb:Drugs-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6007f02c6263b03db15fdfc692239f46 .

	civic-kb:Status-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-6007f02c6263b03db15fdfc692239f46 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-6007f02c6263b03db15fdfc692239f46 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"493"^^xsd:integer .

	civic-kb:Gene-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C20699 ;
		rdf:type	uniprot:Q9Y6Q9 ;
		rdfs:label	"NCOA3 Gene"^^xsd:string ;
		sio:hasValue	"NCOA3"^^xsd:string .

	civic-kb:Variant-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-6007f02c6263b03db15fdfc692239f46 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"High expression determined by immunohistochemistry of NCOA3 was found in 571 out of 1,836 breast cancer samples. Those with high expression had worse overall and disease-specific survival."^^xsd:string .

	civic-kb:Disease-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6007f02c6263b03db15fdfc692239f46 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-6007f02c6263b03db15fdfc692239f46 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6007f02c6263b03db15fdfc692239f46 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6007f02c6263b03db15fdfc692239f46 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-6007f02c6263b03db15fdfc692239f46 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-6007f02c6263b03db15fdfc692239f46 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-6007f02c6263b03db15fdfc692239f46	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-6007f02c6263b03db15fdfc692239f46 .

}

civic-kb:provenance-6007f02c6263b03db15fdfc692239f46 {
	civic-kb:assertion-6007f02c6263b03db15fdfc692239f46 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-6007f02c6263b03db15fdfc692239f46 .

	civic-kb:Status-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-6007f02c6263b03db15fdfc692239f46	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-6007f02c6263b03db15fdfc692239f46 {
	civic-kb:nanoPub-6007f02c6263b03db15fdfc692239f46 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-6007f02c6263b03db15fdfc692239f46
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d54c767e65eb877268dd373c34d811d7 {
	civic-kb:nanoPub-d54c767e65eb877268dd373c34d811d7
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d54c767e65eb877268dd373c34d811d7 ;
		np:hasProvenance civic-kb:provenance-d54c767e65eb877268dd373c34d811d7 ;
		np:hasPublicationInfo civic-kb:pubInfo-d54c767e65eb877268dd373c34d811d7 .
}

civic-kb:assertion-d54c767e65eb877268dd373c34d811d7 {
	civic-kb:Drugs-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d54c767e65eb877268dd373c34d811d7 .

	civic-kb:Status-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d54c767e65eb877268dd373c34d811d7 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d54c767e65eb877268dd373c34d811d7 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"500"^^xsd:integer .

	civic-kb:Gene-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C28656 ;
		rdf:type	uniprot:P06401 ;
		rdfs:label	"PGR Gene"^^xsd:string ;
		sio:hasValue	"PGR"^^xsd:string .

	civic-kb:Variant-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d54c767e65eb877268dd373c34d811d7 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In patients with breast cancer, those with expression of PgR (determined by immunohistochemical staining) had better relapse-free survival than those without expression."^^xsd:string .

	civic-kb:Disease-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d54c767e65eb877268dd373c34d811d7 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d54c767e65eb877268dd373c34d811d7 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d54c767e65eb877268dd373c34d811d7 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d54c767e65eb877268dd373c34d811d7 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Better Outcome"^^xsd:string .

	civic-kb:Variant_Origin-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d54c767e65eb877268dd373c34d811d7 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d54c767e65eb877268dd373c34d811d7 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-d54c767e65eb877268dd373c34d811d7	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d54c767e65eb877268dd373c34d811d7 .

}

civic-kb:provenance-d54c767e65eb877268dd373c34d811d7 {
	civic-kb:assertion-d54c767e65eb877268dd373c34d811d7 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d54c767e65eb877268dd373c34d811d7 .

	civic-kb:Status-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-d54c767e65eb877268dd373c34d811d7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d54c767e65eb877268dd373c34d811d7 {
	civic-kb:nanoPub-d54c767e65eb877268dd373c34d811d7 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d54c767e65eb877268dd373c34d811d7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2cd2b7eff7e46b48d7d8f055c132377c {
	civic-kb:nanoPub-2cd2b7eff7e46b48d7d8f055c132377c
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2cd2b7eff7e46b48d7d8f055c132377c ;
		np:hasProvenance civic-kb:provenance-2cd2b7eff7e46b48d7d8f055c132377c ;
		np:hasPublicationInfo civic-kb:pubInfo-2cd2b7eff7e46b48d7d8f055c132377c .
}

civic-kb:assertion-2cd2b7eff7e46b48d7d8f055c132377c {
	civic-kb:Drugs-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2cd2b7eff7e46b48d7d8f055c132377c .

	civic-kb:Status-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2cd2b7eff7e46b48d7d8f055c132377c ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2cd2b7eff7e46b48d7d8f055c132377c ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"503"^^xsd:integer .

	civic-kb:Gene-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C28656 ;
		rdf:type	uniprot:P06401 ;
		rdfs:label	"PGR Gene"^^xsd:string ;
		sio:hasValue	"PGR"^^xsd:string .

	civic-kb:Variant-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2cd2b7eff7e46b48d7d8f055c132377c ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In patients with breast cancer, those with low expression of PgR had worse disease-free survival than those with high expression."^^xsd:string .

	civic-kb:Disease-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2cd2b7eff7e46b48d7d8f055c132377c ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2cd2b7eff7e46b48d7d8f055c132377c ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2cd2b7eff7e46b48d7d8f055c132377c ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2cd2b7eff7e46b48d7d8f055c132377c ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2cd2b7eff7e46b48d7d8f055c132377c ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2cd2b7eff7e46b48d7d8f055c132377c ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-2cd2b7eff7e46b48d7d8f055c132377c	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2cd2b7eff7e46b48d7d8f055c132377c .

}

civic-kb:provenance-2cd2b7eff7e46b48d7d8f055c132377c {
	civic-kb:assertion-2cd2b7eff7e46b48d7d8f055c132377c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2cd2b7eff7e46b48d7d8f055c132377c .

	civic-kb:Status-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-2cd2b7eff7e46b48d7d8f055c132377c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2cd2b7eff7e46b48d7d8f055c132377c {
	civic-kb:nanoPub-2cd2b7eff7e46b48d7d8f055c132377c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2cd2b7eff7e46b48d7d8f055c132377c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-396dc6ac07362ae15b89dc0fb06f34b5 {
	civic-kb:nanoPub-396dc6ac07362ae15b89dc0fb06f34b5
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-396dc6ac07362ae15b89dc0fb06f34b5 ;
		np:hasProvenance civic-kb:provenance-396dc6ac07362ae15b89dc0fb06f34b5 ;
		np:hasPublicationInfo civic-kb:pubInfo-396dc6ac07362ae15b89dc0fb06f34b5 .
}

civic-kb:assertion-396dc6ac07362ae15b89dc0fb06f34b5 {
	civic-kb:Drugs-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-396dc6ac07362ae15b89dc0fb06f34b5 ;
		sio:hasValue	"Tamoxifen, Exemestane"^^xsd:string .

	civic-kb:Status-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-396dc6ac07362ae15b89dc0fb06f34b5 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-396dc6ac07362ae15b89dc0fb06f34b5 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"502"^^xsd:integer .

	civic-kb:Gene-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C28656 ;
		rdf:type	uniprot:P06401 ;
		rdfs:label	"PGR Gene"^^xsd:string ;
		sio:hasValue	"PGR"^^xsd:string .

	civic-kb:Variant-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-396dc6ac07362ae15b89dc0fb06f34b5 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In patients with breast cancer, those with low expression of PgR treated with tamoxifen had the same disease-free survial as those with high expression of PgR."^^xsd:string .

	civic-kb:Disease-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-396dc6ac07362ae15b89dc0fb06f34b5 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-396dc6ac07362ae15b89dc0fb06f34b5 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-396dc6ac07362ae15b89dc0fb06f34b5 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-396dc6ac07362ae15b89dc0fb06f34b5 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string .

	civic-kb:Variant_Origin-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-396dc6ac07362ae15b89dc0fb06f34b5 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-396dc6ac07362ae15b89dc0fb06f34b5 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-396dc6ac07362ae15b89dc0fb06f34b5	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-396dc6ac07362ae15b89dc0fb06f34b5 .

}

civic-kb:provenance-396dc6ac07362ae15b89dc0fb06f34b5 {
	civic-kb:assertion-396dc6ac07362ae15b89dc0fb06f34b5 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-396dc6ac07362ae15b89dc0fb06f34b5 .

	civic-kb:Status-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-396dc6ac07362ae15b89dc0fb06f34b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-396dc6ac07362ae15b89dc0fb06f34b5 {
	civic-kb:nanoPub-396dc6ac07362ae15b89dc0fb06f34b5 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-396dc6ac07362ae15b89dc0fb06f34b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-93df4d9f2e2b7ea38871b643853a49e0 {
	civic-kb:nanoPub-93df4d9f2e2b7ea38871b643853a49e0
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-93df4d9f2e2b7ea38871b643853a49e0 ;
		np:hasProvenance civic-kb:provenance-93df4d9f2e2b7ea38871b643853a49e0 ;
		np:hasPublicationInfo civic-kb:pubInfo-93df4d9f2e2b7ea38871b643853a49e0 .
}

civic-kb:assertion-93df4d9f2e2b7ea38871b643853a49e0 {
	civic-kb:Drugs-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-93df4d9f2e2b7ea38871b643853a49e0 ;
		rdf:type	chebi:41774 ;
		rdf:type	db:DB00675 ;
		rdfs:label	"Tamoxifen"^^xsd:string ;
		sio:hasValue	"Tamoxifen"^^xsd:string .

	civic-kb:Status-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-93df4d9f2e2b7ea38871b643853a49e0 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-93df4d9f2e2b7ea38871b643853a49e0 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"501"^^xsd:integer .

	civic-kb:Gene-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C28656 ;
		rdf:type	uniprot:P06401 ;
		rdfs:label	"PGR Gene"^^xsd:string ;
		sio:hasValue	"PGR"^^xsd:string .

	civic-kb:Variant-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-93df4d9f2e2b7ea38871b643853a49e0 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In patients with ER-Positive breast cancer, expression of PgR does not effect the outcome of treatment with tamoxifen."^^xsd:string .

	civic-kb:Disease-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-93df4d9f2e2b7ea38871b643853a49e0 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-93df4d9f2e2b7ea38871b643853a49e0 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-93df4d9f2e2b7ea38871b643853a49e0 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-93df4d9f2e2b7ea38871b643853a49e0 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string .

	civic-kb:Variant_Origin-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-93df4d9f2e2b7ea38871b643853a49e0 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-93df4d9f2e2b7ea38871b643853a49e0 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-93df4d9f2e2b7ea38871b643853a49e0	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-93df4d9f2e2b7ea38871b643853a49e0 .

}

civic-kb:provenance-93df4d9f2e2b7ea38871b643853a49e0 {
	civic-kb:assertion-93df4d9f2e2b7ea38871b643853a49e0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-93df4d9f2e2b7ea38871b643853a49e0 .

	civic-kb:Status-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-93df4d9f2e2b7ea38871b643853a49e0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-93df4d9f2e2b7ea38871b643853a49e0 {
	civic-kb:nanoPub-93df4d9f2e2b7ea38871b643853a49e0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-93df4d9f2e2b7ea38871b643853a49e0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-a8c1cc6022d32ba38059c51b09a517a9 {
	civic-kb:nanoPub-a8c1cc6022d32ba38059c51b09a517a9
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-a8c1cc6022d32ba38059c51b09a517a9 ;
		np:hasProvenance civic-kb:provenance-a8c1cc6022d32ba38059c51b09a517a9 ;
		np:hasPublicationInfo civic-kb:pubInfo-a8c1cc6022d32ba38059c51b09a517a9 .
}

civic-kb:assertion-a8c1cc6022d32ba38059c51b09a517a9 {
	civic-kb:Drugs-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a8c1cc6022d32ba38059c51b09a517a9 ;
		rdf:type	db:DB11828 ;
		rdfs:label	"Neratinib"^^xsd:string ;
		sio:hasValue	"Neratinib"^^xsd:string .

	civic-kb:Status-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-a8c1cc6022d32ba38059c51b09a517a9 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-a8c1cc6022d32ba38059c51b09a517a9 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"288"^^xsd:integer .

	civic-kb:Gene-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"V777L"^^xsd:string ;
		sio:hasValue	"V777L"^^xsd:string .

	civic-kb:Description-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-a8c1cc6022d32ba38059c51b09a517a9 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In MCF10A cell lines, the V777L mutation was shown to be sensitive to neratinib."^^xsd:string .

	civic-kb:Disease-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a8c1cc6022d32ba38059c51b09a517a9 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-a8c1cc6022d32ba38059c51b09a517a9 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a8c1cc6022d32ba38059c51b09a517a9 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a8c1cc6022d32ba38059c51b09a517a9 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-a8c1cc6022d32ba38059c51b09a517a9 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-a8c1cc6022d32ba38059c51b09a517a9 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-a8c1cc6022d32ba38059c51b09a517a9	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-a8c1cc6022d32ba38059c51b09a517a9 .

}

civic-kb:provenance-a8c1cc6022d32ba38059c51b09a517a9 {
	civic-kb:assertion-a8c1cc6022d32ba38059c51b09a517a9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-a8c1cc6022d32ba38059c51b09a517a9 .

	civic-kb:Status-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-a8c1cc6022d32ba38059c51b09a517a9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-a8c1cc6022d32ba38059c51b09a517a9 {
	civic-kb:nanoPub-a8c1cc6022d32ba38059c51b09a517a9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-a8c1cc6022d32ba38059c51b09a517a9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d312b2cf51c5a26c7f960a9c654e49e6 {
	civic-kb:nanoPub-d312b2cf51c5a26c7f960a9c654e49e6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d312b2cf51c5a26c7f960a9c654e49e6 ;
		np:hasProvenance civic-kb:provenance-d312b2cf51c5a26c7f960a9c654e49e6 ;
		np:hasPublicationInfo civic-kb:pubInfo-d312b2cf51c5a26c7f960a9c654e49e6 .
}

civic-kb:assertion-d312b2cf51c5a26c7f960a9c654e49e6 {
	civic-kb:Drugs-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d312b2cf51c5a26c7f960a9c654e49e6 ;
		sio:hasValue	"Trastuzumab, Trastuzumab Emtansine"^^xsd:string .

	civic-kb:Status-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d312b2cf51c5a26c7f960a9c654e49e6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d312b2cf51c5a26c7f960a9c654e49e6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"5817"^^xsd:integer .

	civic-kb:Gene-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"V777L"^^xsd:string ;
		sio:hasValue	"V777L"^^xsd:string .

	civic-kb:Description-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d312b2cf51c5a26c7f960a9c654e49e6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a cohort of 205 Her2-receptor amplified breast cancers, 20 experienced recurrence after trastuzumab therapy. Of the 20 recurrent cases, only six patients had metastatic sites, excluding brain metastases, which were resistant to trastuzumab. NGS of thes six clinical specimens before and after trastuzumab therapy revealed one case of intrinsic activating mutation that leads to a valine-to-leucine substitution at codon 777 within the HER2 kinase domain (HER2 V777L)."^^xsd:string .

	civic-kb:Disease-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d312b2cf51c5a26c7f960a9c654e49e6 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d312b2cf51c5a26c7f960a9c654e49e6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d312b2cf51c5a26c7f960a9c654e49e6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d312b2cf51c5a26c7f960a9c654e49e6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d312b2cf51c5a26c7f960a9c654e49e6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d312b2cf51c5a26c7f960a9c654e49e6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-d312b2cf51c5a26c7f960a9c654e49e6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d312b2cf51c5a26c7f960a9c654e49e6 .

}

civic-kb:provenance-d312b2cf51c5a26c7f960a9c654e49e6 {
	civic-kb:assertion-d312b2cf51c5a26c7f960a9c654e49e6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d312b2cf51c5a26c7f960a9c654e49e6 .

	civic-kb:Status-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-d312b2cf51c5a26c7f960a9c654e49e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d312b2cf51c5a26c7f960a9c654e49e6 {
	civic-kb:nanoPub-d312b2cf51c5a26c7f960a9c654e49e6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d312b2cf51c5a26c7f960a9c654e49e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2d1ed1d900f6d94d8f3902f9b600e4e6 {
	civic-kb:nanoPub-2d1ed1d900f6d94d8f3902f9b600e4e6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		np:hasProvenance civic-kb:provenance-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		np:hasPublicationInfo civic-kb:pubInfo-2d1ed1d900f6d94d8f3902f9b600e4e6 .
}

civic-kb:assertion-2d1ed1d900f6d94d8f3902f9b600e4e6 {
	civic-kb:Drugs-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		rdf:type	db:DB11651 ;
		rdfs:label	"Dactolisib"^^xsd:string ;
		sio:hasValue	"BEZ235 (NVP-BEZ235, Dactolisib)"^^xsd:string .

	civic-kb:Status-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"859"^^xsd:integer .

	civic-kb:Gene-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C28539 ;
		rdf:type	uniprot:P10275 ;
		rdfs:label	"AR Gene"^^xsd:string ;
		sio:hasValue	"AR"^^xsd:string .

	civic-kb:Variant-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In-vitro and xenograft studies of response of breast cancer cell lines to PI3K/mTOR inhibitor NVP-BEZ235 showed that sensitivity correlated with expression of the androgen receptor (AR). Reintroduction of AR expression resensitized nonresponsive AR-negative cells to NVP-BEZ235. A dihydrotestosterone (DHT) and NVP-BEZ235 combination achieved tumor regression and complete response in AR/ER expressing tumors (xenografts)."^^xsd:string .

	civic-kb:Disease-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2d1ed1d900f6d94d8f3902f9b600e4e6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-2d1ed1d900f6d94d8f3902f9b600e4e6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2d1ed1d900f6d94d8f3902f9b600e4e6 .

}

civic-kb:provenance-2d1ed1d900f6d94d8f3902f9b600e4e6 {
	civic-kb:assertion-2d1ed1d900f6d94d8f3902f9b600e4e6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2d1ed1d900f6d94d8f3902f9b600e4e6 .

	civic-kb:Status-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-2d1ed1d900f6d94d8f3902f9b600e4e6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2d1ed1d900f6d94d8f3902f9b600e4e6 {
	civic-kb:nanoPub-2d1ed1d900f6d94d8f3902f9b600e4e6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2d1ed1d900f6d94d8f3902f9b600e4e6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-bade4fe013df05770dc057633a90f71b {
	civic-kb:nanoPub-bade4fe013df05770dc057633a90f71b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-bade4fe013df05770dc057633a90f71b ;
		np:hasProvenance civic-kb:provenance-bade4fe013df05770dc057633a90f71b ;
		np:hasPublicationInfo civic-kb:pubInfo-bade4fe013df05770dc057633a90f71b .
}

civic-kb:assertion-bade4fe013df05770dc057633a90f71b {
	civic-kb:Drugs-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-bade4fe013df05770dc057633a90f71b ;
		rdf:type	chebi:41774 ;
		rdf:type	db:DB00675 ;
		rdfs:label	"Tamoxifen"^^xsd:string ;
		sio:hasValue	"Tamoxifen"^^xsd:string .

	civic-kb:Status-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-bade4fe013df05770dc057633a90f71b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-bade4fe013df05770dc057633a90f71b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2783"^^xsd:integer .

	civic-kb:Gene-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"DNA BINDING DOMAIN MUTATION"^^xsd:string .

	civic-kb:Description-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-bade4fe013df05770dc057633a90f71b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a study 202 breast cancer patients undergoing first line tamoxifen treatment, 65 patients had mutations in TP53. Among the p53 wild type population a 66% response rate was reported, where response was considered as complete response, partial response or stable disease. In a patient subgroup with mutations in p53 amino acids that directly interact with DNA, 2 of 11 (18%) of patients responded to tamoxifen."^^xsd:string .

	civic-kb:Disease-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-bade4fe013df05770dc057633a90f71b ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-bade4fe013df05770dc057633a90f71b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-bade4fe013df05770dc057633a90f71b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-bade4fe013df05770dc057633a90f71b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-bade4fe013df05770dc057633a90f71b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-bade4fe013df05770dc057633a90f71b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-bade4fe013df05770dc057633a90f71b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-bade4fe013df05770dc057633a90f71b .

}

civic-kb:provenance-bade4fe013df05770dc057633a90f71b {
	civic-kb:assertion-bade4fe013df05770dc057633a90f71b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-bade4fe013df05770dc057633a90f71b .

	civic-kb:Status-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-bade4fe013df05770dc057633a90f71b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-bade4fe013df05770dc057633a90f71b {
	civic-kb:nanoPub-bade4fe013df05770dc057633a90f71b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-bade4fe013df05770dc057633a90f71b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ee3f8dc00989a1098f7bd95d3cfe98d0 {
	civic-kb:nanoPub-ee3f8dc00989a1098f7bd95d3cfe98d0
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ee3f8dc00989a1098f7bd95d3cfe98d0 ;
		np:hasProvenance civic-kb:provenance-ee3f8dc00989a1098f7bd95d3cfe98d0 ;
		np:hasPublicationInfo civic-kb:pubInfo-ee3f8dc00989a1098f7bd95d3cfe98d0 .
}

civic-kb:assertion-ee3f8dc00989a1098f7bd95d3cfe98d0 {
	civic-kb:Drugs-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ee3f8dc00989a1098f7bd95d3cfe98d0 .

	civic-kb:Status-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ee3f8dc00989a1098f7bd95d3cfe98d0 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ee3f8dc00989a1098f7bd95d3cfe98d0 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4855"^^xsd:integer .

	civic-kb:Gene-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C96022 ;
		rdf:type	uniprot:Q9NZQ7 ;
		rdfs:label	"CD274 Gene"^^xsd:string ;
		sio:hasValue	"CD274"^^xsd:string .

	civic-kb:Variant-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ee3f8dc00989a1098f7bd95d3cfe98d0 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In this meta-analysis, 5 studies totalling 2,546 cases were combined to assess the prognostic association of PD-L1 expression in breast cancer. The combined hazard ratio (HR) for PD-L1 overexpression was 1.76 (OS). The pooled odds ratios (ORs) indicated that PD-L1 expression was associated with positive lymph node metastasis, higher histological grades, estrogen receptor (ER)-negativity, and triple-negative breast cancer (TNBC)."^^xsd:string .

	civic-kb:Disease-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ee3f8dc00989a1098f7bd95d3cfe98d0 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ee3f8dc00989a1098f7bd95d3cfe98d0 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ee3f8dc00989a1098f7bd95d3cfe98d0 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ee3f8dc00989a1098f7bd95d3cfe98d0 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ee3f8dc00989a1098f7bd95d3cfe98d0 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ee3f8dc00989a1098f7bd95d3cfe98d0 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-ee3f8dc00989a1098f7bd95d3cfe98d0	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ee3f8dc00989a1098f7bd95d3cfe98d0 .

}

civic-kb:provenance-ee3f8dc00989a1098f7bd95d3cfe98d0 {
	civic-kb:assertion-ee3f8dc00989a1098f7bd95d3cfe98d0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ee3f8dc00989a1098f7bd95d3cfe98d0 .

	civic-kb:Status-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ee3f8dc00989a1098f7bd95d3cfe98d0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ee3f8dc00989a1098f7bd95d3cfe98d0 {
	civic-kb:nanoPub-ee3f8dc00989a1098f7bd95d3cfe98d0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ee3f8dc00989a1098f7bd95d3cfe98d0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-1497aa1f1e42f4e0d6477438e2de7ead {
	civic-kb:nanoPub-1497aa1f1e42f4e0d6477438e2de7ead
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-1497aa1f1e42f4e0d6477438e2de7ead ;
		np:hasProvenance civic-kb:provenance-1497aa1f1e42f4e0d6477438e2de7ead ;
		np:hasPublicationInfo civic-kb:pubInfo-1497aa1f1e42f4e0d6477438e2de7ead .
}

civic-kb:assertion-1497aa1f1e42f4e0d6477438e2de7ead {
	civic-kb:Drugs-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1497aa1f1e42f4e0d6477438e2de7ead .

	civic-kb:Status-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-1497aa1f1e42f4e0d6477438e2de7ead ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-1497aa1f1e42f4e0d6477438e2de7ead ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4844"^^xsd:integer .

	civic-kb:Gene-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C96022 ;
		rdf:type	uniprot:Q9NZQ7 ;
		rdfs:label	"CD274 Gene"^^xsd:string ;
		sio:hasValue	"CD274"^^xsd:string .

	civic-kb:Variant-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-1497aa1f1e42f4e0d6477438e2de7ead ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A meta-analysis of the role of PD-L1 expression in breast cancer found nine relevant studies with a total 8583 patients. PD-L1 expression was found to be associated with several poor prognostic indicators, such as ductal cancer, high tumor grade, ER negativity, PR negativity, HER2 positivity and aggressive molecular subtypes. PD-L1 overexpression had no significant impact on metastasis-free survival (HR 0.924, 95% CI = 0.747-1.141, p = 0.462), disease-free survival (HR 1.122, 95% CI = 0.878-1.434, p = 0.357) and overall specific survival (HR 0.837, 95% CI = 0.640-1.093, p = 0.191), but significantly correlated with shortened overall survival (HR 1.573, 95% CI = 1.010-2.451, p = 0.045)."^^xsd:string .

	civic-kb:Disease-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1497aa1f1e42f4e0d6477438e2de7ead ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-1497aa1f1e42f4e0d6477438e2de7ead ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1497aa1f1e42f4e0d6477438e2de7ead ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1497aa1f1e42f4e0d6477438e2de7ead ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-1497aa1f1e42f4e0d6477438e2de7ead ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-1497aa1f1e42f4e0d6477438e2de7ead ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-1497aa1f1e42f4e0d6477438e2de7ead	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-1497aa1f1e42f4e0d6477438e2de7ead .

}

civic-kb:provenance-1497aa1f1e42f4e0d6477438e2de7ead {
	civic-kb:assertion-1497aa1f1e42f4e0d6477438e2de7ead prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-1497aa1f1e42f4e0d6477438e2de7ead .

	civic-kb:Status-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-1497aa1f1e42f4e0d6477438e2de7ead	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-1497aa1f1e42f4e0d6477438e2de7ead {
	civic-kb:nanoPub-1497aa1f1e42f4e0d6477438e2de7ead prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-1497aa1f1e42f4e0d6477438e2de7ead
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2ddcc85c4594c5bed027d8971390a07b {
	civic-kb:nanoPub-2ddcc85c4594c5bed027d8971390a07b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2ddcc85c4594c5bed027d8971390a07b ;
		np:hasProvenance civic-kb:provenance-2ddcc85c4594c5bed027d8971390a07b ;
		np:hasPublicationInfo civic-kb:pubInfo-2ddcc85c4594c5bed027d8971390a07b .
}

civic-kb:assertion-2ddcc85c4594c5bed027d8971390a07b {
	civic-kb:Drugs-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2ddcc85c4594c5bed027d8971390a07b ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2ddcc85c4594c5bed027d8971390a07b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2ddcc85c4594c5bed027d8971390a07b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"706"^^xsd:integer .

	civic-kb:Gene-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18352 ;
		rdf:type	uniprot:P31751 ;
		rdfs:label	"AKT2 Gene"^^xsd:string ;
		sio:hasValue	"AKT2"^^xsd:string .

	civic-kb:Variant-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2ddcc85c4594c5bed027d8971390a07b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In HER2+ metastatic breast cancer treated with trastuzumab (n = 74 patients), the expression of AKT2 and pAkt-Thr308 and/or pAkt-Ser473 localized in nucleus+cytoplasm was associated with an improved time to progression (TTP) and overall survival (OS) compared to AKT2 negative tumors as measured by immunohistochemistry."^^xsd:string .

	civic-kb:Disease-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2ddcc85c4594c5bed027d8971390a07b ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2ddcc85c4594c5bed027d8971390a07b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2ddcc85c4594c5bed027d8971390a07b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2ddcc85c4594c5bed027d8971390a07b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2ddcc85c4594c5bed027d8971390a07b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2ddcc85c4594c5bed027d8971390a07b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-2ddcc85c4594c5bed027d8971390a07b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2ddcc85c4594c5bed027d8971390a07b .

}

civic-kb:provenance-2ddcc85c4594c5bed027d8971390a07b {
	civic-kb:assertion-2ddcc85c4594c5bed027d8971390a07b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2ddcc85c4594c5bed027d8971390a07b .

	civic-kb:Status-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-2ddcc85c4594c5bed027d8971390a07b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2ddcc85c4594c5bed027d8971390a07b {
	civic-kb:nanoPub-2ddcc85c4594c5bed027d8971390a07b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2ddcc85c4594c5bed027d8971390a07b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-b68591ba0d65d0760fe3e65c6bbfab8b {
	civic-kb:nanoPub-b68591ba0d65d0760fe3e65c6bbfab8b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-b68591ba0d65d0760fe3e65c6bbfab8b ;
		np:hasProvenance civic-kb:provenance-b68591ba0d65d0760fe3e65c6bbfab8b ;
		np:hasPublicationInfo civic-kb:pubInfo-b68591ba0d65d0760fe3e65c6bbfab8b .
}

civic-kb:assertion-b68591ba0d65d0760fe3e65c6bbfab8b {
	civic-kb:Drugs-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b68591ba0d65d0760fe3e65c6bbfab8b ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-b68591ba0d65d0760fe3e65c6bbfab8b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-b68591ba0d65d0760fe3e65c6bbfab8b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3053"^^xsd:integer .

	civic-kb:Gene-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18386 ;
		rdf:type	uniprot:P21860 ;
		rdfs:label	"ERBB3 Gene"^^xsd:string ;
		sio:hasValue	"ERBB3"^^xsd:string .

	civic-kb:Variant-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-b68591ba0d65d0760fe3e65c6bbfab8b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b68591ba0d65d0760fe3e65c6bbfab8b ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-b68591ba0d65d0760fe3e65c6bbfab8b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b68591ba0d65d0760fe3e65c6bbfab8b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b68591ba0d65d0760fe3e65c6bbfab8b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-b68591ba0d65d0760fe3e65c6bbfab8b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-b68591ba0d65d0760fe3e65c6bbfab8b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-b68591ba0d65d0760fe3e65c6bbfab8b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-b68591ba0d65d0760fe3e65c6bbfab8b .

}

civic-kb:provenance-b68591ba0d65d0760fe3e65c6bbfab8b {
	civic-kb:assertion-b68591ba0d65d0760fe3e65c6bbfab8b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-b68591ba0d65d0760fe3e65c6bbfab8b .

	civic-kb:Status-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-b68591ba0d65d0760fe3e65c6bbfab8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-b68591ba0d65d0760fe3e65c6bbfab8b {
	civic-kb:nanoPub-b68591ba0d65d0760fe3e65c6bbfab8b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-b68591ba0d65d0760fe3e65c6bbfab8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-172843cbc3f3d7e74a4b3da9d6b117db {
	civic-kb:nanoPub-172843cbc3f3d7e74a4b3da9d6b117db
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-172843cbc3f3d7e74a4b3da9d6b117db ;
		np:hasProvenance civic-kb:provenance-172843cbc3f3d7e74a4b3da9d6b117db ;
		np:hasPublicationInfo civic-kb:pubInfo-172843cbc3f3d7e74a4b3da9d6b117db .
}

civic-kb:assertion-172843cbc3f3d7e74a4b3da9d6b117db {
	civic-kb:Drugs-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-172843cbc3f3d7e74a4b3da9d6b117db ;
		rdf:type	chebi:45863 ;
		rdf:type	db:DB01229 ;
		rdfs:label	"Paclitaxel"^^xsd:string ;
		sio:hasValue	"Paclitaxel"^^xsd:string .

	civic-kb:Status-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-172843cbc3f3d7e74a4b3da9d6b117db ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-172843cbc3f3d7e74a4b3da9d6b117db ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"734"^^xsd:integer .

	civic-kb:Gene-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C90089 ;
		rdf:type	uniprot:Q99836 ;
		rdfs:label	"MYD88 Gene"^^xsd:string ;
		sio:hasValue	"MYD88"^^xsd:string .

	civic-kb:Variant-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-172843cbc3f3d7e74a4b3da9d6b117db ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In this retrospective analysis of 211 breast cancer tissues, MYD88 overexpression was correlated  with poor survival. In-vitro experiments showed a decrease in sensitivity towards paclitaxel in cell-lines with high MYD88 expression."^^xsd:string .

	civic-kb:Disease-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-172843cbc3f3d7e74a4b3da9d6b117db ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-172843cbc3f3d7e74a4b3da9d6b117db ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-172843cbc3f3d7e74a4b3da9d6b117db ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-172843cbc3f3d7e74a4b3da9d6b117db ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-172843cbc3f3d7e74a4b3da9d6b117db ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-172843cbc3f3d7e74a4b3da9d6b117db ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-172843cbc3f3d7e74a4b3da9d6b117db	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-172843cbc3f3d7e74a4b3da9d6b117db .

}

civic-kb:provenance-172843cbc3f3d7e74a4b3da9d6b117db {
	civic-kb:assertion-172843cbc3f3d7e74a4b3da9d6b117db prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-172843cbc3f3d7e74a4b3da9d6b117db .

	civic-kb:Status-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-172843cbc3f3d7e74a4b3da9d6b117db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-172843cbc3f3d7e74a4b3da9d6b117db {
	civic-kb:nanoPub-172843cbc3f3d7e74a4b3da9d6b117db prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-172843cbc3f3d7e74a4b3da9d6b117db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-df6f2e1cbadff1c06e8f7d009b182fab {
	civic-kb:nanoPub-df6f2e1cbadff1c06e8f7d009b182fab
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-df6f2e1cbadff1c06e8f7d009b182fab ;
		np:hasProvenance civic-kb:provenance-df6f2e1cbadff1c06e8f7d009b182fab ;
		np:hasPublicationInfo civic-kb:pubInfo-df6f2e1cbadff1c06e8f7d009b182fab .
}

civic-kb:assertion-df6f2e1cbadff1c06e8f7d009b182fab {
	civic-kb:Drugs-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-df6f2e1cbadff1c06e8f7d009b182fab ;
		rdf:type	chebi:49960 ;
		rdf:type	db:DB05294 ;
		rdf:type	db:DB08764 ;
		rdfs:label	"Vandetanib"^^xsd:string ;
		sio:hasValue	"Vandetanib"^^xsd:string .

	civic-kb:Status-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-df6f2e1cbadff1c06e8f7d009b182fab ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-df6f2e1cbadff1c06e8f7d009b182fab ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"740"^^xsd:integer .

	civic-kb:Gene-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18539 ;
		rdf:type	uniprot:P07949 ;
		rdfs:label	"RET Gene"^^xsd:string ;
		sio:hasValue	"RET"^^xsd:string .

	civic-kb:Variant-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-df6f2e1cbadff1c06e8f7d009b182fab ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Vandetanib was tested in 4 murine models of patient-derived xenografts. In xenografts with high expression of EGFR or RET, vandetanib led to tumor regression, in those without high expression, vandetanib slowed tumor growth."^^xsd:string .

	civic-kb:Disease-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-df6f2e1cbadff1c06e8f7d009b182fab ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-df6f2e1cbadff1c06e8f7d009b182fab ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-df6f2e1cbadff1c06e8f7d009b182fab ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-df6f2e1cbadff1c06e8f7d009b182fab ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-df6f2e1cbadff1c06e8f7d009b182fab ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-df6f2e1cbadff1c06e8f7d009b182fab ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-df6f2e1cbadff1c06e8f7d009b182fab	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-df6f2e1cbadff1c06e8f7d009b182fab .

}

civic-kb:provenance-df6f2e1cbadff1c06e8f7d009b182fab {
	civic-kb:assertion-df6f2e1cbadff1c06e8f7d009b182fab prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-df6f2e1cbadff1c06e8f7d009b182fab .

	civic-kb:Status-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-df6f2e1cbadff1c06e8f7d009b182fab	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-df6f2e1cbadff1c06e8f7d009b182fab {
	civic-kb:nanoPub-df6f2e1cbadff1c06e8f7d009b182fab prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-df6f2e1cbadff1c06e8f7d009b182fab
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-bcb2fdd4d48f4dfefe760ffe13f14e44 {
	civic-kb:nanoPub-bcb2fdd4d48f4dfefe760ffe13f14e44
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		np:hasProvenance civic-kb:provenance-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		np:hasPublicationInfo civic-kb:pubInfo-bcb2fdd4d48f4dfefe760ffe13f14e44 .
}

civic-kb:assertion-bcb2fdd4d48f4dfefe760ffe13f14e44 {
	civic-kb:Drugs-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"955"^^xsd:integer .

	civic-kb:Gene-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Trastuzumab was more effective in cell lines (SKBR3 vs. drug-resistant SKBR3/R) and 17 patient samples that exhibit elevated PTEN expression (by IHC)."^^xsd:string .

	civic-kb:Disease-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-bcb2fdd4d48f4dfefe760ffe13f14e44 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-bcb2fdd4d48f4dfefe760ffe13f14e44	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-bcb2fdd4d48f4dfefe760ffe13f14e44 .

}

civic-kb:provenance-bcb2fdd4d48f4dfefe760ffe13f14e44 {
	civic-kb:assertion-bcb2fdd4d48f4dfefe760ffe13f14e44 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-bcb2fdd4d48f4dfefe760ffe13f14e44 .

	civic-kb:Status-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-bcb2fdd4d48f4dfefe760ffe13f14e44	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-bcb2fdd4d48f4dfefe760ffe13f14e44 {
	civic-kb:nanoPub-bcb2fdd4d48f4dfefe760ffe13f14e44 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-bcb2fdd4d48f4dfefe760ffe13f14e44
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-09620f863b4a3b7c3a2afab0d2d3454e {
	civic-kb:nanoPub-09620f863b4a3b7c3a2afab0d2d3454e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-09620f863b4a3b7c3a2afab0d2d3454e ;
		np:hasProvenance civic-kb:provenance-09620f863b4a3b7c3a2afab0d2d3454e ;
		np:hasPublicationInfo civic-kb:pubInfo-09620f863b4a3b7c3a2afab0d2d3454e .
}

civic-kb:assertion-09620f863b4a3b7c3a2afab0d2d3454e {
	civic-kb:Drugs-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-09620f863b4a3b7c3a2afab0d2d3454e ;
		sio:hasValue	"Everolimus, Fulvestrant"^^xsd:string .

	civic-kb:Status-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-09620f863b4a3b7c3a2afab0d2d3454e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-09620f863b4a3b7c3a2afab0d2d3454e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1624"^^xsd:integer .

	civic-kb:Gene-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18256 ;
		rdf:type	uniprot:P60484 ;
		rdfs:label	"PTEN Gene"^^xsd:string ;
		sio:hasValue	"PTEN"^^xsd:string .

	civic-kb:Variant-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-09620f863b4a3b7c3a2afab0d2d3454e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Case report of a 44-year-old patient with recurrent HER2-positive breast cancer. The primary tumor was HR positive; however, the metastatic tumor was HR negative. The patient was resistant to classical chemotherapeutic agents and anti-HER2 treatment. Thus, the combination of everolimus and fulvestrant was administered. The patient experienced stable disease and PFS of 10 months. Genetic testing of pleural effusion after disease progression revealed a PIK3CA H1047R gene mutation but was positive for PTEN expression (IHC)."^^xsd:string .

	civic-kb:Disease-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-09620f863b4a3b7c3a2afab0d2d3454e ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-09620f863b4a3b7c3a2afab0d2d3454e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-09620f863b4a3b7c3a2afab0d2d3454e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-09620f863b4a3b7c3a2afab0d2d3454e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-09620f863b4a3b7c3a2afab0d2d3454e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-09620f863b4a3b7c3a2afab0d2d3454e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"1"^^xsd:integer .

	civic-kb:evidence-09620f863b4a3b7c3a2afab0d2d3454e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-09620f863b4a3b7c3a2afab0d2d3454e .

}

civic-kb:provenance-09620f863b4a3b7c3a2afab0d2d3454e {
	civic-kb:assertion-09620f863b4a3b7c3a2afab0d2d3454e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-09620f863b4a3b7c3a2afab0d2d3454e .

	civic-kb:Status-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-09620f863b4a3b7c3a2afab0d2d3454e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-09620f863b4a3b7c3a2afab0d2d3454e {
	civic-kb:nanoPub-09620f863b4a3b7c3a2afab0d2d3454e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-09620f863b4a3b7c3a2afab0d2d3454e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-7bd1d1642b02986d3dd6ba16484b8c9c {
	civic-kb:nanoPub-7bd1d1642b02986d3dd6ba16484b8c9c
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-7bd1d1642b02986d3dd6ba16484b8c9c ;
		np:hasProvenance civic-kb:provenance-7bd1d1642b02986d3dd6ba16484b8c9c ;
		np:hasPublicationInfo civic-kb:pubInfo-7bd1d1642b02986d3dd6ba16484b8c9c .
}

civic-kb:assertion-7bd1d1642b02986d3dd6ba16484b8c9c {
	civic-kb:Drugs-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7bd1d1642b02986d3dd6ba16484b8c9c ;
		rdf:type	db:DB00997 ;
		rdfs:label	"Doxorubicin"^^xsd:string ;
		sio:hasValue	"Doxorubicin"^^xsd:string .

	civic-kb:Status-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-7bd1d1642b02986d3dd6ba16484b8c9c ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-7bd1d1642b02986d3dd6ba16484b8c9c ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"909"^^xsd:integer .

	civic-kb:Gene-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17801 ;
		rdf:type	uniprot:P11388 ;
		rdfs:label	"TOP2A Gene"^^xsd:string ;
		sio:hasValue	"TOP2A"^^xsd:string .

	civic-kb:Variant-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-7bd1d1642b02986d3dd6ba16484b8c9c ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a retrospective study, TOP2A expression was assessed by IHC for 108 breast cancer patients (from TAX 303 trial). TOP2A expression was associated with a higher probability of response in doxorubicin treated but not in docetaxel treated breast cancer patients."^^xsd:string .

	civic-kb:Disease-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7bd1d1642b02986d3dd6ba16484b8c9c ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-7bd1d1642b02986d3dd6ba16484b8c9c ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7bd1d1642b02986d3dd6ba16484b8c9c ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7bd1d1642b02986d3dd6ba16484b8c9c ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-7bd1d1642b02986d3dd6ba16484b8c9c ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-7bd1d1642b02986d3dd6ba16484b8c9c ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-7bd1d1642b02986d3dd6ba16484b8c9c	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-7bd1d1642b02986d3dd6ba16484b8c9c .

}

civic-kb:provenance-7bd1d1642b02986d3dd6ba16484b8c9c {
	civic-kb:assertion-7bd1d1642b02986d3dd6ba16484b8c9c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-7bd1d1642b02986d3dd6ba16484b8c9c .

	civic-kb:Status-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-7bd1d1642b02986d3dd6ba16484b8c9c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-7bd1d1642b02986d3dd6ba16484b8c9c {
	civic-kb:nanoPub-7bd1d1642b02986d3dd6ba16484b8c9c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-7bd1d1642b02986d3dd6ba16484b8c9c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-10025b084d213f915768749751c4f36a {
	civic-kb:nanoPub-10025b084d213f915768749751c4f36a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-10025b084d213f915768749751c4f36a ;
		np:hasProvenance civic-kb:provenance-10025b084d213f915768749751c4f36a ;
		np:hasPublicationInfo civic-kb:pubInfo-10025b084d213f915768749751c4f36a .
}

civic-kb:assertion-10025b084d213f915768749751c4f36a {
	civic-kb:Drugs-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-10025b084d213f915768749751c4f36a ;
		rdf:type	ncit:C1490 ;
		rdfs:label	"Taxane"^^xsd:string ;
		sio:hasValue	"Taxane"^^xsd:string .

	civic-kb:Status-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-10025b084d213f915768749751c4f36a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-10025b084d213f915768749751c4f36a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"921"^^xsd:integer .

	civic-kb:Gene-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C104242 ;
		rdf:type	uniprot:Q13509 ;
		rdfs:label	"TUBB3 Gene"^^xsd:string ;
		sio:hasValue	"TUBB3"^^xsd:string .

	civic-kb:Variant-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-10025b084d213f915768749751c4f36a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"High expression of betaIII-tubulin, as assessed in 85 breast cancers by IHC, was associated with better pathological response."^^xsd:string .

	civic-kb:Disease-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-10025b084d213f915768749751c4f36a ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-10025b084d213f915768749751c4f36a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-10025b084d213f915768749751c4f36a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-10025b084d213f915768749751c4f36a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-10025b084d213f915768749751c4f36a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-10025b084d213f915768749751c4f36a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-10025b084d213f915768749751c4f36a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-10025b084d213f915768749751c4f36a .

}

civic-kb:provenance-10025b084d213f915768749751c4f36a {
	civic-kb:assertion-10025b084d213f915768749751c4f36a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-10025b084d213f915768749751c4f36a .

	civic-kb:Status-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-10025b084d213f915768749751c4f36a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-10025b084d213f915768749751c4f36a {
	civic-kb:nanoPub-10025b084d213f915768749751c4f36a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-10025b084d213f915768749751c4f36a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-da783be10b9c55c83438dbb9a6f9837f {
	civic-kb:nanoPub-da783be10b9c55c83438dbb9a6f9837f
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-da783be10b9c55c83438dbb9a6f9837f ;
		np:hasProvenance civic-kb:provenance-da783be10b9c55c83438dbb9a6f9837f ;
		np:hasPublicationInfo civic-kb:pubInfo-da783be10b9c55c83438dbb9a6f9837f .
}

civic-kb:assertion-da783be10b9c55c83438dbb9a6f9837f {
	civic-kb:Drugs-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-da783be10b9c55c83438dbb9a6f9837f ;
		rdf:type	db:DB00445 ;
		rdfs:label	"Epirubicin"^^xsd:string ;
		sio:hasValue	"Epirubicin"^^xsd:string .

	civic-kb:Status-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-da783be10b9c55c83438dbb9a6f9837f ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-da783be10b9c55c83438dbb9a6f9837f ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"928"^^xsd:integer .

	civic-kb:Gene-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C104394 ;
		rdf:type	uniprot:Q9BZS1 ;
		rdfs:label	"FOXP3 Gene"^^xsd:string ;
		sio:hasValue	"FOXP3"^^xsd:string .

	civic-kb:Variant-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-da783be10b9c55c83438dbb9a6f9837f ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"1,097 patients with breast cancer were evaluated for FOXP3 expression by IHC. FOXP3 expression was found in 405 tumor samples and associated with improved OS in patients treated with anthracycline-based adjuvant chemotherapy (6 cycles of 'FEC100' aka epirubicin + cyclophosphamide + 5-fluorouracil) but not in patients treated with sequential anthracycline->taxane (3 cycles of FEC100 followed by 3 cycles of docetaxel). In-vitro experiments confirmed that FOXP3 expression enhance anthracycline efficacy. The in vitro data consisted of testing the sensitivity of various breast cancer cell lines to anthracyclines after treatment with valproic acid (which increases FOXP3 expression). The authors observed that, while valproic acid has no intrinsic cytotoxic effect on tumor cells, it enhanced the cytotoxic effect of epirubicin specifically in cell lines where FOXP3 expression was increased."^^xsd:string .

	civic-kb:Disease-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-da783be10b9c55c83438dbb9a6f9837f ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-da783be10b9c55c83438dbb9a6f9837f ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-da783be10b9c55c83438dbb9a6f9837f ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-da783be10b9c55c83438dbb9a6f9837f ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-da783be10b9c55c83438dbb9a6f9837f ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-da783be10b9c55c83438dbb9a6f9837f ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-da783be10b9c55c83438dbb9a6f9837f	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-da783be10b9c55c83438dbb9a6f9837f .

}

civic-kb:provenance-da783be10b9c55c83438dbb9a6f9837f {
	civic-kb:assertion-da783be10b9c55c83438dbb9a6f9837f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-da783be10b9c55c83438dbb9a6f9837f .

	civic-kb:Status-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-da783be10b9c55c83438dbb9a6f9837f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-da783be10b9c55c83438dbb9a6f9837f {
	civic-kb:nanoPub-da783be10b9c55c83438dbb9a6f9837f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-da783be10b9c55c83438dbb9a6f9837f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-44d4001143fd0fae56732d770bb36d35 {
	civic-kb:nanoPub-44d4001143fd0fae56732d770bb36d35
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-44d4001143fd0fae56732d770bb36d35 ;
		np:hasProvenance civic-kb:provenance-44d4001143fd0fae56732d770bb36d35 ;
		np:hasPublicationInfo civic-kb:pubInfo-44d4001143fd0fae56732d770bb36d35 .
}

civic-kb:assertion-44d4001143fd0fae56732d770bb36d35 {
	civic-kb:Drugs-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-44d4001143fd0fae56732d770bb36d35 ;
		sio:hasValue	"Paclitaxel, Monomethyl Auristatin E"^^xsd:string .

	civic-kb:Status-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-44d4001143fd0fae56732d770bb36d35 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-44d4001143fd0fae56732d770bb36d35 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"951"^^xsd:integer .

	civic-kb:Gene-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C106021 ;
		rdf:type	uniprot:O15438 ;
		rdfs:label	"ABCC3 Gene"^^xsd:string ;
		sio:hasValue	"ABCC3"^^xsd:string .

	civic-kb:Variant-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-44d4001143fd0fae56732d770bb36d35 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"44 cell lines and 145 patient samples were utilized in various aspects of this study. 31 breast cancer cell lines for in vitro sensitivity to paclitaxel and Monomethyl Auristatin E (MMAE). Genome wide amplification was assessed by Affymetrix SNP arrays and expression was assessed by Affymetrix gene expression arrays. ABCC3 amplification (and expression) in ERBB2 (HER2) amplified breast cancer cell lines was associated with resistance to paclitaxel and  MMAE. Three independently derived EVSA-T cell lines overexpressing ABCC3 were at least 20-fold less sensitive to paclitaxel and MMAE based on EC50 values."^^xsd:string .

	civic-kb:Disease-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-44d4001143fd0fae56732d770bb36d35 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-44d4001143fd0fae56732d770bb36d35 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-44d4001143fd0fae56732d770bb36d35 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-44d4001143fd0fae56732d770bb36d35 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-44d4001143fd0fae56732d770bb36d35 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-44d4001143fd0fae56732d770bb36d35 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-44d4001143fd0fae56732d770bb36d35	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-44d4001143fd0fae56732d770bb36d35 .

}

civic-kb:provenance-44d4001143fd0fae56732d770bb36d35 {
	civic-kb:assertion-44d4001143fd0fae56732d770bb36d35 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-44d4001143fd0fae56732d770bb36d35 .

	civic-kb:Status-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-44d4001143fd0fae56732d770bb36d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-44d4001143fd0fae56732d770bb36d35 {
	civic-kb:nanoPub-44d4001143fd0fae56732d770bb36d35 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-44d4001143fd0fae56732d770bb36d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-56709f1926fa4847f537e3b9f29caad2 {
	civic-kb:nanoPub-56709f1926fa4847f537e3b9f29caad2
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-56709f1926fa4847f537e3b9f29caad2 ;
		np:hasProvenance civic-kb:provenance-56709f1926fa4847f537e3b9f29caad2 ;
		np:hasPublicationInfo civic-kb:pubInfo-56709f1926fa4847f537e3b9f29caad2 .
}

civic-kb:assertion-56709f1926fa4847f537e3b9f29caad2 {
	civic-kb:Drugs-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-56709f1926fa4847f537e3b9f29caad2 ;
		sio:hasValue	"Palbociclib (PD0332991), Letrozole"^^xsd:string .

	civic-kb:Status-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-56709f1926fa4847f537e3b9f29caad2 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-56709f1926fa4847f537e3b9f29caad2 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1765"^^xsd:integer .

	civic-kb:Gene-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18022 ;
		rdf:type	uniprot:P42771 ;
		rdfs:label	"CDKN2A Gene"^^xsd:string ;
		sio:hasValue	"CDKN2A"^^xsd:string .

	civic-kb:Variant-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss"^^xsd:string ;
		sio:hasValue	"LOSS"^^xsd:string .

	civic-kb:Description-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-56709f1926fa4847f537e3b9f29caad2 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A patient with metastatic ER-positive, her2-negative breast cancer with CDKN2A loss experienced a short-lived (~3-month) clinical response to palbociclib when given in combination with letrozole."^^xsd:string .

	civic-kb:Disease-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-56709f1926fa4847f537e3b9f29caad2 ;
		rdf:type	doid:0060080 ;
		rdfs:label	"Her2-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-56709f1926fa4847f537e3b9f29caad2 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-56709f1926fa4847f537e3b9f29caad2 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-56709f1926fa4847f537e3b9f29caad2 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-56709f1926fa4847f537e3b9f29caad2 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-56709f1926fa4847f537e3b9f29caad2 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-56709f1926fa4847f537e3b9f29caad2	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-56709f1926fa4847f537e3b9f29caad2 .

}

civic-kb:provenance-56709f1926fa4847f537e3b9f29caad2 {
	civic-kb:assertion-56709f1926fa4847f537e3b9f29caad2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-56709f1926fa4847f537e3b9f29caad2 .

	civic-kb:Status-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-56709f1926fa4847f537e3b9f29caad2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-56709f1926fa4847f537e3b9f29caad2 {
	civic-kb:nanoPub-56709f1926fa4847f537e3b9f29caad2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-56709f1926fa4847f537e3b9f29caad2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-227250660ef370ceeac8f32ff734b979 {
	civic-kb:nanoPub-227250660ef370ceeac8f32ff734b979
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-227250660ef370ceeac8f32ff734b979 ;
		np:hasProvenance civic-kb:provenance-227250660ef370ceeac8f32ff734b979 ;
		np:hasPublicationInfo civic-kb:pubInfo-227250660ef370ceeac8f32ff734b979 .
}

civic-kb:assertion-227250660ef370ceeac8f32ff734b979 {
	civic-kb:Drugs-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-227250660ef370ceeac8f32ff734b979 .

	civic-kb:Status-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-227250660ef370ceeac8f32ff734b979 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-227250660ef370ceeac8f32ff734b979 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"397"^^xsd:integer .

	civic-kb:Gene-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R273H"^^xsd:string .

	civic-kb:Description-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-227250660ef370ceeac8f32ff734b979 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer patients who harbor R273H mutation have worse overall survival than those with wild type TP53, but have better prognosis than those with R248W mutation."^^xsd:string .

	civic-kb:Disease-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-227250660ef370ceeac8f32ff734b979 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-227250660ef370ceeac8f32ff734b979 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-227250660ef370ceeac8f32ff734b979 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-227250660ef370ceeac8f32ff734b979 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-227250660ef370ceeac8f32ff734b979 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-227250660ef370ceeac8f32ff734b979 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-227250660ef370ceeac8f32ff734b979	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-227250660ef370ceeac8f32ff734b979 .

}

civic-kb:provenance-227250660ef370ceeac8f32ff734b979 {
	civic-kb:assertion-227250660ef370ceeac8f32ff734b979 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-227250660ef370ceeac8f32ff734b979 .

	civic-kb:Status-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-227250660ef370ceeac8f32ff734b979	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-227250660ef370ceeac8f32ff734b979 {
	civic-kb:nanoPub-227250660ef370ceeac8f32ff734b979 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-227250660ef370ceeac8f32ff734b979
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ae0a004f524662fc339b96d715914c8f {
	civic-kb:nanoPub-ae0a004f524662fc339b96d715914c8f
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ae0a004f524662fc339b96d715914c8f ;
		np:hasProvenance civic-kb:provenance-ae0a004f524662fc339b96d715914c8f ;
		np:hasPublicationInfo civic-kb:pubInfo-ae0a004f524662fc339b96d715914c8f .
}

civic-kb:assertion-ae0a004f524662fc339b96d715914c8f {
	civic-kb:Drugs-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ae0a004f524662fc339b96d715914c8f .

	civic-kb:Status-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ae0a004f524662fc339b96d715914c8f ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ae0a004f524662fc339b96d715914c8f ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"398"^^xsd:integer .

	civic-kb:Gene-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R273H"^^xsd:string .

	civic-kb:Description-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ae0a004f524662fc339b96d715914c8f ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In breast cancer patients harboring TP53 mutation, mutations in DNA contact regions such as R273 are prognostic for a worse relapse-free survival compared to other non-silent mutations in TP53."^^xsd:string .

	civic-kb:Disease-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ae0a004f524662fc339b96d715914c8f ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ae0a004f524662fc339b96d715914c8f ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ae0a004f524662fc339b96d715914c8f ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ae0a004f524662fc339b96d715914c8f ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ae0a004f524662fc339b96d715914c8f ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ae0a004f524662fc339b96d715914c8f ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-ae0a004f524662fc339b96d715914c8f	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ae0a004f524662fc339b96d715914c8f .

}

civic-kb:provenance-ae0a004f524662fc339b96d715914c8f {
	civic-kb:assertion-ae0a004f524662fc339b96d715914c8f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ae0a004f524662fc339b96d715914c8f .

	civic-kb:Status-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ae0a004f524662fc339b96d715914c8f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ae0a004f524662fc339b96d715914c8f {
	civic-kb:nanoPub-ae0a004f524662fc339b96d715914c8f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ae0a004f524662fc339b96d715914c8f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-572dc8aa6bccaa8e85c4c8ef0b77ac4a {
	civic-kb:nanoPub-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		np:hasProvenance civic-kb:provenance-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		np:hasPublicationInfo civic-kb:pubInfo-572dc8aa6bccaa8e85c4c8ef0b77ac4a .
}

civic-kb:assertion-572dc8aa6bccaa8e85c4c8ef0b77ac4a {
	civic-kb:Drugs-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		sio:hasValue	"CX-5461, CX-3543"^^xsd:string .

	civic-kb:Status-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1925"^^xsd:integer .

	civic-kb:Gene-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18120 ;
		rdf:type	uniprot:P51587 ;
		rdfs:label	"BRCA2 Gene"^^xsd:string ;
		sio:hasValue	"BRCA2"^^xsd:string .

	civic-kb:Variant-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss of Function"^^xsd:string ;
		sio:hasValue	"LOSS-OF-FUNCTION"^^xsd:string .

	civic-kb:Description-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The authors show that in the CX-5461 and CX-3543, G-quadruplex stabilizing agents, demonstrate specific toxicity against BRCA deficient breast cancer derived cells and polyclonal patient-derived xenograft models. The BRCA and NHE J pathways are required for the repair of CX-5461 and CX-3543-induced DNA damage and failure to do so leads to lethality."^^xsd:string .

	civic-kb:Disease-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Unknown"^^xsd:string .

	civic-kb:Trust_Rating-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-572dc8aa6bccaa8e85c4c8ef0b77ac4a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-572dc8aa6bccaa8e85c4c8ef0b77ac4a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-572dc8aa6bccaa8e85c4c8ef0b77ac4a .

}

civic-kb:provenance-572dc8aa6bccaa8e85c4c8ef0b77ac4a {
	civic-kb:assertion-572dc8aa6bccaa8e85c4c8ef0b77ac4a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-572dc8aa6bccaa8e85c4c8ef0b77ac4a .

	civic-kb:Status-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-572dc8aa6bccaa8e85c4c8ef0b77ac4a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-572dc8aa6bccaa8e85c4c8ef0b77ac4a {
	civic-kb:nanoPub-572dc8aa6bccaa8e85c4c8ef0b77ac4a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-572dc8aa6bccaa8e85c4c8ef0b77ac4a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-7458f3a07213444df6d15fd11fbdac03 {
	civic-kb:nanoPub-7458f3a07213444df6d15fd11fbdac03
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-7458f3a07213444df6d15fd11fbdac03 ;
		np:hasProvenance civic-kb:provenance-7458f3a07213444df6d15fd11fbdac03 ;
		np:hasPublicationInfo civic-kb:pubInfo-7458f3a07213444df6d15fd11fbdac03 .
}

civic-kb:assertion-7458f3a07213444df6d15fd11fbdac03 {
	civic-kb:Drugs-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7458f3a07213444df6d15fd11fbdac03 ;
		rdf:type	db:DB11760 ;
		rdfs:label	"Talazoparib"^^xsd:string ;
		sio:hasValue	"Talazoparib"^^xsd:string .

	civic-kb:Status-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-7458f3a07213444df6d15fd11fbdac03 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-7458f3a07213444df6d15fd11fbdac03 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4839"^^xsd:integer .

	civic-kb:Gene-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18120 ;
		rdf:type	uniprot:P51587 ;
		rdfs:label	"BRCA2 Gene"^^xsd:string ;
		sio:hasValue	"BRCA2"^^xsd:string .

	civic-kb:Variant-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss of Function"^^xsd:string ;
		sio:hasValue	"LOSS-OF-FUNCTION"^^xsd:string .

	civic-kb:Description-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-7458f3a07213444df6d15fd11fbdac03 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In part 2 of a two-part dose-escalation phase I trial (NCT01286987), 71 patients with Ewings sarcoma, breast, ovarian, small cell lung, or pancreatic cancers received 1.0 mg/day talazoparib treatment. Of patients with BRCA mutation-associated breast and ovarian cancers, confirmed responses were observed in 7 of 14 (50%) and 5 of 12 (42%) patients, respectively."^^xsd:string .

	civic-kb:Disease-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7458f3a07213444df6d15fd11fbdac03 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-7458f3a07213444df6d15fd11fbdac03 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7458f3a07213444df6d15fd11fbdac03 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7458f3a07213444df6d15fd11fbdac03 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-7458f3a07213444df6d15fd11fbdac03 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-7458f3a07213444df6d15fd11fbdac03 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-7458f3a07213444df6d15fd11fbdac03	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-7458f3a07213444df6d15fd11fbdac03 .

}

civic-kb:provenance-7458f3a07213444df6d15fd11fbdac03 {
	civic-kb:assertion-7458f3a07213444df6d15fd11fbdac03 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-7458f3a07213444df6d15fd11fbdac03 .

	civic-kb:Status-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-7458f3a07213444df6d15fd11fbdac03	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-7458f3a07213444df6d15fd11fbdac03 {
	civic-kb:nanoPub-7458f3a07213444df6d15fd11fbdac03 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-7458f3a07213444df6d15fd11fbdac03
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-59a31d9f8fd126dd58432a3d556f03fd {
	civic-kb:nanoPub-59a31d9f8fd126dd58432a3d556f03fd
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-59a31d9f8fd126dd58432a3d556f03fd ;
		np:hasProvenance civic-kb:provenance-59a31d9f8fd126dd58432a3d556f03fd ;
		np:hasPublicationInfo civic-kb:pubInfo-59a31d9f8fd126dd58432a3d556f03fd .
}

civic-kb:assertion-59a31d9f8fd126dd58432a3d556f03fd {
	civic-kb:Drugs-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-59a31d9f8fd126dd58432a3d556f03fd ;
		rdf:type	dron:00730843 ;
		rdf:type	db:DB09074 ;
		rdfs:label	"Olaparib"^^xsd:string ;
		sio:hasValue	"Olaparib"^^xsd:string .

	civic-kb:Status-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-59a31d9f8fd126dd58432a3d556f03fd ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-59a31d9f8fd126dd58432a3d556f03fd ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"5816"^^xsd:integer .

	civic-kb:Gene-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18120 ;
		rdf:type	uniprot:P51587 ;
		rdfs:label	"BRCA2 Gene"^^xsd:string ;
		sio:hasValue	"BRCA2"^^xsd:string .

	civic-kb:Variant-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss of Function"^^xsd:string ;
		sio:hasValue	"LOSS-OF-FUNCTION"^^xsd:string .

	civic-kb:Description-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-59a31d9f8fd126dd58432a3d556f03fd ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"302 patients (234 with progression events) with HER2-negative metastatic breast cancer and with a confirmed deleterious or suspected deleterious germline BRCA mutation (164 BRCA1, 129 BRCA2) had significantly improved progression-free survival and better response rate to olaparib (PARP inhibitor) than standard therapy (7.0 mo vs 4.2 mo, hazard ratio 0.58, 95% CI 0.43-0.8) in this randomized phase 3 trial (NCT02000622). For BRCA2 patients specifically, the hazard ratio was 0.68, 95% CI 0.45-0.1.07."^^xsd:string .

	civic-kb:Disease-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-59a31d9f8fd126dd58432a3d556f03fd ;
		rdf:type	doid:0060080 ;
		rdfs:label	"Her2-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-59a31d9f8fd126dd58432a3d556f03fd ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-59a31d9f8fd126dd58432a3d556f03fd ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-59a31d9f8fd126dd58432a3d556f03fd ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-59a31d9f8fd126dd58432a3d556f03fd ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-59a31d9f8fd126dd58432a3d556f03fd ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-59a31d9f8fd126dd58432a3d556f03fd	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-59a31d9f8fd126dd58432a3d556f03fd .

}

civic-kb:provenance-59a31d9f8fd126dd58432a3d556f03fd {
	civic-kb:assertion-59a31d9f8fd126dd58432a3d556f03fd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-59a31d9f8fd126dd58432a3d556f03fd .

	civic-kb:Status-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-59a31d9f8fd126dd58432a3d556f03fd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-59a31d9f8fd126dd58432a3d556f03fd {
	civic-kb:nanoPub-59a31d9f8fd126dd58432a3d556f03fd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-59a31d9f8fd126dd58432a3d556f03fd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-3c58038e6fd060c8dbf4e2bcf5c236c2 {
	civic-kb:nanoPub-3c58038e6fd060c8dbf4e2bcf5c236c2
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		np:hasProvenance civic-kb:provenance-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		np:hasPublicationInfo civic-kb:pubInfo-3c58038e6fd060c8dbf4e2bcf5c236c2 .
}

civic-kb:assertion-3c58038e6fd060c8dbf4e2bcf5c236c2 {
	civic-kb:Drugs-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		rdf:type	dron:00018949 ;
		rdf:type	db:DB06287 ;
		rdfs:label	"Temsirolimus"^^xsd:string ;
		sio:hasValue	"Temsirolimus"^^xsd:string .

	civic-kb:Status-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"715"^^xsd:integer .

	civic-kb:Gene-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17425 ;
		rdf:type	uniprot:P35240 ;
		rdfs:label	"NF2 Gene"^^xsd:string ;
		sio:hasValue	"NF2"^^xsd:string .

	civic-kb:Variant-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"K159FS*16"^^xsd:string .

	civic-kb:Description-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"23 patients were treated with temsirolimus containing regimens. 1 patient with a complete response >3 years had a K159fs*16 mutation in NF2. 2 patients were tested for NF2 mutations."^^xsd:string .

	civic-kb:Disease-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-3c58038e6fd060c8dbf4e2bcf5c236c2 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-3c58038e6fd060c8dbf4e2bcf5c236c2	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-3c58038e6fd060c8dbf4e2bcf5c236c2 .

}

civic-kb:provenance-3c58038e6fd060c8dbf4e2bcf5c236c2 {
	civic-kb:assertion-3c58038e6fd060c8dbf4e2bcf5c236c2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-3c58038e6fd060c8dbf4e2bcf5c236c2 .

	civic-kb:Status-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-3c58038e6fd060c8dbf4e2bcf5c236c2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-3c58038e6fd060c8dbf4e2bcf5c236c2 {
	civic-kb:nanoPub-3c58038e6fd060c8dbf4e2bcf5c236c2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-3c58038e6fd060c8dbf4e2bcf5c236c2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-a6ecca3085873905fbde964a850e176c {
	civic-kb:nanoPub-a6ecca3085873905fbde964a850e176c
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-a6ecca3085873905fbde964a850e176c ;
		np:hasProvenance civic-kb:provenance-a6ecca3085873905fbde964a850e176c ;
		np:hasPublicationInfo civic-kb:pubInfo-a6ecca3085873905fbde964a850e176c .
}

civic-kb:assertion-a6ecca3085873905fbde964a850e176c {
	civic-kb:Drugs-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a6ecca3085873905fbde964a850e176c ;
		rdf:type	db:DB11828 ;
		rdfs:label	"Neratinib"^^xsd:string ;
		sio:hasValue	"Neratinib"^^xsd:string .

	civic-kb:Status-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-a6ecca3085873905fbde964a850e176c ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-a6ecca3085873905fbde964a850e176c ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"289"^^xsd:integer .

	civic-kb:Gene-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"V842I"^^xsd:string .

	civic-kb:Description-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-a6ecca3085873905fbde964a850e176c ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In MCF10A cell lines, the V842I mutation was shown to be sensitive to neratinib."^^xsd:string .

	civic-kb:Disease-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a6ecca3085873905fbde964a850e176c ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-a6ecca3085873905fbde964a850e176c ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a6ecca3085873905fbde964a850e176c ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a6ecca3085873905fbde964a850e176c ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-a6ecca3085873905fbde964a850e176c ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-a6ecca3085873905fbde964a850e176c ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-a6ecca3085873905fbde964a850e176c	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-a6ecca3085873905fbde964a850e176c .

}

civic-kb:provenance-a6ecca3085873905fbde964a850e176c {
	civic-kb:assertion-a6ecca3085873905fbde964a850e176c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-a6ecca3085873905fbde964a850e176c .

	civic-kb:Status-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-a6ecca3085873905fbde964a850e176c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-a6ecca3085873905fbde964a850e176c {
	civic-kb:nanoPub-a6ecca3085873905fbde964a850e176c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-a6ecca3085873905fbde964a850e176c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d9dda1c87fd887c5211b8626545aeb4e {
	civic-kb:nanoPub-d9dda1c87fd887c5211b8626545aeb4e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d9dda1c87fd887c5211b8626545aeb4e ;
		np:hasProvenance civic-kb:provenance-d9dda1c87fd887c5211b8626545aeb4e ;
		np:hasPublicationInfo civic-kb:pubInfo-d9dda1c87fd887c5211b8626545aeb4e .
}

civic-kb:assertion-d9dda1c87fd887c5211b8626545aeb4e {
	civic-kb:Drugs-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d9dda1c87fd887c5211b8626545aeb4e .

	civic-kb:Status-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d9dda1c87fd887c5211b8626545aeb4e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d9dda1c87fd887c5211b8626545aeb4e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"973"^^xsd:integer .

	civic-kb:Gene-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"SERUM LEVELS"^^xsd:string .

	civic-kb:Description-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d9dda1c87fd887c5211b8626545aeb4e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Serum and tissue levels of HER2 (ERBB2) were analyzed in 1,902 breast cancer patients treated with lapatinib or control. In the control group (n = 936), higher serum HER2 (sHER2) was associated with worse prognosis in multivariable analyses (progression free survival hazard ratio per 10 ng/mL: PFS, 1.024; P < .001; and OS, 1.018; P < .001)."^^xsd:string .

	civic-kb:Disease-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d9dda1c87fd887c5211b8626545aeb4e ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d9dda1c87fd887c5211b8626545aeb4e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d9dda1c87fd887c5211b8626545aeb4e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d9dda1c87fd887c5211b8626545aeb4e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d9dda1c87fd887c5211b8626545aeb4e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d9dda1c87fd887c5211b8626545aeb4e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-d9dda1c87fd887c5211b8626545aeb4e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d9dda1c87fd887c5211b8626545aeb4e .

}

civic-kb:provenance-d9dda1c87fd887c5211b8626545aeb4e {
	civic-kb:assertion-d9dda1c87fd887c5211b8626545aeb4e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d9dda1c87fd887c5211b8626545aeb4e .

	civic-kb:Status-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-d9dda1c87fd887c5211b8626545aeb4e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d9dda1c87fd887c5211b8626545aeb4e {
	civic-kb:nanoPub-d9dda1c87fd887c5211b8626545aeb4e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d9dda1c87fd887c5211b8626545aeb4e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f7a173ad8ad6f8ce0743ca3e59bef3ba {
	civic-kb:nanoPub-f7a173ad8ad6f8ce0743ca3e59bef3ba
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		np:hasProvenance civic-kb:provenance-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		np:hasPublicationInfo civic-kb:pubInfo-f7a173ad8ad6f8ce0743ca3e59bef3ba .
}

civic-kb:assertion-f7a173ad8ad6f8ce0743ca3e59bef3ba {
	civic-kb:Drugs-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"972"^^xsd:integer .

	civic-kb:Gene-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"SERUM LEVELS"^^xsd:string .

	civic-kb:Description-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Serum and tissue levels of HER2 (ERBB2) were analyzed in 1,902 breast cancer patients treated with lapatinib or control.
Serum HER2 (sHER2) levels measured by ELISA were higher in patients with HER2 amplification (median sHER2 levels were 25.1 ng/mL in patients with HER2-positive tumors). Serum HER2 levels were Independent predictors of lapatinib progression free survival benefit (HR per 10-ng/mL increase in serum HER2: lapatinib-containing therapies, 1.009 v nonlapatinib-containing therapies, 1.044; P interaction < .001). Tissue HER2 levels were also predictive, but within this subgroup, serum HER2 still independently predicted lapatinib PFS benefit."^^xsd:string .

	civic-kb:Disease-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f7a173ad8ad6f8ce0743ca3e59bef3ba ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-f7a173ad8ad6f8ce0743ca3e59bef3ba	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f7a173ad8ad6f8ce0743ca3e59bef3ba .

}

civic-kb:provenance-f7a173ad8ad6f8ce0743ca3e59bef3ba {
	civic-kb:assertion-f7a173ad8ad6f8ce0743ca3e59bef3ba prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f7a173ad8ad6f8ce0743ca3e59bef3ba .

	civic-kb:Status-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-f7a173ad8ad6f8ce0743ca3e59bef3ba	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f7a173ad8ad6f8ce0743ca3e59bef3ba {
	civic-kb:nanoPub-f7a173ad8ad6f8ce0743ca3e59bef3ba prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f7a173ad8ad6f8ce0743ca3e59bef3ba
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8647c24a47043cac00f42b4dd0f7086a {
	civic-kb:nanoPub-8647c24a47043cac00f42b4dd0f7086a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8647c24a47043cac00f42b4dd0f7086a ;
		np:hasProvenance civic-kb:provenance-8647c24a47043cac00f42b4dd0f7086a ;
		np:hasPublicationInfo civic-kb:pubInfo-8647c24a47043cac00f42b4dd0f7086a .
}

civic-kb:assertion-8647c24a47043cac00f42b4dd0f7086a {
	civic-kb:Drugs-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8647c24a47043cac00f42b4dd0f7086a ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8647c24a47043cac00f42b4dd0f7086a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8647c24a47043cac00f42b4dd0f7086a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"860"^^xsd:integer .

	civic-kb:Gene-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C20060 ;
		rdf:type	uniprot:P46527 ;
		rdfs:label	"CDKN1B Gene"^^xsd:string ;
		sio:hasValue	"CDKN1B"^^xsd:string .

	civic-kb:Variant-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"CYTOPLASMIC MISLOCALIZATION"^^xsd:string .

	civic-kb:Description-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8647c24a47043cac00f42b4dd0f7086a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Cytoplasmic localization of p27 (CDKN1B) leads to lapatinib resistance in HER2+ breast cancer cell lines. p27 knockout resensitiuzed cells to lapatinib."^^xsd:string .

	civic-kb:Disease-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8647c24a47043cac00f42b4dd0f7086a ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8647c24a47043cac00f42b4dd0f7086a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8647c24a47043cac00f42b4dd0f7086a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8647c24a47043cac00f42b4dd0f7086a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8647c24a47043cac00f42b4dd0f7086a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8647c24a47043cac00f42b4dd0f7086a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-8647c24a47043cac00f42b4dd0f7086a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8647c24a47043cac00f42b4dd0f7086a .

}

civic-kb:provenance-8647c24a47043cac00f42b4dd0f7086a {
	civic-kb:assertion-8647c24a47043cac00f42b4dd0f7086a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8647c24a47043cac00f42b4dd0f7086a .

	civic-kb:Status-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-8647c24a47043cac00f42b4dd0f7086a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8647c24a47043cac00f42b4dd0f7086a {
	civic-kb:nanoPub-8647c24a47043cac00f42b4dd0f7086a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8647c24a47043cac00f42b4dd0f7086a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-92c5293c96b139a87b2f4e9ba8b043c0 {
	civic-kb:nanoPub-92c5293c96b139a87b2f4e9ba8b043c0
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-92c5293c96b139a87b2f4e9ba8b043c0 ;
		np:hasProvenance civic-kb:provenance-92c5293c96b139a87b2f4e9ba8b043c0 ;
		np:hasPublicationInfo civic-kb:pubInfo-92c5293c96b139a87b2f4e9ba8b043c0 .
}

civic-kb:assertion-92c5293c96b139a87b2f4e9ba8b043c0 {
	civic-kb:Drugs-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-92c5293c96b139a87b2f4e9ba8b043c0 ;
		rdf:type	dron:00013476 ;
		rdf:type	db:DB00877 ;
		rdfs:label	"Sirolimus"^^xsd:string ;
		sio:hasValue	"Rapamycin (Sirolimus)"^^xsd:string .

	civic-kb:Status-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-92c5293c96b139a87b2f4e9ba8b043c0 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-92c5293c96b139a87b2f4e9ba8b043c0 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1543"^^xsd:integer .

	civic-kb:Gene-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38928 ;
		rdf:type	uniprot:P42345 ;
		rdfs:label	"MTOR Gene"^^xsd:string ;
		sio:hasValue	"MTOR"^^xsd:string .

	civic-kb:Variant-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"F2108L"^^xsd:string .

	civic-kb:Description-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-92c5293c96b139a87b2f4e9ba8b043c0 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF-7 breast cancer cell line was exposed to mTOR inhibitors AZD8055 or rapamycin until resistance developed. Deep sequencing revealed an MTOR F2108L mutation in rapamycin-resistant clones (RR2 cells). Downstream signalling was independent of inhibitor presence in these clones and expression of the mutations in MDA-MB-468 cells led to resistance."^^xsd:string .

	civic-kb:Disease-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-92c5293c96b139a87b2f4e9ba8b043c0 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-92c5293c96b139a87b2f4e9ba8b043c0 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-92c5293c96b139a87b2f4e9ba8b043c0 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-92c5293c96b139a87b2f4e9ba8b043c0 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-92c5293c96b139a87b2f4e9ba8b043c0 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-92c5293c96b139a87b2f4e9ba8b043c0 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-92c5293c96b139a87b2f4e9ba8b043c0	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-92c5293c96b139a87b2f4e9ba8b043c0 .

}

civic-kb:provenance-92c5293c96b139a87b2f4e9ba8b043c0 {
	civic-kb:assertion-92c5293c96b139a87b2f4e9ba8b043c0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-92c5293c96b139a87b2f4e9ba8b043c0 .

	civic-kb:Status-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-92c5293c96b139a87b2f4e9ba8b043c0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-92c5293c96b139a87b2f4e9ba8b043c0 {
	civic-kb:nanoPub-92c5293c96b139a87b2f4e9ba8b043c0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-92c5293c96b139a87b2f4e9ba8b043c0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-9c4b8f0c99b35bf1ca6ec6dc9064e969 {
	civic-kb:nanoPub-9c4b8f0c99b35bf1ca6ec6dc9064e969
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		np:hasProvenance civic-kb:provenance-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		np:hasPublicationInfo civic-kb:pubInfo-9c4b8f0c99b35bf1ca6ec6dc9064e969 .
}

civic-kb:assertion-9c4b8f0c99b35bf1ca6ec6dc9064e969 {
	civic-kb:Drugs-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		rdf:type	db:DB11828 ;
		rdfs:label	"Neratinib"^^xsd:string ;
		sio:hasValue	"Neratinib"^^xsd:string .

	civic-kb:Status-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"284"^^xsd:integer .

	civic-kb:Gene-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L755W"^^xsd:string .

	civic-kb:Description-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF10A cells transduced with ERBB2 harboring an L755W mutation were sensitive to the irreversible kinase inhibitor neratinib in an matrigel colony forming assay."^^xsd:string .

	civic-kb:Disease-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-9c4b8f0c99b35bf1ca6ec6dc9064e969 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-9c4b8f0c99b35bf1ca6ec6dc9064e969	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-9c4b8f0c99b35bf1ca6ec6dc9064e969 .

}

civic-kb:provenance-9c4b8f0c99b35bf1ca6ec6dc9064e969 {
	civic-kb:assertion-9c4b8f0c99b35bf1ca6ec6dc9064e969 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-9c4b8f0c99b35bf1ca6ec6dc9064e969 .

	civic-kb:Status-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-9c4b8f0c99b35bf1ca6ec6dc9064e969	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-9c4b8f0c99b35bf1ca6ec6dc9064e969 {
	civic-kb:nanoPub-9c4b8f0c99b35bf1ca6ec6dc9064e969 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-9c4b8f0c99b35bf1ca6ec6dc9064e969
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-599d17aac2a6a28ae2d0024fcda5a002 {
	civic-kb:nanoPub-599d17aac2a6a28ae2d0024fcda5a002
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-599d17aac2a6a28ae2d0024fcda5a002 ;
		np:hasProvenance civic-kb:provenance-599d17aac2a6a28ae2d0024fcda5a002 ;
		np:hasPublicationInfo civic-kb:pubInfo-599d17aac2a6a28ae2d0024fcda5a002 .
}

civic-kb:assertion-599d17aac2a6a28ae2d0024fcda5a002 {
	civic-kb:Drugs-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-599d17aac2a6a28ae2d0024fcda5a002 ;
		sio:hasValue	"Go6983, GF109203X"^^xsd:string .

	civic-kb:Status-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-599d17aac2a6a28ae2d0024fcda5a002 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-599d17aac2a6a28ae2d0024fcda5a002 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"6000"^^xsd:integer .

	civic-kb:Gene-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	uniprot:Q86UE8 ;
		rdfs:label	"TLK2 Gene"^^xsd:string ;
		sio:hasValue	"TLK2"^^xsd:string .

	civic-kb:Variant-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-599d17aac2a6a28ae2d0024fcda5a002 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-599d17aac2a6a28ae2d0024fcda5a002 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-599d17aac2a6a28ae2d0024fcda5a002 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-599d17aac2a6a28ae2d0024fcda5a002 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-599d17aac2a6a28ae2d0024fcda5a002 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-599d17aac2a6a28ae2d0024fcda5a002 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-599d17aac2a6a28ae2d0024fcda5a002 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-599d17aac2a6a28ae2d0024fcda5a002	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-599d17aac2a6a28ae2d0024fcda5a002 .

}

civic-kb:provenance-599d17aac2a6a28ae2d0024fcda5a002 {
	civic-kb:assertion-599d17aac2a6a28ae2d0024fcda5a002 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-599d17aac2a6a28ae2d0024fcda5a002 .

	civic-kb:Status-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-599d17aac2a6a28ae2d0024fcda5a002	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-599d17aac2a6a28ae2d0024fcda5a002 {
	civic-kb:nanoPub-599d17aac2a6a28ae2d0024fcda5a002 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-599d17aac2a6a28ae2d0024fcda5a002
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-5859352eb874bfbfe8a373f619c02512 {
	civic-kb:nanoPub-5859352eb874bfbfe8a373f619c02512
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-5859352eb874bfbfe8a373f619c02512 ;
		np:hasProvenance civic-kb:provenance-5859352eb874bfbfe8a373f619c02512 ;
		np:hasPublicationInfo civic-kb:pubInfo-5859352eb874bfbfe8a373f619c02512 .
}

civic-kb:assertion-5859352eb874bfbfe8a373f619c02512 {
	civic-kb:Drugs-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5859352eb874bfbfe8a373f619c02512 ;
		rdfs:label	"Spliceostatin A"^^xsd:string ;
		sio:hasValue	"Spliceostatin A"^^xsd:string .

	civic-kb:Status-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-5859352eb874bfbfe8a373f619c02512 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-5859352eb874bfbfe8a373f619c02512 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1417"^^xsd:integer .

	civic-kb:Gene-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C98284 ;
		rdf:type	uniprot:O75533 ;
		rdfs:label	"SF3B1 Gene"^^xsd:string ;
		sio:hasValue	"SF3B1"^^xsd:string .

	civic-kb:Variant-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"K700E"^^xsd:string .

	civic-kb:Description-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-5859352eb874bfbfe8a373f619c02512 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Mutations in SF3B1 were identified in 21/936 ER positive vs. 1/289 ER negative breast cancers. Mutation was recurrent (K700E in 74% or K666Q or K666E in another 9% of tumors). Treatment of two SF3B1 mutant cell lines (pancreatic and endometrial with K700 and K666 mutation, respectively) and six wild-type controls showed that mutant cell lines were significantly more sensitive to spliceostatin A (SF3b complex inhibitor)."^^xsd:string .

	civic-kb:Disease-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5859352eb874bfbfe8a373f619c02512 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-5859352eb874bfbfe8a373f619c02512 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5859352eb874bfbfe8a373f619c02512 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5859352eb874bfbfe8a373f619c02512 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-5859352eb874bfbfe8a373f619c02512 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-5859352eb874bfbfe8a373f619c02512 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-5859352eb874bfbfe8a373f619c02512	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-5859352eb874bfbfe8a373f619c02512 .

}

civic-kb:provenance-5859352eb874bfbfe8a373f619c02512 {
	civic-kb:assertion-5859352eb874bfbfe8a373f619c02512 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-5859352eb874bfbfe8a373f619c02512 .

	civic-kb:Status-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-5859352eb874bfbfe8a373f619c02512	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-5859352eb874bfbfe8a373f619c02512 {
	civic-kb:nanoPub-5859352eb874bfbfe8a373f619c02512 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-5859352eb874bfbfe8a373f619c02512
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-44dc93c46d3780f7e0bd290ddcdfb876 {
	civic-kb:nanoPub-44dc93c46d3780f7e0bd290ddcdfb876
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-44dc93c46d3780f7e0bd290ddcdfb876 ;
		np:hasProvenance civic-kb:provenance-44dc93c46d3780f7e0bd290ddcdfb876 ;
		np:hasPublicationInfo civic-kb:pubInfo-44dc93c46d3780f7e0bd290ddcdfb876 .
}

civic-kb:assertion-44dc93c46d3780f7e0bd290ddcdfb876 {
	civic-kb:Drugs-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-44dc93c46d3780f7e0bd290ddcdfb876 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-44dc93c46d3780f7e0bd290ddcdfb876 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-44dc93c46d3780f7e0bd290ddcdfb876 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1449"^^xsd:integer .

	civic-kb:Gene-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C20350 ;
		rdf:type	uniprot:O15392 ;
		rdfs:label	"BIRC5 Gene"^^xsd:string ;
		sio:hasValue	"BIRC5"^^xsd:string .

	civic-kb:Variant-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-44dc93c46d3780f7e0bd290ddcdfb876 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"13 HER2 breast cancer patients were treated with trastuzumab and then trastuzumab + docetaxel prior to surgery. Pretreatment biopsies and post-treatment surgical samples were obtained, and microarray performed. 5 of 13 patients responded to treatment, and pretreatment biopsies from non-responders showed significantly higher survivin (BIRC5) mRNA (p=0.026) levels than responders. In HER2 positive, trastuzumab-sensitive BT474 cells, overexpression of survivin blunted sensitivity to trastuzumab. In HER2 positive trastuzumab-resistant breast cancer cell lines, knockdown of survivin with RNAi or with YM155 induced growth inhibition and apoptosis."^^xsd:string .

	civic-kb:Disease-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-44dc93c46d3780f7e0bd290ddcdfb876 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-44dc93c46d3780f7e0bd290ddcdfb876 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-44dc93c46d3780f7e0bd290ddcdfb876 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-44dc93c46d3780f7e0bd290ddcdfb876 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-44dc93c46d3780f7e0bd290ddcdfb876 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-44dc93c46d3780f7e0bd290ddcdfb876 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-44dc93c46d3780f7e0bd290ddcdfb876	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-44dc93c46d3780f7e0bd290ddcdfb876 .

}

civic-kb:provenance-44dc93c46d3780f7e0bd290ddcdfb876 {
	civic-kb:assertion-44dc93c46d3780f7e0bd290ddcdfb876 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-44dc93c46d3780f7e0bd290ddcdfb876 .

	civic-kb:Status-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-44dc93c46d3780f7e0bd290ddcdfb876	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-44dc93c46d3780f7e0bd290ddcdfb876 {
	civic-kb:nanoPub-44dc93c46d3780f7e0bd290ddcdfb876 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-44dc93c46d3780f7e0bd290ddcdfb876
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d568e7d2522726e47f9ca5ec63951379 {
	civic-kb:nanoPub-d568e7d2522726e47f9ca5ec63951379
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d568e7d2522726e47f9ca5ec63951379 ;
		np:hasProvenance civic-kb:provenance-d568e7d2522726e47f9ca5ec63951379 ;
		np:hasPublicationInfo civic-kb:pubInfo-d568e7d2522726e47f9ca5ec63951379 .
}

civic-kb:assertion-d568e7d2522726e47f9ca5ec63951379 {
	civic-kb:Drugs-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d568e7d2522726e47f9ca5ec63951379 ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d568e7d2522726e47f9ca5ec63951379 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d568e7d2522726e47f9ca5ec63951379 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3052"^^xsd:integer .

	civic-kb:Gene-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Non-amplification"^^xsd:string ;
		sio:hasValue	"NON-AMPLIFICATION"^^xsd:string .

	civic-kb:Description-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d568e7d2522726e47f9ca5ec63951379 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d568e7d2522726e47f9ca5ec63951379 ;
		rdf:type	doid:0060080 ;
		rdfs:label	"Her2-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d568e7d2522726e47f9ca5ec63951379 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d568e7d2522726e47f9ca5ec63951379 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d568e7d2522726e47f9ca5ec63951379 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d568e7d2522726e47f9ca5ec63951379 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d568e7d2522726e47f9ca5ec63951379 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-d568e7d2522726e47f9ca5ec63951379	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d568e7d2522726e47f9ca5ec63951379 .

}

civic-kb:provenance-d568e7d2522726e47f9ca5ec63951379 {
	civic-kb:assertion-d568e7d2522726e47f9ca5ec63951379 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d568e7d2522726e47f9ca5ec63951379 .

	civic-kb:Status-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-d568e7d2522726e47f9ca5ec63951379	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d568e7d2522726e47f9ca5ec63951379 {
	civic-kb:nanoPub-d568e7d2522726e47f9ca5ec63951379 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d568e7d2522726e47f9ca5ec63951379
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-b521a5553277174144a7f7fb3fc64163 {
	civic-kb:nanoPub-b521a5553277174144a7f7fb3fc64163
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-b521a5553277174144a7f7fb3fc64163 ;
		np:hasProvenance civic-kb:provenance-b521a5553277174144a7f7fb3fc64163 ;
		np:hasPublicationInfo civic-kb:pubInfo-b521a5553277174144a7f7fb3fc64163 .
}

civic-kb:assertion-b521a5553277174144a7f7fb3fc64163 {
	civic-kb:Drugs-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b521a5553277174144a7f7fb3fc64163 ;
		sio:hasValue	"Trastuzumab, Lapatinib"^^xsd:string .

	civic-kb:Status-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-b521a5553277174144a7f7fb3fc64163 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-b521a5553277174144a7f7fb3fc64163 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1008"^^xsd:integer .

	civic-kb:Gene-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-b521a5553277174144a7f7fb3fc64163 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"This Phase III trial compared the activity of lapatinib vs. trastuzumab vs. sequential trastuzumab followed by lapatinib vs. lapatinib plus trastuzumab in an adjuvant treatment setting.  8381 women were randomized to one of four treatment arms. Patients had HER2 positive non-metastatic operable BC. The primary endpoint was disease free survival.  First results report that after median 4.5 year follow up, a non significant 16% improvement in DFS was seen in trastuzumab + lapatinib vs. trastuzumab alone.  The results are interpreted as showing no added benefit for labatinib addition to trastuzumab in the adjuvant treatment context.  This trial is ongoing but not recruiting patients (NCT00490139)."^^xsd:string .

	civic-kb:Disease-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b521a5553277174144a7f7fb3fc64163 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-b521a5553277174144a7f7fb3fc64163 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b521a5553277174144a7f7fb3fc64163 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b521a5553277174144a7f7fb3fc64163 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-b521a5553277174144a7f7fb3fc64163 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-b521a5553277174144a7f7fb3fc64163 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-b521a5553277174144a7f7fb3fc64163	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-b521a5553277174144a7f7fb3fc64163 .

}

civic-kb:provenance-b521a5553277174144a7f7fb3fc64163 {
	civic-kb:assertion-b521a5553277174144a7f7fb3fc64163 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-b521a5553277174144a7f7fb3fc64163 .

	civic-kb:Status-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-b521a5553277174144a7f7fb3fc64163	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-b521a5553277174144a7f7fb3fc64163 {
	civic-kb:nanoPub-b521a5553277174144a7f7fb3fc64163 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-b521a5553277174144a7f7fb3fc64163
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-eab265d6a5244966d9c6c7518023effc {
	civic-kb:nanoPub-eab265d6a5244966d9c6c7518023effc
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-eab265d6a5244966d9c6c7518023effc ;
		np:hasProvenance civic-kb:provenance-eab265d6a5244966d9c6c7518023effc ;
		np:hasPublicationInfo civic-kb:pubInfo-eab265d6a5244966d9c6c7518023effc .
}

civic-kb:assertion-eab265d6a5244966d9c6c7518023effc {
	civic-kb:Drugs-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-eab265d6a5244966d9c6c7518023effc ;
		sio:hasValue	"Pertuzumab, Trastuzumab, Docetaxel"^^xsd:string .

	civic-kb:Status-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-eab265d6a5244966d9c6c7518023effc ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-eab265d6a5244966d9c6c7518023effc ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1077"^^xsd:integer .

	civic-kb:Gene-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-eab265d6a5244966d9c6c7518023effc ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"CLEOPATRA (NCT00567190) was a Phase III, randomized and double-blind, placebo-controlled study of 808 patients with HER2-positive metastatic breast cancer.  Patients were HER2-positive by IHC3+ or FISH, and patients who had received prior hormonal treatment or adjuvant/neo-adjuvant therapy with or without trastuzumab for longer than 12 months before randomization were also eligible.  The two arms of the study were trastuzumab and docetaxel with either placebo or pertuzumab.  Median PFS in the placebo arm was 12.4 months while in the petuzumab arm 18.5 months was achieved.  Median OS in the control arm was 40.8 months and 56.5 months with pertuzumab.  These strong results make a case for dual antibody blockade in first line treatments of HER2-positive metastatic breast cancer."^^xsd:string .

	civic-kb:Disease-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-eab265d6a5244966d9c6c7518023effc ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-eab265d6a5244966d9c6c7518023effc ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-eab265d6a5244966d9c6c7518023effc ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-eab265d6a5244966d9c6c7518023effc ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-eab265d6a5244966d9c6c7518023effc ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-eab265d6a5244966d9c6c7518023effc ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-eab265d6a5244966d9c6c7518023effc	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-eab265d6a5244966d9c6c7518023effc .

}

civic-kb:provenance-eab265d6a5244966d9c6c7518023effc {
	civic-kb:assertion-eab265d6a5244966d9c6c7518023effc prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-eab265d6a5244966d9c6c7518023effc .

	civic-kb:Status-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-eab265d6a5244966d9c6c7518023effc	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-eab265d6a5244966d9c6c7518023effc {
	civic-kb:nanoPub-eab265d6a5244966d9c6c7518023effc prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-eab265d6a5244966d9c6c7518023effc
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2521f0b02995ab3beb97be627fa7776e {
	civic-kb:nanoPub-2521f0b02995ab3beb97be627fa7776e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2521f0b02995ab3beb97be627fa7776e ;
		np:hasProvenance civic-kb:provenance-2521f0b02995ab3beb97be627fa7776e ;
		np:hasPublicationInfo civic-kb:pubInfo-2521f0b02995ab3beb97be627fa7776e .
}

civic-kb:assertion-2521f0b02995ab3beb97be627fa7776e {
	civic-kb:Drugs-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2521f0b02995ab3beb97be627fa7776e ;
		rdf:type	dron:00730818 ;
		rdf:type	db:DB05773 ;
		rdfs:label	"Trastuzumab Emtansine"^^xsd:string ;
		sio:hasValue	"Trastuzumab Emtansine"^^xsd:string .

	civic-kb:Status-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2521f0b02995ab3beb97be627fa7776e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2521f0b02995ab3beb97be627fa7776e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1160"^^xsd:integer .

	civic-kb:Gene-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2521f0b02995ab3beb97be627fa7776e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The EMILIA study (NCT00829166) was a Phase II trial to assess the efficacy of trastuzumab emtansine (T-DM1, n=495) in comparison to lapatinib plus capecitabine (n=496), in treatment of advanced HER2 positive breast cancer.  Patients were required to have progressed on or after treatments involving trastuzumab and a taxane, and no prior exposure to lapatinib or T-DM1.   Primary endpoints included independently assessed progression free survival (PFS) and safety. PFS was 9.6 months in T-DM1 group vs. 6.4 months in lapatinib plus capecitabine.  Rates of adverse events of grade 3 or higher were greater with lapatinib plus capecitabine.  These results, together with other trials such as TH3RESA indicate promise for T-DM1 therapy in HER2 amplification, and this will be further studied in an arm of the NCI-MATCH trial."^^xsd:string .

	civic-kb:Disease-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2521f0b02995ab3beb97be627fa7776e ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2521f0b02995ab3beb97be627fa7776e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2521f0b02995ab3beb97be627fa7776e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2521f0b02995ab3beb97be627fa7776e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2521f0b02995ab3beb97be627fa7776e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2521f0b02995ab3beb97be627fa7776e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-2521f0b02995ab3beb97be627fa7776e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2521f0b02995ab3beb97be627fa7776e .

}

civic-kb:provenance-2521f0b02995ab3beb97be627fa7776e {
	civic-kb:assertion-2521f0b02995ab3beb97be627fa7776e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2521f0b02995ab3beb97be627fa7776e .

	civic-kb:Status-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-2521f0b02995ab3beb97be627fa7776e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2521f0b02995ab3beb97be627fa7776e {
	civic-kb:nanoPub-2521f0b02995ab3beb97be627fa7776e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2521f0b02995ab3beb97be627fa7776e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-35b5995e606d49555bf986a89f19fba9 {
	civic-kb:nanoPub-35b5995e606d49555bf986a89f19fba9
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-35b5995e606d49555bf986a89f19fba9 ;
		np:hasProvenance civic-kb:provenance-35b5995e606d49555bf986a89f19fba9 ;
		np:hasPublicationInfo civic-kb:pubInfo-35b5995e606d49555bf986a89f19fba9 .
}

civic-kb:assertion-35b5995e606d49555bf986a89f19fba9 {
	civic-kb:Drugs-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-35b5995e606d49555bf986a89f19fba9 ;
		sio:hasValue	"Lapatinib, Capecitabine"^^xsd:string .

	civic-kb:Status-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-35b5995e606d49555bf986a89f19fba9 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-35b5995e606d49555bf986a89f19fba9 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1132"^^xsd:integer .

	civic-kb:Gene-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-35b5995e606d49555bf986a89f19fba9 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"This Phase III trial took patients with locally advanced or metastatic HER2 (ERBB2) positive breast cancer that had progressed on prior trastuzumab treatment.  Patients were given capecitabine (n=161) or lapatinib plus capecitabine (n=163). The primary endpoint of the study was time to progression. Median time to progression was 4.4 months in the capecitabine group and 8.4 months in capecitabine plus lapatinib group (hazard ratio was 0.49 ; 95% confidence interval, 0.34 to 0.71; P<0.001).  The results indicated that lapatinib may be useful in addressing the problem of trastuzumab progression in HER2 breast cancer."^^xsd:string .

	civic-kb:Disease-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-35b5995e606d49555bf986a89f19fba9 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-35b5995e606d49555bf986a89f19fba9 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-35b5995e606d49555bf986a89f19fba9 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-35b5995e606d49555bf986a89f19fba9 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-35b5995e606d49555bf986a89f19fba9 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-35b5995e606d49555bf986a89f19fba9 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-35b5995e606d49555bf986a89f19fba9	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-35b5995e606d49555bf986a89f19fba9 .

}

civic-kb:provenance-35b5995e606d49555bf986a89f19fba9 {
	civic-kb:assertion-35b5995e606d49555bf986a89f19fba9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-35b5995e606d49555bf986a89f19fba9 .

	civic-kb:Status-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-35b5995e606d49555bf986a89f19fba9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-35b5995e606d49555bf986a89f19fba9 {
	civic-kb:nanoPub-35b5995e606d49555bf986a89f19fba9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-35b5995e606d49555bf986a89f19fba9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-b7adb529a3523250b7a2a36288cebbf0 {
	civic-kb:nanoPub-b7adb529a3523250b7a2a36288cebbf0
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-b7adb529a3523250b7a2a36288cebbf0 ;
		np:hasProvenance civic-kb:provenance-b7adb529a3523250b7a2a36288cebbf0 ;
		np:hasPublicationInfo civic-kb:pubInfo-b7adb529a3523250b7a2a36288cebbf0 .
}

civic-kb:assertion-b7adb529a3523250b7a2a36288cebbf0 {
	civic-kb:Drugs-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b7adb529a3523250b7a2a36288cebbf0 ;
		rdf:type	dron:00730818 ;
		rdf:type	db:DB05773 ;
		rdfs:label	"Trastuzumab Emtansine"^^xsd:string ;
		sio:hasValue	"Trastuzumab Emtansine"^^xsd:string .

	civic-kb:Status-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-b7adb529a3523250b7a2a36288cebbf0 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-b7adb529a3523250b7a2a36288cebbf0 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1159"^^xsd:integer .

	civic-kb:Gene-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-b7adb529a3523250b7a2a36288cebbf0 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The Phase III trial, TH3RESA (NCT01419197), was performed in patients with advanced HER2 breast cancer that was heavily pretreated.  Patients were required to have prior exposure to trastuzumab and lapatinib as well as a taxane.  This patient population has not seen many studies, responds poorly to late-line treatment with trastuzumab, and in this study was treated with trastuzumab emtansine (T-DM1, n=404) vs. physician's choice (usually trastuzumab plus chemotherapy, n=198).  Results showed progression free survival was 6.2 months in T-DM1 treatment vs. 3.3 months under physician's choice, along with lower incidence of grade 3 or worse events with T-DM1.  The authors conclude that their findings in this heavily pretreated population, along with findings in the EMILIA trial, indicate promise for antibody-drug conjugates.  The NCI-MATCH trial with further study T-DM1 in the context of HER2 amplification."^^xsd:string .

	civic-kb:Disease-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b7adb529a3523250b7a2a36288cebbf0 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-b7adb529a3523250b7a2a36288cebbf0 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b7adb529a3523250b7a2a36288cebbf0 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b7adb529a3523250b7a2a36288cebbf0 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-b7adb529a3523250b7a2a36288cebbf0 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-b7adb529a3523250b7a2a36288cebbf0 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-b7adb529a3523250b7a2a36288cebbf0	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-b7adb529a3523250b7a2a36288cebbf0 .

}

civic-kb:provenance-b7adb529a3523250b7a2a36288cebbf0 {
	civic-kb:assertion-b7adb529a3523250b7a2a36288cebbf0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-b7adb529a3523250b7a2a36288cebbf0 .

	civic-kb:Status-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-b7adb529a3523250b7a2a36288cebbf0	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-b7adb529a3523250b7a2a36288cebbf0 {
	civic-kb:nanoPub-b7adb529a3523250b7a2a36288cebbf0 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-b7adb529a3523250b7a2a36288cebbf0
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-60c3dd329a32501a8b298b66527cb6da {
	civic-kb:nanoPub-60c3dd329a32501a8b298b66527cb6da
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-60c3dd329a32501a8b298b66527cb6da ;
		np:hasProvenance civic-kb:provenance-60c3dd329a32501a8b298b66527cb6da ;
		np:hasPublicationInfo civic-kb:pubInfo-60c3dd329a32501a8b298b66527cb6da .
}

civic-kb:assertion-60c3dd329a32501a8b298b66527cb6da {
	civic-kb:Drugs-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-60c3dd329a32501a8b298b66527cb6da ;
		sio:hasValue	"Afatinib, Trastuzumab"^^xsd:string .

	civic-kb:Status-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-60c3dd329a32501a8b298b66527cb6da ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-60c3dd329a32501a8b298b66527cb6da ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1013"^^xsd:integer .

	civic-kb:Gene-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-60c3dd329a32501a8b298b66527cb6da ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Trastuzumab resistance is thought to consist of multiple compensatory mechanisms involving ErbB family members such as increased signaling through ErbB family heterodimers.  The irreversible TKI afatinib blocks EGFR, HER2, ErbB3 and ErbB4.  Thus afatinib was studied in this Phase I trial of trastuzumab-progressed HER2 positive metastatic BC (MBC) in combination with continued trastuzumab treatment, where trastuzumab is still the perferred treatment for trastuzumab-progressed MBC.  Objective response and disease control rates were 11% and 39%.  The authors conclude that the clinical activity observed in this trial warrants further work with afatinib and trastuzumab combination therapy."^^xsd:string .

	civic-kb:Disease-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-60c3dd329a32501a8b298b66527cb6da ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-60c3dd329a32501a8b298b66527cb6da ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-60c3dd329a32501a8b298b66527cb6da ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-60c3dd329a32501a8b298b66527cb6da ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-60c3dd329a32501a8b298b66527cb6da ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-60c3dd329a32501a8b298b66527cb6da ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-60c3dd329a32501a8b298b66527cb6da	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-60c3dd329a32501a8b298b66527cb6da .

}

civic-kb:provenance-60c3dd329a32501a8b298b66527cb6da {
	civic-kb:assertion-60c3dd329a32501a8b298b66527cb6da prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-60c3dd329a32501a8b298b66527cb6da .

	civic-kb:Status-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-60c3dd329a32501a8b298b66527cb6da	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-60c3dd329a32501a8b298b66527cb6da {
	civic-kb:nanoPub-60c3dd329a32501a8b298b66527cb6da prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-60c3dd329a32501a8b298b66527cb6da
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-a1961dfefb19a83e7e7368fb32e73ea6 {
	civic-kb:nanoPub-a1961dfefb19a83e7e7368fb32e73ea6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-a1961dfefb19a83e7e7368fb32e73ea6 ;
		np:hasProvenance civic-kb:provenance-a1961dfefb19a83e7e7368fb32e73ea6 ;
		np:hasPublicationInfo civic-kb:pubInfo-a1961dfefb19a83e7e7368fb32e73ea6 .
}

civic-kb:assertion-a1961dfefb19a83e7e7368fb32e73ea6 {
	civic-kb:Drugs-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a1961dfefb19a83e7e7368fb32e73ea6 ;
		sio:hasValue	"Lapatinib, Trastuzumab"^^xsd:string .

	civic-kb:Status-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-a1961dfefb19a83e7e7368fb32e73ea6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-a1961dfefb19a83e7e7368fb32e73ea6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1007"^^xsd:integer .

	civic-kb:Gene-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-a1961dfefb19a83e7e7368fb32e73ea6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In light of results showing increased PFS using mAB plus TKI in heavily pretreated patients, the efficacy of trastuzumab plus lapatinib in a neoadjuvant setting with untreated stage II or IIIA HER2 positive breast cancer was assessed.  In this randomized 3 arm phase II study (CHER-LOB), patients received (A) chemotherapy plus trastuzumab, (B) chemotherapy plus lapatinib, or (C) chemotherapy plus trastuzumab and lapatinib, with pathologic complete response (pCR) as endpoint.  From 121 patients, pCR rates were 25% in arm A, 26.3% in arm B, and 46.7% in arm C.  The authors conclude these results support the superiority of dual-HER2 inhibition in the neoadjuvant context of HER2 positive BC."^^xsd:string .

	civic-kb:Disease-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a1961dfefb19a83e7e7368fb32e73ea6 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-a1961dfefb19a83e7e7368fb32e73ea6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a1961dfefb19a83e7e7368fb32e73ea6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a1961dfefb19a83e7e7368fb32e73ea6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-a1961dfefb19a83e7e7368fb32e73ea6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-a1961dfefb19a83e7e7368fb32e73ea6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-a1961dfefb19a83e7e7368fb32e73ea6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-a1961dfefb19a83e7e7368fb32e73ea6 .

}

civic-kb:provenance-a1961dfefb19a83e7e7368fb32e73ea6 {
	civic-kb:assertion-a1961dfefb19a83e7e7368fb32e73ea6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-a1961dfefb19a83e7e7368fb32e73ea6 .

	civic-kb:Status-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-a1961dfefb19a83e7e7368fb32e73ea6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-a1961dfefb19a83e7e7368fb32e73ea6 {
	civic-kb:nanoPub-a1961dfefb19a83e7e7368fb32e73ea6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-a1961dfefb19a83e7e7368fb32e73ea6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-03654e60a2f9bc1822bf2702f18007c9 {
	civic-kb:nanoPub-03654e60a2f9bc1822bf2702f18007c9
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-03654e60a2f9bc1822bf2702f18007c9 ;
		np:hasProvenance civic-kb:provenance-03654e60a2f9bc1822bf2702f18007c9 ;
		np:hasPublicationInfo civic-kb:pubInfo-03654e60a2f9bc1822bf2702f18007c9 .
}

civic-kb:assertion-03654e60a2f9bc1822bf2702f18007c9 {
	civic-kb:Drugs-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-03654e60a2f9bc1822bf2702f18007c9 ;
		rdf:type	db:DB08916 ;
		rdfs:label	"Afatinib"^^xsd:string ;
		sio:hasValue	"Afatinib"^^xsd:string .

	civic-kb:Status-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-03654e60a2f9bc1822bf2702f18007c9 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-03654e60a2f9bc1822bf2702f18007c9 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1010"^^xsd:integer .

	civic-kb:Gene-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-03654e60a2f9bc1822bf2702f18007c9 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"With multiple mechanisms of HER reprogramming thought to be behind trastuzumab resistance, including increased expression of ErbB members, afatinib, which broadly and irreversibly targets ErbB receptors was tested in a single arm phase II trial on advanced stage HER2 positive metastatic breast cancer. From 41 treated patients, 10% had partial response, 37% had stable disease as best response and 46% achieved clinical benefit.  Median progression free survival (PFS) was 15.1 weeks and median overall survival (OS) was 61.0 weeks. The authors conclude that Afatinib monotherapy shows promise in treatment of metastatic HER2 positive breast cancer that has progressed under trastuzumab."^^xsd:string .

	civic-kb:Disease-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-03654e60a2f9bc1822bf2702f18007c9 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-03654e60a2f9bc1822bf2702f18007c9 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-03654e60a2f9bc1822bf2702f18007c9 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-03654e60a2f9bc1822bf2702f18007c9 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-03654e60a2f9bc1822bf2702f18007c9 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-03654e60a2f9bc1822bf2702f18007c9 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-03654e60a2f9bc1822bf2702f18007c9	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-03654e60a2f9bc1822bf2702f18007c9 .

}

civic-kb:provenance-03654e60a2f9bc1822bf2702f18007c9 {
	civic-kb:assertion-03654e60a2f9bc1822bf2702f18007c9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-03654e60a2f9bc1822bf2702f18007c9 .

	civic-kb:Status-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-03654e60a2f9bc1822bf2702f18007c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-03654e60a2f9bc1822bf2702f18007c9 {
	civic-kb:nanoPub-03654e60a2f9bc1822bf2702f18007c9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-03654e60a2f9bc1822bf2702f18007c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c9c26214c17f564a8829ce85ce14393c {
	civic-kb:nanoPub-c9c26214c17f564a8829ce85ce14393c
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c9c26214c17f564a8829ce85ce14393c ;
		np:hasProvenance civic-kb:provenance-c9c26214c17f564a8829ce85ce14393c ;
		np:hasPublicationInfo civic-kb:pubInfo-c9c26214c17f564a8829ce85ce14393c .
}

civic-kb:assertion-c9c26214c17f564a8829ce85ce14393c {
	civic-kb:Drugs-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c9c26214c17f564a8829ce85ce14393c ;
		sio:hasValue	"Lapatinib, Trastuzumab"^^xsd:string .

	civic-kb:Status-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c9c26214c17f564a8829ce85ce14393c ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c9c26214c17f564a8829ce85ce14393c ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1009"^^xsd:integer .

	civic-kb:Gene-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c9c26214c17f564a8829ce85ce14393c ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"This Phase III study (EGF104900) was motivated by preclinical and other data demonstrating synergistic activity between lapatinib and trastuzumab against HER2 positive breast cancer (BC) cells.  In this study of HER2 positive metastatic BC which had progressed on trastuzumab, two arms were compared: lapatinib vs. lapatinib + trastuzumab. Progression free survival (PFS) was the primary endpoint. For 296 patients, 148 in each arm, median PFS of 8.1 weeks for lapatinib and 12.0 for combination therapy was observed (P=0.008).  The authors conclude that in the context of metastatic trastuzumab-progressed HER2 positive BC, trastuzumab with lapatinib TKI addition is a favorable treatment."^^xsd:string .

	civic-kb:Disease-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c9c26214c17f564a8829ce85ce14393c ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c9c26214c17f564a8829ce85ce14393c ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c9c26214c17f564a8829ce85ce14393c ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c9c26214c17f564a8829ce85ce14393c ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c9c26214c17f564a8829ce85ce14393c ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c9c26214c17f564a8829ce85ce14393c ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-c9c26214c17f564a8829ce85ce14393c	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c9c26214c17f564a8829ce85ce14393c .

}

civic-kb:provenance-c9c26214c17f564a8829ce85ce14393c {
	civic-kb:assertion-c9c26214c17f564a8829ce85ce14393c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c9c26214c17f564a8829ce85ce14393c .

	civic-kb:Status-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-c9c26214c17f564a8829ce85ce14393c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c9c26214c17f564a8829ce85ce14393c {
	civic-kb:nanoPub-c9c26214c17f564a8829ce85ce14393c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c9c26214c17f564a8829ce85ce14393c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-fa30ea7cd2ccc13c652997aca4fb3894 {
	civic-kb:nanoPub-fa30ea7cd2ccc13c652997aca4fb3894
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-fa30ea7cd2ccc13c652997aca4fb3894 ;
		np:hasProvenance civic-kb:provenance-fa30ea7cd2ccc13c652997aca4fb3894 ;
		np:hasPublicationInfo civic-kb:pubInfo-fa30ea7cd2ccc13c652997aca4fb3894 .
}

civic-kb:assertion-fa30ea7cd2ccc13c652997aca4fb3894 {
	civic-kb:Drugs-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fa30ea7cd2ccc13c652997aca4fb3894 ;
		rdf:type	db:DB08916 ;
		rdfs:label	"Afatinib"^^xsd:string ;
		sio:hasValue	"Afatinib"^^xsd:string .

	civic-kb:Status-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-fa30ea7cd2ccc13c652997aca4fb3894 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-fa30ea7cd2ccc13c652997aca4fb3894 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1011"^^xsd:integer .

	civic-kb:Gene-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-fa30ea7cd2ccc13c652997aca4fb3894 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"This Phase II trial (LUX-Breast 3 - NCT01441596) compared afatinib, afatinib plus vinorelbine, or investigator's choice of treatment.  121 patients with HER2 overexpressing breast cancer with CNS recurrence or regression who had previously progressed on trastuzumab or lapatinib were assigned to 3 arms, with endpoint in the intention-to-treat population being patient benefit at 12 weeks defined as absence of CNS or extra CNS progression, no tumor related worsening of neurological symptoms and no increase in corticosteroid dose. Benefit was seen in 30% of 40 patients assigned to afatinib alone, 34.2% of 38 assigned to afatinib plus vinorelbine, and 41.9% of 43 assigned to investigator's treatment choice.  Differences were not statistically significant, and afatanib patients experienced more adverse effects.  While Afatanib did show response in HER2 breast cancer patients, it was not better than investigator's treatment choice and the investigators state that no further development of afatinib for HER2 breast cancer will be planned."^^xsd:string .

	civic-kb:Disease-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fa30ea7cd2ccc13c652997aca4fb3894 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-fa30ea7cd2ccc13c652997aca4fb3894 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fa30ea7cd2ccc13c652997aca4fb3894 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fa30ea7cd2ccc13c652997aca4fb3894 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-fa30ea7cd2ccc13c652997aca4fb3894 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-fa30ea7cd2ccc13c652997aca4fb3894 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-fa30ea7cd2ccc13c652997aca4fb3894	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-fa30ea7cd2ccc13c652997aca4fb3894 .

}

civic-kb:provenance-fa30ea7cd2ccc13c652997aca4fb3894 {
	civic-kb:assertion-fa30ea7cd2ccc13c652997aca4fb3894 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-fa30ea7cd2ccc13c652997aca4fb3894 .

	civic-kb:Status-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-fa30ea7cd2ccc13c652997aca4fb3894	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-fa30ea7cd2ccc13c652997aca4fb3894 {
	civic-kb:nanoPub-fa30ea7cd2ccc13c652997aca4fb3894 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-fa30ea7cd2ccc13c652997aca4fb3894
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-61ced7979c5f68543155a02e6114e5b2 {
	civic-kb:nanoPub-61ced7979c5f68543155a02e6114e5b2
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-61ced7979c5f68543155a02e6114e5b2 ;
		np:hasProvenance civic-kb:provenance-61ced7979c5f68543155a02e6114e5b2 ;
		np:hasPublicationInfo civic-kb:pubInfo-61ced7979c5f68543155a02e6114e5b2 .
}

civic-kb:assertion-61ced7979c5f68543155a02e6114e5b2 {
	civic-kb:Drugs-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-61ced7979c5f68543155a02e6114e5b2 ;
		sio:hasValue	"Lapatinib, Trastuzumab"^^xsd:string .

	civic-kb:Status-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-61ced7979c5f68543155a02e6114e5b2 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-61ced7979c5f68543155a02e6114e5b2 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1006"^^xsd:integer .

	civic-kb:Gene-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-61ced7979c5f68543155a02e6114e5b2 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In-vitro studies using ERBB2 over-expressing breast cancer cell lines BT474 and SKBR3 (with ERBB2 amplification) showed apoptosis under either labatinib or trastuzumab treatment.  A marked synergistic apoptotic effect under lapatinib and trastuzumab co-treatment was observed in BT474 cells, and a milder synergistic effect was observed in SKBR3 cells."^^xsd:string .

	civic-kb:Disease-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-61ced7979c5f68543155a02e6114e5b2 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-61ced7979c5f68543155a02e6114e5b2 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-61ced7979c5f68543155a02e6114e5b2 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-61ced7979c5f68543155a02e6114e5b2 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-61ced7979c5f68543155a02e6114e5b2 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-61ced7979c5f68543155a02e6114e5b2 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-61ced7979c5f68543155a02e6114e5b2	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-61ced7979c5f68543155a02e6114e5b2 .

}

civic-kb:provenance-61ced7979c5f68543155a02e6114e5b2 {
	civic-kb:assertion-61ced7979c5f68543155a02e6114e5b2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-61ced7979c5f68543155a02e6114e5b2 .

	civic-kb:Status-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-61ced7979c5f68543155a02e6114e5b2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-61ced7979c5f68543155a02e6114e5b2 {
	civic-kb:nanoPub-61ced7979c5f68543155a02e6114e5b2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-61ced7979c5f68543155a02e6114e5b2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-5117683f1522401995ee5285412506f2 {
	civic-kb:nanoPub-5117683f1522401995ee5285412506f2
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-5117683f1522401995ee5285412506f2 ;
		np:hasProvenance civic-kb:provenance-5117683f1522401995ee5285412506f2 ;
		np:hasPublicationInfo civic-kb:pubInfo-5117683f1522401995ee5285412506f2 .
}

civic-kb:assertion-5117683f1522401995ee5285412506f2 {
	civic-kb:Drugs-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5117683f1522401995ee5285412506f2 ;
		rdf:type	db:DB11828 ;
		rdfs:label	"Neratinib"^^xsd:string ;
		sio:hasValue	"Neratinib"^^xsd:string .

	civic-kb:Status-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-5117683f1522401995ee5285412506f2 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-5117683f1522401995ee5285412506f2 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1113"^^xsd:integer .

	civic-kb:Gene-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-5117683f1522401995ee5285412506f2 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In this two arm, Phase III study (NCT00878709) of the efficacy of a 12 month course of the TKI neratinib after trastuzumab-based adjuvant therapy of early stage HER2-positive breast cancer was assessed using invasive disease-free survival as primary endpoint.  HER2 positivity was assessed via FISH.  At 2 year follow-up, 70 vs. 109 disease-free survival events had occurred and disease-free survival rates were 93.9% vs. 91.6% (significant) in neratinib vs. placebo groups respectively.  Distant disease-free survival and time to distant recurrence were similar in both groups.  These results are an interesting contrast to results of long-term adjuvant therapy with trastuzumab (HERA) which did not show significant benefit."^^xsd:string .

	civic-kb:Disease-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5117683f1522401995ee5285412506f2 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-5117683f1522401995ee5285412506f2 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5117683f1522401995ee5285412506f2 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5117683f1522401995ee5285412506f2 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-5117683f1522401995ee5285412506f2 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-5117683f1522401995ee5285412506f2 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-5117683f1522401995ee5285412506f2	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-5117683f1522401995ee5285412506f2 .

}

civic-kb:provenance-5117683f1522401995ee5285412506f2 {
	civic-kb:assertion-5117683f1522401995ee5285412506f2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-5117683f1522401995ee5285412506f2 .

	civic-kb:Status-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-5117683f1522401995ee5285412506f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-5117683f1522401995ee5285412506f2 {
	civic-kb:nanoPub-5117683f1522401995ee5285412506f2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-5117683f1522401995ee5285412506f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-9adc86ad3e211d9eff98f7318c41bf8b {
	civic-kb:nanoPub-9adc86ad3e211d9eff98f7318c41bf8b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-9adc86ad3e211d9eff98f7318c41bf8b ;
		np:hasProvenance civic-kb:provenance-9adc86ad3e211d9eff98f7318c41bf8b ;
		np:hasPublicationInfo civic-kb:pubInfo-9adc86ad3e211d9eff98f7318c41bf8b .
}

civic-kb:assertion-9adc86ad3e211d9eff98f7318c41bf8b {
	civic-kb:Drugs-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9adc86ad3e211d9eff98f7318c41bf8b ;
		sio:hasValue	"Trastuzumab, XL147 (Pilaralisib)"^^xsd:string .

	civic-kb:Status-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-9adc86ad3e211d9eff98f7318c41bf8b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-9adc86ad3e211d9eff98f7318c41bf8b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1448"^^xsd:integer .

	civic-kb:Gene-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-9adc86ad3e211d9eff98f7318c41bf8b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In 5 trastuzumab resistant HER2 overexpressing breast cancer cell lines, combination of the pan-PI3K inhibitor XL147 and trastuzumab treatment induced cell death to similar or greater levels than XL147 alone. In three trastuzumab resistant cell lines tested, colony formation in matrigel was markedly inhibited by combination treatment. Apoptotic markers were apparent with combination treatment. In athymic mice, trastuzumab resistant cell line HR6 was used in tumor xenografts and tumors were allowed to form. Mice subsequently treated with trastuzumab or XL147 showed continued tumor growth without marked difference from control, while combination treatment essentially halted tumor growth rate."^^xsd:string .

	civic-kb:Disease-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9adc86ad3e211d9eff98f7318c41bf8b ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-9adc86ad3e211d9eff98f7318c41bf8b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9adc86ad3e211d9eff98f7318c41bf8b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9adc86ad3e211d9eff98f7318c41bf8b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-9adc86ad3e211d9eff98f7318c41bf8b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-9adc86ad3e211d9eff98f7318c41bf8b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-9adc86ad3e211d9eff98f7318c41bf8b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-9adc86ad3e211d9eff98f7318c41bf8b .

}

civic-kb:provenance-9adc86ad3e211d9eff98f7318c41bf8b {
	civic-kb:assertion-9adc86ad3e211d9eff98f7318c41bf8b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-9adc86ad3e211d9eff98f7318c41bf8b .

	civic-kb:Status-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-9adc86ad3e211d9eff98f7318c41bf8b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-9adc86ad3e211d9eff98f7318c41bf8b {
	civic-kb:nanoPub-9adc86ad3e211d9eff98f7318c41bf8b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-9adc86ad3e211d9eff98f7318c41bf8b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-933faecb44bce32abb928c54de63b6ee {
	civic-kb:nanoPub-933faecb44bce32abb928c54de63b6ee
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-933faecb44bce32abb928c54de63b6ee ;
		np:hasProvenance civic-kb:provenance-933faecb44bce32abb928c54de63b6ee ;
		np:hasPublicationInfo civic-kb:pubInfo-933faecb44bce32abb928c54de63b6ee .
}

civic-kb:assertion-933faecb44bce32abb928c54de63b6ee {
	civic-kb:Drugs-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-933faecb44bce32abb928c54de63b6ee ;
		sio:hasValue	"Pertuzumab, Trastuzumab, Docetaxel"^^xsd:string .

	civic-kb:Status-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-933faecb44bce32abb928c54de63b6ee ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-933faecb44bce32abb928c54de63b6ee ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1437"^^xsd:integer .

	civic-kb:Gene-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-933faecb44bce32abb928c54de63b6ee ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a randomized phase 3 trial, HER2 positive metastatic breast cancer patients given first-line treatment of pertuzumab plus trastuzumb plus docetaxel experienced improved progression free survival (18.5 vs 12.4 months,  P<0.001) and increased objective response rate (80.2% vs 69.3%, P=0.001) than the control group given placebo plus trastuzumab plus docetaxel."^^xsd:string .

	civic-kb:Disease-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-933faecb44bce32abb928c54de63b6ee ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-933faecb44bce32abb928c54de63b6ee ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-933faecb44bce32abb928c54de63b6ee ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-933faecb44bce32abb928c54de63b6ee ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-933faecb44bce32abb928c54de63b6ee ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-933faecb44bce32abb928c54de63b6ee ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-933faecb44bce32abb928c54de63b6ee	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-933faecb44bce32abb928c54de63b6ee .

}

civic-kb:provenance-933faecb44bce32abb928c54de63b6ee {
	civic-kb:assertion-933faecb44bce32abb928c54de63b6ee prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-933faecb44bce32abb928c54de63b6ee .

	civic-kb:Status-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-933faecb44bce32abb928c54de63b6ee	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-933faecb44bce32abb928c54de63b6ee {
	civic-kb:nanoPub-933faecb44bce32abb928c54de63b6ee prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-933faecb44bce32abb928c54de63b6ee
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f99a8b9446aafa26e63fbdc3de5c58b5 {
	civic-kb:nanoPub-f99a8b9446aafa26e63fbdc3de5c58b5
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		np:hasProvenance civic-kb:provenance-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		np:hasPublicationInfo civic-kb:pubInfo-f99a8b9446aafa26e63fbdc3de5c58b5 .
}

civic-kb:assertion-f99a8b9446aafa26e63fbdc3de5c58b5 {
	civic-kb:Drugs-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		sio:hasValue	"Lapatinib, Trastuzumab"^^xsd:string .

	civic-kb:Status-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1439"^^xsd:integer .

	civic-kb:Gene-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a randomized open label phase 3 study (NCT00553358), women with HER2 positive primary breast cancer treated with lapatinib plus trasuzumab had higher rates of pathological complete responses than seen in control groups receiving either IV trastuzumab or oral lapatinib alone (combination treatment pCR rate of 51% vs 29.5% and 24.7% for trastuzumab and lapatinib alone, respectively)."^^xsd:string .

	civic-kb:Disease-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f99a8b9446aafa26e63fbdc3de5c58b5 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-f99a8b9446aafa26e63fbdc3de5c58b5	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f99a8b9446aafa26e63fbdc3de5c58b5 .

}

civic-kb:provenance-f99a8b9446aafa26e63fbdc3de5c58b5 {
	civic-kb:assertion-f99a8b9446aafa26e63fbdc3de5c58b5 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f99a8b9446aafa26e63fbdc3de5c58b5 .

	civic-kb:Status-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-f99a8b9446aafa26e63fbdc3de5c58b5	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f99a8b9446aafa26e63fbdc3de5c58b5 {
	civic-kb:nanoPub-f99a8b9446aafa26e63fbdc3de5c58b5 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f99a8b9446aafa26e63fbdc3de5c58b5
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-6d12b2ee6fbc91c972d2ab3321782f96 {
	civic-kb:nanoPub-6d12b2ee6fbc91c972d2ab3321782f96
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-6d12b2ee6fbc91c972d2ab3321782f96 ;
		np:hasProvenance civic-kb:provenance-6d12b2ee6fbc91c972d2ab3321782f96 ;
		np:hasPublicationInfo civic-kb:pubInfo-6d12b2ee6fbc91c972d2ab3321782f96 .
}

civic-kb:assertion-6d12b2ee6fbc91c972d2ab3321782f96 {
	civic-kb:Drugs-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6d12b2ee6fbc91c972d2ab3321782f96 ;
		rdf:type	chebi:50914 ;
		rdfs:label	"Tgx 221"^^xsd:string ;
		sio:hasValue	"Tgx 221"^^xsd:string .

	civic-kb:Status-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-6d12b2ee6fbc91c972d2ab3321782f96 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-6d12b2ee6fbc91c972d2ab3321782f96 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1382"^^xsd:integer .

	civic-kb:Gene-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-6d12b2ee6fbc91c972d2ab3321782f96 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Treatment of cells obtained from MMTV-NeuT mouse mammary tumors with the p110beta selective inhibitor TGX-221 showed significant but minimal reductions in lipid kinase activity and negligible reductions in phospho Akt levels. In simmilar cells subjected to p110alpha isoform knockout, TGX-221 treatment fully blocked Akt activation, indicating that TGX-221 was fully inhibiting the p110beta isoform. Athymic mice recieved MMTV-NeuT tumor cell transplants and were treated with TGX-221, which resulted in significant but minimal reduction in tumor growth compared to controls."^^xsd:string .

	civic-kb:Disease-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6d12b2ee6fbc91c972d2ab3321782f96 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-6d12b2ee6fbc91c972d2ab3321782f96 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6d12b2ee6fbc91c972d2ab3321782f96 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6d12b2ee6fbc91c972d2ab3321782f96 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-6d12b2ee6fbc91c972d2ab3321782f96 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-6d12b2ee6fbc91c972d2ab3321782f96 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-6d12b2ee6fbc91c972d2ab3321782f96	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-6d12b2ee6fbc91c972d2ab3321782f96 .

}

civic-kb:provenance-6d12b2ee6fbc91c972d2ab3321782f96 {
	civic-kb:assertion-6d12b2ee6fbc91c972d2ab3321782f96 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-6d12b2ee6fbc91c972d2ab3321782f96 .

	civic-kb:Status-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-6d12b2ee6fbc91c972d2ab3321782f96	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-6d12b2ee6fbc91c972d2ab3321782f96 {
	civic-kb:nanoPub-6d12b2ee6fbc91c972d2ab3321782f96 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-6d12b2ee6fbc91c972d2ab3321782f96
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-211962c853e555b23e121c29090701db {
	civic-kb:nanoPub-211962c853e555b23e121c29090701db
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-211962c853e555b23e121c29090701db ;
		np:hasProvenance civic-kb:provenance-211962c853e555b23e121c29090701db ;
		np:hasPublicationInfo civic-kb:pubInfo-211962c853e555b23e121c29090701db .
}

civic-kb:assertion-211962c853e555b23e121c29090701db {
	civic-kb:Drugs-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-211962c853e555b23e121c29090701db ;
		rdf:type	dron:00730818 ;
		rdf:type	db:DB05773 ;
		rdfs:label	"Trastuzumab Emtansine"^^xsd:string ;
		sio:hasValue	"Trastuzumab Emtansine"^^xsd:string .

	civic-kb:Status-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-211962c853e555b23e121c29090701db ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-211962c853e555b23e121c29090701db ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1432"^^xsd:integer .

	civic-kb:Gene-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-211962c853e555b23e121c29090701db ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a randomized phase II study, first line treatment of HER2-positive metastatic breast cancer with trastuzumab emtansine (T-DM1) resulted in improved progression free survival and fewer serious adverse effects when compared to treatment with combination trastuzumab plus docetaxel (HT) (median follow up 14 months, median PFS with T-DM1 14.2 vs 9.2 with HT)."^^xsd:string .

	civic-kb:Disease-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-211962c853e555b23e121c29090701db ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-211962c853e555b23e121c29090701db ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-211962c853e555b23e121c29090701db ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-211962c853e555b23e121c29090701db ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-211962c853e555b23e121c29090701db ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-211962c853e555b23e121c29090701db	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-211962c853e555b23e121c29090701db ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-211962c853e555b23e121c29090701db	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-211962c853e555b23e121c29090701db .

}

civic-kb:provenance-211962c853e555b23e121c29090701db {
	civic-kb:assertion-211962c853e555b23e121c29090701db prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-211962c853e555b23e121c29090701db .

	civic-kb:Status-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-211962c853e555b23e121c29090701db	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-211962c853e555b23e121c29090701db {
	civic-kb:nanoPub-211962c853e555b23e121c29090701db prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-211962c853e555b23e121c29090701db
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-4629b2fdccb53cc3f9e1bf15bdd05c4f {
	civic-kb:nanoPub-4629b2fdccb53cc3f9e1bf15bdd05c4f
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		np:hasProvenance civic-kb:provenance-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		np:hasPublicationInfo civic-kb:pubInfo-4629b2fdccb53cc3f9e1bf15bdd05c4f .
}

civic-kb:assertion-4629b2fdccb53cc3f9e1bf15bdd05c4f {
	civic-kb:Drugs-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1380"^^xsd:integer .

	civic-kb:Gene-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The HER2/Neu mammary tumor mouse model MMTV-NeuT was employed to demonstrate dependence of HER2 tumor formation on PIK3 p110alpha isoform. MMTV-NeuT mice were crossed with floxed p110alpha mice. Diassacociated tumors cells from these mice were treated with Cre adenovirus to delete p110alpha, or GFP adenovirus, and cells were transplanted into athymic mice. GFP treated cells formed new tumors, while p110alpha deletion blocked tumor formation indicating tumor dependence on PI3KA. Next, MMTV-NeuT tumors were dissociated and treated with pan-PI3K inhibitor GDC-0941. Reduced lipid kinase activity and reduced phospho-Akt levels were seen in these cells. Administration of 125 mg/kg GDC-0941 to athymic mice with transplantation of tumor cells caused marked reduction of tumor cell volume in comparison to control treatment."^^xsd:string .

	civic-kb:Disease-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-4629b2fdccb53cc3f9e1bf15bdd05c4f ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-4629b2fdccb53cc3f9e1bf15bdd05c4f	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-4629b2fdccb53cc3f9e1bf15bdd05c4f .

}

civic-kb:provenance-4629b2fdccb53cc3f9e1bf15bdd05c4f {
	civic-kb:assertion-4629b2fdccb53cc3f9e1bf15bdd05c4f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-4629b2fdccb53cc3f9e1bf15bdd05c4f .

	civic-kb:Status-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-4629b2fdccb53cc3f9e1bf15bdd05c4f	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-4629b2fdccb53cc3f9e1bf15bdd05c4f {
	civic-kb:nanoPub-4629b2fdccb53cc3f9e1bf15bdd05c4f prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-4629b2fdccb53cc3f9e1bf15bdd05c4f
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d8567df1c46c4fa0ded638d1681d3076 {
	civic-kb:nanoPub-d8567df1c46c4fa0ded638d1681d3076
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d8567df1c46c4fa0ded638d1681d3076 ;
		np:hasProvenance civic-kb:provenance-d8567df1c46c4fa0ded638d1681d3076 ;
		np:hasPublicationInfo civic-kb:pubInfo-d8567df1c46c4fa0ded638d1681d3076 .
}

civic-kb:assertion-d8567df1c46c4fa0ded638d1681d3076 {
	civic-kb:Drugs-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d8567df1c46c4fa0ded638d1681d3076 ;
		rdf:type	db:DB11828 ;
		rdfs:label	"Neratinib"^^xsd:string ;
		sio:hasValue	"Neratinib"^^xsd:string .

	civic-kb:Status-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d8567df1c46c4fa0ded638d1681d3076 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d8567df1c46c4fa0ded638d1681d3076 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"761"^^xsd:integer .

	civic-kb:Gene-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d8567df1c46c4fa0ded638d1681d3076 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Oral neratinib showed objective response rates of 24 and 56% respectively in prior-trastuzumab and trastuzumab-naive cohorts in a Phase II trial with a primary endpoint of 16-week progression free survival."^^xsd:string .

	civic-kb:Disease-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d8567df1c46c4fa0ded638d1681d3076 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d8567df1c46c4fa0ded638d1681d3076 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d8567df1c46c4fa0ded638d1681d3076 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d8567df1c46c4fa0ded638d1681d3076 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d8567df1c46c4fa0ded638d1681d3076 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d8567df1c46c4fa0ded638d1681d3076 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-d8567df1c46c4fa0ded638d1681d3076	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d8567df1c46c4fa0ded638d1681d3076 .

}

civic-kb:provenance-d8567df1c46c4fa0ded638d1681d3076 {
	civic-kb:assertion-d8567df1c46c4fa0ded638d1681d3076 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d8567df1c46c4fa0ded638d1681d3076 .

	civic-kb:Status-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-d8567df1c46c4fa0ded638d1681d3076	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d8567df1c46c4fa0ded638d1681d3076 {
	civic-kb:nanoPub-d8567df1c46c4fa0ded638d1681d3076 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d8567df1c46c4fa0ded638d1681d3076
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-56fadb83ce5c49817ef75ae38c41f3c9 {
	civic-kb:nanoPub-56fadb83ce5c49817ef75ae38c41f3c9
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-56fadb83ce5c49817ef75ae38c41f3c9 ;
		np:hasProvenance civic-kb:provenance-56fadb83ce5c49817ef75ae38c41f3c9 ;
		np:hasPublicationInfo civic-kb:pubInfo-56fadb83ce5c49817ef75ae38c41f3c9 .
}

civic-kb:assertion-56fadb83ce5c49817ef75ae38c41f3c9 {
	civic-kb:Drugs-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-56fadb83ce5c49817ef75ae38c41f3c9 ;
		rdfs:label	"AKTi-1/2"^^xsd:string ;
		sio:hasValue	"AKTi-1/2"^^xsd:string .

	civic-kb:Status-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-56fadb83ce5c49817ef75ae38c41f3c9 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-56fadb83ce5c49817ef75ae38c41f3c9 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"760"^^xsd:integer .

	civic-kb:Gene-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-56fadb83ce5c49817ef75ae38c41f3c9 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Xenografts established from breast cancer cell lines with ERBB2 amplification and PIK3CA mutation (BT474) or PIK3CA mutation alone (MCF7) were effectively inhibited in-vivo with an AKT1/2-inhibitor (AKTi-1/2; naphthyridinone)."^^xsd:string .

	civic-kb:Disease-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-56fadb83ce5c49817ef75ae38c41f3c9 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-56fadb83ce5c49817ef75ae38c41f3c9 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-56fadb83ce5c49817ef75ae38c41f3c9 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-56fadb83ce5c49817ef75ae38c41f3c9 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-56fadb83ce5c49817ef75ae38c41f3c9 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-56fadb83ce5c49817ef75ae38c41f3c9 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-56fadb83ce5c49817ef75ae38c41f3c9	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-56fadb83ce5c49817ef75ae38c41f3c9 .

}

civic-kb:provenance-56fadb83ce5c49817ef75ae38c41f3c9 {
	civic-kb:assertion-56fadb83ce5c49817ef75ae38c41f3c9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-56fadb83ce5c49817ef75ae38c41f3c9 .

	civic-kb:Status-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-56fadb83ce5c49817ef75ae38c41f3c9	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-56fadb83ce5c49817ef75ae38c41f3c9 {
	civic-kb:nanoPub-56fadb83ce5c49817ef75ae38c41f3c9 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-56fadb83ce5c49817ef75ae38c41f3c9
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-969db005c527f92a29d43eb427d9e297 {
	civic-kb:nanoPub-969db005c527f92a29d43eb427d9e297
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-969db005c527f92a29d43eb427d9e297 ;
		np:hasProvenance civic-kb:provenance-969db005c527f92a29d43eb427d9e297 ;
		np:hasPublicationInfo civic-kb:pubInfo-969db005c527f92a29d43eb427d9e297 .
}

civic-kb:assertion-969db005c527f92a29d43eb427d9e297 {
	civic-kb:Drugs-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-969db005c527f92a29d43eb427d9e297 ;
		rdf:type	db:DB08916 ;
		rdfs:label	"Afatinib"^^xsd:string ;
		sio:hasValue	"Afatinib"^^xsd:string .

	civic-kb:Status-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-969db005c527f92a29d43eb427d9e297 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-969db005c527f92a29d43eb427d9e297 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1012"^^xsd:integer .

	civic-kb:Gene-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-969db005c527f92a29d43eb427d9e297 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"LUX-Breast 1 is a phase 3 trial (NCT01125566) which enrolled 508 patients with metastatic HER2 positive BC who had progressed after adjuvant or first-line trastuzumab. It was thought that the wider range of ErbB family blocking and irreversible properties of afatinib could be beneficial in trastuzumab resistant cancer cells, since ErbB family members are thought to play a role in trastuzumab resistance. Primary endpoint was intention-to-treat group PFS. 339 patients were assigned to afatanib + vinorelbine and 169  to trastuzumab + vinorelbine.  Recruitment was stopped prematurely when it was deemed unlikely that the increased PFS would be seen in the afatinib group. Median PFS was 5.5 months in the afatinib group and 5.6 months in the trastuzumab group.  Afatanib plus vinorelbine was less well tolerated than trastuzumab plus vinorelbine, and the authors conclude that trastuzumab remains the best choice for treatment of trastuzumab-progressed HER2 positive metastatic BC."^^xsd:string .

	civic-kb:Disease-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-969db005c527f92a29d43eb427d9e297 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-969db005c527f92a29d43eb427d9e297 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-969db005c527f92a29d43eb427d9e297 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-969db005c527f92a29d43eb427d9e297 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-969db005c527f92a29d43eb427d9e297 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-969db005c527f92a29d43eb427d9e297 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-969db005c527f92a29d43eb427d9e297	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-969db005c527f92a29d43eb427d9e297 .

}

civic-kb:provenance-969db005c527f92a29d43eb427d9e297 {
	civic-kb:assertion-969db005c527f92a29d43eb427d9e297 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-969db005c527f92a29d43eb427d9e297 .

	civic-kb:Status-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-969db005c527f92a29d43eb427d9e297	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-969db005c527f92a29d43eb427d9e297 {
	civic-kb:nanoPub-969db005c527f92a29d43eb427d9e297 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-969db005c527f92a29d43eb427d9e297
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-07ebbb91e9415bff8b871df22fbf91f3 {
	civic-kb:nanoPub-07ebbb91e9415bff8b871df22fbf91f3
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-07ebbb91e9415bff8b871df22fbf91f3 ;
		np:hasProvenance civic-kb:provenance-07ebbb91e9415bff8b871df22fbf91f3 ;
		np:hasPublicationInfo civic-kb:pubInfo-07ebbb91e9415bff8b871df22fbf91f3 .
}

civic-kb:assertion-07ebbb91e9415bff8b871df22fbf91f3 {
	civic-kb:Drugs-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-07ebbb91e9415bff8b871df22fbf91f3 ;
		sio:hasValue	"Afatinib, Lapatinib, Trastuzumab"^^xsd:string .

	civic-kb:Status-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-07ebbb91e9415bff8b871df22fbf91f3 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-07ebbb91e9415bff8b871df22fbf91f3 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"887"^^xsd:integer .

	civic-kb:Gene-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-07ebbb91e9415bff8b871df22fbf91f3 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In this phase 2 trial, treatment-naive, ERBB2-positive (by IHC) breast cancer patients with stage IIIA, B, C or inflammatory disease were randomized 1:1:1 to afatinib (n = 10), lapatinib (n = 8), or trastuzumab (n = 11). The primary end point was objective response rate. Objective response was seen in 8 afatinib-, 6 lapatinib-, and 4 trastuzumab-treated patients. Afatinib demonstrated clinical activity that compared favorably to trastuzumab and lapatinib for neoadjuvant treatment of HER2-positive breast cancer."^^xsd:string .

	civic-kb:Disease-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-07ebbb91e9415bff8b871df22fbf91f3 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-07ebbb91e9415bff8b871df22fbf91f3 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-07ebbb91e9415bff8b871df22fbf91f3 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-07ebbb91e9415bff8b871df22fbf91f3 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-07ebbb91e9415bff8b871df22fbf91f3 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-07ebbb91e9415bff8b871df22fbf91f3 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-07ebbb91e9415bff8b871df22fbf91f3	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-07ebbb91e9415bff8b871df22fbf91f3 .

}

civic-kb:provenance-07ebbb91e9415bff8b871df22fbf91f3 {
	civic-kb:assertion-07ebbb91e9415bff8b871df22fbf91f3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-07ebbb91e9415bff8b871df22fbf91f3 .

	civic-kb:Status-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-07ebbb91e9415bff8b871df22fbf91f3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-07ebbb91e9415bff8b871df22fbf91f3 {
	civic-kb:nanoPub-07ebbb91e9415bff8b871df22fbf91f3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-07ebbb91e9415bff8b871df22fbf91f3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-9a8e2967abb42f8dd4656a9603bfc49c {
	civic-kb:nanoPub-9a8e2967abb42f8dd4656a9603bfc49c
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-9a8e2967abb42f8dd4656a9603bfc49c ;
		np:hasProvenance civic-kb:provenance-9a8e2967abb42f8dd4656a9603bfc49c ;
		np:hasPublicationInfo civic-kb:pubInfo-9a8e2967abb42f8dd4656a9603bfc49c .
}

civic-kb:assertion-9a8e2967abb42f8dd4656a9603bfc49c {
	civic-kb:Drugs-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9a8e2967abb42f8dd4656a9603bfc49c ;
		sio:hasValue	"Trastuzumab, Palbociclib (PD0332991)"^^xsd:string .

	civic-kb:Status-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-9a8e2967abb42f8dd4656a9603bfc49c ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-9a8e2967abb42f8dd4656a9603bfc49c ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1561"^^xsd:integer .

	civic-kb:Gene-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-9a8e2967abb42f8dd4656a9603bfc49c ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a panel of 47 breast cancer cell lines, HER2 overexpressing cells were among those more sensitive to CDK4/6 inhibitor Palbociclib (PD0332991). In the trastuzumab sensitive cell line Bt474, palbociclib synergized with trastuzumab in growth inhibition, while in 2 trastuzumab resistant cell lines, addition of trastuzumab to palbociclib treatment resulted in increased growth inhibition over palbociclib alone."^^xsd:string .

	civic-kb:Disease-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9a8e2967abb42f8dd4656a9603bfc49c ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-9a8e2967abb42f8dd4656a9603bfc49c ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9a8e2967abb42f8dd4656a9603bfc49c ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9a8e2967abb42f8dd4656a9603bfc49c ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-9a8e2967abb42f8dd4656a9603bfc49c ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-9a8e2967abb42f8dd4656a9603bfc49c ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-9a8e2967abb42f8dd4656a9603bfc49c	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-9a8e2967abb42f8dd4656a9603bfc49c .

}

civic-kb:provenance-9a8e2967abb42f8dd4656a9603bfc49c {
	civic-kb:assertion-9a8e2967abb42f8dd4656a9603bfc49c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-9a8e2967abb42f8dd4656a9603bfc49c .

	civic-kb:Status-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-9a8e2967abb42f8dd4656a9603bfc49c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-9a8e2967abb42f8dd4656a9603bfc49c {
	civic-kb:nanoPub-9a8e2967abb42f8dd4656a9603bfc49c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-9a8e2967abb42f8dd4656a9603bfc49c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-3c369c901683e341dce8ebb9d929af2d {
	civic-kb:nanoPub-3c369c901683e341dce8ebb9d929af2d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-3c369c901683e341dce8ebb9d929af2d ;
		np:hasProvenance civic-kb:provenance-3c369c901683e341dce8ebb9d929af2d ;
		np:hasPublicationInfo civic-kb:pubInfo-3c369c901683e341dce8ebb9d929af2d .
}

civic-kb:assertion-3c369c901683e341dce8ebb9d929af2d {
	civic-kb:Drugs-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-3c369c901683e341dce8ebb9d929af2d ;
		rdf:type	db:DB08916 ;
		rdfs:label	"Afatinib"^^xsd:string ;
		sio:hasValue	"Afatinib"^^xsd:string .

	civic-kb:Status-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-3c369c901683e341dce8ebb9d929af2d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-3c369c901683e341dce8ebb9d929af2d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"961"^^xsd:integer .

	civic-kb:Gene-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-3c369c901683e341dce8ebb9d929af2d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A phase II study involving adult female patients, >=18 years, with stage IIIB or IV HER2-positive (by IHC and/or in situ fluorescence) metastatic breast cancer. All patients were previously treated with trastuzumab and a median of three chemotherapy lines. 41 patients received 50 mg afatinib once-daily until disease progression and the primary endpoint was objective response rate. 4 patients (10% of 41 treated; 11% of evaluable patients) had partial response and 15 patients (37% of 41) had stable disease as best response. Thus a total of 19 (46% of 41) achieved clinical benefit. Median progression-free survival was 15.1 weeks."^^xsd:string .

	civic-kb:Disease-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-3c369c901683e341dce8ebb9d929af2d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-3c369c901683e341dce8ebb9d929af2d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-3c369c901683e341dce8ebb9d929af2d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-3c369c901683e341dce8ebb9d929af2d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-3c369c901683e341dce8ebb9d929af2d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-3c369c901683e341dce8ebb9d929af2d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-3c369c901683e341dce8ebb9d929af2d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-3c369c901683e341dce8ebb9d929af2d .

}

civic-kb:provenance-3c369c901683e341dce8ebb9d929af2d {
	civic-kb:assertion-3c369c901683e341dce8ebb9d929af2d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-3c369c901683e341dce8ebb9d929af2d .

	civic-kb:Status-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-3c369c901683e341dce8ebb9d929af2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-3c369c901683e341dce8ebb9d929af2d {
	civic-kb:nanoPub-3c369c901683e341dce8ebb9d929af2d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-3c369c901683e341dce8ebb9d929af2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ebead556adb36bfaa140e9553b02afef {
	civic-kb:nanoPub-ebead556adb36bfaa140e9553b02afef
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ebead556adb36bfaa140e9553b02afef ;
		np:hasProvenance civic-kb:provenance-ebead556adb36bfaa140e9553b02afef ;
		np:hasPublicationInfo civic-kb:pubInfo-ebead556adb36bfaa140e9553b02afef .
}

civic-kb:assertion-ebead556adb36bfaa140e9553b02afef {
	civic-kb:Drugs-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ebead556adb36bfaa140e9553b02afef ;
		rdfs:label	"A66"^^xsd:string ;
		sio:hasValue	"A66"^^xsd:string .

	civic-kb:Status-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ebead556adb36bfaa140e9553b02afef ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ebead556adb36bfaa140e9553b02afef ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1381"^^xsd:integer .

	civic-kb:Gene-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ebead556adb36bfaa140e9553b02afef ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Pharmacologic (A66; p110alpha specific inhibitor) or genetic (cre-mediated knockout) ablation of the p110alpha PI3K isoform reduced tumor growth and tumor formation, respectively, in athymic mice transplanted with cells transduced by MMTV-NeuT (mammary specific overexpression of HER2 that effectively induces tumors). A66 treatment of cells from MMTV-NeuT mouse tumors resulted in decreased lipid kinase activity and phospho Akt levels."^^xsd:string .

	civic-kb:Disease-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ebead556adb36bfaa140e9553b02afef ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ebead556adb36bfaa140e9553b02afef ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ebead556adb36bfaa140e9553b02afef ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ebead556adb36bfaa140e9553b02afef ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ebead556adb36bfaa140e9553b02afef ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ebead556adb36bfaa140e9553b02afef ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-ebead556adb36bfaa140e9553b02afef	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ebead556adb36bfaa140e9553b02afef .

}

civic-kb:provenance-ebead556adb36bfaa140e9553b02afef {
	civic-kb:assertion-ebead556adb36bfaa140e9553b02afef prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ebead556adb36bfaa140e9553b02afef .

	civic-kb:Status-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ebead556adb36bfaa140e9553b02afef	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ebead556adb36bfaa140e9553b02afef {
	civic-kb:nanoPub-ebead556adb36bfaa140e9553b02afef prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ebead556adb36bfaa140e9553b02afef
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-12ed70711ef12602b54d5478c805c63d {
	civic-kb:nanoPub-12ed70711ef12602b54d5478c805c63d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-12ed70711ef12602b54d5478c805c63d ;
		np:hasProvenance civic-kb:provenance-12ed70711ef12602b54d5478c805c63d ;
		np:hasPublicationInfo civic-kb:pubInfo-12ed70711ef12602b54d5478c805c63d .
}

civic-kb:assertion-12ed70711ef12602b54d5478c805c63d {
	civic-kb:Drugs-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-12ed70711ef12602b54d5478c805c63d ;
		rdfs:label	"PP242"^^xsd:string ;
		sio:hasValue	"PP242"^^xsd:string .

	civic-kb:Status-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-12ed70711ef12602b54d5478c805c63d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-12ed70711ef12602b54d5478c805c63d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1613"^^xsd:integer .

	civic-kb:Gene-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-12ed70711ef12602b54d5478c805c63d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a panel of 31 breast cancer cell lines with varied mutation backgrounds, 10 cell lines harbored HER2 (ERBB2) amplification. Sensitivity to the mTORC1/2 inhibitor PP242 was assessed, and 8/10 HER2 positive cell lines were reported to be sensitive (IC50 < 1 micro molar PP242).  8/21 without HER2 amplification were reported as resistant (IC50 > 1 micro molar PP242). This pattern of HER2 positive cell sensitivity was not reported with the rapamycin analog  mTORC1 inhibitor everolimus."^^xsd:string .

	civic-kb:Disease-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-12ed70711ef12602b54d5478c805c63d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-12ed70711ef12602b54d5478c805c63d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-12ed70711ef12602b54d5478c805c63d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-12ed70711ef12602b54d5478c805c63d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-12ed70711ef12602b54d5478c805c63d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-12ed70711ef12602b54d5478c805c63d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-12ed70711ef12602b54d5478c805c63d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-12ed70711ef12602b54d5478c805c63d .

}

civic-kb:provenance-12ed70711ef12602b54d5478c805c63d {
	civic-kb:assertion-12ed70711ef12602b54d5478c805c63d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-12ed70711ef12602b54d5478c805c63d .

	civic-kb:Status-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-12ed70711ef12602b54d5478c805c63d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-12ed70711ef12602b54d5478c805c63d {
	civic-kb:nanoPub-12ed70711ef12602b54d5478c805c63d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-12ed70711ef12602b54d5478c805c63d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-786b93810b14dd11316ebbd93ea2088e {
	civic-kb:nanoPub-786b93810b14dd11316ebbd93ea2088e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-786b93810b14dd11316ebbd93ea2088e ;
		np:hasProvenance civic-kb:provenance-786b93810b14dd11316ebbd93ea2088e ;
		np:hasPublicationInfo civic-kb:pubInfo-786b93810b14dd11316ebbd93ea2088e .
}

civic-kb:assertion-786b93810b14dd11316ebbd93ea2088e {
	civic-kb:Drugs-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-786b93810b14dd11316ebbd93ea2088e ;
		rdf:type	dron:00730818 ;
		rdf:type	db:DB05773 ;
		rdfs:label	"Trastuzumab Emtansine"^^xsd:string ;
		sio:hasValue	"Trastuzumab Emtansine"^^xsd:string .

	civic-kb:Status-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-786b93810b14dd11316ebbd93ea2088e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-786b93810b14dd11316ebbd93ea2088e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1764"^^xsd:integer .

	civic-kb:Gene-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-786b93810b14dd11316ebbd93ea2088e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In the single arm Phase II study (TDM4258g) breast cancer patients who had progressed on previous anti-HER2 therapy were given transtuzumab emtansine (T-DM1), a HER2 monoclonal antibody and antimicrotubule drug conjugate. 95 trial participants with archival primary tumor were reassessed for HER2 status (positivity defined by FISH or IHC 3+), and 74 patients were confirmed for HER2 positivity and 21 were normal. Overall response rate was 33.8% (95% CI, 23.2% to 44.9%) in patients with confirmed HER2-positive tumors and 4.8% (95% CI, 1.0% to 21.8%) in HER2 normal patients. Median PFS was 8.2 months (95% CI, 4.4 months to not estimable) in patients with confirmed HER2-positive tumors and 2.6 months (95% CI, 1.4 to 3.9 months) in HER2 normal patients."^^xsd:string .

	civic-kb:Disease-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-786b93810b14dd11316ebbd93ea2088e ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-786b93810b14dd11316ebbd93ea2088e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-786b93810b14dd11316ebbd93ea2088e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-786b93810b14dd11316ebbd93ea2088e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-786b93810b14dd11316ebbd93ea2088e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-786b93810b14dd11316ebbd93ea2088e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-786b93810b14dd11316ebbd93ea2088e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-786b93810b14dd11316ebbd93ea2088e .

}

civic-kb:provenance-786b93810b14dd11316ebbd93ea2088e {
	civic-kb:assertion-786b93810b14dd11316ebbd93ea2088e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-786b93810b14dd11316ebbd93ea2088e .

	civic-kb:Status-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-786b93810b14dd11316ebbd93ea2088e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-786b93810b14dd11316ebbd93ea2088e {
	civic-kb:nanoPub-786b93810b14dd11316ebbd93ea2088e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-786b93810b14dd11316ebbd93ea2088e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ecaf0157d72acf53ad33b0234f110623 {
	civic-kb:nanoPub-ecaf0157d72acf53ad33b0234f110623
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ecaf0157d72acf53ad33b0234f110623 ;
		np:hasProvenance civic-kb:provenance-ecaf0157d72acf53ad33b0234f110623 ;
		np:hasPublicationInfo civic-kb:pubInfo-ecaf0157d72acf53ad33b0234f110623 .
}

civic-kb:assertion-ecaf0157d72acf53ad33b0234f110623 {
	civic-kb:Drugs-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ecaf0157d72acf53ad33b0234f110623 ;
		sio:hasValue	"Trastuzumab, Capecitabine"^^xsd:string .

	civic-kb:Status-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ecaf0157d72acf53ad33b0234f110623 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ecaf0157d72acf53ad33b0234f110623 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1133"^^xsd:integer .

	civic-kb:Gene-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ecaf0157d72acf53ad33b0234f110623 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In this Phase III trial, trastuzumab-based treatment was assessed in women with locally advanced or metastatic HER2 positive breast cancer who had progressed on trastuzumab.  Patients had 12 weeks or greater previous trastuzumab treatment with time since end of last cycle less than 6 weeks.  Primary endpoint was time to progression.  78 patients were assigned to each group, with median time to progression of 5.6 months in capecitabine group and 8.2 months in trastuzumab plus capecitabine group.  The results are in contrast to the principle of change of treatment on disease progression, and authors suggest that chemotherapy-sensitizing mechanisms of trastuzumab remain intact in HER2 breast cancer cells with trastuzumab progression."^^xsd:string .

	civic-kb:Disease-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ecaf0157d72acf53ad33b0234f110623 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ecaf0157d72acf53ad33b0234f110623 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ecaf0157d72acf53ad33b0234f110623 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ecaf0157d72acf53ad33b0234f110623 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ecaf0157d72acf53ad33b0234f110623 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ecaf0157d72acf53ad33b0234f110623 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-ecaf0157d72acf53ad33b0234f110623	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ecaf0157d72acf53ad33b0234f110623 .

}

civic-kb:provenance-ecaf0157d72acf53ad33b0234f110623 {
	civic-kb:assertion-ecaf0157d72acf53ad33b0234f110623 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ecaf0157d72acf53ad33b0234f110623 .

	civic-kb:Status-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ecaf0157d72acf53ad33b0234f110623	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ecaf0157d72acf53ad33b0234f110623 {
	civic-kb:nanoPub-ecaf0157d72acf53ad33b0234f110623 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ecaf0157d72acf53ad33b0234f110623
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c4ce6eec91c98fb414a982e727fc469a {
	civic-kb:nanoPub-c4ce6eec91c98fb414a982e727fc469a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c4ce6eec91c98fb414a982e727fc469a ;
		np:hasProvenance civic-kb:provenance-c4ce6eec91c98fb414a982e727fc469a ;
		np:hasPublicationInfo civic-kb:pubInfo-c4ce6eec91c98fb414a982e727fc469a .
}

civic-kb:assertion-c4ce6eec91c98fb414a982e727fc469a {
	civic-kb:Drugs-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c4ce6eec91c98fb414a982e727fc469a ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c4ce6eec91c98fb414a982e727fc469a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c4ce6eec91c98fb414a982e727fc469a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1122"^^xsd:integer .

	civic-kb:Gene-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c4ce6eec91c98fb414a982e727fc469a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"HERA was a Phase III trial assessing application of trastuzumab in an extended adjuvant setting.  Patients were HER2 positive with completely excised invasive BC, node positive or negative, and having undergone prior adjuvant or neo-adjuvant chemotherapy.  In the 3 arm study patients were given trastuzumab courses of 1 year, 2 years, or untreated.  At the first planned interim analysis, trastuzumab treatment for one year was compared with observation alone.  A significant difference in disease-free survival was seen with 220 DFS events out of 1693 in the observation arm versus 127 DFS events out of 1694 in the 1 year trastuzumab arm.  1 year adjuvant trastuzumab is currently the standard of care."^^xsd:string .

	civic-kb:Disease-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c4ce6eec91c98fb414a982e727fc469a ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c4ce6eec91c98fb414a982e727fc469a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"A"^^xsd:string .

	civic-kb:Evidence_Type-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c4ce6eec91c98fb414a982e727fc469a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c4ce6eec91c98fb414a982e727fc469a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c4ce6eec91c98fb414a982e727fc469a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c4ce6eec91c98fb414a982e727fc469a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-c4ce6eec91c98fb414a982e727fc469a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c4ce6eec91c98fb414a982e727fc469a .

}

civic-kb:provenance-c4ce6eec91c98fb414a982e727fc469a {
	civic-kb:assertion-c4ce6eec91c98fb414a982e727fc469a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c4ce6eec91c98fb414a982e727fc469a .

	civic-kb:Status-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-c4ce6eec91c98fb414a982e727fc469a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c4ce6eec91c98fb414a982e727fc469a {
	civic-kb:nanoPub-c4ce6eec91c98fb414a982e727fc469a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c4ce6eec91c98fb414a982e727fc469a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-b70095d86ea96797f72a6634b1961373 {
	civic-kb:nanoPub-b70095d86ea96797f72a6634b1961373
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-b70095d86ea96797f72a6634b1961373 ;
		np:hasProvenance civic-kb:provenance-b70095d86ea96797f72a6634b1961373 ;
		np:hasPublicationInfo civic-kb:pubInfo-b70095d86ea96797f72a6634b1961373 .
}

civic-kb:assertion-b70095d86ea96797f72a6634b1961373 {
	civic-kb:Drugs-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b70095d86ea96797f72a6634b1961373 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-b70095d86ea96797f72a6634b1961373 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-b70095d86ea96797f72a6634b1961373 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"528"^^xsd:integer .

	civic-kb:Gene-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-b70095d86ea96797f72a6634b1961373 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A randomized clinical trial of 469 patients with previously untreated, HER2-positive, metastatic breast cancer demonstrated improved time to disease progression, objective response rate, and duration of response for patients who received trastuzumab in addition to chemotherapy compared to chemotherapy alone."^^xsd:string .

	civic-kb:Disease-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b70095d86ea96797f72a6634b1961373 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-b70095d86ea96797f72a6634b1961373 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b70095d86ea96797f72a6634b1961373 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b70095d86ea96797f72a6634b1961373 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-b70095d86ea96797f72a6634b1961373 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-b70095d86ea96797f72a6634b1961373 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-b70095d86ea96797f72a6634b1961373	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-b70095d86ea96797f72a6634b1961373 .

}

civic-kb:provenance-b70095d86ea96797f72a6634b1961373 {
	civic-kb:assertion-b70095d86ea96797f72a6634b1961373 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-b70095d86ea96797f72a6634b1961373 .

	civic-kb:Status-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-b70095d86ea96797f72a6634b1961373	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-b70095d86ea96797f72a6634b1961373 {
	civic-kb:nanoPub-b70095d86ea96797f72a6634b1961373 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-b70095d86ea96797f72a6634b1961373
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ac6dbafd65ffec9ddee41f9d411b3302 {
	civic-kb:nanoPub-ac6dbafd65ffec9ddee41f9d411b3302
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ac6dbafd65ffec9ddee41f9d411b3302 ;
		np:hasProvenance civic-kb:provenance-ac6dbafd65ffec9ddee41f9d411b3302 ;
		np:hasPublicationInfo civic-kb:pubInfo-ac6dbafd65ffec9ddee41f9d411b3302 .
}

civic-kb:assertion-ac6dbafd65ffec9ddee41f9d411b3302 {
	civic-kb:Drugs-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ac6dbafd65ffec9ddee41f9d411b3302 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ac6dbafd65ffec9ddee41f9d411b3302 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ac6dbafd65ffec9ddee41f9d411b3302 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"529"^^xsd:integer .

	civic-kb:Gene-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ac6dbafd65ffec9ddee41f9d411b3302 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A randomized clinical trial of 186 patients with previously untreated, HER2-positive, metastatic breast cancer demonstrated improved overall survival, response rate, response duration, time to progression, and time to treatment failure for patients who received trastuzumab in addition to chemotherapy (docetaxel) compared to chemotherapy alone."^^xsd:string .

	civic-kb:Disease-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ac6dbafd65ffec9ddee41f9d411b3302 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ac6dbafd65ffec9ddee41f9d411b3302 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ac6dbafd65ffec9ddee41f9d411b3302 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ac6dbafd65ffec9ddee41f9d411b3302 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ac6dbafd65ffec9ddee41f9d411b3302 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ac6dbafd65ffec9ddee41f9d411b3302 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-ac6dbafd65ffec9ddee41f9d411b3302	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ac6dbafd65ffec9ddee41f9d411b3302 .

}

civic-kb:provenance-ac6dbafd65ffec9ddee41f9d411b3302 {
	civic-kb:assertion-ac6dbafd65ffec9ddee41f9d411b3302 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ac6dbafd65ffec9ddee41f9d411b3302 .

	civic-kb:Status-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ac6dbafd65ffec9ddee41f9d411b3302	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ac6dbafd65ffec9ddee41f9d411b3302 {
	civic-kb:nanoPub-ac6dbafd65ffec9ddee41f9d411b3302 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ac6dbafd65ffec9ddee41f9d411b3302
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-b2c5761fcc9d24e83df0d36592e581dd {
	civic-kb:nanoPub-b2c5761fcc9d24e83df0d36592e581dd
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-b2c5761fcc9d24e83df0d36592e581dd ;
		np:hasProvenance civic-kb:provenance-b2c5761fcc9d24e83df0d36592e581dd ;
		np:hasPublicationInfo civic-kb:pubInfo-b2c5761fcc9d24e83df0d36592e581dd .
}

civic-kb:assertion-b2c5761fcc9d24e83df0d36592e581dd {
	civic-kb:Drugs-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b2c5761fcc9d24e83df0d36592e581dd ;
		rdf:type	chebi:49960 ;
		rdf:type	db:DB05294 ;
		rdf:type	db:DB08764 ;
		rdfs:label	"Vandetanib"^^xsd:string ;
		sio:hasValue	"Vandetanib"^^xsd:string .

	civic-kb:Status-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-b2c5761fcc9d24e83df0d36592e581dd ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-b2c5761fcc9d24e83df0d36592e581dd ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2992"^^xsd:integer .

	civic-kb:Gene-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18539 ;
		rdf:type	uniprot:P07949 ;
		rdfs:label	"RET Gene"^^xsd:string ;
		sio:hasValue	"RET"^^xsd:string .

	civic-kb:Variant-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-b2c5761fcc9d24e83df0d36592e581dd ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The activity of Vandetanib was tested in vivo in three PDX models of TNBC and one model of HER2+ BC with different expression levels of RET and EGFR. Vandetanib induced tumor regression in PDX models with high expression of RET or EGFR. The effect was associated with inhibition of RET/EGFR phosphorylation and MAP kinase pathway and increased necrosis. In a PDX model with no expression of RET nor EGFR, Vandetanib slowed tumor growth without inducing tumor regression. In addition, treatment by Vandetanib decreased expression of murine Vegf receptors and the endothelial marker Cd31 in the four PDX models tested, suggesting inhibition of tumor vascularization."^^xsd:string .

	civic-kb:Disease-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b2c5761fcc9d24e83df0d36592e581dd ;
		rdf:type	efo:1000650 ;
		rdf:type	doid:0060076 ;
		rdfs:label	"Estrogen-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-b2c5761fcc9d24e83df0d36592e581dd ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b2c5761fcc9d24e83df0d36592e581dd ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b2c5761fcc9d24e83df0d36592e581dd ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-b2c5761fcc9d24e83df0d36592e581dd ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-b2c5761fcc9d24e83df0d36592e581dd ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-b2c5761fcc9d24e83df0d36592e581dd	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-b2c5761fcc9d24e83df0d36592e581dd .

}

civic-kb:provenance-b2c5761fcc9d24e83df0d36592e581dd {
	civic-kb:assertion-b2c5761fcc9d24e83df0d36592e581dd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-b2c5761fcc9d24e83df0d36592e581dd .

	civic-kb:Status-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-b2c5761fcc9d24e83df0d36592e581dd	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-b2c5761fcc9d24e83df0d36592e581dd {
	civic-kb:nanoPub-b2c5761fcc9d24e83df0d36592e581dd prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-b2c5761fcc9d24e83df0d36592e581dd
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-fc5dda51df1a078d055737e18fa106e7 {
	civic-kb:nanoPub-fc5dda51df1a078d055737e18fa106e7
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-fc5dda51df1a078d055737e18fa106e7 ;
		np:hasProvenance civic-kb:provenance-fc5dda51df1a078d055737e18fa106e7 ;
		np:hasPublicationInfo civic-kb:pubInfo-fc5dda51df1a078d055737e18fa106e7 .
}

civic-kb:assertion-fc5dda51df1a078d055737e18fa106e7 {
	civic-kb:Drugs-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fc5dda51df1a078d055737e18fa106e7 ;
		sio:hasValue	"Fulvestrant, Palbociclib (PD0332991)"^^xsd:string .

	civic-kb:Status-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-fc5dda51df1a078d055737e18fa106e7 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-fc5dda51df1a078d055737e18fa106e7 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1527"^^xsd:integer .

	civic-kb:Gene-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C97384 ;
		rdf:type	uniprot:Q00534 ;
		rdfs:label	"CDK6 Gene"^^xsd:string ;
		sio:hasValue	"CDK6"^^xsd:string .

	civic-kb:Variant-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-fc5dda51df1a078d055737e18fa106e7 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Four fulvestrant (estrogen receptor degrader) resistant cell lines were derived from parent fulvestrant sensitive ER+ MCF-7/SO.5 breast cancer cell line. Derivative cell lines showed some sensitivity to CDK4/6 inhibitor palbociclib, and increased growth inhibition when treated with fulvestrant and palbociclib together."^^xsd:string .

	civic-kb:Disease-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fc5dda51df1a078d055737e18fa106e7 ;
		rdf:type	efo:1000649 ;
		rdf:type	doid:0060075 ;
		rdfs:label	"Estrogen-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-fc5dda51df1a078d055737e18fa106e7 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fc5dda51df1a078d055737e18fa106e7 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fc5dda51df1a078d055737e18fa106e7 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-fc5dda51df1a078d055737e18fa106e7 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-fc5dda51df1a078d055737e18fa106e7 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-fc5dda51df1a078d055737e18fa106e7	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-fc5dda51df1a078d055737e18fa106e7 .

}

civic-kb:provenance-fc5dda51df1a078d055737e18fa106e7 {
	civic-kb:assertion-fc5dda51df1a078d055737e18fa106e7 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-fc5dda51df1a078d055737e18fa106e7 .

	civic-kb:Status-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-fc5dda51df1a078d055737e18fa106e7	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-fc5dda51df1a078d055737e18fa106e7 {
	civic-kb:nanoPub-fc5dda51df1a078d055737e18fa106e7 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-fc5dda51df1a078d055737e18fa106e7
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8b9873aaa0d32b02a5a067d045b17186 {
	civic-kb:nanoPub-8b9873aaa0d32b02a5a067d045b17186
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8b9873aaa0d32b02a5a067d045b17186 ;
		np:hasProvenance civic-kb:provenance-8b9873aaa0d32b02a5a067d045b17186 ;
		np:hasPublicationInfo civic-kb:pubInfo-8b9873aaa0d32b02a5a067d045b17186 .
}

civic-kb:assertion-8b9873aaa0d32b02a5a067d045b17186 {
	civic-kb:Drugs-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8b9873aaa0d32b02a5a067d045b17186 ;
		rdf:type	dron:00018972 ;
		rdf:type	db:DB00947 ;
		rdfs:label	"Fulvestrant"^^xsd:string ;
		sio:hasValue	"Fulvestrant"^^xsd:string .

	civic-kb:Status-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8b9873aaa0d32b02a5a067d045b17186 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8b9873aaa0d32b02a5a067d045b17186 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1526"^^xsd:integer .

	civic-kb:Gene-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C97384 ;
		rdf:type	uniprot:Q00534 ;
		rdfs:label	"CDK6 Gene"^^xsd:string ;
		sio:hasValue	"CDK6"^^xsd:string .

	civic-kb:Variant-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8b9873aaa0d32b02a5a067d045b17186 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In two cohorts (n=45 and n=46) of ER+ breast cancer patients who had received fulvestrant, CDK6 overexpression correlated with shorter median time to progression in both cohorts (2.5 vs. 8.2 months and 3.4 vs. 8.9 months for CDK6 overexpression vs. normal expression). CDK6 expression did not correlate with other lines of treatment (N=68, tamoxifen or endocrine therapy). Four fulvestrant-resistant cell lines were derived from estrogen responsive and fulvestrant sensitive parental breast cancer cell line MCF-7/SO.5. Gene expression profiling showed upregulation of CDK6 in the fulvestrant resistant derivatives. Knockdown of CDK6 in these derivative cells resulted in fulvestrant sensitivity."^^xsd:string .

	civic-kb:Disease-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8b9873aaa0d32b02a5a067d045b17186 ;
		rdf:type	efo:1000649 ;
		rdf:type	doid:0060075 ;
		rdfs:label	"Estrogen-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8b9873aaa0d32b02a5a067d045b17186 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8b9873aaa0d32b02a5a067d045b17186 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8b9873aaa0d32b02a5a067d045b17186 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8b9873aaa0d32b02a5a067d045b17186 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8b9873aaa0d32b02a5a067d045b17186 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-8b9873aaa0d32b02a5a067d045b17186	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8b9873aaa0d32b02a5a067d045b17186 .

}

civic-kb:provenance-8b9873aaa0d32b02a5a067d045b17186 {
	civic-kb:assertion-8b9873aaa0d32b02a5a067d045b17186 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8b9873aaa0d32b02a5a067d045b17186 .

	civic-kb:Status-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-8b9873aaa0d32b02a5a067d045b17186	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8b9873aaa0d32b02a5a067d045b17186 {
	civic-kb:nanoPub-8b9873aaa0d32b02a5a067d045b17186 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8b9873aaa0d32b02a5a067d045b17186
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-548c9195205c104176c80a9d069564ca {
	civic-kb:nanoPub-548c9195205c104176c80a9d069564ca
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-548c9195205c104176c80a9d069564ca ;
		np:hasProvenance civic-kb:provenance-548c9195205c104176c80a9d069564ca ;
		np:hasPublicationInfo civic-kb:pubInfo-548c9195205c104176c80a9d069564ca .
}

civic-kb:assertion-548c9195205c104176c80a9d069564ca {
	civic-kb:Drugs-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-548c9195205c104176c80a9d069564ca ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib (PD0332991)"^^xsd:string .

	civic-kb:Status-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-548c9195205c104176c80a9d069564ca ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-548c9195205c104176c80a9d069564ca ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1535"^^xsd:integer .

	civic-kb:Gene-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17360 ;
		rdf:type	uniprot:P06400 ;
		rdfs:label	"RB1 Gene"^^xsd:string ;
		sio:hasValue	"RB1"^^xsd:string .

	civic-kb:Variant-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss of Function"^^xsd:string ;
		sio:hasValue	"LOSS-OF-FUNCTION"^^xsd:string .

	civic-kb:Description-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-548c9195205c104176c80a9d069564ca ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In 3 ER positive and 2 ER negative breast cancer cell lines with intact Rb, significant growth inhibition, as measured by BrdU incorporation, was seen with incubation in CDK4/6 inhibitor palbociclib (PD-0332991). In contrast, two ER negative cell lines lacking detectable Rb were fully resistant to palbociclib. Knockdown of Rb in 3 of the tested Rb positive cell lines led to moderate palbociclib resistance in short term incubation experiments. 
In longer term (15 day) palbociclib incubations of ER negative MDA-MB-231 cells and ER positive MCF-7 cells, significant resistance to palbociclib was seen in Rb knockdown conditions while wild-type Rb cells maintained sensitivity."^^xsd:string .

	civic-kb:Disease-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-548c9195205c104176c80a9d069564ca ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-548c9195205c104176c80a9d069564ca ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-548c9195205c104176c80a9d069564ca ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-548c9195205c104176c80a9d069564ca ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-548c9195205c104176c80a9d069564ca ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-548c9195205c104176c80a9d069564ca ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-548c9195205c104176c80a9d069564ca	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-548c9195205c104176c80a9d069564ca .

}

civic-kb:provenance-548c9195205c104176c80a9d069564ca {
	civic-kb:assertion-548c9195205c104176c80a9d069564ca prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-548c9195205c104176c80a9d069564ca .

	civic-kb:Status-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-548c9195205c104176c80a9d069564ca	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-548c9195205c104176c80a9d069564ca {
	civic-kb:nanoPub-548c9195205c104176c80a9d069564ca prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-548c9195205c104176c80a9d069564ca
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-1584932e66d4e76cd97bab24ebe8a6b3 {
	civic-kb:nanoPub-1584932e66d4e76cd97bab24ebe8a6b3
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-1584932e66d4e76cd97bab24ebe8a6b3 ;
		np:hasProvenance civic-kb:provenance-1584932e66d4e76cd97bab24ebe8a6b3 ;
		np:hasPublicationInfo civic-kb:pubInfo-1584932e66d4e76cd97bab24ebe8a6b3 .
}

civic-kb:assertion-1584932e66d4e76cd97bab24ebe8a6b3 {
	civic-kb:Drugs-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1584932e66d4e76cd97bab24ebe8a6b3 ;
		sio:hasValue	"Letrozole, Palbociclib (PD0332991)"^^xsd:string .

	civic-kb:Status-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-1584932e66d4e76cd97bab24ebe8a6b3 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-1584932e66d4e76cd97bab24ebe8a6b3 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1541"^^xsd:integer .

	civic-kb:Gene-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-1584932e66d4e76cd97bab24ebe8a6b3 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A phase 2 clinical trial evaluated 165 patients with oestrogen receptor positive and HER2-negative breast cancer such that 84 patients received combination therapy of palbociclib plus letrozole and 81 patients received letrozole alone. The combination therapy arm had higher median duration of progression-free survival when compared to the letrozole only group (20.2 months vs. 10.2 months; p<0.0004). A subcategory of patients taking combination therapy, who lacked mutations in p16 or CCND1 (n=34), had an even higher median free survival of 26.1 months.  Noticeable side effects in the combination therapy group included neutropenia (54%) leucopenia (19%), fatigue (4%) back pain (2%), diarrhea (2%) and pulmonary embolism (4%)."^^xsd:string .

	civic-kb:Disease-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1584932e66d4e76cd97bab24ebe8a6b3 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-1584932e66d4e76cd97bab24ebe8a6b3 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1584932e66d4e76cd97bab24ebe8a6b3 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1584932e66d4e76cd97bab24ebe8a6b3 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-1584932e66d4e76cd97bab24ebe8a6b3 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-1584932e66d4e76cd97bab24ebe8a6b3 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-1584932e66d4e76cd97bab24ebe8a6b3	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-1584932e66d4e76cd97bab24ebe8a6b3 .

}

civic-kb:provenance-1584932e66d4e76cd97bab24ebe8a6b3 {
	civic-kb:assertion-1584932e66d4e76cd97bab24ebe8a6b3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-1584932e66d4e76cd97bab24ebe8a6b3 .

	civic-kb:Status-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-1584932e66d4e76cd97bab24ebe8a6b3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-1584932e66d4e76cd97bab24ebe8a6b3 {
	civic-kb:nanoPub-1584932e66d4e76cd97bab24ebe8a6b3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-1584932e66d4e76cd97bab24ebe8a6b3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-db78634872ee3ae34f65b410e1553f85 {
	civic-kb:nanoPub-db78634872ee3ae34f65b410e1553f85
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-db78634872ee3ae34f65b410e1553f85 ;
		np:hasProvenance civic-kb:provenance-db78634872ee3ae34f65b410e1553f85 ;
		np:hasPublicationInfo civic-kb:pubInfo-db78634872ee3ae34f65b410e1553f85 .
}

civic-kb:assertion-db78634872ee3ae34f65b410e1553f85 {
	civic-kb:Drugs-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-db78634872ee3ae34f65b410e1553f85 ;
		rdf:type	dron:00013476 ;
		rdf:type	db:DB00877 ;
		rdfs:label	"Sirolimus"^^xsd:string ;
		sio:hasValue	"Rapamycin (Sirolimus)"^^xsd:string .

	civic-kb:Status-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-db78634872ee3ae34f65b410e1553f85 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"rejected"^^xsd:string .

	civic-kb:Evidence_ID-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-db78634872ee3ae34f65b410e1553f85 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1546"^^xsd:integer .

	civic-kb:Gene-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38928 ;
		rdf:type	uniprot:P42345 ;
		rdfs:label	"MTOR Gene"^^xsd:string ;
		sio:hasValue	"MTOR"^^xsd:string .

	civic-kb:Variant-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"M2327I"^^xsd:string .

	civic-kb:Description-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-db78634872ee3ae34f65b410e1553f85 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF-7 breast cancer cell line was exposed to mTOR inhibitor rapamycin until resistance developed. Deep sequencing revealed an MTOR A2034V mutation in the resistant clone. Downstream signalling was independent of inhibitor presence in these clones and expression of the mutation in another cell line led to resistance. A novel mTOR inhibitor RapaLink-1 was designed and showed efficacy in A2034V mTOR mutant cell lines in-vivo and in-vitro. AZD8055 also retained efficacy in these clones in xenograft."^^xsd:string .

	civic-kb:Disease-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-db78634872ee3ae34f65b410e1553f85 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-db78634872ee3ae34f65b410e1553f85 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-db78634872ee3ae34f65b410e1553f85 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-db78634872ee3ae34f65b410e1553f85 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-db78634872ee3ae34f65b410e1553f85 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-db78634872ee3ae34f65b410e1553f85 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-db78634872ee3ae34f65b410e1553f85	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-db78634872ee3ae34f65b410e1553f85 .

}

civic-kb:provenance-db78634872ee3ae34f65b410e1553f85 {
	civic-kb:assertion-db78634872ee3ae34f65b410e1553f85 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-db78634872ee3ae34f65b410e1553f85 .

	civic-kb:Status-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-db78634872ee3ae34f65b410e1553f85	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-db78634872ee3ae34f65b410e1553f85 {
	civic-kb:nanoPub-db78634872ee3ae34f65b410e1553f85 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-db78634872ee3ae34f65b410e1553f85
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-e04179d587574e1918f32dc45cc80707 {
	civic-kb:nanoPub-e04179d587574e1918f32dc45cc80707
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-e04179d587574e1918f32dc45cc80707 ;
		np:hasProvenance civic-kb:provenance-e04179d587574e1918f32dc45cc80707 ;
		np:hasPublicationInfo civic-kb:pubInfo-e04179d587574e1918f32dc45cc80707 .
}

civic-kb:assertion-e04179d587574e1918f32dc45cc80707 {
	civic-kb:Drugs-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-e04179d587574e1918f32dc45cc80707 ;
		rdf:type	db:DB12774 ;
		rdfs:label	"AZD-8055"^^xsd:string ;
		sio:hasValue	"AZD8055"^^xsd:string .

	civic-kb:Status-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-e04179d587574e1918f32dc45cc80707 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-e04179d587574e1918f32dc45cc80707 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1544"^^xsd:integer .

	civic-kb:Gene-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38928 ;
		rdf:type	uniprot:P42345 ;
		rdfs:label	"MTOR Gene"^^xsd:string ;
		sio:hasValue	"MTOR"^^xsd:string .

	civic-kb:Variant-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"M2327I"^^xsd:string .

	civic-kb:Description-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-e04179d587574e1918f32dc45cc80707 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF-7 breast cancer cell line was exposed to mTOR inhibitor AZD8055 until resistance developed. Deep sequencing revealed an MTOR M2327I mutation in the AZD8055-resistant clone. Downstream signalling was independent of inhibitor presence in these clones and expression of the mutation in MDA-MB-468 cells led to resistance. Tumor volume grew more rapidly in mice with xenografts of M2327I mTOR mutant MCF7 cells treated with AZD8055 than rapamycin or RapaLink-1 treatment."^^xsd:string .

	civic-kb:Disease-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-e04179d587574e1918f32dc45cc80707 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-e04179d587574e1918f32dc45cc80707 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-e04179d587574e1918f32dc45cc80707 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-e04179d587574e1918f32dc45cc80707 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-e04179d587574e1918f32dc45cc80707 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-e04179d587574e1918f32dc45cc80707 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-e04179d587574e1918f32dc45cc80707	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-e04179d587574e1918f32dc45cc80707 .

}

civic-kb:provenance-e04179d587574e1918f32dc45cc80707 {
	civic-kb:assertion-e04179d587574e1918f32dc45cc80707 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-e04179d587574e1918f32dc45cc80707 .

	civic-kb:Status-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-e04179d587574e1918f32dc45cc80707	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-e04179d587574e1918f32dc45cc80707 {
	civic-kb:nanoPub-e04179d587574e1918f32dc45cc80707 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-e04179d587574e1918f32dc45cc80707
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-51e2ca9928f07c02c71446ce28378ff6 {
	civic-kb:nanoPub-51e2ca9928f07c02c71446ce28378ff6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-51e2ca9928f07c02c71446ce28378ff6 ;
		np:hasProvenance civic-kb:provenance-51e2ca9928f07c02c71446ce28378ff6 ;
		np:hasPublicationInfo civic-kb:pubInfo-51e2ca9928f07c02c71446ce28378ff6 .
}

civic-kb:assertion-51e2ca9928f07c02c71446ce28378ff6 {
	civic-kb:Drugs-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-51e2ca9928f07c02c71446ce28378ff6 ;
		sio:hasValue	"RapaLink-1, Rapamycin (Sirolimus)"^^xsd:string .

	civic-kb:Status-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-51e2ca9928f07c02c71446ce28378ff6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-51e2ca9928f07c02c71446ce28378ff6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1545"^^xsd:integer .

	civic-kb:Gene-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38928 ;
		rdf:type	uniprot:P42345 ;
		rdfs:label	"MTOR Gene"^^xsd:string ;
		sio:hasValue	"MTOR"^^xsd:string .

	civic-kb:Variant-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"M2327I"^^xsd:string .

	civic-kb:Description-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-51e2ca9928f07c02c71446ce28378ff6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF-7 breast cancer cell line was exposed to mTOR inhibitor AZD8055 until resistance developed. Deep sequencing revealed an MTOR M2327I mutation in the AZD8055-resistant clone. These cells remained sensitive to rapamycin and RapaLink-1 in vitro and in mouse xenografts. Expression of the mutation in MDA-MB-468 cells led to AZD8055 resistance and these cells were also rapamycin and RapaLink-1 sensitive."^^xsd:string .

	civic-kb:Disease-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-51e2ca9928f07c02c71446ce28378ff6 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-51e2ca9928f07c02c71446ce28378ff6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-51e2ca9928f07c02c71446ce28378ff6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-51e2ca9928f07c02c71446ce28378ff6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-51e2ca9928f07c02c71446ce28378ff6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-51e2ca9928f07c02c71446ce28378ff6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-51e2ca9928f07c02c71446ce28378ff6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-51e2ca9928f07c02c71446ce28378ff6 .

}

civic-kb:provenance-51e2ca9928f07c02c71446ce28378ff6 {
	civic-kb:assertion-51e2ca9928f07c02c71446ce28378ff6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-51e2ca9928f07c02c71446ce28378ff6 .

	civic-kb:Status-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-51e2ca9928f07c02c71446ce28378ff6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-51e2ca9928f07c02c71446ce28378ff6 {
	civic-kb:nanoPub-51e2ca9928f07c02c71446ce28378ff6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-51e2ca9928f07c02c71446ce28378ff6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-26909d6ae4df9fa21e226f0bc81a7c3e {
	civic-kb:nanoPub-26909d6ae4df9fa21e226f0bc81a7c3e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-26909d6ae4df9fa21e226f0bc81a7c3e ;
		np:hasProvenance civic-kb:provenance-26909d6ae4df9fa21e226f0bc81a7c3e ;
		np:hasPublicationInfo civic-kb:pubInfo-26909d6ae4df9fa21e226f0bc81a7c3e .
}

civic-kb:assertion-26909d6ae4df9fa21e226f0bc81a7c3e {
	civic-kb:Drugs-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-26909d6ae4df9fa21e226f0bc81a7c3e ;
		rdf:type	dron:00013476 ;
		rdf:type	db:DB00877 ;
		rdfs:label	"Sirolimus"^^xsd:string ;
		sio:hasValue	"Rapamycin (Sirolimus)"^^xsd:string .

	civic-kb:Status-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-26909d6ae4df9fa21e226f0bc81a7c3e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-26909d6ae4df9fa21e226f0bc81a7c3e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1547"^^xsd:integer .

	civic-kb:Gene-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38928 ;
		rdf:type	uniprot:P42345 ;
		rdfs:label	"MTOR Gene"^^xsd:string ;
		sio:hasValue	"MTOR"^^xsd:string .

	civic-kb:Variant-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"A2034V"^^xsd:string .

	civic-kb:Description-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-26909d6ae4df9fa21e226f0bc81a7c3e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF-7 breast cancer cell line was exposed to mTOR inhibitor rapamycin until resistance developed. Deep sequencing revealed an MTOR A2034V mutation in the resistant clone. Downstream signalling was independent of inhibitor presence in these clones and expression of the mutation in MDA-MB-468 cells led to resistance. Xenografts of these cells were more resistant to rapamycin than AZD8055 or RapaLink-1 treatment."^^xsd:string .

	civic-kb:Disease-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-26909d6ae4df9fa21e226f0bc81a7c3e ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-26909d6ae4df9fa21e226f0bc81a7c3e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-26909d6ae4df9fa21e226f0bc81a7c3e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-26909d6ae4df9fa21e226f0bc81a7c3e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-26909d6ae4df9fa21e226f0bc81a7c3e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-26909d6ae4df9fa21e226f0bc81a7c3e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-26909d6ae4df9fa21e226f0bc81a7c3e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-26909d6ae4df9fa21e226f0bc81a7c3e .

}

civic-kb:provenance-26909d6ae4df9fa21e226f0bc81a7c3e {
	civic-kb:assertion-26909d6ae4df9fa21e226f0bc81a7c3e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-26909d6ae4df9fa21e226f0bc81a7c3e .

	civic-kb:Status-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-26909d6ae4df9fa21e226f0bc81a7c3e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-26909d6ae4df9fa21e226f0bc81a7c3e {
	civic-kb:nanoPub-26909d6ae4df9fa21e226f0bc81a7c3e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-26909d6ae4df9fa21e226f0bc81a7c3e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f9cac4ae37b2a933dd30efd5d7cd21a3 {
	civic-kb:nanoPub-f9cac4ae37b2a933dd30efd5d7cd21a3
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		np:hasProvenance civic-kb:provenance-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		np:hasPublicationInfo civic-kb:pubInfo-f9cac4ae37b2a933dd30efd5d7cd21a3 .
}

civic-kb:assertion-f9cac4ae37b2a933dd30efd5d7cd21a3 {
	civic-kb:Drugs-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		sio:hasValue	"AZD8055, RapaLink-1"^^xsd:string .

	civic-kb:Status-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1548"^^xsd:integer .

	civic-kb:Gene-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38928 ;
		rdf:type	uniprot:P42345 ;
		rdfs:label	"MTOR Gene"^^xsd:string ;
		sio:hasValue	"MTOR"^^xsd:string .

	civic-kb:Variant-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"A2034V"^^xsd:string .

	civic-kb:Description-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF-7 breast cancer cell line was exposed to mTOR inhibitor rapamycin until resistance developed. Deep sequencing revealed an MTOR A2034V mutation in the resistant clone (RR1). Downstream signalling was independent of inhibitor presence in these clones and expression of the mutation in MDA-MB-468 cells led to resistance to rapamycin but maintained sensistivity to AZD8055. A novel mTOR inhibitor RapaLink-1 was designed and showed efficacy in A2034V mTOR mutant cell lines in-vivo and in-vitro. AZD8055 also retained efficacy in these clones in xenograft."^^xsd:string .

	civic-kb:Disease-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f9cac4ae37b2a933dd30efd5d7cd21a3 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-f9cac4ae37b2a933dd30efd5d7cd21a3	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f9cac4ae37b2a933dd30efd5d7cd21a3 .

}

civic-kb:provenance-f9cac4ae37b2a933dd30efd5d7cd21a3 {
	civic-kb:assertion-f9cac4ae37b2a933dd30efd5d7cd21a3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f9cac4ae37b2a933dd30efd5d7cd21a3 .

	civic-kb:Status-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-f9cac4ae37b2a933dd30efd5d7cd21a3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f9cac4ae37b2a933dd30efd5d7cd21a3 {
	civic-kb:nanoPub-f9cac4ae37b2a933dd30efd5d7cd21a3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f9cac4ae37b2a933dd30efd5d7cd21a3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8e253f2824303373d48547112e334d35 {
	civic-kb:nanoPub-8e253f2824303373d48547112e334d35
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8e253f2824303373d48547112e334d35 ;
		np:hasProvenance civic-kb:provenance-8e253f2824303373d48547112e334d35 ;
		np:hasPublicationInfo civic-kb:pubInfo-8e253f2824303373d48547112e334d35 .
}

civic-kb:assertion-8e253f2824303373d48547112e334d35 {
	civic-kb:Drugs-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8e253f2824303373d48547112e334d35 ;
		sio:hasValue	"Neratinib, Lapatinib"^^xsd:string .

	civic-kb:Status-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8e253f2824303373d48547112e334d35 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8e253f2824303373d48547112e334d35 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"286"^^xsd:integer .

	civic-kb:Gene-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R678Q"^^xsd:string .

	civic-kb:Description-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8e253f2824303373d48547112e334d35 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF10A cells transduced with ERBB2 harboring an R678Q mutation were sensitive to lapatinib and the irreversible kinase inhibitor neratinib in an matrigel colony forming assay."^^xsd:string .

	civic-kb:Disease-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8e253f2824303373d48547112e334d35 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8e253f2824303373d48547112e334d35 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8e253f2824303373d48547112e334d35 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8e253f2824303373d48547112e334d35 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8e253f2824303373d48547112e334d35 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8e253f2824303373d48547112e334d35 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-8e253f2824303373d48547112e334d35	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8e253f2824303373d48547112e334d35 .

}

civic-kb:provenance-8e253f2824303373d48547112e334d35 {
	civic-kb:assertion-8e253f2824303373d48547112e334d35 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8e253f2824303373d48547112e334d35 .

	civic-kb:Status-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-8e253f2824303373d48547112e334d35	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8e253f2824303373d48547112e334d35 {
	civic-kb:nanoPub-8e253f2824303373d48547112e334d35 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8e253f2824303373d48547112e334d35
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-e9b3a790d13bfa634e6e3f35c6bc0eed {
	civic-kb:nanoPub-e9b3a790d13bfa634e6e3f35c6bc0eed
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-e9b3a790d13bfa634e6e3f35c6bc0eed ;
		np:hasProvenance civic-kb:provenance-e9b3a790d13bfa634e6e3f35c6bc0eed ;
		np:hasPublicationInfo civic-kb:pubInfo-e9b3a790d13bfa634e6e3f35c6bc0eed .
}

civic-kb:assertion-e9b3a790d13bfa634e6e3f35c6bc0eed {
	civic-kb:Drugs-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-e9b3a790d13bfa634e6e3f35c6bc0eed .

	civic-kb:Status-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-e9b3a790d13bfa634e6e3f35c6bc0eed ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-e9b3a790d13bfa634e6e3f35c6bc0eed ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1593"^^xsd:integer .

	civic-kb:Gene-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C28636 ;
		rdf:type	uniprot:P46013 ;
		rdfs:label	"MKI67 Gene"^^xsd:string ;
		sio:hasValue	"MKI67"^^xsd:string .

	civic-kb:Variant-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-e9b3a790d13bfa634e6e3f35c6bc0eed ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A quantitative meta-analysis was performed to assess optimal IHC-calculated cutoff values for the prognostic use of proliferative biomarker Ki67 in breast cancer. The studies included ER positive and negative cases, and the MIB-1 antibody was used in the large majority of studies. 25 studies that employed multivariate analysis were used, and a hazard ratio of 2.05 for overall survival was obtained when Ki67 cutoff value was set at greater or equal to 25%."^^xsd:string .

	civic-kb:Disease-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-e9b3a790d13bfa634e6e3f35c6bc0eed ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-e9b3a790d13bfa634e6e3f35c6bc0eed ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-e9b3a790d13bfa634e6e3f35c6bc0eed ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-e9b3a790d13bfa634e6e3f35c6bc0eed ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-e9b3a790d13bfa634e6e3f35c6bc0eed ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-e9b3a790d13bfa634e6e3f35c6bc0eed ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-e9b3a790d13bfa634e6e3f35c6bc0eed	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-e9b3a790d13bfa634e6e3f35c6bc0eed .

}

civic-kb:provenance-e9b3a790d13bfa634e6e3f35c6bc0eed {
	civic-kb:assertion-e9b3a790d13bfa634e6e3f35c6bc0eed prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-e9b3a790d13bfa634e6e3f35c6bc0eed .

	civic-kb:Status-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-e9b3a790d13bfa634e6e3f35c6bc0eed	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-e9b3a790d13bfa634e6e3f35c6bc0eed {
	civic-kb:nanoPub-e9b3a790d13bfa634e6e3f35c6bc0eed prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-e9b3a790d13bfa634e6e3f35c6bc0eed
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8b28886c9175223a5dfa9b1b8865677c {
	civic-kb:nanoPub-8b28886c9175223a5dfa9b1b8865677c
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8b28886c9175223a5dfa9b1b8865677c ;
		np:hasProvenance civic-kb:provenance-8b28886c9175223a5dfa9b1b8865677c ;
		np:hasPublicationInfo civic-kb:pubInfo-8b28886c9175223a5dfa9b1b8865677c .
}

civic-kb:assertion-8b28886c9175223a5dfa9b1b8865677c {
	civic-kb:Drugs-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8b28886c9175223a5dfa9b1b8865677c ;
		rdf:type	db:DB05928 ;
		rdfs:label	"Dovitinib"^^xsd:string ;
		sio:hasValue	"Dovitinib"^^xsd:string .

	civic-kb:Status-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8b28886c9175223a5dfa9b1b8865677c ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8b28886c9175223a5dfa9b1b8865677c ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1605"^^xsd:integer .

	civic-kb:Gene-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C19931 ;
		rdf:type	uniprot:P21802 ;
		rdfs:label	"FGFR2 Gene"^^xsd:string ;
		sio:hasValue	"FGFR2"^^xsd:string .

	civic-kb:Variant-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8b28886c9175223a5dfa9b1b8865677c ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Dovitinib was evaluated in-vitro, in xenograft and in a phase 2 study. Dovitinib inhibited proliferation in one FGFR1- and one FGFR2-amplified breast cancer cell lines at higher IC50 values than in 11 nonamplified cell lines. Dovitinib inhibited tumor growth and caused regression in both a FGFR1- and FGFR2-amplified xenograft model. 81 patients were enrolled in the trial and treated with dovitinib. 2 patients were reported to harbor FGFR2 amplifications and both had a reduction in tumor size of 18.5 and 28.2%, respectively. When FGFR1, FGF3 and FGFR2 amplifications were combined, a combined FGF-pathway amplified patient group had a higher mean reduction in target lesion size than patients with FGF-non-amplified tumors."^^xsd:string .

	civic-kb:Disease-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8b28886c9175223a5dfa9b1b8865677c ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8b28886c9175223a5dfa9b1b8865677c ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8b28886c9175223a5dfa9b1b8865677c ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8b28886c9175223a5dfa9b1b8865677c ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8b28886c9175223a5dfa9b1b8865677c ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8b28886c9175223a5dfa9b1b8865677c ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-8b28886c9175223a5dfa9b1b8865677c	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8b28886c9175223a5dfa9b1b8865677c .

}

civic-kb:provenance-8b28886c9175223a5dfa9b1b8865677c {
	civic-kb:assertion-8b28886c9175223a5dfa9b1b8865677c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8b28886c9175223a5dfa9b1b8865677c .

	civic-kb:Status-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-8b28886c9175223a5dfa9b1b8865677c	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8b28886c9175223a5dfa9b1b8865677c {
	civic-kb:nanoPub-8b28886c9175223a5dfa9b1b8865677c prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8b28886c9175223a5dfa9b1b8865677c
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-42905ef9ccffafb5205d31a5a16e859e {
	civic-kb:nanoPub-42905ef9ccffafb5205d31a5a16e859e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-42905ef9ccffafb5205d31a5a16e859e ;
		np:hasProvenance civic-kb:provenance-42905ef9ccffafb5205d31a5a16e859e ;
		np:hasPublicationInfo civic-kb:pubInfo-42905ef9ccffafb5205d31a5a16e859e .
}

civic-kb:assertion-42905ef9ccffafb5205d31a5a16e859e {
	civic-kb:Drugs-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-42905ef9ccffafb5205d31a5a16e859e ;
		rdf:type	db:DB05928 ;
		rdfs:label	"Dovitinib"^^xsd:string ;
		sio:hasValue	"Dovitinib"^^xsd:string .

	civic-kb:Status-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-42905ef9ccffafb5205d31a5a16e859e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-42905ef9ccffafb5205d31a5a16e859e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1606"^^xsd:integer .

	civic-kb:Gene-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18408 ;
		rdf:type	uniprot:P11487 ;
		rdfs:label	"FGF3 Gene"^^xsd:string ;
		sio:hasValue	"FGF3"^^xsd:string .

	civic-kb:Variant-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-42905ef9ccffafb5205d31a5a16e859e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-42905ef9ccffafb5205d31a5a16e859e ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-42905ef9ccffafb5205d31a5a16e859e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-42905ef9ccffafb5205d31a5a16e859e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-42905ef9ccffafb5205d31a5a16e859e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-42905ef9ccffafb5205d31a5a16e859e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-42905ef9ccffafb5205d31a5a16e859e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-42905ef9ccffafb5205d31a5a16e859e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-42905ef9ccffafb5205d31a5a16e859e .

}

civic-kb:provenance-42905ef9ccffafb5205d31a5a16e859e {
	civic-kb:assertion-42905ef9ccffafb5205d31a5a16e859e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-42905ef9ccffafb5205d31a5a16e859e .

	civic-kb:Status-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-42905ef9ccffafb5205d31a5a16e859e	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-42905ef9ccffafb5205d31a5a16e859e {
	civic-kb:nanoPub-42905ef9ccffafb5205d31a5a16e859e prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-42905ef9ccffafb5205d31a5a16e859e
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c1c0f3f169248e58fe786c7d704c518b {
	civic-kb:nanoPub-c1c0f3f169248e58fe786c7d704c518b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c1c0f3f169248e58fe786c7d704c518b ;
		np:hasProvenance civic-kb:provenance-c1c0f3f169248e58fe786c7d704c518b ;
		np:hasPublicationInfo civic-kb:pubInfo-c1c0f3f169248e58fe786c7d704c518b .
}

civic-kb:assertion-c1c0f3f169248e58fe786c7d704c518b {
	civic-kb:Drugs-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c1c0f3f169248e58fe786c7d704c518b ;
		rdf:type	db:DB12015 ;
		rdfs:label	"Alpelisib"^^xsd:string ;
		sio:hasValue	"Alpelisib (NVP-BYL719)"^^xsd:string .

	civic-kb:Status-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c1c0f3f169248e58fe786c7d704c518b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c1c0f3f169248e58fe786c7d704c518b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1609"^^xsd:integer .

	civic-kb:Gene-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17360 ;
		rdf:type	uniprot:P06400 ;
		rdfs:label	"RB1 Gene"^^xsd:string ;
		sio:hasValue	"RB1"^^xsd:string .

	civic-kb:Variant-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"PHOSPHORYLATION"^^xsd:string .

	civic-kb:Description-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c1c0f3f169248e58fe786c7d704c518b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The p110alpha-specific PI3K inhibitor BYL719 was used on a panel of five PI3K inhibitor sensitive and five resistant breast cancer cell lines. Sensitive cells (IC50<400nM) showed reduced phospho-Rb (p-Rb) western blot levels in response to BYL719 treatment, while resistant cell lines (IC50>800nM) showed significantly less reduction in p-Rb after BYL719. Paired biopsies before and after treatment were taken from a set of eight patients classified as either responder or non-responder to BYL719. Responder samples showed significantly reduced p-Rb staining after treatment in comparison to non-responder biopsies. In biopsies taken from a group of three responders who progressed, p-Rb levels were increased after progression."^^xsd:string .

	civic-kb:Disease-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c1c0f3f169248e58fe786c7d704c518b ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c1c0f3f169248e58fe786c7d704c518b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c1c0f3f169248e58fe786c7d704c518b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c1c0f3f169248e58fe786c7d704c518b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c1c0f3f169248e58fe786c7d704c518b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c1c0f3f169248e58fe786c7d704c518b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-c1c0f3f169248e58fe786c7d704c518b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c1c0f3f169248e58fe786c7d704c518b .

}

civic-kb:provenance-c1c0f3f169248e58fe786c7d704c518b {
	civic-kb:assertion-c1c0f3f169248e58fe786c7d704c518b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c1c0f3f169248e58fe786c7d704c518b .

	civic-kb:Status-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-c1c0f3f169248e58fe786c7d704c518b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c1c0f3f169248e58fe786c7d704c518b {
	civic-kb:nanoPub-c1c0f3f169248e58fe786c7d704c518b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c1c0f3f169248e58fe786c7d704c518b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ab20023826283c6bef0ea23aa2e49783 {
	civic-kb:nanoPub-ab20023826283c6bef0ea23aa2e49783
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ab20023826283c6bef0ea23aa2e49783 ;
		np:hasProvenance civic-kb:provenance-ab20023826283c6bef0ea23aa2e49783 ;
		np:hasPublicationInfo civic-kb:pubInfo-ab20023826283c6bef0ea23aa2e49783 .
}

civic-kb:assertion-ab20023826283c6bef0ea23aa2e49783 {
	civic-kb:Drugs-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ab20023826283c6bef0ea23aa2e49783 ;
		rdfs:label	"PP242"^^xsd:string ;
		sio:hasValue	"PP242"^^xsd:string .

	civic-kb:Status-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ab20023826283c6bef0ea23aa2e49783 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ab20023826283c6bef0ea23aa2e49783 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1612"^^xsd:integer .

	civic-kb:Gene-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C97733 ;
		rdf:type	uniprot:P27986 ;
		rdfs:label	"PIK3R1 Gene"^^xsd:string ;
		sio:hasValue	"PIK3R1"^^xsd:string .

	civic-kb:Variant-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ab20023826283c6bef0ea23aa2e49783 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Sensitivity to mTORC1/2 inhibitor PP242 was assessed in a panel of breast cancer cell lines with various mutation backgrounds. PTEN and PIK3CA mutations were heavily represented in the panel. However, a PTEN and PIK3CA wild type cell line 'HS578T' was found to harbor a mutation in the PI3K regulatory protein PIK3R1. Like PIK3CA mutant cell lines, the PIK3R1 mutant HS578T line was also determined to be sensitive to PP242. Approximately 70% of PIK3CA wild type lines were not sensitive to PP242. This suggests that mutations in the PI3K holoenzyme may be targetable by mTORC1/2 inhibition."^^xsd:string .

	civic-kb:Disease-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ab20023826283c6bef0ea23aa2e49783 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ab20023826283c6bef0ea23aa2e49783 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ab20023826283c6bef0ea23aa2e49783 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ab20023826283c6bef0ea23aa2e49783 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ab20023826283c6bef0ea23aa2e49783 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ab20023826283c6bef0ea23aa2e49783 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-ab20023826283c6bef0ea23aa2e49783	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ab20023826283c6bef0ea23aa2e49783 .

}

civic-kb:provenance-ab20023826283c6bef0ea23aa2e49783 {
	civic-kb:assertion-ab20023826283c6bef0ea23aa2e49783 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ab20023826283c6bef0ea23aa2e49783 .

	civic-kb:Status-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-ab20023826283c6bef0ea23aa2e49783	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ab20023826283c6bef0ea23aa2e49783 {
	civic-kb:nanoPub-ab20023826283c6bef0ea23aa2e49783 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ab20023826283c6bef0ea23aa2e49783
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-1efdeb4524d06e4c50332afad8650280 {
	civic-kb:nanoPub-1efdeb4524d06e4c50332afad8650280
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-1efdeb4524d06e4c50332afad8650280 ;
		np:hasProvenance civic-kb:provenance-1efdeb4524d06e4c50332afad8650280 ;
		np:hasPublicationInfo civic-kb:pubInfo-1efdeb4524d06e4c50332afad8650280 .
}

civic-kb:assertion-1efdeb4524d06e4c50332afad8650280 {
	civic-kb:Drugs-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1efdeb4524d06e4c50332afad8650280 ;
		rdf:type	db:DB11828 ;
		rdfs:label	"Neratinib"^^xsd:string ;
		sio:hasValue	"Neratinib"^^xsd:string .

	civic-kb:Status-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-1efdeb4524d06e4c50332afad8650280 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-1efdeb4524d06e4c50332afad8650280 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"5338"^^xsd:integer .

	civic-kb:Gene-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-1efdeb4524d06e4c50332afad8650280 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"16 patients with HER2-mutated metastatic breast cancer were treated with neratinib monotherapy. Of these 16 patients, 14 had known-activating mutations and 2 had mutations of unknown significance. Five of the 16 patients achieved clinical benefit including 1 complete response (6%), 1 partial response (6%) and 3 with stable disease >24 weeks (19%). Clinical benefit was observed across different HER2 mutations including L755S, V777_G778 insGSP, P780_Y781 insGSP, V842I, S310F, and L869R."^^xsd:string .

	civic-kb:Disease-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1efdeb4524d06e4c50332afad8650280 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-1efdeb4524d06e4c50332afad8650280 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1efdeb4524d06e4c50332afad8650280 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1efdeb4524d06e4c50332afad8650280 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-1efdeb4524d06e4c50332afad8650280 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-1efdeb4524d06e4c50332afad8650280 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-1efdeb4524d06e4c50332afad8650280	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-1efdeb4524d06e4c50332afad8650280 .

}

civic-kb:provenance-1efdeb4524d06e4c50332afad8650280 {
	civic-kb:assertion-1efdeb4524d06e4c50332afad8650280 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-1efdeb4524d06e4c50332afad8650280 .

	civic-kb:Status-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-1efdeb4524d06e4c50332afad8650280	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-1efdeb4524d06e4c50332afad8650280 {
	civic-kb:nanoPub-1efdeb4524d06e4c50332afad8650280 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-1efdeb4524d06e4c50332afad8650280
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-7474e84fe706134ef114f7c2b19c774b {
	civic-kb:nanoPub-7474e84fe706134ef114f7c2b19c774b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-7474e84fe706134ef114f7c2b19c774b ;
		np:hasProvenance civic-kb:provenance-7474e84fe706134ef114f7c2b19c774b ;
		np:hasPublicationInfo civic-kb:pubInfo-7474e84fe706134ef114f7c2b19c774b .
}

civic-kb:assertion-7474e84fe706134ef114f7c2b19c774b {
	civic-kb:Drugs-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7474e84fe706134ef114f7c2b19c774b ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib (PD0332991)"^^xsd:string .

	civic-kb:Status-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-7474e84fe706134ef114f7c2b19c774b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-7474e84fe706134ef114f7c2b19c774b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1630"^^xsd:integer .

	civic-kb:Gene-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17360 ;
		rdf:type	uniprot:P06400 ;
		rdfs:label	"RB1 Gene"^^xsd:string ;
		sio:hasValue	"RB1"^^xsd:string .

	civic-kb:Variant-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"M695FS*26"^^xsd:string ;
		sio:hasValue	"M695FS*26"^^xsd:string .

	civic-kb:Description-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-7474e84fe706134ef114f7c2b19c774b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Preclinical study in breast cancer cell lines treated with CDK4/6 inhibitor palbociclib. Palbociclib-resistant xenografts from one cell line (PDX244) were developed in-vivo. In resistant xenografts, western blot analysis showed a decrease of pRb protein levels in 4 of 7 CDK4/6-acquired resistant tumors and a sustained expression of the E2F target cyclin E2, in contrast to CDK4/6 inhibitor-sensitive PDX244. Genomic characterization of PDX244LR1 showed the acquisition of an RB1 frameshift mutation (RB1 p.M695fs*26)."^^xsd:string .

	civic-kb:Disease-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7474e84fe706134ef114f7c2b19c774b ;
		rdf:type	efo:1000649 ;
		rdf:type	doid:0060075 ;
		rdfs:label	"Estrogen-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-7474e84fe706134ef114f7c2b19c774b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7474e84fe706134ef114f7c2b19c774b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7474e84fe706134ef114f7c2b19c774b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-7474e84fe706134ef114f7c2b19c774b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-7474e84fe706134ef114f7c2b19c774b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-7474e84fe706134ef114f7c2b19c774b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-7474e84fe706134ef114f7c2b19c774b .

}

civic-kb:provenance-7474e84fe706134ef114f7c2b19c774b {
	civic-kb:assertion-7474e84fe706134ef114f7c2b19c774b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-7474e84fe706134ef114f7c2b19c774b .

	civic-kb:Status-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-7474e84fe706134ef114f7c2b19c774b	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-7474e84fe706134ef114f7c2b19c774b {
	civic-kb:nanoPub-7474e84fe706134ef114f7c2b19c774b prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-7474e84fe706134ef114f7c2b19c774b
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2a8f725842304680c5fda9cd9d5d313d {
	civic-kb:nanoPub-2a8f725842304680c5fda9cd9d5d313d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2a8f725842304680c5fda9cd9d5d313d ;
		np:hasProvenance civic-kb:provenance-2a8f725842304680c5fda9cd9d5d313d ;
		np:hasPublicationInfo civic-kb:pubInfo-2a8f725842304680c5fda9cd9d5d313d .
}

civic-kb:assertion-2a8f725842304680c5fda9cd9d5d313d {
	civic-kb:Drugs-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2a8f725842304680c5fda9cd9d5d313d .

	civic-kb:Status-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2a8f725842304680c5fda9cd9d5d313d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2a8f725842304680c5fda9cd9d5d313d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1679"^^xsd:integer .

	civic-kb:Gene-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18120 ;
		rdf:type	uniprot:P51587 ;
		rdfs:label	"BRCA2 Gene"^^xsd:string ;
		sio:hasValue	"BRCA2"^^xsd:string .

	civic-kb:Variant-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"D3095E"^^xsd:string .

	civic-kb:Description-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2a8f725842304680c5fda9cd9d5d313d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2a8f725842304680c5fda9cd9d5d313d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2a8f725842304680c5fda9cd9d5d313d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2a8f725842304680c5fda9cd9d5d313d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Diagnostic"^^xsd:string .

	civic-kb:Evidence_Direction-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2a8f725842304680c5fda9cd9d5d313d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Positive"^^xsd:string .

	civic-kb:Variant_Origin-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2a8f725842304680c5fda9cd9d5d313d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2a8f725842304680c5fda9cd9d5d313d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"1"^^xsd:integer .

	civic-kb:evidence-2a8f725842304680c5fda9cd9d5d313d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2a8f725842304680c5fda9cd9d5d313d .

}

civic-kb:provenance-2a8f725842304680c5fda9cd9d5d313d {
	civic-kb:assertion-2a8f725842304680c5fda9cd9d5d313d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2a8f725842304680c5fda9cd9d5d313d .

	civic-kb:Status-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-2a8f725842304680c5fda9cd9d5d313d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2a8f725842304680c5fda9cd9d5d313d {
	civic-kb:nanoPub-2a8f725842304680c5fda9cd9d5d313d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2a8f725842304680c5fda9cd9d5d313d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8d605ed0820a9f3d51119cfbfeb3fb8a {
	civic-kb:nanoPub-8d605ed0820a9f3d51119cfbfeb3fb8a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		np:hasProvenance civic-kb:provenance-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		np:hasPublicationInfo civic-kb:pubInfo-8d605ed0820a9f3d51119cfbfeb3fb8a .
}

civic-kb:assertion-8d605ed0820a9f3d51119cfbfeb3fb8a {
	civic-kb:Drugs-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		rdf:type	ncit:C1740 ;
		rdf:type	chebi:50790 ;
		rdfs:label	"Aromatase Inhibitor"^^xsd:string ;
		sio:hasValue	"Aromatase Inhibitor"^^xsd:string .

	civic-kb:Status-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1727"^^xsd:integer .

	civic-kb:Gene-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"S463P"^^xsd:string ;
		sio:hasValue	"S463P"^^xsd:string .

	civic-kb:Description-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		rdf:type	efo:1000649 ;
		rdf:type	doid:0060075 ;
		rdfs:label	"Estrogen-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8d605ed0820a9f3d51119cfbfeb3fb8a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-8d605ed0820a9f3d51119cfbfeb3fb8a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8d605ed0820a9f3d51119cfbfeb3fb8a .

}

civic-kb:provenance-8d605ed0820a9f3d51119cfbfeb3fb8a {
	civic-kb:assertion-8d605ed0820a9f3d51119cfbfeb3fb8a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8d605ed0820a9f3d51119cfbfeb3fb8a .

	civic-kb:Status-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-8d605ed0820a9f3d51119cfbfeb3fb8a	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8d605ed0820a9f3d51119cfbfeb3fb8a {
	civic-kb:nanoPub-8d605ed0820a9f3d51119cfbfeb3fb8a prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8d605ed0820a9f3d51119cfbfeb3fb8a
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-6e36e4c36aa7bb891ecd441234b16677 {
	civic-kb:nanoPub-6e36e4c36aa7bb891ecd441234b16677
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-6e36e4c36aa7bb891ecd441234b16677 ;
		np:hasProvenance civic-kb:provenance-6e36e4c36aa7bb891ecd441234b16677 ;
		np:hasPublicationInfo civic-kb:pubInfo-6e36e4c36aa7bb891ecd441234b16677 .
}

civic-kb:assertion-6e36e4c36aa7bb891ecd441234b16677 {
	civic-kb:Drugs-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6e36e4c36aa7bb891ecd441234b16677 ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib"^^xsd:string .

	civic-kb:Status-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-6e36e4c36aa7bb891ecd441234b16677 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-6e36e4c36aa7bb891ecd441234b16677 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4815"^^xsd:integer .

	civic-kb:Gene-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"S463P"^^xsd:string ;
		sio:hasValue	"S463P"^^xsd:string .

	civic-kb:Description-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-6e36e4c36aa7bb891ecd441234b16677 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase 3 clinical trial (NCT01942135) of 360 premenopausal and postmenopausal women with advanced, hormone receptor-positive breast cancer who had progressed during prior endocrine therapy, patients with ESR1 mutations (91/360), including ESR1 S463P (n=4), treated with palbociclib and fulvestrant were associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (HR:0.43; 95% CI:0.25-0.74; P=0.002). Patient without detected ESR1 mutation treated with palbociclib and fulvestrant were also associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (9.5 vs. 5.4 months; HR:0.49; 95% CI:0.35-0.70; P<0.001)."^^xsd:string .

	civic-kb:Disease-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6e36e4c36aa7bb891ecd441234b16677 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-6e36e4c36aa7bb891ecd441234b16677 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6e36e4c36aa7bb891ecd441234b16677 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6e36e4c36aa7bb891ecd441234b16677 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-6e36e4c36aa7bb891ecd441234b16677 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-6e36e4c36aa7bb891ecd441234b16677 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-6e36e4c36aa7bb891ecd441234b16677	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-6e36e4c36aa7bb891ecd441234b16677 .

}

civic-kb:provenance-6e36e4c36aa7bb891ecd441234b16677 {
	civic-kb:assertion-6e36e4c36aa7bb891ecd441234b16677 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-6e36e4c36aa7bb891ecd441234b16677 .

	civic-kb:Status-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-6e36e4c36aa7bb891ecd441234b16677	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-6e36e4c36aa7bb891ecd441234b16677 {
	civic-kb:nanoPub-6e36e4c36aa7bb891ecd441234b16677 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-6e36e4c36aa7bb891ecd441234b16677
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-4e8b57654b449895a7e2fc87e264ffe3 {
	civic-kb:nanoPub-4e8b57654b449895a7e2fc87e264ffe3
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-4e8b57654b449895a7e2fc87e264ffe3 ;
		np:hasProvenance civic-kb:provenance-4e8b57654b449895a7e2fc87e264ffe3 ;
		np:hasPublicationInfo civic-kb:pubInfo-4e8b57654b449895a7e2fc87e264ffe3 .
}

civic-kb:assertion-4e8b57654b449895a7e2fc87e264ffe3 {
	civic-kb:Drugs-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4e8b57654b449895a7e2fc87e264ffe3 ;
		rdf:type	db:DB12015 ;
		rdfs:label	"Alpelisib"^^xsd:string ;
		sio:hasValue	"Alpelisib (NVP-BYL719)"^^xsd:string .

	civic-kb:Status-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-4e8b57654b449895a7e2fc87e264ffe3 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-4e8b57654b449895a7e2fc87e264ffe3 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1730"^^xsd:integer .

	civic-kb:Gene-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C101559 ;
		rdf:type	uniprot:O00141 ;
		rdfs:label	"SGK1 Gene"^^xsd:string ;
		sio:hasValue	"SGK1"^^xsd:string .

	civic-kb:Variant-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-4e8b57654b449895a7e2fc87e264ffe3 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A group of 18 breast cancer patients were treated with PI3Kalpha inhibitor alpelisib plus an aromatase inhbitor (NCT01870505). 3 out of 3 patients expressing high tumor SGK1 mRNA had disease progression as best response with median progression free survival (PFS) of 56 days, while 15 patients classified with low to medium SGK1 mRNA had median PFS 111 days with 4/15 having disease progression as best response."^^xsd:string .

	civic-kb:Disease-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4e8b57654b449895a7e2fc87e264ffe3 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-4e8b57654b449895a7e2fc87e264ffe3 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4e8b57654b449895a7e2fc87e264ffe3 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4e8b57654b449895a7e2fc87e264ffe3 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-4e8b57654b449895a7e2fc87e264ffe3 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-4e8b57654b449895a7e2fc87e264ffe3 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-4e8b57654b449895a7e2fc87e264ffe3	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-4e8b57654b449895a7e2fc87e264ffe3 .

}

civic-kb:provenance-4e8b57654b449895a7e2fc87e264ffe3 {
	civic-kb:assertion-4e8b57654b449895a7e2fc87e264ffe3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-4e8b57654b449895a7e2fc87e264ffe3 .

	civic-kb:Status-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-4e8b57654b449895a7e2fc87e264ffe3	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-4e8b57654b449895a7e2fc87e264ffe3 {
	civic-kb:nanoPub-4e8b57654b449895a7e2fc87e264ffe3 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-4e8b57654b449895a7e2fc87e264ffe3
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-b1d674685ce0667fee9458d95e106e16 {
	civic-kb:nanoPub-b1d674685ce0667fee9458d95e106e16
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-b1d674685ce0667fee9458d95e106e16 ;
		np:hasProvenance civic-kb:provenance-b1d674685ce0667fee9458d95e106e16 ;
		np:hasPublicationInfo civic-kb:pubInfo-b1d674685ce0667fee9458d95e106e16 .
}

civic-kb:assertion-b1d674685ce0667fee9458d95e106e16 {
	civic-kb:Drugs-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b1d674685ce0667fee9458d95e106e16 ;
		rdf:type	db:DB12015 ;
		rdfs:label	"Alpelisib"^^xsd:string ;
		sio:hasValue	"Alpelisib (NVP-BYL719)"^^xsd:string .

	civic-kb:Status-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-b1d674685ce0667fee9458d95e106e16 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-b1d674685ce0667fee9458d95e106e16 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1729"^^xsd:integer .

	civic-kb:Gene-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C101559 ;
		rdf:type	uniprot:O00141 ;
		rdfs:label	"SGK1 Gene"^^xsd:string ;
		sio:hasValue	"SGK1"^^xsd:string .

	civic-kb:Variant-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-b1d674685ce0667fee9458d95e106e16 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"SGK1 mRNA expression was elevated in five breast cancer cell lines which were resistant to PI3Kalpha inhibitor alpelisib in comparison to five sensitive cell lines. Western blots showed clear elevation of protein levels in 3/5 resistant cell lines. Ectopic SGK1 expression in sensitive MDA-MB-361 cells resulted in alpelisib resistance and preservation of phopho-S6K and phospho-4EBP with alpelisib treatment. Knockdown of SGK1 in resistant HCC1954 cells increased alpelisib sensitivity and reduced p-S6K and p-4EBP levels with alpelisib treatment. Promoter methylation at SGK1 was increased in sensitive cells compared to alpelisib resistant cell lines."^^xsd:string .

	civic-kb:Disease-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b1d674685ce0667fee9458d95e106e16 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-b1d674685ce0667fee9458d95e106e16 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b1d674685ce0667fee9458d95e106e16 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b1d674685ce0667fee9458d95e106e16 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-b1d674685ce0667fee9458d95e106e16 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-b1d674685ce0667fee9458d95e106e16 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-b1d674685ce0667fee9458d95e106e16	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-b1d674685ce0667fee9458d95e106e16 .

}

civic-kb:provenance-b1d674685ce0667fee9458d95e106e16 {
	civic-kb:assertion-b1d674685ce0667fee9458d95e106e16 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-b1d674685ce0667fee9458d95e106e16 .

	civic-kb:Status-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-b1d674685ce0667fee9458d95e106e16	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-b1d674685ce0667fee9458d95e106e16 {
	civic-kb:nanoPub-b1d674685ce0667fee9458d95e106e16 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-b1d674685ce0667fee9458d95e106e16
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c29c718f800127564a21f11f85407f54 {
	civic-kb:nanoPub-c29c718f800127564a21f11f85407f54
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c29c718f800127564a21f11f85407f54 ;
		np:hasProvenance civic-kb:provenance-c29c718f800127564a21f11f85407f54 ;
		np:hasPublicationInfo civic-kb:pubInfo-c29c718f800127564a21f11f85407f54 .
}

civic-kb:assertion-c29c718f800127564a21f11f85407f54 {
	civic-kb:Drugs-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c29c718f800127564a21f11f85407f54 ;
		sio:hasValue	"BYL719 (Alpelisib), SGK1-Inh"^^xsd:string .

	civic-kb:Status-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c29c718f800127564a21f11f85407f54 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c29c718f800127564a21f11f85407f54 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1731"^^xsd:integer .

	civic-kb:Gene-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C101559 ;
		rdf:type	uniprot:O00141 ;
		rdfs:label	"SGK1 Gene"^^xsd:string ;
		sio:hasValue	"SGK1"^^xsd:string .

	civic-kb:Variant-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c29c718f800127564a21f11f85407f54 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The alpelisib (PI3Kalpha inhibitor) resistant breast cancer cell line HCC1954 was treated with alpelsisb alone or in combination with the SGK1 kinase inhibitor SGK1-Inh. Addition of SGK1 reduced viability over alpelisib alone, and phospho-S6K as well as phospho-4EBP1 levels decreased with combination treatment. HCC1954 xenografts showed increased tumor volume with treatment of alpelisib or SGK1-Inh alone, but only combination treatment resulted in lack of volume increase and decreased phospho-S6K levels in tumors by IHC."^^xsd:string .

	civic-kb:Disease-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c29c718f800127564a21f11f85407f54 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c29c718f800127564a21f11f85407f54 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c29c718f800127564a21f11f85407f54 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c29c718f800127564a21f11f85407f54 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c29c718f800127564a21f11f85407f54 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c29c718f800127564a21f11f85407f54 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-c29c718f800127564a21f11f85407f54	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c29c718f800127564a21f11f85407f54 .

}

civic-kb:provenance-c29c718f800127564a21f11f85407f54 {
	civic-kb:assertion-c29c718f800127564a21f11f85407f54 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c29c718f800127564a21f11f85407f54 .

	civic-kb:Status-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-c29c718f800127564a21f11f85407f54	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c29c718f800127564a21f11f85407f54 {
	civic-kb:nanoPub-c29c718f800127564a21f11f85407f54 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c29c718f800127564a21f11f85407f54
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c72fb8cc679eeee1d76599f107a97fce {
	civic-kb:nanoPub-c72fb8cc679eeee1d76599f107a97fce
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c72fb8cc679eeee1d76599f107a97fce ;
		np:hasProvenance civic-kb:provenance-c72fb8cc679eeee1d76599f107a97fce ;
		np:hasPublicationInfo civic-kb:pubInfo-c72fb8cc679eeee1d76599f107a97fce .
}

civic-kb:assertion-c72fb8cc679eeee1d76599f107a97fce {
	civic-kb:Drugs-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c72fb8cc679eeee1d76599f107a97fce .

	civic-kb:Status-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c72fb8cc679eeee1d76599f107a97fce ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c72fb8cc679eeee1d76599f107a97fce ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1758"^^xsd:integer .

	civic-kb:Gene-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18120 ;
		rdf:type	uniprot:P51587 ;
		rdfs:label	"BRCA2 Gene"^^xsd:string ;
		sio:hasValue	"BRCA2"^^xsd:string .

	civic-kb:Variant-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"TRUNCATING MUTATION"^^xsd:string .

	civic-kb:Description-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c72fb8cc679eeee1d76599f107a97fce ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"De novo Alu element insertions were identified within the BRCA2 coding sequences in 3 out of 50 Portuguese families. However, the segregation data and mRNA results in this study were conflicting or inconclusive."^^xsd:string .

	civic-kb:Disease-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c72fb8cc679eeee1d76599f107a97fce ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c72fb8cc679eeee1d76599f107a97fce ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c72fb8cc679eeee1d76599f107a97fce ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predisposing"^^xsd:string .

	civic-kb:Evidence_Direction-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c72fb8cc679eeee1d76599f107a97fce ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Uncertain Significance"^^xsd:string .

	civic-kb:Variant_Origin-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c72fb8cc679eeee1d76599f107a97fce ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c72fb8cc679eeee1d76599f107a97fce ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"1"^^xsd:integer .

	civic-kb:evidence-c72fb8cc679eeee1d76599f107a97fce	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c72fb8cc679eeee1d76599f107a97fce .

}

civic-kb:provenance-c72fb8cc679eeee1d76599f107a97fce {
	civic-kb:assertion-c72fb8cc679eeee1d76599f107a97fce prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c72fb8cc679eeee1d76599f107a97fce .

	civic-kb:Status-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-c72fb8cc679eeee1d76599f107a97fce	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c72fb8cc679eeee1d76599f107a97fce {
	civic-kb:nanoPub-c72fb8cc679eeee1d76599f107a97fce prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c72fb8cc679eeee1d76599f107a97fce
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8c1c3f1bb070175bb38655dd29b76368 {
	civic-kb:nanoPub-8c1c3f1bb070175bb38655dd29b76368
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8c1c3f1bb070175bb38655dd29b76368 ;
		np:hasProvenance civic-kb:provenance-8c1c3f1bb070175bb38655dd29b76368 ;
		np:hasPublicationInfo civic-kb:pubInfo-8c1c3f1bb070175bb38655dd29b76368 .
}

civic-kb:assertion-8c1c3f1bb070175bb38655dd29b76368 {
	civic-kb:Drugs-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8c1c3f1bb070175bb38655dd29b76368 .

	civic-kb:Status-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8c1c3f1bb070175bb38655dd29b76368 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8c1c3f1bb070175bb38655dd29b76368 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1759"^^xsd:integer .

	civic-kb:Gene-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17965 ;
		rdf:type	uniprot:P38398 ;
		rdfs:label	"BRCA1 Gene"^^xsd:string ;
		sio:hasValue	"BRCA1"^^xsd:string .

	civic-kb:Variant-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Alu insertion"^^xsd:string .

	civic-kb:Description-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8c1c3f1bb070175bb38655dd29b76368 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a Portuguese family with 6 cases of breast cancer and 1 of ovarian cancer, a 46 year old woman was diagnosed with breast cancer. She was negative for BRCA1/2 mutations using standard methods but a Southern blot identified a ~350bp Alu element (AluYa5 subtype) insertion in exon 3. RT-PCR revealed exon 3 was excluded from the spliced transcript in this patient. Blood samples from 24 family members were collected and the Alu element was identified in the 3 with ovarian or breast cancer that had evaluable samples."^^xsd:string .

	civic-kb:Disease-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8c1c3f1bb070175bb38655dd29b76368 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8c1c3f1bb070175bb38655dd29b76368 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8c1c3f1bb070175bb38655dd29b76368 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predisposing"^^xsd:string .

	civic-kb:Evidence_Direction-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8c1c3f1bb070175bb38655dd29b76368 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Likely Pathogenic"^^xsd:string .

	civic-kb:Variant_Origin-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8c1c3f1bb070175bb38655dd29b76368 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8c1c3f1bb070175bb38655dd29b76368 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-8c1c3f1bb070175bb38655dd29b76368	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8c1c3f1bb070175bb38655dd29b76368 .

}

civic-kb:provenance-8c1c3f1bb070175bb38655dd29b76368 {
	civic-kb:assertion-8c1c3f1bb070175bb38655dd29b76368 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8c1c3f1bb070175bb38655dd29b76368 .

	civic-kb:Status-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-8c1c3f1bb070175bb38655dd29b76368	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8c1c3f1bb070175bb38655dd29b76368 {
	civic-kb:nanoPub-8c1c3f1bb070175bb38655dd29b76368 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8c1c3f1bb070175bb38655dd29b76368
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-fa08e59db879ae9b6a8bdaf62ffc44f2 {
	civic-kb:nanoPub-fa08e59db879ae9b6a8bdaf62ffc44f2
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-fa08e59db879ae9b6a8bdaf62ffc44f2 ;
		np:hasProvenance civic-kb:provenance-fa08e59db879ae9b6a8bdaf62ffc44f2 ;
		np:hasPublicationInfo civic-kb:pubInfo-fa08e59db879ae9b6a8bdaf62ffc44f2 .
}

civic-kb:assertion-fa08e59db879ae9b6a8bdaf62ffc44f2 {
	civic-kb:Drugs-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fa08e59db879ae9b6a8bdaf62ffc44f2 .

	civic-kb:Status-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-fa08e59db879ae9b6a8bdaf62ffc44f2 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-fa08e59db879ae9b6a8bdaf62ffc44f2 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1761"^^xsd:integer .

	civic-kb:Gene-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C95286 ;
		rdf:type	uniprot:B2CW77 ;
		rdfs:label	"KLLN Gene"^^xsd:string ;
		sio:hasValue	"KLLN"^^xsd:string .

	civic-kb:Variant-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"PROMOTER METHYLATION"^^xsd:string .

	civic-kb:Description-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-fa08e59db879ae9b6a8bdaf62ffc44f2 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"123 patients with Cowden or Cowden-like syndrome (from the IRB8458-PTEN series) and 50 unaffected individuals without PTEN variants were analyzed for germline methylation and expression of PTEN and KILLIN. 45 out of 123 patients (37%; 95% CI, 29%-45%) showed hypermethylation of the bidirectional promoter of PTEN and KILLIN. Individuals with KILLIN-promoter methylation had a 3-fold increased prevalence of breast cancer (35/42 vs 24/64; p<0.0001) over individuals with germline PTEN mutations."^^xsd:string .

	civic-kb:Disease-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fa08e59db879ae9b6a8bdaf62ffc44f2 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-fa08e59db879ae9b6a8bdaf62ffc44f2 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fa08e59db879ae9b6a8bdaf62ffc44f2 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predisposing"^^xsd:string .

	civic-kb:Evidence_Direction-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fa08e59db879ae9b6a8bdaf62ffc44f2 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Positive"^^xsd:string .

	civic-kb:Variant_Origin-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-fa08e59db879ae9b6a8bdaf62ffc44f2 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-fa08e59db879ae9b6a8bdaf62ffc44f2 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-fa08e59db879ae9b6a8bdaf62ffc44f2	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-fa08e59db879ae9b6a8bdaf62ffc44f2 .

}

civic-kb:provenance-fa08e59db879ae9b6a8bdaf62ffc44f2 {
	civic-kb:assertion-fa08e59db879ae9b6a8bdaf62ffc44f2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-fa08e59db879ae9b6a8bdaf62ffc44f2 .

	civic-kb:Status-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-fa08e59db879ae9b6a8bdaf62ffc44f2	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-fa08e59db879ae9b6a8bdaf62ffc44f2 {
	civic-kb:nanoPub-fa08e59db879ae9b6a8bdaf62ffc44f2 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-fa08e59db879ae9b6a8bdaf62ffc44f2
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f50f34e80be7bd48860ad6a0ca2f4447 {
	civic-kb:nanoPub-f50f34e80be7bd48860ad6a0ca2f4447
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f50f34e80be7bd48860ad6a0ca2f4447 ;
		np:hasProvenance civic-kb:provenance-f50f34e80be7bd48860ad6a0ca2f4447 ;
		np:hasPublicationInfo civic-kb:pubInfo-f50f34e80be7bd48860ad6a0ca2f4447 .
}

civic-kb:assertion-f50f34e80be7bd48860ad6a0ca2f4447 {
	civic-kb:Drugs-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f50f34e80be7bd48860ad6a0ca2f4447 .

	civic-kb:Status-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f50f34e80be7bd48860ad6a0ca2f4447 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f50f34e80be7bd48860ad6a0ca2f4447 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1784"^^xsd:integer .

	civic-kb:Gene-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C26517 ;
		rdf:type	uniprot:P10635 ;
		rdfs:label	"CYP2D6 Gene"^^xsd:string ;
		sio:hasValue	"CYP2D6"^^xsd:string .

	civic-kb:Variant-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Loss of Function"^^xsd:string ;
		sio:hasValue	"LOSS-OF-FUNCTION"^^xsd:string .

	civic-kb:Description-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f50f34e80be7bd48860ad6a0ca2f4447 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Meta-analysis of 25 studies involving 13,629 women with tamoxifen treated breast cancer. The meta-analysis investigated the association between CYP2D6 genotypes and response to tamoxifen treatment (loss/reduced function vs. unchanged/increased function). The authors examine a prevailing hypothesis that individuals carrying a reduced function CYP2D6 allele have poorer outcomes due to less metabolism of tamoxifen to active metabolites. The study concludes that there is insufficient evidence to support use of CYP2D6 genotyping as a guide for tamoxifen use in breast cancer."^^xsd:string .

	civic-kb:Disease-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f50f34e80be7bd48860ad6a0ca2f4447 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f50f34e80be7bd48860ad6a0ca2f4447 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f50f34e80be7bd48860ad6a0ca2f4447 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f50f34e80be7bd48860ad6a0ca2f4447 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f50f34e80be7bd48860ad6a0ca2f4447 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Polymorphism"^^xsd:string .

	civic-kb:Trust_Rating-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f50f34e80be7bd48860ad6a0ca2f4447 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-f50f34e80be7bd48860ad6a0ca2f4447	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f50f34e80be7bd48860ad6a0ca2f4447 .

}

civic-kb:provenance-f50f34e80be7bd48860ad6a0ca2f4447 {
	civic-kb:assertion-f50f34e80be7bd48860ad6a0ca2f4447 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f50f34e80be7bd48860ad6a0ca2f4447 .

	civic-kb:Status-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-f50f34e80be7bd48860ad6a0ca2f4447	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f50f34e80be7bd48860ad6a0ca2f4447 {
	civic-kb:nanoPub-f50f34e80be7bd48860ad6a0ca2f4447 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f50f34e80be7bd48860ad6a0ca2f4447
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c47c41b5935fc5a1891f426b515c77ac {
	civic-kb:nanoPub-c47c41b5935fc5a1891f426b515c77ac
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c47c41b5935fc5a1891f426b515c77ac ;
		np:hasProvenance civic-kb:provenance-c47c41b5935fc5a1891f426b515c77ac ;
		np:hasPublicationInfo civic-kb:pubInfo-c47c41b5935fc5a1891f426b515c77ac .
}

civic-kb:assertion-c47c41b5935fc5a1891f426b515c77ac {
	civic-kb:Drugs-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c47c41b5935fc5a1891f426b515c77ac ;
		rdf:type	db:DB04468 ;
		rdfs:label	"Afimoxifene"^^xsd:string ;
		sio:hasValue	"4-hydroxytamoxifen"^^xsd:string .

	civic-kb:Status-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c47c41b5935fc5a1891f426b515c77ac ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c47c41b5935fc5a1891f426b515c77ac ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1105"^^xsd:integer .

	civic-kb:Gene-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C19929 ;
		rdf:type	uniprot:P11362 ;
		rdfs:label	"FGFR1 Gene"^^xsd:string ;
		sio:hasValue	"FGFR1"^^xsd:string .

	civic-kb:Variant-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c47c41b5935fc5a1891f426b515c77ac ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"FGFR1-amplified breast cancer cell lines show resistance to 4-hydroxytamoxifen, which is reversed by small interfering RNA silencing of FGFR1."^^xsd:string .

	civic-kb:Disease-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c47c41b5935fc5a1891f426b515c77ac ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c47c41b5935fc5a1891f426b515c77ac ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c47c41b5935fc5a1891f426b515c77ac ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c47c41b5935fc5a1891f426b515c77ac ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c47c41b5935fc5a1891f426b515c77ac ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c47c41b5935fc5a1891f426b515c77ac ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-c47c41b5935fc5a1891f426b515c77ac	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c47c41b5935fc5a1891f426b515c77ac .

}

civic-kb:provenance-c47c41b5935fc5a1891f426b515c77ac {
	civic-kb:assertion-c47c41b5935fc5a1891f426b515c77ac prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c47c41b5935fc5a1891f426b515c77ac .

	civic-kb:Status-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-c47c41b5935fc5a1891f426b515c77ac	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c47c41b5935fc5a1891f426b515c77ac {
	civic-kb:nanoPub-c47c41b5935fc5a1891f426b515c77ac prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c47c41b5935fc5a1891f426b515c77ac
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-33ed9719ff71f76933a5e731164cb458 {
	civic-kb:nanoPub-33ed9719ff71f76933a5e731164cb458
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-33ed9719ff71f76933a5e731164cb458 ;
		np:hasProvenance civic-kb:provenance-33ed9719ff71f76933a5e731164cb458 ;
		np:hasPublicationInfo civic-kb:pubInfo-33ed9719ff71f76933a5e731164cb458 .
}

civic-kb:assertion-33ed9719ff71f76933a5e731164cb458 {
	civic-kb:Drugs-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-33ed9719ff71f76933a5e731164cb458 ;
		rdf:type	db:DB05928 ;
		rdfs:label	"Dovitinib"^^xsd:string ;
		sio:hasValue	"Dovitinib"^^xsd:string .

	civic-kb:Status-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-33ed9719ff71f76933a5e731164cb458 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-33ed9719ff71f76933a5e731164cb458 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1604"^^xsd:integer .

	civic-kb:Gene-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C19929 ;
		rdf:type	uniprot:P11362 ;
		rdfs:label	"FGFR1 Gene"^^xsd:string ;
		sio:hasValue	"FGFR1"^^xsd:string .

	civic-kb:Variant-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-33ed9719ff71f76933a5e731164cb458 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Dovitinib was evaluated in-vitro, in xenograft and in a phase 2 study.
Dovitinib inhibited proliferation in one FGFR1- and one FGFR2-amplified breast cancer cell lines at higher IC50 values than in 11 nonamplified cell lines. Dovitinib inhibited tumor growth and caused regression in both a FGFR1- and FGFR2-amplified xenograft model.
81 patients were enrolled in the trial and treated with dovitinib. Unconfirmed response or stable disease >6 months was observed in 25% of FGFR1-amplified/HR-positive vs. 3% FGFR1-nonamplified/HR-positive breast cancer patientes. When FGF3 and FGFR2 amplifications were also assessed, a combined FGF-pathway amplified patient group had a higher mean reduction in target lesion size than patients with FGF-non-amplified tumors."^^xsd:string .

	civic-kb:Disease-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-33ed9719ff71f76933a5e731164cb458 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-33ed9719ff71f76933a5e731164cb458 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-33ed9719ff71f76933a5e731164cb458 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-33ed9719ff71f76933a5e731164cb458 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-33ed9719ff71f76933a5e731164cb458 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-33ed9719ff71f76933a5e731164cb458 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-33ed9719ff71f76933a5e731164cb458	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-33ed9719ff71f76933a5e731164cb458 .

}

civic-kb:provenance-33ed9719ff71f76933a5e731164cb458 {
	civic-kb:assertion-33ed9719ff71f76933a5e731164cb458 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-33ed9719ff71f76933a5e731164cb458 .

	civic-kb:Status-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-33ed9719ff71f76933a5e731164cb458	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-33ed9719ff71f76933a5e731164cb458 {
	civic-kb:nanoPub-33ed9719ff71f76933a5e731164cb458 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-33ed9719ff71f76933a5e731164cb458
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-41535455c64c8345d2744030a655cac6 {
	civic-kb:nanoPub-41535455c64c8345d2744030a655cac6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-41535455c64c8345d2744030a655cac6 ;
		np:hasProvenance civic-kb:provenance-41535455c64c8345d2744030a655cac6 ;
		np:hasPublicationInfo civic-kb:pubInfo-41535455c64c8345d2744030a655cac6 .
}

civic-kb:assertion-41535455c64c8345d2744030a655cac6 {
	civic-kb:Drugs-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-41535455c64c8345d2744030a655cac6 ;
		rdf:type	db:DB08901 ;
		rdfs:label	"Ponatinib"^^xsd:string ;
		sio:hasValue	"Ponatinib"^^xsd:string .

	civic-kb:Status-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-41535455c64c8345d2744030a655cac6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-41535455c64c8345d2744030a655cac6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1767"^^xsd:integer .

	civic-kb:Gene-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C19929 ;
		rdf:type	uniprot:P11362 ;
		rdfs:label	"FGFR1 Gene"^^xsd:string ;
		sio:hasValue	"FGFR1"^^xsd:string .

	civic-kb:Variant-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-41535455c64c8345d2744030a655cac6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In MDA-MB-134 cells (ER-positive breast cancer cells with amplified FGFR1) ponatinib potently inhibited cell growth with a GI50 value of 23 nmol/L and inhibited FGFR1 phosphorylation with an IC50 value of 7 nmol/L."^^xsd:string .

	civic-kb:Disease-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-41535455c64c8345d2744030a655cac6 ;
		rdf:type	efo:1000649 ;
		rdf:type	doid:0060075 ;
		rdfs:label	"Estrogen-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-41535455c64c8345d2744030a655cac6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-41535455c64c8345d2744030a655cac6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-41535455c64c8345d2744030a655cac6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-41535455c64c8345d2744030a655cac6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-41535455c64c8345d2744030a655cac6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-41535455c64c8345d2744030a655cac6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-41535455c64c8345d2744030a655cac6 .

}

civic-kb:provenance-41535455c64c8345d2744030a655cac6 {
	civic-kb:assertion-41535455c64c8345d2744030a655cac6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-41535455c64c8345d2744030a655cac6 .

	civic-kb:Status-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-41535455c64c8345d2744030a655cac6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-41535455c64c8345d2744030a655cac6 {
	civic-kb:nanoPub-41535455c64c8345d2744030a655cac6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-41535455c64c8345d2744030a655cac6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d3eaf2c72860571f1ee6841af3b53b2d {
	civic-kb:nanoPub-d3eaf2c72860571f1ee6841af3b53b2d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d3eaf2c72860571f1ee6841af3b53b2d ;
		np:hasProvenance civic-kb:provenance-d3eaf2c72860571f1ee6841af3b53b2d ;
		np:hasPublicationInfo civic-kb:pubInfo-d3eaf2c72860571f1ee6841af3b53b2d .
}

civic-kb:assertion-d3eaf2c72860571f1ee6841af3b53b2d {
	civic-kb:Drugs-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d3eaf2c72860571f1ee6841af3b53b2d ;
		rdf:type	db:DB12247 ;
		rdfs:label	"AZD-4547"^^xsd:string ;
		sio:hasValue	"AZD4547"^^xsd:string .

	civic-kb:Status-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d3eaf2c72860571f1ee6841af3b53b2d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d3eaf2c72860571f1ee6841af3b53b2d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1991"^^xsd:integer .

	civic-kb:Gene-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C19929 ;
		rdf:type	uniprot:P11362 ;
		rdfs:label	"FGFR1 Gene"^^xsd:string ;
		sio:hasValue	"FGFR1"^^xsd:string .

	civic-kb:Variant-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d3eaf2c72860571f1ee6841af3b53b2d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Activity of the FGFR-selective inhibitor AZD4547 in FGFR1-amplified breast cancer and FGFR2-amplified gastroesophageal cancer was analyzed in this study. 341 patients with advanced cancer were screened by FISH, identifying FGFR1 amplification in 18% of advanced HER2-negative breast cancers and FGFR2 amplification in 9% of advanced gastroesophageal cancer. 1 patient had a confirmed response among 8 patients treated with FGFR1-amplified breast cancer. In a preclinical model, FGFR1 amplification in breast cancer cell lines was less pronounced than FGFR2-amplifications in gastroesophageal cancers, which also had a higher response rate in the trial, indicating that high level amplification is associated with response and less common in FGFR1-amplified breast cancer."^^xsd:string .

	civic-kb:Disease-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d3eaf2c72860571f1ee6841af3b53b2d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d3eaf2c72860571f1ee6841af3b53b2d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d3eaf2c72860571f1ee6841af3b53b2d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d3eaf2c72860571f1ee6841af3b53b2d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d3eaf2c72860571f1ee6841af3b53b2d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d3eaf2c72860571f1ee6841af3b53b2d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-d3eaf2c72860571f1ee6841af3b53b2d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d3eaf2c72860571f1ee6841af3b53b2d .

}

civic-kb:provenance-d3eaf2c72860571f1ee6841af3b53b2d {
	civic-kb:assertion-d3eaf2c72860571f1ee6841af3b53b2d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d3eaf2c72860571f1ee6841af3b53b2d .

	civic-kb:Status-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-d3eaf2c72860571f1ee6841af3b53b2d	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d3eaf2c72860571f1ee6841af3b53b2d {
	civic-kb:nanoPub-d3eaf2c72860571f1ee6841af3b53b2d prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d3eaf2c72860571f1ee6841af3b53b2d
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f9bd3aac878f58e2005fde68379d99f6 {
	civic-kb:nanoPub-f9bd3aac878f58e2005fde68379d99f6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f9bd3aac878f58e2005fde68379d99f6 ;
		np:hasProvenance civic-kb:provenance-f9bd3aac878f58e2005fde68379d99f6 ;
		np:hasPublicationInfo civic-kb:pubInfo-f9bd3aac878f58e2005fde68379d99f6 .
}

civic-kb:assertion-f9bd3aac878f58e2005fde68379d99f6 {
	civic-kb:Drugs-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f9bd3aac878f58e2005fde68379d99f6 ;
		rdfs:label	"BGJ-398"^^xsd:string ;
		sio:hasValue	"BGJ-398"^^xsd:string .

	civic-kb:Status-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f9bd3aac878f58e2005fde68379d99f6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f9bd3aac878f58e2005fde68379d99f6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1909"^^xsd:integer .

	civic-kb:Gene-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C19929 ;
		rdf:type	uniprot:P11362 ;
		rdfs:label	"FGFR1 Gene"^^xsd:string ;
		sio:hasValue	"FGFR1"^^xsd:string .

	civic-kb:Variant-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C45581 ;
		rdfs:label	"Amplification"^^xsd:string ;
		sio:hasValue	"AMPLIFICATION"^^xsd:string .

	civic-kb:Description-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f9bd3aac878f58e2005fde68379d99f6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Phase 1 study of FGFR-inhibitor BGJ398 in advanced cancer with FGFR-aberrations. Among the 26 patients with breast cancer and FGFR1/2 amplification (n=25,  n= 21 with FGFR1 amplification only) or FGFR3 mutation (n=1) four (15.4%) had a reduced tumor burden. In total, 10 of 32 patients with breast cancer treated at doses >100mg had a best response of SD."^^xsd:string .

	civic-kb:Disease-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f9bd3aac878f58e2005fde68379d99f6 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f9bd3aac878f58e2005fde68379d99f6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f9bd3aac878f58e2005fde68379d99f6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f9bd3aac878f58e2005fde68379d99f6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f9bd3aac878f58e2005fde68379d99f6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f9bd3aac878f58e2005fde68379d99f6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-f9bd3aac878f58e2005fde68379d99f6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f9bd3aac878f58e2005fde68379d99f6 .

}

civic-kb:provenance-f9bd3aac878f58e2005fde68379d99f6 {
	civic-kb:assertion-f9bd3aac878f58e2005fde68379d99f6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f9bd3aac878f58e2005fde68379d99f6 .

	civic-kb:Status-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Description-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Disease-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:evidence-f9bd3aac878f58e2005fde68379d99f6	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f9bd3aac878f58e2005fde68379d99f6 {
	civic-kb:nanoPub-f9bd3aac878f58e2005fde68379d99f6 prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime .

	civic-kb:Drugs-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f9bd3aac878f58e2005fde68379d99f6
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-73b2a0ceb354711ac64627d9314b3e71 {
	civic-kb:nanoPub-73b2a0ceb354711ac64627d9314b3e71
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-73b2a0ceb354711ac64627d9314b3e71 ;
		np:hasProvenance civic-kb:provenance-73b2a0ceb354711ac64627d9314b3e71 ;
		np:hasPublicationInfo civic-kb:pubInfo-73b2a0ceb354711ac64627d9314b3e71 .
}

civic-kb:assertion-73b2a0ceb354711ac64627d9314b3e71 {
	civic-kb:Drugs-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-73b2a0ceb354711ac64627d9314b3e71 ;
		rdf:type	db:DB11986 ;
		rdfs:label	"Entrectinib"^^xsd:string ;
		sio:hasValue	"Entrectinib"^^xsd:string .

	civic-kb:Status-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-73b2a0ceb354711ac64627d9314b3e71 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-73b2a0ceb354711ac64627d9314b3e71 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1874"^^xsd:integer .

	civic-kb:Gene-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C24647 ;
		rdf:type	uniprot:Q16288 ;
		rdfs:label	"NTRK3 Gene"^^xsd:string ;
		sio:hasValue	"NTRK3"^^xsd:string .

	civic-kb:Variant-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"ETV6-NTRK3 G623R"^^xsd:string .

	civic-kb:Description-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-73b2a0ceb354711ac64627d9314b3e71 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Case report of a patient with mammary analogue secretory carcinoma (MASC) harboring an etv6-ntrk3 fusion. The patient was treated with entrectinib and exhibited a partial response for 7 months followed by disease progression.  A NTRK3 exon 16 G623R (c.1867G>A) mutation was identified in the progressive tumor. Cell line and structural models revealed that this mutation conferred relative resistance to entrectinib."^^xsd:string .

	civic-kb:Disease-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-73b2a0ceb354711ac64627d9314b3e71 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-73b2a0ceb354711ac64627d9314b3e71 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-73b2a0ceb354711ac64627d9314b3e71 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-73b2a0ceb354711ac64627d9314b3e71 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-73b2a0ceb354711ac64627d9314b3e71 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-73b2a0ceb354711ac64627d9314b3e71 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-73b2a0ceb354711ac64627d9314b3e71	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-73b2a0ceb354711ac64627d9314b3e71 .

}

civic-kb:provenance-73b2a0ceb354711ac64627d9314b3e71 {
	civic-kb:assertion-73b2a0ceb354711ac64627d9314b3e71 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-73b2a0ceb354711ac64627d9314b3e71 .

	civic-kb:Status-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Gene-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:32Z"^^xsd:dateTime  .

	civic-kb:Variant-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-73b2a0ceb354711ac64627d9314b3e71	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-73b2a0ceb354711ac64627d9314b3e71 {
	civic-kb:nanoPub-73b2a0ceb354711ac64627d9314b3e71 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:32Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-73b2a0ceb354711ac64627d9314b3e71
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8367b20677a41a66d33e8c8c84261a5a {
	civic-kb:nanoPub-8367b20677a41a66d33e8c8c84261a5a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8367b20677a41a66d33e8c8c84261a5a ;
		np:hasProvenance civic-kb:provenance-8367b20677a41a66d33e8c8c84261a5a ;
		np:hasPublicationInfo civic-kb:pubInfo-8367b20677a41a66d33e8c8c84261a5a .
}

civic-kb:assertion-8367b20677a41a66d33e8c8c84261a5a {
	civic-kb:Drugs-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8367b20677a41a66d33e8c8c84261a5a ;
		rdf:type	dron:00730818 ;
		rdf:type	db:DB05773 ;
		rdfs:label	"Ado-trastuzumab Emtansine"^^xsd:string ;
		sio:hasValue	"Ado-trastuzumab Emtansine"^^xsd:string .

	civic-kb:Status-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8367b20677a41a66d33e8c8c84261a5a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8367b20677a41a66d33e8c8c84261a5a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4840"^^xsd:integer .

	civic-kb:Gene-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8367b20677a41a66d33e8c8c84261a5a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Trastuzumab emtansine has its indication for patients with HER2-positive metastatic breast cancer after therapy with Trastuzumab and Taxane, approval based on PFS and preliminary OS data. EMILIA was a randomised open-label, phase III study for patients with HER2-positive, unresectable, locally advanced, or metastatic breast cancer previously treated with Trastuzumab and a Taxane, randomized 1:1 to Trastuzumab-emtansine or Capecitabine plus Lapatinib. 991 patients were enrolled. Median OS was 29.9m vs. 25.9m. Fewer grade 3 or worse AE occurred with trastuzumab emtansine than with capecitabine plus lapatinib control treatment."^^xsd:string .

	civic-kb:Disease-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8367b20677a41a66d33e8c8c84261a5a ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8367b20677a41a66d33e8c8c84261a5a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8367b20677a41a66d33e8c8c84261a5a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8367b20677a41a66d33e8c8c84261a5a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8367b20677a41a66d33e8c8c84261a5a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8367b20677a41a66d33e8c8c84261a5a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-8367b20677a41a66d33e8c8c84261a5a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8367b20677a41a66d33e8c8c84261a5a .

}

civic-kb:provenance-8367b20677a41a66d33e8c8c84261a5a {
	civic-kb:assertion-8367b20677a41a66d33e8c8c84261a5a prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8367b20677a41a66d33e8c8c84261a5a .

	civic-kb:Status-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-8367b20677a41a66d33e8c8c84261a5a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8367b20677a41a66d33e8c8c84261a5a {
	civic-kb:nanoPub-8367b20677a41a66d33e8c8c84261a5a prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8367b20677a41a66d33e8c8c84261a5a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-4201d4ceb6603103074c174dfaab4841 {
	civic-kb:nanoPub-4201d4ceb6603103074c174dfaab4841
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-4201d4ceb6603103074c174dfaab4841 ;
		np:hasProvenance civic-kb:provenance-4201d4ceb6603103074c174dfaab4841 ;
		np:hasPublicationInfo civic-kb:pubInfo-4201d4ceb6603103074c174dfaab4841 .
}

civic-kb:assertion-4201d4ceb6603103074c174dfaab4841 {
	civic-kb:Drugs-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4201d4ceb6603103074c174dfaab4841 ;
		rdf:type	chebi:46345 ;
		rdf:type	db:DB00544 ;
		rdfs:label	"Fluorouracil"^^xsd:string ;
		sio:hasValue	"5-Fluoropyrimidine"^^xsd:string .

	civic-kb:Status-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-4201d4ceb6603103074c174dfaab4841 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-4201d4ceb6603103074c174dfaab4841 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1980"^^xsd:integer .

	civic-kb:Gene-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C103994 ;
		rdf:type	uniprot:Q13126 ;
		rdfs:label	"MTAP Gene"^^xsd:string ;
		sio:hasValue	"MTAP"^^xsd:string .

	civic-kb:Variant-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"DELETION"^^xsd:string .

	civic-kb:Description-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-4201d4ceb6603103074c174dfaab4841 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MTAP and CDKN2A gene (RT-qPCR) and protein (western-blotting) expresison as well as promoter methylation status  was analyzed in breast cancer patients and seven breast cancer cell lines. Knockdown of MTAP in one cell line increased sensitivity to inhibitors of de novo adenine synthesis (5-FU, AZA and MTX), mainly 5-FU."^^xsd:string .

	civic-kb:Disease-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4201d4ceb6603103074c174dfaab4841 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-4201d4ceb6603103074c174dfaab4841 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4201d4ceb6603103074c174dfaab4841 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4201d4ceb6603103074c174dfaab4841 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-4201d4ceb6603103074c174dfaab4841 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-4201d4ceb6603103074c174dfaab4841 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"1"^^xsd:integer .

	civic-kb:evidence-4201d4ceb6603103074c174dfaab4841	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-4201d4ceb6603103074c174dfaab4841 .

}

civic-kb:provenance-4201d4ceb6603103074c174dfaab4841 {
	civic-kb:assertion-4201d4ceb6603103074c174dfaab4841 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-4201d4ceb6603103074c174dfaab4841 .

	civic-kb:Status-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-4201d4ceb6603103074c174dfaab4841	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-4201d4ceb6603103074c174dfaab4841 {
	civic-kb:nanoPub-4201d4ceb6603103074c174dfaab4841 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-4201d4ceb6603103074c174dfaab4841
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-50a9bc662c817991e56db53d7ffdc7c8 {
	civic-kb:nanoPub-50a9bc662c817991e56db53d7ffdc7c8
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-50a9bc662c817991e56db53d7ffdc7c8 ;
		np:hasProvenance civic-kb:provenance-50a9bc662c817991e56db53d7ffdc7c8 ;
		np:hasPublicationInfo civic-kb:pubInfo-50a9bc662c817991e56db53d7ffdc7c8 .
}

civic-kb:assertion-50a9bc662c817991e56db53d7ffdc7c8 {
	civic-kb:Drugs-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-50a9bc662c817991e56db53d7ffdc7c8 ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-50a9bc662c817991e56db53d7ffdc7c8 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-50a9bc662c817991e56db53d7ffdc7c8 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2041"^^xsd:integer .

	civic-kb:Gene-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545Q"^^xsd:string .

	civic-kb:Description-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-50a9bc662c817991e56db53d7ffdc7c8 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines (n=54, P=0.005)."^^xsd:string .

	civic-kb:Disease-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-50a9bc662c817991e56db53d7ffdc7c8 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-50a9bc662c817991e56db53d7ffdc7c8 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-50a9bc662c817991e56db53d7ffdc7c8 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-50a9bc662c817991e56db53d7ffdc7c8 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-50a9bc662c817991e56db53d7ffdc7c8 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-50a9bc662c817991e56db53d7ffdc7c8 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-50a9bc662c817991e56db53d7ffdc7c8	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-50a9bc662c817991e56db53d7ffdc7c8 .

}

civic-kb:provenance-50a9bc662c817991e56db53d7ffdc7c8 {
	civic-kb:assertion-50a9bc662c817991e56db53d7ffdc7c8 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-50a9bc662c817991e56db53d7ffdc7c8 .

	civic-kb:Status-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-50a9bc662c817991e56db53d7ffdc7c8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-50a9bc662c817991e56db53d7ffdc7c8 {
	civic-kb:nanoPub-50a9bc662c817991e56db53d7ffdc7c8 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-50a9bc662c817991e56db53d7ffdc7c8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-b30d6b60490a734a4a1f8561f2c224b7 {
	civic-kb:nanoPub-b30d6b60490a734a4a1f8561f2c224b7
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-b30d6b60490a734a4a1f8561f2c224b7 ;
		np:hasProvenance civic-kb:provenance-b30d6b60490a734a4a1f8561f2c224b7 ;
		np:hasPublicationInfo civic-kb:pubInfo-b30d6b60490a734a4a1f8561f2c224b7 .
}

civic-kb:assertion-b30d6b60490a734a4a1f8561f2c224b7 {
	civic-kb:Drugs-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b30d6b60490a734a4a1f8561f2c224b7 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-b30d6b60490a734a4a1f8561f2c224b7 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-b30d6b60490a734a4a1f8561f2c224b7 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2045"^^xsd:integer .

	civic-kb:Gene-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545Q"^^xsd:string .

	civic-kb:Description-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-b30d6b60490a734a4a1f8561f2c224b7 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines."^^xsd:string .

	civic-kb:Disease-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b30d6b60490a734a4a1f8561f2c224b7 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-b30d6b60490a734a4a1f8561f2c224b7 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b30d6b60490a734a4a1f8561f2c224b7 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b30d6b60490a734a4a1f8561f2c224b7 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-b30d6b60490a734a4a1f8561f2c224b7 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-b30d6b60490a734a4a1f8561f2c224b7 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-b30d6b60490a734a4a1f8561f2c224b7	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-b30d6b60490a734a4a1f8561f2c224b7 .

}

civic-kb:provenance-b30d6b60490a734a4a1f8561f2c224b7 {
	civic-kb:assertion-b30d6b60490a734a4a1f8561f2c224b7 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-b30d6b60490a734a4a1f8561f2c224b7 .

	civic-kb:Status-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-b30d6b60490a734a4a1f8561f2c224b7	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-b30d6b60490a734a4a1f8561f2c224b7 {
	civic-kb:nanoPub-b30d6b60490a734a4a1f8561f2c224b7 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-b30d6b60490a734a4a1f8561f2c224b7
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-9375fe061c735a5a1d38def257a999f4 {
	civic-kb:nanoPub-9375fe061c735a5a1d38def257a999f4
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-9375fe061c735a5a1d38def257a999f4 ;
		np:hasProvenance civic-kb:provenance-9375fe061c735a5a1d38def257a999f4 ;
		np:hasPublicationInfo civic-kb:pubInfo-9375fe061c735a5a1d38def257a999f4 .
}

civic-kb:assertion-9375fe061c735a5a1d38def257a999f4 {
	civic-kb:Drugs-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9375fe061c735a5a1d38def257a999f4 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-9375fe061c735a5a1d38def257a999f4 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-9375fe061c735a5a1d38def257a999f4 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2044"^^xsd:integer .

	civic-kb:Gene-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545Q"^^xsd:string .

	civic-kb:Description-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-9375fe061c735a5a1d38def257a999f4 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9375fe061c735a5a1d38def257a999f4 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-9375fe061c735a5a1d38def257a999f4 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9375fe061c735a5a1d38def257a999f4 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9375fe061c735a5a1d38def257a999f4 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-9375fe061c735a5a1d38def257a999f4 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-9375fe061c735a5a1d38def257a999f4 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-9375fe061c735a5a1d38def257a999f4	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-9375fe061c735a5a1d38def257a999f4 .

}

civic-kb:provenance-9375fe061c735a5a1d38def257a999f4 {
	civic-kb:assertion-9375fe061c735a5a1d38def257a999f4 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-9375fe061c735a5a1d38def257a999f4 .

	civic-kb:Status-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-9375fe061c735a5a1d38def257a999f4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-9375fe061c735a5a1d38def257a999f4 {
	civic-kb:nanoPub-9375fe061c735a5a1d38def257a999f4 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-9375fe061c735a5a1d38def257a999f4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-a1f900ac5ea008f2654c33cadc1cdab8 {
	civic-kb:nanoPub-a1f900ac5ea008f2654c33cadc1cdab8
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-a1f900ac5ea008f2654c33cadc1cdab8 ;
		np:hasProvenance civic-kb:provenance-a1f900ac5ea008f2654c33cadc1cdab8 ;
		np:hasPublicationInfo civic-kb:pubInfo-a1f900ac5ea008f2654c33cadc1cdab8 .
}

civic-kb:assertion-a1f900ac5ea008f2654c33cadc1cdab8 {
	civic-kb:Drugs-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a1f900ac5ea008f2654c33cadc1cdab8 ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-a1f900ac5ea008f2654c33cadc1cdab8 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-a1f900ac5ea008f2654c33cadc1cdab8 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2042"^^xsd:integer .

	civic-kb:Gene-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545Q"^^xsd:string .

	civic-kb:Description-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-a1f900ac5ea008f2654c33cadc1cdab8 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-a1f900ac5ea008f2654c33cadc1cdab8 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-a1f900ac5ea008f2654c33cadc1cdab8 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a1f900ac5ea008f2654c33cadc1cdab8 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-a1f900ac5ea008f2654c33cadc1cdab8 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-a1f900ac5ea008f2654c33cadc1cdab8 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-a1f900ac5ea008f2654c33cadc1cdab8 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-a1f900ac5ea008f2654c33cadc1cdab8	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-a1f900ac5ea008f2654c33cadc1cdab8 .

}

civic-kb:provenance-a1f900ac5ea008f2654c33cadc1cdab8 {
	civic-kb:assertion-a1f900ac5ea008f2654c33cadc1cdab8 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-a1f900ac5ea008f2654c33cadc1cdab8 .

	civic-kb:Status-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-a1f900ac5ea008f2654c33cadc1cdab8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-a1f900ac5ea008f2654c33cadc1cdab8 {
	civic-kb:nanoPub-a1f900ac5ea008f2654c33cadc1cdab8 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-a1f900ac5ea008f2654c33cadc1cdab8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-7b7596f59fc0e8a8c76a25ab2d6f0d1c {
	civic-kb:nanoPub-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		np:hasProvenance civic-kb:provenance-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		np:hasPublicationInfo civic-kb:pubInfo-7b7596f59fc0e8a8c76a25ab2d6f0d1c .
}

civic-kb:assertion-7b7596f59fc0e8a8c76a25ab2d6f0d1c {
	civic-kb:Drugs-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2043"^^xsd:integer .

	civic-kb:Gene-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545Q"^^xsd:string .

	civic-kb:Description-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In HER2-positive metastic breast cancer patients treated with trastuzumab-based therapy, the presence of a PIK3CA mutation was associated with an increased risk of progression (HR:2.50, 95% CI:1.35-4.61, P=0.003, univariate analysis; HR:1.86, 95% CI:1.13-3.05, P=0.014, multivariate analysis) and reduced time to progression (HR:2.50, 95% CI:1.35-4.61, P=0.003) compared to wildtype PIK3CA."^^xsd:string .

	civic-kb:Disease-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-7b7596f59fc0e8a8c76a25ab2d6f0d1c ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-7b7596f59fc0e8a8c76a25ab2d6f0d1c	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-7b7596f59fc0e8a8c76a25ab2d6f0d1c .

}

civic-kb:provenance-7b7596f59fc0e8a8c76a25ab2d6f0d1c {
	civic-kb:assertion-7b7596f59fc0e8a8c76a25ab2d6f0d1c prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-7b7596f59fc0e8a8c76a25ab2d6f0d1c .

	civic-kb:Status-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-7b7596f59fc0e8a8c76a25ab2d6f0d1c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-7b7596f59fc0e8a8c76a25ab2d6f0d1c {
	civic-kb:nanoPub-7b7596f59fc0e8a8c76a25ab2d6f0d1c prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-7b7596f59fc0e8a8c76a25ab2d6f0d1c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d625d259ae021807e6b3d519379579e2 {
	civic-kb:nanoPub-d625d259ae021807e6b3d519379579e2
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d625d259ae021807e6b3d519379579e2 ;
		np:hasProvenance civic-kb:provenance-d625d259ae021807e6b3d519379579e2 ;
		np:hasPublicationInfo civic-kb:pubInfo-d625d259ae021807e6b3d519379579e2 .
}

civic-kb:assertion-d625d259ae021807e6b3d519379579e2 {
	civic-kb:Drugs-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d625d259ae021807e6b3d519379579e2 ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d625d259ae021807e6b3d519379579e2 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d625d259ae021807e6b3d519379579e2 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2071"^^xsd:integer .

	civic-kb:Gene-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545V"^^xsd:string .

	civic-kb:Description-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d625d259ae021807e6b3d519379579e2 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines (n=54, P=0.005)."^^xsd:string .

	civic-kb:Disease-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d625d259ae021807e6b3d519379579e2 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d625d259ae021807e6b3d519379579e2 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d625d259ae021807e6b3d519379579e2 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d625d259ae021807e6b3d519379579e2 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d625d259ae021807e6b3d519379579e2 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d625d259ae021807e6b3d519379579e2 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-d625d259ae021807e6b3d519379579e2	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d625d259ae021807e6b3d519379579e2 .

}

civic-kb:provenance-d625d259ae021807e6b3d519379579e2 {
	civic-kb:assertion-d625d259ae021807e6b3d519379579e2 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d625d259ae021807e6b3d519379579e2 .

	civic-kb:Status-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-d625d259ae021807e6b3d519379579e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d625d259ae021807e6b3d519379579e2 {
	civic-kb:nanoPub-d625d259ae021807e6b3d519379579e2 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d625d259ae021807e6b3d519379579e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-68ec4ac4094355be96f82e77bdb83b40 {
	civic-kb:nanoPub-68ec4ac4094355be96f82e77bdb83b40
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-68ec4ac4094355be96f82e77bdb83b40 ;
		np:hasProvenance civic-kb:provenance-68ec4ac4094355be96f82e77bdb83b40 ;
		np:hasPublicationInfo civic-kb:pubInfo-68ec4ac4094355be96f82e77bdb83b40 .
}

civic-kb:assertion-68ec4ac4094355be96f82e77bdb83b40 {
	civic-kb:Drugs-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-68ec4ac4094355be96f82e77bdb83b40 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-68ec4ac4094355be96f82e77bdb83b40 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-68ec4ac4094355be96f82e77bdb83b40 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2072"^^xsd:integer .

	civic-kb:Gene-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545V"^^xsd:string .

	civic-kb:Description-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-68ec4ac4094355be96f82e77bdb83b40 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In HER2-positive metastic breast cancer patients treated with trastuzumab-based therapy, the presence of a PIK3CA mutation was associated with an increased risk of progression (HR:2.50, 95% CI:1.35-4.61, P=0.003, univariate analysis; HR:1.86, 95% CI:1.13-3.05, P=0.014, multivariate analysis) and reduced time to progression (HR:2.50, 95% CI:1.35-4.61, P=0.003) compared to wildtype PIK3CA."^^xsd:string .

	civic-kb:Disease-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-68ec4ac4094355be96f82e77bdb83b40 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-68ec4ac4094355be96f82e77bdb83b40 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-68ec4ac4094355be96f82e77bdb83b40 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-68ec4ac4094355be96f82e77bdb83b40 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-68ec4ac4094355be96f82e77bdb83b40 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-68ec4ac4094355be96f82e77bdb83b40 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-68ec4ac4094355be96f82e77bdb83b40	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-68ec4ac4094355be96f82e77bdb83b40 .

}

civic-kb:provenance-68ec4ac4094355be96f82e77bdb83b40 {
	civic-kb:assertion-68ec4ac4094355be96f82e77bdb83b40 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-68ec4ac4094355be96f82e77bdb83b40 .

	civic-kb:Status-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-68ec4ac4094355be96f82e77bdb83b40	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-68ec4ac4094355be96f82e77bdb83b40 {
	civic-kb:nanoPub-68ec4ac4094355be96f82e77bdb83b40 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-68ec4ac4094355be96f82e77bdb83b40
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-b623f91427aad5dcb4817560b2a9f642 {
	civic-kb:nanoPub-b623f91427aad5dcb4817560b2a9f642
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-b623f91427aad5dcb4817560b2a9f642 ;
		np:hasProvenance civic-kb:provenance-b623f91427aad5dcb4817560b2a9f642 ;
		np:hasPublicationInfo civic-kb:pubInfo-b623f91427aad5dcb4817560b2a9f642 .
}

civic-kb:assertion-b623f91427aad5dcb4817560b2a9f642 {
	civic-kb:Drugs-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b623f91427aad5dcb4817560b2a9f642 ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-b623f91427aad5dcb4817560b2a9f642 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-b623f91427aad5dcb4817560b2a9f642 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2074"^^xsd:integer .

	civic-kb:Gene-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Q546K"^^xsd:string .

	civic-kb:Description-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-b623f91427aad5dcb4817560b2a9f642 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines (n=54, P=0.005)."^^xsd:string .

	civic-kb:Disease-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-b623f91427aad5dcb4817560b2a9f642 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-b623f91427aad5dcb4817560b2a9f642 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b623f91427aad5dcb4817560b2a9f642 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-b623f91427aad5dcb4817560b2a9f642 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-b623f91427aad5dcb4817560b2a9f642 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-b623f91427aad5dcb4817560b2a9f642 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-b623f91427aad5dcb4817560b2a9f642	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-b623f91427aad5dcb4817560b2a9f642 .

}

civic-kb:provenance-b623f91427aad5dcb4817560b2a9f642 {
	civic-kb:assertion-b623f91427aad5dcb4817560b2a9f642 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-b623f91427aad5dcb4817560b2a9f642 .

	civic-kb:Status-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-b623f91427aad5dcb4817560b2a9f642	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-b623f91427aad5dcb4817560b2a9f642 {
	civic-kb:nanoPub-b623f91427aad5dcb4817560b2a9f642 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-b623f91427aad5dcb4817560b2a9f642
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d4833dfedd4ba68b0708f99a08674849 {
	civic-kb:nanoPub-d4833dfedd4ba68b0708f99a08674849
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d4833dfedd4ba68b0708f99a08674849 ;
		np:hasProvenance civic-kb:provenance-d4833dfedd4ba68b0708f99a08674849 ;
		np:hasPublicationInfo civic-kb:pubInfo-d4833dfedd4ba68b0708f99a08674849 .
}

civic-kb:assertion-d4833dfedd4ba68b0708f99a08674849 {
	civic-kb:Drugs-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d4833dfedd4ba68b0708f99a08674849 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d4833dfedd4ba68b0708f99a08674849 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d4833dfedd4ba68b0708f99a08674849 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2078"^^xsd:integer .

	civic-kb:Gene-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Q546K"^^xsd:string .

	civic-kb:Description-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d4833dfedd4ba68b0708f99a08674849 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines."^^xsd:string .

	civic-kb:Disease-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d4833dfedd4ba68b0708f99a08674849 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d4833dfedd4ba68b0708f99a08674849 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d4833dfedd4ba68b0708f99a08674849 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d4833dfedd4ba68b0708f99a08674849 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d4833dfedd4ba68b0708f99a08674849 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d4833dfedd4ba68b0708f99a08674849 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-d4833dfedd4ba68b0708f99a08674849	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d4833dfedd4ba68b0708f99a08674849 .

}

civic-kb:provenance-d4833dfedd4ba68b0708f99a08674849 {
	civic-kb:assertion-d4833dfedd4ba68b0708f99a08674849 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d4833dfedd4ba68b0708f99a08674849 .

	civic-kb:Status-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-d4833dfedd4ba68b0708f99a08674849	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d4833dfedd4ba68b0708f99a08674849 {
	civic-kb:nanoPub-d4833dfedd4ba68b0708f99a08674849 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d4833dfedd4ba68b0708f99a08674849
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-7f3d7792eedc01d0a9f7edc441064dd4 {
	civic-kb:nanoPub-7f3d7792eedc01d0a9f7edc441064dd4
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-7f3d7792eedc01d0a9f7edc441064dd4 ;
		np:hasProvenance civic-kb:provenance-7f3d7792eedc01d0a9f7edc441064dd4 ;
		np:hasPublicationInfo civic-kb:pubInfo-7f3d7792eedc01d0a9f7edc441064dd4 .
}

civic-kb:assertion-7f3d7792eedc01d0a9f7edc441064dd4 {
	civic-kb:Drugs-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7f3d7792eedc01d0a9f7edc441064dd4 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-7f3d7792eedc01d0a9f7edc441064dd4 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-7f3d7792eedc01d0a9f7edc441064dd4 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2077"^^xsd:integer .

	civic-kb:Gene-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Q546K"^^xsd:string .

	civic-kb:Description-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-7f3d7792eedc01d0a9f7edc441064dd4 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7f3d7792eedc01d0a9f7edc441064dd4 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-7f3d7792eedc01d0a9f7edc441064dd4 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7f3d7792eedc01d0a9f7edc441064dd4 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7f3d7792eedc01d0a9f7edc441064dd4 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-7f3d7792eedc01d0a9f7edc441064dd4 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-7f3d7792eedc01d0a9f7edc441064dd4 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-7f3d7792eedc01d0a9f7edc441064dd4	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-7f3d7792eedc01d0a9f7edc441064dd4 .

}

civic-kb:provenance-7f3d7792eedc01d0a9f7edc441064dd4 {
	civic-kb:assertion-7f3d7792eedc01d0a9f7edc441064dd4 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-7f3d7792eedc01d0a9f7edc441064dd4 .

	civic-kb:Status-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-7f3d7792eedc01d0a9f7edc441064dd4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-7f3d7792eedc01d0a9f7edc441064dd4 {
	civic-kb:nanoPub-7f3d7792eedc01d0a9f7edc441064dd4 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-7f3d7792eedc01d0a9f7edc441064dd4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d515dc7e31c147e22a5a2fb5a9115643 {
	civic-kb:nanoPub-d515dc7e31c147e22a5a2fb5a9115643
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d515dc7e31c147e22a5a2fb5a9115643 ;
		np:hasProvenance civic-kb:provenance-d515dc7e31c147e22a5a2fb5a9115643 ;
		np:hasPublicationInfo civic-kb:pubInfo-d515dc7e31c147e22a5a2fb5a9115643 .
}

civic-kb:assertion-d515dc7e31c147e22a5a2fb5a9115643 {
	civic-kb:Drugs-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d515dc7e31c147e22a5a2fb5a9115643 ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d515dc7e31c147e22a5a2fb5a9115643 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d515dc7e31c147e22a5a2fb5a9115643 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2075"^^xsd:integer .

	civic-kb:Gene-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Q546K"^^xsd:string .

	civic-kb:Description-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d515dc7e31c147e22a5a2fb5a9115643 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d515dc7e31c147e22a5a2fb5a9115643 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d515dc7e31c147e22a5a2fb5a9115643 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d515dc7e31c147e22a5a2fb5a9115643 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d515dc7e31c147e22a5a2fb5a9115643 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d515dc7e31c147e22a5a2fb5a9115643 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d515dc7e31c147e22a5a2fb5a9115643 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-d515dc7e31c147e22a5a2fb5a9115643	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d515dc7e31c147e22a5a2fb5a9115643 .

}

civic-kb:provenance-d515dc7e31c147e22a5a2fb5a9115643 {
	civic-kb:assertion-d515dc7e31c147e22a5a2fb5a9115643 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d515dc7e31c147e22a5a2fb5a9115643 .

	civic-kb:Status-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-d515dc7e31c147e22a5a2fb5a9115643	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d515dc7e31c147e22a5a2fb5a9115643 {
	civic-kb:nanoPub-d515dc7e31c147e22a5a2fb5a9115643 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d515dc7e31c147e22a5a2fb5a9115643
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c9490b177158c4e5b4ac268bfe165bdb {
	civic-kb:nanoPub-c9490b177158c4e5b4ac268bfe165bdb
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c9490b177158c4e5b4ac268bfe165bdb ;
		np:hasProvenance civic-kb:provenance-c9490b177158c4e5b4ac268bfe165bdb ;
		np:hasPublicationInfo civic-kb:pubInfo-c9490b177158c4e5b4ac268bfe165bdb .
}

civic-kb:assertion-c9490b177158c4e5b4ac268bfe165bdb {
	civic-kb:Drugs-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c9490b177158c4e5b4ac268bfe165bdb ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c9490b177158c4e5b4ac268bfe165bdb ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c9490b177158c4e5b4ac268bfe165bdb ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2076"^^xsd:integer .

	civic-kb:Gene-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Q546K"^^xsd:string .

	civic-kb:Description-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c9490b177158c4e5b4ac268bfe165bdb ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In HER2-positive metastic breast cancer patients treated with trastuzumab-based therapy, the presence of a PIK3CA mutation was associated with an increased risk of progression (HR:2.50, 95% CI:1.35-4.61, P=0.003, univariate analysis; HR:1.86, 95% CI:1.13-3.05, P=0.014, multivariate analysis) and reduced time to progression (HR:2.50, 95% CI:1.35-4.61, P=0.003) compared to wildtype PIK3CA."^^xsd:string .

	civic-kb:Disease-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c9490b177158c4e5b4ac268bfe165bdb ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c9490b177158c4e5b4ac268bfe165bdb ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c9490b177158c4e5b4ac268bfe165bdb ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c9490b177158c4e5b4ac268bfe165bdb ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c9490b177158c4e5b4ac268bfe165bdb ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c9490b177158c4e5b4ac268bfe165bdb ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-c9490b177158c4e5b4ac268bfe165bdb	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c9490b177158c4e5b4ac268bfe165bdb .

}

civic-kb:provenance-c9490b177158c4e5b4ac268bfe165bdb {
	civic-kb:assertion-c9490b177158c4e5b4ac268bfe165bdb prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c9490b177158c4e5b4ac268bfe165bdb .

	civic-kb:Status-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-c9490b177158c4e5b4ac268bfe165bdb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c9490b177158c4e5b4ac268bfe165bdb {
	civic-kb:nanoPub-c9490b177158c4e5b4ac268bfe165bdb prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c9490b177158c4e5b4ac268bfe165bdb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-7206c2020c2aedd6c9bc683304ab4638 {
	civic-kb:nanoPub-7206c2020c2aedd6c9bc683304ab4638
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-7206c2020c2aedd6c9bc683304ab4638 ;
		np:hasProvenance civic-kb:provenance-7206c2020c2aedd6c9bc683304ab4638 ;
		np:hasPublicationInfo civic-kb:pubInfo-7206c2020c2aedd6c9bc683304ab4638 .
}

civic-kb:assertion-7206c2020c2aedd6c9bc683304ab4638 {
	civic-kb:Drugs-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7206c2020c2aedd6c9bc683304ab4638 ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-7206c2020c2aedd6c9bc683304ab4638 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-7206c2020c2aedd6c9bc683304ab4638 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3005"^^xsd:integer .

	civic-kb:Gene-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L755P"^^xsd:string .

	civic-kb:Description-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-7206c2020c2aedd6c9bc683304ab4638 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7206c2020c2aedd6c9bc683304ab4638 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-7206c2020c2aedd6c9bc683304ab4638 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7206c2020c2aedd6c9bc683304ab4638 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7206c2020c2aedd6c9bc683304ab4638 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-7206c2020c2aedd6c9bc683304ab4638 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-7206c2020c2aedd6c9bc683304ab4638 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"1"^^xsd:integer .

	civic-kb:evidence-7206c2020c2aedd6c9bc683304ab4638	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-7206c2020c2aedd6c9bc683304ab4638 .

}

civic-kb:provenance-7206c2020c2aedd6c9bc683304ab4638 {
	civic-kb:assertion-7206c2020c2aedd6c9bc683304ab4638 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-7206c2020c2aedd6c9bc683304ab4638 .

	civic-kb:Status-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-7206c2020c2aedd6c9bc683304ab4638	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-7206c2020c2aedd6c9bc683304ab4638 {
	civic-kb:nanoPub-7206c2020c2aedd6c9bc683304ab4638 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-7206c2020c2aedd6c9bc683304ab4638
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-2ae7531f877771a90062c111b3dc19b2 {
	civic-kb:nanoPub-2ae7531f877771a90062c111b3dc19b2
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-2ae7531f877771a90062c111b3dc19b2 ;
		np:hasProvenance civic-kb:provenance-2ae7531f877771a90062c111b3dc19b2 ;
		np:hasPublicationInfo civic-kb:pubInfo-2ae7531f877771a90062c111b3dc19b2 .
}

civic-kb:assertion-2ae7531f877771a90062c111b3dc19b2 {
	civic-kb:Drugs-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2ae7531f877771a90062c111b3dc19b2 ;
		sio:hasValue	"Carboplatin, Eribulin"^^xsd:string .

	civic-kb:Status-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-2ae7531f877771a90062c111b3dc19b2 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-2ae7531f877771a90062c111b3dc19b2 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2969"^^xsd:integer .

	civic-kb:Gene-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C24284 ;
		rdf:type	uniprot:P24941 ;
		rdfs:label	"CDK2 Gene"^^xsd:string ;
		sio:hasValue	"CDK2"^^xsd:string .

	civic-kb:Variant-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdfs:label	"Cytoplasmic Expression"^^xsd:string ;
		sio:hasValue	"CYTOPLASMIC EXPRESSION"^^xsd:string .

	civic-kb:Description-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-2ae7531f877771a90062c111b3dc19b2 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a Phase 2 trial, HRD score, HR deficiency status, and cytoplasmic CDK2 predicted pathologic complete remission to neoadjuvant therapy with carboplatin and eribulin in early stage TNBC patients."^^xsd:string .

	civic-kb:Disease-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-2ae7531f877771a90062c111b3dc19b2 ;
		rdf:type	efo:0005537 ;
		rdf:type	ncit:C71428 ;
		rdf:type	doid:60081 ;
		rdfs:label	"Triple-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Triple-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-2ae7531f877771a90062c111b3dc19b2 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2ae7531f877771a90062c111b3dc19b2 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-2ae7531f877771a90062c111b3dc19b2 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-2ae7531f877771a90062c111b3dc19b2 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-2ae7531f877771a90062c111b3dc19b2 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-2ae7531f877771a90062c111b3dc19b2	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-2ae7531f877771a90062c111b3dc19b2 .

}

civic-kb:provenance-2ae7531f877771a90062c111b3dc19b2 {
	civic-kb:assertion-2ae7531f877771a90062c111b3dc19b2 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-2ae7531f877771a90062c111b3dc19b2 .

	civic-kb:Status-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-2ae7531f877771a90062c111b3dc19b2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-2ae7531f877771a90062c111b3dc19b2 {
	civic-kb:nanoPub-2ae7531f877771a90062c111b3dc19b2 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-2ae7531f877771a90062c111b3dc19b2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-4cb7d8d7c212c07039f238ca9e51ade8 {
	civic-kb:nanoPub-4cb7d8d7c212c07039f238ca9e51ade8
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-4cb7d8d7c212c07039f238ca9e51ade8 ;
		np:hasProvenance civic-kb:provenance-4cb7d8d7c212c07039f238ca9e51ade8 ;
		np:hasPublicationInfo civic-kb:pubInfo-4cb7d8d7c212c07039f238ca9e51ade8 .
}

civic-kb:assertion-4cb7d8d7c212c07039f238ca9e51ade8 {
	civic-kb:Drugs-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4cb7d8d7c212c07039f238ca9e51ade8 ;
		rdf:type	db:DB12745 ;
		rdfs:label	"GSK690693"^^xsd:string ;
		sio:hasValue	"GSK690693"^^xsd:string .

	civic-kb:Status-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-4cb7d8d7c212c07039f238ca9e51ade8 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-4cb7d8d7c212c07039f238ca9e51ade8 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3001"^^xsd:integer .

	civic-kb:Gene-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C20937 ;
		rdf:type	uniprot:Q9Y243 ;
		rdfs:label	"AKT3 Gene"^^xsd:string ;
		sio:hasValue	"AKT3"^^xsd:string .

	civic-kb:Variant-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-4cb7d8d7c212c07039f238ca9e51ade8 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Overexpression of AKT3 in lumenal breast cancer cell line SKBR3, which does not express the AKT3 isoform, induced a statistically significant 2.7 fold increase in IC50 for pan-AKT inhibitor GSK690693."^^xsd:string .

	civic-kb:Disease-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4cb7d8d7c212c07039f238ca9e51ade8 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-4cb7d8d7c212c07039f238ca9e51ade8 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4cb7d8d7c212c07039f238ca9e51ade8 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4cb7d8d7c212c07039f238ca9e51ade8 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-4cb7d8d7c212c07039f238ca9e51ade8 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-4cb7d8d7c212c07039f238ca9e51ade8 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-4cb7d8d7c212c07039f238ca9e51ade8	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-4cb7d8d7c212c07039f238ca9e51ade8 .

}

civic-kb:provenance-4cb7d8d7c212c07039f238ca9e51ade8 {
	civic-kb:assertion-4cb7d8d7c212c07039f238ca9e51ade8 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-4cb7d8d7c212c07039f238ca9e51ade8 .

	civic-kb:Status-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-4cb7d8d7c212c07039f238ca9e51ade8	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-4cb7d8d7c212c07039f238ca9e51ade8 {
	civic-kb:nanoPub-4cb7d8d7c212c07039f238ca9e51ade8 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-4cb7d8d7c212c07039f238ca9e51ade8
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-84964d508258ebd621ecb4603e9c6a6c {
	civic-kb:nanoPub-84964d508258ebd621ecb4603e9c6a6c
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-84964d508258ebd621ecb4603e9c6a6c ;
		np:hasProvenance civic-kb:provenance-84964d508258ebd621ecb4603e9c6a6c ;
		np:hasPublicationInfo civic-kb:pubInfo-84964d508258ebd621ecb4603e9c6a6c .
}

civic-kb:assertion-84964d508258ebd621ecb4603e9c6a6c {
	civic-kb:Drugs-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-84964d508258ebd621ecb4603e9c6a6c ;
		rdfs:label	"AKT3 Inhibitor"^^xsd:string ;
		sio:hasValue	"AKT3 Inhibitor"^^xsd:string .

	civic-kb:Status-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-84964d508258ebd621ecb4603e9c6a6c ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-84964d508258ebd621ecb4603e9c6a6c ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1923"^^xsd:integer .

	civic-kb:Gene-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C20937 ;
		rdf:type	uniprot:Q9Y243 ;
		rdfs:label	"AKT3 Gene"^^xsd:string ;
		sio:hasValue	"AKT3"^^xsd:string .

	civic-kb:Variant-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-84964d508258ebd621ecb4603e9c6a6c ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"AKT3 was found to be preferentially required for the proliferation and tumor growth of TNBC. It was found to be upregulated in a set of TNBC cell lines compared to other breast cancer types. Depletion of AKT3 in TNBC sensitizes cells to the pan-Akt inhibitor GSK690693. It was found that depletion of Akt3 potentially inhibits the growth of TNBC cell lines in three-dimensional (3D) spheroid cultures and in mouse xenograft models, which imply that therapeutic targeting of AKT3 may provide a new treatment option for TNBCs."^^xsd:string .

	civic-kb:Disease-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-84964d508258ebd621ecb4603e9c6a6c ;
		rdf:type	efo:0005537 ;
		rdf:type	ncit:C71428 ;
		rdf:type	doid:60081 ;
		rdfs:label	"Triple-receptor Negative Breast Cancer"^^xsd:string ;
		sio:hasValue	"Triple-receptor Negative Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-84964d508258ebd621ecb4603e9c6a6c ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"E"^^xsd:string .

	civic-kb:Evidence_Type-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-84964d508258ebd621ecb4603e9c6a6c ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-84964d508258ebd621ecb4603e9c6a6c ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-84964d508258ebd621ecb4603e9c6a6c ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-84964d508258ebd621ecb4603e9c6a6c ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-84964d508258ebd621ecb4603e9c6a6c	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-84964d508258ebd621ecb4603e9c6a6c .

}

civic-kb:provenance-84964d508258ebd621ecb4603e9c6a6c {
	civic-kb:assertion-84964d508258ebd621ecb4603e9c6a6c prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-84964d508258ebd621ecb4603e9c6a6c .

	civic-kb:Status-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-84964d508258ebd621ecb4603e9c6a6c	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-84964d508258ebd621ecb4603e9c6a6c {
	civic-kb:nanoPub-84964d508258ebd621ecb4603e9c6a6c prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-84964d508258ebd621ecb4603e9c6a6c
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d13ce363c3451cf7e622361757852a74 {
	civic-kb:nanoPub-d13ce363c3451cf7e622361757852a74
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d13ce363c3451cf7e622361757852a74 ;
		np:hasProvenance civic-kb:provenance-d13ce363c3451cf7e622361757852a74 ;
		np:hasPublicationInfo civic-kb:pubInfo-d13ce363c3451cf7e622361757852a74 .
}

civic-kb:assertion-d13ce363c3451cf7e622361757852a74 {
	civic-kb:Drugs-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d13ce363c3451cf7e622361757852a74 ;
		rdfs:label	"MK-2206"^^xsd:string ;
		sio:hasValue	"MK-2206"^^xsd:string .

	civic-kb:Status-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d13ce363c3451cf7e622361757852a74 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d13ce363c3451cf7e622361757852a74 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1922"^^xsd:integer .

	civic-kb:Gene-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C20937 ;
		rdf:type	uniprot:Q9Y243 ;
		rdfs:label	"AKT3 Gene"^^xsd:string ;
		sio:hasValue	"AKT3"^^xsd:string .

	civic-kb:Variant-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d13ce363c3451cf7e622361757852a74 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Upregulation of AKT3 due to epigenetic reprogramming may confer acquired resistance to AKT inhibitor (MK2206) in breast cancer preclinical model."^^xsd:string .

	civic-kb:Disease-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d13ce363c3451cf7e622361757852a74 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d13ce363c3451cf7e622361757852a74 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d13ce363c3451cf7e622361757852a74 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d13ce363c3451cf7e622361757852a74 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d13ce363c3451cf7e622361757852a74 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d13ce363c3451cf7e622361757852a74 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-d13ce363c3451cf7e622361757852a74	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d13ce363c3451cf7e622361757852a74 .

}

civic-kb:provenance-d13ce363c3451cf7e622361757852a74 {
	civic-kb:assertion-d13ce363c3451cf7e622361757852a74 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d13ce363c3451cf7e622361757852a74 .

	civic-kb:Status-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-d13ce363c3451cf7e622361757852a74	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d13ce363c3451cf7e622361757852a74 {
	civic-kb:nanoPub-d13ce363c3451cf7e622361757852a74 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d13ce363c3451cf7e622361757852a74
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-5be2070c9c2edd6bbccbc2065d9b3272 {
	civic-kb:nanoPub-5be2070c9c2edd6bbccbc2065d9b3272
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-5be2070c9c2edd6bbccbc2065d9b3272 ;
		np:hasProvenance civic-kb:provenance-5be2070c9c2edd6bbccbc2065d9b3272 ;
		np:hasPublicationInfo civic-kb:pubInfo-5be2070c9c2edd6bbccbc2065d9b3272 .
}

civic-kb:assertion-5be2070c9c2edd6bbccbc2065d9b3272 {
	civic-kb:Drugs-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5be2070c9c2edd6bbccbc2065d9b3272 ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-5be2070c9c2edd6bbccbc2065d9b3272 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-5be2070c9c2edd6bbccbc2065d9b3272 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3006"^^xsd:integer .

	civic-kb:Gene-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"T798M"^^xsd:string .

	civic-kb:Description-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-5be2070c9c2edd6bbccbc2065d9b3272 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5be2070c9c2edd6bbccbc2065d9b3272 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-5be2070c9c2edd6bbccbc2065d9b3272 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5be2070c9c2edd6bbccbc2065d9b3272 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5be2070c9c2edd6bbccbc2065d9b3272 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-5be2070c9c2edd6bbccbc2065d9b3272 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-5be2070c9c2edd6bbccbc2065d9b3272 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"1"^^xsd:integer .

	civic-kb:evidence-5be2070c9c2edd6bbccbc2065d9b3272	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-5be2070c9c2edd6bbccbc2065d9b3272 .

}

civic-kb:provenance-5be2070c9c2edd6bbccbc2065d9b3272 {
	civic-kb:assertion-5be2070c9c2edd6bbccbc2065d9b3272 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-5be2070c9c2edd6bbccbc2065d9b3272 .

	civic-kb:Status-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-5be2070c9c2edd6bbccbc2065d9b3272	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-5be2070c9c2edd6bbccbc2065d9b3272 {
	civic-kb:nanoPub-5be2070c9c2edd6bbccbc2065d9b3272 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-5be2070c9c2edd6bbccbc2065d9b3272
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f863ccb4815d337e7374f7549583f769 {
	civic-kb:nanoPub-f863ccb4815d337e7374f7549583f769
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f863ccb4815d337e7374f7549583f769 ;
		np:hasProvenance civic-kb:provenance-f863ccb4815d337e7374f7549583f769 ;
		np:hasPublicationInfo civic-kb:pubInfo-f863ccb4815d337e7374f7549583f769 .
}

civic-kb:assertion-f863ccb4815d337e7374f7549583f769 {
	civic-kb:Drugs-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f863ccb4815d337e7374f7549583f769 ;
		rdf:type	dron:00730818 ;
		rdf:type	db:DB05773 ;
		rdfs:label	"Ado-trastuzumab Emtansine"^^xsd:string ;
		sio:hasValue	"Ado-trastuzumab Emtansine"^^xsd:string .

	civic-kb:Status-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f863ccb4815d337e7374f7549583f769 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f863ccb4815d337e7374f7549583f769 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2346"^^xsd:integer .

	civic-kb:Gene-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"C420R"^^xsd:string .

	civic-kb:Description-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f863ccb4815d337e7374f7549583f769 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase 3 clinical trial (NCT00829166), metastatic breast cancer patients with PIK3CA mutation (n=40), including patients with PIK3CA C420R, treated with ado-trastuzumab were associated with improved median progression free survival (10.9 vs. 9.8 months), as compared to patients with wild-type PIK3CA (n=93). Further, the patients harboring PIK3CA mutations (n=79) were associated with a decrease in disease progression (ado-trastuzumab relative to standard chemotherapy; HR:0.45; 95% CI:0.25-0.82), as compared to patients with wild-type PIK3CA (n=180; HR:0.74; 95% CI:0.50-1.10). In an in vitro study, EFM-192A cell line expressing PIK3CA C420R mutation was associated with increased sensitivity to ado-trastuzumab emtansine treatment compared to trastuzumab treated EFM-192A cells. Sensitivity was determined by assessing cell viability."^^xsd:string .

	civic-kb:Disease-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f863ccb4815d337e7374f7549583f769 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f863ccb4815d337e7374f7549583f769 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f863ccb4815d337e7374f7549583f769 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f863ccb4815d337e7374f7549583f769 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f863ccb4815d337e7374f7549583f769 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f863ccb4815d337e7374f7549583f769 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-f863ccb4815d337e7374f7549583f769	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f863ccb4815d337e7374f7549583f769 .

}

civic-kb:provenance-f863ccb4815d337e7374f7549583f769 {
	civic-kb:assertion-f863ccb4815d337e7374f7549583f769 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f863ccb4815d337e7374f7549583f769 .

	civic-kb:Status-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-f863ccb4815d337e7374f7549583f769	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f863ccb4815d337e7374f7549583f769 {
	civic-kb:nanoPub-f863ccb4815d337e7374f7549583f769 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f863ccb4815d337e7374f7549583f769
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-95b87cd7cc8482a4145b8a4fef6bcd49 {
	civic-kb:nanoPub-95b87cd7cc8482a4145b8a4fef6bcd49
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		np:hasProvenance civic-kb:provenance-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		np:hasPublicationInfo civic-kb:pubInfo-95b87cd7cc8482a4145b8a4fef6bcd49 .
}

civic-kb:assertion-95b87cd7cc8482a4145b8a4fef6bcd49 {
	civic-kb:Drugs-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		rdf:type	dron:00018834 ;
		rdf:type	db:DB00398 ;
		rdfs:label	"Sorafenib"^^xsd:string ;
		sio:hasValue	"Sorafenib"^^xsd:string .

	civic-kb:Status-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2811"^^xsd:integer .

	civic-kb:Gene-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18363 ;
		rdf:type	uniprot:P15056 ;
		rdfs:label	"BRAF Gene"^^xsd:string ;
		sio:hasValue	"BRAF"^^xsd:string .

	civic-kb:Variant-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"G464V"^^xsd:string .

	civic-kb:Description-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In an attempt to block both MAPK and PI3K/Akt pathways, two signaling inhibitors (sorafenib, a BRAF kinase inhibitor, and ceramide, an agent that dephosphorylates Akt) were used in cell culture and mouse cancer models. In combination, sorafenib and ceramide increased apoptosis in MDA-MB-231 breast cells (P<0.05) and also blocked tumor development in mouse xenograft experiments (P<0.05) compared to non-treated or signal treatment animals."^^xsd:string .

	civic-kb:Disease-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-95b87cd7cc8482a4145b8a4fef6bcd49 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-95b87cd7cc8482a4145b8a4fef6bcd49	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-95b87cd7cc8482a4145b8a4fef6bcd49 .

}

civic-kb:provenance-95b87cd7cc8482a4145b8a4fef6bcd49 {
	civic-kb:assertion-95b87cd7cc8482a4145b8a4fef6bcd49 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-95b87cd7cc8482a4145b8a4fef6bcd49 .

	civic-kb:Status-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-95b87cd7cc8482a4145b8a4fef6bcd49	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-95b87cd7cc8482a4145b8a4fef6bcd49 {
	civic-kb:nanoPub-95b87cd7cc8482a4145b8a4fef6bcd49 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-95b87cd7cc8482a4145b8a4fef6bcd49
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-1190fd04dac3ce534e1c3d0793884199 {
	civic-kb:nanoPub-1190fd04dac3ce534e1c3d0793884199
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-1190fd04dac3ce534e1c3d0793884199 ;
		np:hasProvenance civic-kb:provenance-1190fd04dac3ce534e1c3d0793884199 ;
		np:hasPublicationInfo civic-kb:pubInfo-1190fd04dac3ce534e1c3d0793884199 .
}

civic-kb:assertion-1190fd04dac3ce534e1c3d0793884199 {
	civic-kb:Drugs-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1190fd04dac3ce534e1c3d0793884199 ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-1190fd04dac3ce534e1c3d0793884199 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-1190fd04dac3ce534e1c3d0793884199 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2058"^^xsd:integer .

	civic-kb:Gene-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545G"^^xsd:string .

	civic-kb:Description-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-1190fd04dac3ce534e1c3d0793884199 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines (n=54, P=0.005)."^^xsd:string .

	civic-kb:Disease-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1190fd04dac3ce534e1c3d0793884199 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-1190fd04dac3ce534e1c3d0793884199 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1190fd04dac3ce534e1c3d0793884199 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1190fd04dac3ce534e1c3d0793884199 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-1190fd04dac3ce534e1c3d0793884199 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-1190fd04dac3ce534e1c3d0793884199 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-1190fd04dac3ce534e1c3d0793884199	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-1190fd04dac3ce534e1c3d0793884199 .

}

civic-kb:provenance-1190fd04dac3ce534e1c3d0793884199 {
	civic-kb:assertion-1190fd04dac3ce534e1c3d0793884199 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-1190fd04dac3ce534e1c3d0793884199 .

	civic-kb:Status-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-1190fd04dac3ce534e1c3d0793884199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-1190fd04dac3ce534e1c3d0793884199 {
	civic-kb:nanoPub-1190fd04dac3ce534e1c3d0793884199 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-1190fd04dac3ce534e1c3d0793884199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d58980409d13c2531215001c4bcf68af {
	civic-kb:nanoPub-d58980409d13c2531215001c4bcf68af
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d58980409d13c2531215001c4bcf68af ;
		np:hasProvenance civic-kb:provenance-d58980409d13c2531215001c4bcf68af ;
		np:hasPublicationInfo civic-kb:pubInfo-d58980409d13c2531215001c4bcf68af .
}

civic-kb:assertion-d58980409d13c2531215001c4bcf68af {
	civic-kb:Drugs-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d58980409d13c2531215001c4bcf68af ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d58980409d13c2531215001c4bcf68af ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d58980409d13c2531215001c4bcf68af ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2062"^^xsd:integer .

	civic-kb:Gene-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545G"^^xsd:string .

	civic-kb:Description-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d58980409d13c2531215001c4bcf68af ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines."^^xsd:string .

	civic-kb:Disease-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d58980409d13c2531215001c4bcf68af ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d58980409d13c2531215001c4bcf68af ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d58980409d13c2531215001c4bcf68af ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d58980409d13c2531215001c4bcf68af ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d58980409d13c2531215001c4bcf68af ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d58980409d13c2531215001c4bcf68af ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-d58980409d13c2531215001c4bcf68af	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d58980409d13c2531215001c4bcf68af .

}

civic-kb:provenance-d58980409d13c2531215001c4bcf68af {
	civic-kb:assertion-d58980409d13c2531215001c4bcf68af prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d58980409d13c2531215001c4bcf68af .

	civic-kb:Status-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-d58980409d13c2531215001c4bcf68af	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d58980409d13c2531215001c4bcf68af {
	civic-kb:nanoPub-d58980409d13c2531215001c4bcf68af prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d58980409d13c2531215001c4bcf68af
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-5607a7fa10981261b12cfaccb0de212d {
	civic-kb:nanoPub-5607a7fa10981261b12cfaccb0de212d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-5607a7fa10981261b12cfaccb0de212d ;
		np:hasProvenance civic-kb:provenance-5607a7fa10981261b12cfaccb0de212d ;
		np:hasPublicationInfo civic-kb:pubInfo-5607a7fa10981261b12cfaccb0de212d .
}

civic-kb:assertion-5607a7fa10981261b12cfaccb0de212d {
	civic-kb:Drugs-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5607a7fa10981261b12cfaccb0de212d ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-5607a7fa10981261b12cfaccb0de212d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-5607a7fa10981261b12cfaccb0de212d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2061"^^xsd:integer .

	civic-kb:Gene-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545G"^^xsd:string .

	civic-kb:Description-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-5607a7fa10981261b12cfaccb0de212d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5607a7fa10981261b12cfaccb0de212d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-5607a7fa10981261b12cfaccb0de212d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5607a7fa10981261b12cfaccb0de212d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5607a7fa10981261b12cfaccb0de212d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-5607a7fa10981261b12cfaccb0de212d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-5607a7fa10981261b12cfaccb0de212d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-5607a7fa10981261b12cfaccb0de212d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-5607a7fa10981261b12cfaccb0de212d .

}

civic-kb:provenance-5607a7fa10981261b12cfaccb0de212d {
	civic-kb:assertion-5607a7fa10981261b12cfaccb0de212d prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-5607a7fa10981261b12cfaccb0de212d .

	civic-kb:Status-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-5607a7fa10981261b12cfaccb0de212d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-5607a7fa10981261b12cfaccb0de212d {
	civic-kb:nanoPub-5607a7fa10981261b12cfaccb0de212d prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-5607a7fa10981261b12cfaccb0de212d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c2b020931448651c23656fac4f72268d {
	civic-kb:nanoPub-c2b020931448651c23656fac4f72268d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c2b020931448651c23656fac4f72268d ;
		np:hasProvenance civic-kb:provenance-c2b020931448651c23656fac4f72268d ;
		np:hasPublicationInfo civic-kb:pubInfo-c2b020931448651c23656fac4f72268d .
}

civic-kb:assertion-c2b020931448651c23656fac4f72268d {
	civic-kb:Drugs-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c2b020931448651c23656fac4f72268d ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c2b020931448651c23656fac4f72268d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c2b020931448651c23656fac4f72268d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2059"^^xsd:integer .

	civic-kb:Gene-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545G"^^xsd:string .

	civic-kb:Description-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c2b020931448651c23656fac4f72268d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c2b020931448651c23656fac4f72268d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c2b020931448651c23656fac4f72268d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c2b020931448651c23656fac4f72268d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c2b020931448651c23656fac4f72268d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c2b020931448651c23656fac4f72268d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c2b020931448651c23656fac4f72268d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-c2b020931448651c23656fac4f72268d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c2b020931448651c23656fac4f72268d .

}

civic-kb:provenance-c2b020931448651c23656fac4f72268d {
	civic-kb:assertion-c2b020931448651c23656fac4f72268d prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c2b020931448651c23656fac4f72268d .

	civic-kb:Status-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-c2b020931448651c23656fac4f72268d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c2b020931448651c23656fac4f72268d {
	civic-kb:nanoPub-c2b020931448651c23656fac4f72268d prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c2b020931448651c23656fac4f72268d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-abcdf0d1e6c0c87763cc120509667bef {
	civic-kb:nanoPub-abcdf0d1e6c0c87763cc120509667bef
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-abcdf0d1e6c0c87763cc120509667bef ;
		np:hasProvenance civic-kb:provenance-abcdf0d1e6c0c87763cc120509667bef ;
		np:hasPublicationInfo civic-kb:pubInfo-abcdf0d1e6c0c87763cc120509667bef .
}

civic-kb:assertion-abcdf0d1e6c0c87763cc120509667bef {
	civic-kb:Drugs-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-abcdf0d1e6c0c87763cc120509667bef ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-abcdf0d1e6c0c87763cc120509667bef ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-abcdf0d1e6c0c87763cc120509667bef ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2060"^^xsd:integer .

	civic-kb:Gene-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E545G"^^xsd:string .

	civic-kb:Description-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-abcdf0d1e6c0c87763cc120509667bef ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In HER2-positive metastic breast cancer patients treated with trastuzumab-based therapy, the presence of a PIK3CA mutation was associated with an increased risk of progression (HR:2.50, 95% CI:1.35-4.61, P=0.003, univariate analysis; HR:1.86, 95% CI:1.13-3.05, P=0.014, multivariate analysis) and reduced time to progression (HR:2.50, 95% CI:1.35-4.61, P=0.003) compared to wildtype PIK3CA."^^xsd:string .

	civic-kb:Disease-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-abcdf0d1e6c0c87763cc120509667bef ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-abcdf0d1e6c0c87763cc120509667bef ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-abcdf0d1e6c0c87763cc120509667bef ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-abcdf0d1e6c0c87763cc120509667bef ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-abcdf0d1e6c0c87763cc120509667bef ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-abcdf0d1e6c0c87763cc120509667bef ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-abcdf0d1e6c0c87763cc120509667bef	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-abcdf0d1e6c0c87763cc120509667bef .

}

civic-kb:provenance-abcdf0d1e6c0c87763cc120509667bef {
	civic-kb:assertion-abcdf0d1e6c0c87763cc120509667bef prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-abcdf0d1e6c0c87763cc120509667bef .

	civic-kb:Status-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-abcdf0d1e6c0c87763cc120509667bef	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-abcdf0d1e6c0c87763cc120509667bef {
	civic-kb:nanoPub-abcdf0d1e6c0c87763cc120509667bef prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-abcdf0d1e6c0c87763cc120509667bef
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ec4bed4f399c16a68dc751c3171ce671 {
	civic-kb:nanoPub-ec4bed4f399c16a68dc751c3171ce671
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ec4bed4f399c16a68dc751c3171ce671 ;
		np:hasProvenance civic-kb:provenance-ec4bed4f399c16a68dc751c3171ce671 ;
		np:hasPublicationInfo civic-kb:pubInfo-ec4bed4f399c16a68dc751c3171ce671 .
}

civic-kb:assertion-ec4bed4f399c16a68dc751c3171ce671 {
	civic-kb:Drugs-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ec4bed4f399c16a68dc751c3171ce671 ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ec4bed4f399c16a68dc751c3171ce671 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ec4bed4f399c16a68dc751c3171ce671 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2085"^^xsd:integer .

	civic-kb:Gene-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Q546E"^^xsd:string .

	civic-kb:Description-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ec4bed4f399c16a68dc751c3171ce671 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines (n=54, P=0.005)."^^xsd:string .

	civic-kb:Disease-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ec4bed4f399c16a68dc751c3171ce671 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ec4bed4f399c16a68dc751c3171ce671 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ec4bed4f399c16a68dc751c3171ce671 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ec4bed4f399c16a68dc751c3171ce671 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ec4bed4f399c16a68dc751c3171ce671 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ec4bed4f399c16a68dc751c3171ce671 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-ec4bed4f399c16a68dc751c3171ce671	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ec4bed4f399c16a68dc751c3171ce671 .

}

civic-kb:provenance-ec4bed4f399c16a68dc751c3171ce671 {
	civic-kb:assertion-ec4bed4f399c16a68dc751c3171ce671 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ec4bed4f399c16a68dc751c3171ce671 .

	civic-kb:Status-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-ec4bed4f399c16a68dc751c3171ce671	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ec4bed4f399c16a68dc751c3171ce671 {
	civic-kb:nanoPub-ec4bed4f399c16a68dc751c3171ce671 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ec4bed4f399c16a68dc751c3171ce671
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-35d6315fd077d8514a0596eefacb04de {
	civic-kb:nanoPub-35d6315fd077d8514a0596eefacb04de
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-35d6315fd077d8514a0596eefacb04de ;
		np:hasProvenance civic-kb:provenance-35d6315fd077d8514a0596eefacb04de ;
		np:hasPublicationInfo civic-kb:pubInfo-35d6315fd077d8514a0596eefacb04de .
}

civic-kb:assertion-35d6315fd077d8514a0596eefacb04de {
	civic-kb:Drugs-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-35d6315fd077d8514a0596eefacb04de ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-35d6315fd077d8514a0596eefacb04de ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-35d6315fd077d8514a0596eefacb04de ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2089"^^xsd:integer .

	civic-kb:Gene-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Q546E"^^xsd:string .

	civic-kb:Description-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-35d6315fd077d8514a0596eefacb04de ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines."^^xsd:string .

	civic-kb:Disease-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-35d6315fd077d8514a0596eefacb04de ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-35d6315fd077d8514a0596eefacb04de ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-35d6315fd077d8514a0596eefacb04de ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-35d6315fd077d8514a0596eefacb04de ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-35d6315fd077d8514a0596eefacb04de ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-35d6315fd077d8514a0596eefacb04de ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-35d6315fd077d8514a0596eefacb04de	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-35d6315fd077d8514a0596eefacb04de .

}

civic-kb:provenance-35d6315fd077d8514a0596eefacb04de {
	civic-kb:assertion-35d6315fd077d8514a0596eefacb04de prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-35d6315fd077d8514a0596eefacb04de .

	civic-kb:Status-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-35d6315fd077d8514a0596eefacb04de	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-35d6315fd077d8514a0596eefacb04de {
	civic-kb:nanoPub-35d6315fd077d8514a0596eefacb04de prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-35d6315fd077d8514a0596eefacb04de
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-be909b5115b69fcbb971664a8d92559e {
	civic-kb:nanoPub-be909b5115b69fcbb971664a8d92559e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-be909b5115b69fcbb971664a8d92559e ;
		np:hasProvenance civic-kb:provenance-be909b5115b69fcbb971664a8d92559e ;
		np:hasPublicationInfo civic-kb:pubInfo-be909b5115b69fcbb971664a8d92559e .
}

civic-kb:assertion-be909b5115b69fcbb971664a8d92559e {
	civic-kb:Drugs-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-be909b5115b69fcbb971664a8d92559e ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-be909b5115b69fcbb971664a8d92559e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-be909b5115b69fcbb971664a8d92559e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2088"^^xsd:integer .

	civic-kb:Gene-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Q546E"^^xsd:string .

	civic-kb:Description-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-be909b5115b69fcbb971664a8d92559e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-be909b5115b69fcbb971664a8d92559e ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-be909b5115b69fcbb971664a8d92559e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-be909b5115b69fcbb971664a8d92559e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-be909b5115b69fcbb971664a8d92559e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-be909b5115b69fcbb971664a8d92559e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-be909b5115b69fcbb971664a8d92559e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-be909b5115b69fcbb971664a8d92559e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-be909b5115b69fcbb971664a8d92559e .

}

civic-kb:provenance-be909b5115b69fcbb971664a8d92559e {
	civic-kb:assertion-be909b5115b69fcbb971664a8d92559e prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-be909b5115b69fcbb971664a8d92559e .

	civic-kb:Status-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-be909b5115b69fcbb971664a8d92559e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-be909b5115b69fcbb971664a8d92559e {
	civic-kb:nanoPub-be909b5115b69fcbb971664a8d92559e prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-be909b5115b69fcbb971664a8d92559e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-1eb78f6900b6a897f95d2714ce5b244e {
	civic-kb:nanoPub-1eb78f6900b6a897f95d2714ce5b244e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-1eb78f6900b6a897f95d2714ce5b244e ;
		np:hasProvenance civic-kb:provenance-1eb78f6900b6a897f95d2714ce5b244e ;
		np:hasPublicationInfo civic-kb:pubInfo-1eb78f6900b6a897f95d2714ce5b244e .
}

civic-kb:assertion-1eb78f6900b6a897f95d2714ce5b244e {
	civic-kb:Drugs-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1eb78f6900b6a897f95d2714ce5b244e ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-1eb78f6900b6a897f95d2714ce5b244e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-1eb78f6900b6a897f95d2714ce5b244e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2086"^^xsd:integer .

	civic-kb:Gene-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Q546E"^^xsd:string .

	civic-kb:Description-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-1eb78f6900b6a897f95d2714ce5b244e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA mutations were more frequent in grade 2 than in grade 3 invasive breast cancer."^^xsd:string .

	civic-kb:Disease-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1eb78f6900b6a897f95d2714ce5b244e ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-1eb78f6900b6a897f95d2714ce5b244e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1eb78f6900b6a897f95d2714ce5b244e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1eb78f6900b6a897f95d2714ce5b244e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-1eb78f6900b6a897f95d2714ce5b244e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-1eb78f6900b6a897f95d2714ce5b244e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-1eb78f6900b6a897f95d2714ce5b244e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-1eb78f6900b6a897f95d2714ce5b244e .

}

civic-kb:provenance-1eb78f6900b6a897f95d2714ce5b244e {
	civic-kb:assertion-1eb78f6900b6a897f95d2714ce5b244e prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-1eb78f6900b6a897f95d2714ce5b244e .

	civic-kb:Status-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-1eb78f6900b6a897f95d2714ce5b244e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-1eb78f6900b6a897f95d2714ce5b244e {
	civic-kb:nanoPub-1eb78f6900b6a897f95d2714ce5b244e prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-1eb78f6900b6a897f95d2714ce5b244e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-4cf81b4d9ce3b16ab494370c02c9409f {
	civic-kb:nanoPub-4cf81b4d9ce3b16ab494370c02c9409f
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-4cf81b4d9ce3b16ab494370c02c9409f ;
		np:hasProvenance civic-kb:provenance-4cf81b4d9ce3b16ab494370c02c9409f ;
		np:hasPublicationInfo civic-kb:pubInfo-4cf81b4d9ce3b16ab494370c02c9409f .
}

civic-kb:assertion-4cf81b4d9ce3b16ab494370c02c9409f {
	civic-kb:Drugs-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4cf81b4d9ce3b16ab494370c02c9409f ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-4cf81b4d9ce3b16ab494370c02c9409f ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-4cf81b4d9ce3b16ab494370c02c9409f ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2087"^^xsd:integer .

	civic-kb:Gene-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Q546E"^^xsd:string .

	civic-kb:Description-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-4cf81b4d9ce3b16ab494370c02c9409f ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In HER2-positive metastic breast cancer patients treated with trastuzumab-based therapy, the presence of a PIK3CA mutation was associated with an increased risk of progression (HR:2.50, 95% CI:1.35-4.61, P=0.003, univariate analysis; HR:1.86, 95% CI:1.13-3.05, P=0.014, multivariate analysis) and reduced time to progression (HR:2.50, 95% CI:1.35-4.61, P=0.003) compared to wildtype PIK3CA."^^xsd:string .

	civic-kb:Disease-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4cf81b4d9ce3b16ab494370c02c9409f ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-4cf81b4d9ce3b16ab494370c02c9409f ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4cf81b4d9ce3b16ab494370c02c9409f ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4cf81b4d9ce3b16ab494370c02c9409f ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-4cf81b4d9ce3b16ab494370c02c9409f ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-4cf81b4d9ce3b16ab494370c02c9409f ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-4cf81b4d9ce3b16ab494370c02c9409f	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-4cf81b4d9ce3b16ab494370c02c9409f .

}

civic-kb:provenance-4cf81b4d9ce3b16ab494370c02c9409f {
	civic-kb:assertion-4cf81b4d9ce3b16ab494370c02c9409f prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-4cf81b4d9ce3b16ab494370c02c9409f .

	civic-kb:Status-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-4cf81b4d9ce3b16ab494370c02c9409f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-4cf81b4d9ce3b16ab494370c02c9409f {
	civic-kb:nanoPub-4cf81b4d9ce3b16ab494370c02c9409f prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-4cf81b4d9ce3b16ab494370c02c9409f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-dc8c25ed5f795329f7e73f17ef3cfba5 {
	civic-kb:nanoPub-dc8c25ed5f795329f7e73f17ef3cfba5
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		np:hasProvenance civic-kb:provenance-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		np:hasPublicationInfo civic-kb:pubInfo-dc8c25ed5f795329f7e73f17ef3cfba5 .
}

civic-kb:assertion-dc8c25ed5f795329f7e73f17ef3cfba5 {
	civic-kb:Drugs-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		rdf:type	dron:00730818 ;
		rdf:type	db:DB05773 ;
		rdfs:label	"Ado-trastuzumab Emtansine"^^xsd:string ;
		sio:hasValue	"Ado-trastuzumab Emtansine"^^xsd:string .

	civic-kb:Status-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2866"^^xsd:integer .

	civic-kb:Gene-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"K111N"^^xsd:string .

	civic-kb:Description-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase 3 clinical trial (NCT00829166), metastatic breast cancer patients with PIK3CA mutation (n=40), including patients with PIK3CA K111N, treated with ado-trastuzumab were associated with improved median progression free survival (10.9 vs. 9.8 months), as compared to patients with wild-type PIK3CA (n=93). Further, the patients harboring PIK3CA mutations (n=79) were associated with a decrease in disease progression (ado-trastuzumab relative to standard chemotherapy; HR:0.45; 95% CI:0.25-0.82), as compared to patients with wild-type PIK3CA (n=180; HR:0.74; 95% CI:0.50-1.10). In an in vitro study, BT-474 cell line expressing PIK3CA K111N mutation was associated with increased sensitivity to ado-trastuzumab emtansine treatment compared to trastuzumab treated BT-474 cells. Sensitivity was determined by assessing cell viability. Further, in an in vivo study, BT-474M1 xenografts expressing PIK3CA K111N were reportedly sensitive to ado-trastuzumab emtansine, as assessed by tumor growth."^^xsd:string .

	civic-kb:Disease-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-dc8c25ed5f795329f7e73f17ef3cfba5 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-dc8c25ed5f795329f7e73f17ef3cfba5	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-dc8c25ed5f795329f7e73f17ef3cfba5 .

}

civic-kb:provenance-dc8c25ed5f795329f7e73f17ef3cfba5 {
	civic-kb:assertion-dc8c25ed5f795329f7e73f17ef3cfba5 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-dc8c25ed5f795329f7e73f17ef3cfba5 .

	civic-kb:Status-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-dc8c25ed5f795329f7e73f17ef3cfba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-dc8c25ed5f795329f7e73f17ef3cfba5 {
	civic-kb:nanoPub-dc8c25ed5f795329f7e73f17ef3cfba5 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-dc8c25ed5f795329f7e73f17ef3cfba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-79c5cce204b80f1d7dde8fd9f8d9c01e {
	civic-kb:nanoPub-79c5cce204b80f1d7dde8fd9f8d9c01e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		np:hasProvenance civic-kb:provenance-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		np:hasPublicationInfo civic-kb:pubInfo-79c5cce204b80f1d7dde8fd9f8d9c01e .
}

civic-kb:assertion-79c5cce204b80f1d7dde8fd9f8d9c01e {
	civic-kb:Drugs-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		rdf:type	dron:00730818 ;
		rdf:type	db:DB05773 ;
		rdfs:label	"Ado-trastuzumab Emtansine"^^xsd:string ;
		sio:hasValue	"Ado-trastuzumab Emtansine"^^xsd:string .

	civic-kb:Status-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2867"^^xsd:integer .

	civic-kb:Gene-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"I391M"^^xsd:string .

	civic-kb:Description-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase 3 clinical trial (NCT00829166), metastatic breast cancer patients with PIK3CA mutation (n=40), including patients with PIK3CA I391M, treated with ado-trastuzumab were associated with improved median progression free survival (10.9 vs. 9.8 months), as compared to patients with wild-type PIK3CA (n=93). Further, the patients harboring PIK3CA mutations (n=79) were associated with a decrease in disease progression (ado-trastuzumab relative to standard chemotherapy; HR:0.45; 95% CI:0.25-0.82), as compared to patients with wild-type PIK3CA (n=180; HR:0.74; 95% CI:0.50-1.10). In an in vitro study, ZR-75-30 cell line expressing PIK3CA I391M mutation was associated with increased sensitivity to ado-trastuzumab emtansine treatment compared to trastuzumab treated ZR-75-30 cells. Sensitivity was determined by assessing cell viability."^^xsd:string .

	civic-kb:Disease-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-79c5cce204b80f1d7dde8fd9f8d9c01e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-79c5cce204b80f1d7dde8fd9f8d9c01e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-79c5cce204b80f1d7dde8fd9f8d9c01e .

}

civic-kb:provenance-79c5cce204b80f1d7dde8fd9f8d9c01e {
	civic-kb:assertion-79c5cce204b80f1d7dde8fd9f8d9c01e prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-79c5cce204b80f1d7dde8fd9f8d9c01e .

	civic-kb:Status-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-79c5cce204b80f1d7dde8fd9f8d9c01e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-79c5cce204b80f1d7dde8fd9f8d9c01e {
	civic-kb:nanoPub-79c5cce204b80f1d7dde8fd9f8d9c01e prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-79c5cce204b80f1d7dde8fd9f8d9c01e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-be554134f44cd68fba04f09a90455aa0 {
	civic-kb:nanoPub-be554134f44cd68fba04f09a90455aa0
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-be554134f44cd68fba04f09a90455aa0 ;
		np:hasProvenance civic-kb:provenance-be554134f44cd68fba04f09a90455aa0 ;
		np:hasPublicationInfo civic-kb:pubInfo-be554134f44cd68fba04f09a90455aa0 .
}

civic-kb:assertion-be554134f44cd68fba04f09a90455aa0 {
	civic-kb:Drugs-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-be554134f44cd68fba04f09a90455aa0 ;
		sio:hasValue	"Neratinib, Lapatinib"^^xsd:string .

	civic-kb:Status-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-be554134f44cd68fba04f09a90455aa0 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-be554134f44cd68fba04f09a90455aa0 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"279"^^xsd:integer .

	civic-kb:Gene-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"D769H"^^xsd:string .

	civic-kb:Description-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-be554134f44cd68fba04f09a90455aa0 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In MCF10A cell lines, the D769H mutation was shown to be sensitive to neratinib."^^xsd:string .

	civic-kb:Disease-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-be554134f44cd68fba04f09a90455aa0 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-be554134f44cd68fba04f09a90455aa0 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-be554134f44cd68fba04f09a90455aa0 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-be554134f44cd68fba04f09a90455aa0 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-be554134f44cd68fba04f09a90455aa0 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-be554134f44cd68fba04f09a90455aa0 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-be554134f44cd68fba04f09a90455aa0	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-be554134f44cd68fba04f09a90455aa0 .

}

civic-kb:provenance-be554134f44cd68fba04f09a90455aa0 {
	civic-kb:assertion-be554134f44cd68fba04f09a90455aa0 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-be554134f44cd68fba04f09a90455aa0 .

	civic-kb:Status-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-be554134f44cd68fba04f09a90455aa0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-be554134f44cd68fba04f09a90455aa0 {
	civic-kb:nanoPub-be554134f44cd68fba04f09a90455aa0 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-be554134f44cd68fba04f09a90455aa0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-76fd36129a66c0eb5315ec062cca4d55 {
	civic-kb:nanoPub-76fd36129a66c0eb5315ec062cca4d55
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-76fd36129a66c0eb5315ec062cca4d55 ;
		np:hasProvenance civic-kb:provenance-76fd36129a66c0eb5315ec062cca4d55 ;
		np:hasPublicationInfo civic-kb:pubInfo-76fd36129a66c0eb5315ec062cca4d55 .
}

civic-kb:assertion-76fd36129a66c0eb5315ec062cca4d55 {
	civic-kb:Drugs-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-76fd36129a66c0eb5315ec062cca4d55 .

	civic-kb:Status-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-76fd36129a66c0eb5315ec062cca4d55 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-76fd36129a66c0eb5315ec062cca4d55 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"793"^^xsd:integer .

	civic-kb:Gene-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C19929 ;
		rdf:type	uniprot:P11362 ;
		rdfs:label	"FGFR1 Gene"^^xsd:string ;
		sio:hasValue	"FGFR1"^^xsd:string .

	civic-kb:Variant-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C16608 ;
		rdfs:label	"Expression"^^xsd:string ;
		sio:hasValue	"EXPRESSION"^^xsd:string .

	civic-kb:Description-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-76fd36129a66c0eb5315ec062cca4d55 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"FGFR1 expression, was assessed by IHC in 1,086 invasive breast cancers. FGFR1 expression was mainly associated with luminal cancer subtypes. Multivariate Cox regression analysis showed FGFR1 to be an independent poor prognostic marker in luminal A cancers for disease free survival (hazard ratio = 3.341, p = 0.008). In luminal A cancers, FGFR1 expression was also significantly associated with higher pN (lymph node metastases; p = 0.023) and pT (unfavorable tumor characteristics; p = 0.003) stages and lymphovascular invasion (p = 0.010)."^^xsd:string .

	civic-kb:Disease-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-76fd36129a66c0eb5315ec062cca4d55 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-76fd36129a66c0eb5315ec062cca4d55 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-76fd36129a66c0eb5315ec062cca4d55 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-76fd36129a66c0eb5315ec062cca4d55 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-76fd36129a66c0eb5315ec062cca4d55 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-76fd36129a66c0eb5315ec062cca4d55 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-76fd36129a66c0eb5315ec062cca4d55	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-76fd36129a66c0eb5315ec062cca4d55 .

}

civic-kb:provenance-76fd36129a66c0eb5315ec062cca4d55 {
	civic-kb:assertion-76fd36129a66c0eb5315ec062cca4d55 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-76fd36129a66c0eb5315ec062cca4d55 .

	civic-kb:Status-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-76fd36129a66c0eb5315ec062cca4d55	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-76fd36129a66c0eb5315ec062cca4d55 {
	civic-kb:nanoPub-76fd36129a66c0eb5315ec062cca4d55 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-76fd36129a66c0eb5315ec062cca4d55
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8bf7dff55aa77be27dc804b8cb69746a {
	civic-kb:nanoPub-8bf7dff55aa77be27dc804b8cb69746a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8bf7dff55aa77be27dc804b8cb69746a ;
		np:hasProvenance civic-kb:provenance-8bf7dff55aa77be27dc804b8cb69746a ;
		np:hasPublicationInfo civic-kb:pubInfo-8bf7dff55aa77be27dc804b8cb69746a .
}

civic-kb:assertion-8bf7dff55aa77be27dc804b8cb69746a {
	civic-kb:Drugs-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8bf7dff55aa77be27dc804b8cb69746a ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8bf7dff55aa77be27dc804b8cb69746a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8bf7dff55aa77be27dc804b8cb69746a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3022"^^xsd:integer .

	civic-kb:Gene-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"V773"^^xsd:string .

	civic-kb:Description-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8bf7dff55aa77be27dc804b8cb69746a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"V773L was identified in 2/338 HER2-negative tumors (2/1248 total tumors). In vitro studies showed that MCF10A cells with HER2 V773L were sensitive to trastuzumab treatment."^^xsd:string .

	civic-kb:Disease-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8bf7dff55aa77be27dc804b8cb69746a ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8bf7dff55aa77be27dc804b8cb69746a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8bf7dff55aa77be27dc804b8cb69746a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8bf7dff55aa77be27dc804b8cb69746a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8bf7dff55aa77be27dc804b8cb69746a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8bf7dff55aa77be27dc804b8cb69746a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-8bf7dff55aa77be27dc804b8cb69746a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8bf7dff55aa77be27dc804b8cb69746a .

}

civic-kb:provenance-8bf7dff55aa77be27dc804b8cb69746a {
	civic-kb:assertion-8bf7dff55aa77be27dc804b8cb69746a prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8bf7dff55aa77be27dc804b8cb69746a .

	civic-kb:Status-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-8bf7dff55aa77be27dc804b8cb69746a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8bf7dff55aa77be27dc804b8cb69746a {
	civic-kb:nanoPub-8bf7dff55aa77be27dc804b8cb69746a prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8bf7dff55aa77be27dc804b8cb69746a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-e4912a5b202adec30ad96333c48f92e9 {
	civic-kb:nanoPub-e4912a5b202adec30ad96333c48f92e9
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-e4912a5b202adec30ad96333c48f92e9 ;
		np:hasProvenance civic-kb:provenance-e4912a5b202adec30ad96333c48f92e9 ;
		np:hasPublicationInfo civic-kb:pubInfo-e4912a5b202adec30ad96333c48f92e9 .
}

civic-kb:assertion-e4912a5b202adec30ad96333c48f92e9 {
	civic-kb:Drugs-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-e4912a5b202adec30ad96333c48f92e9 ;
		rdf:type	db:DB11828 ;
		rdfs:label	"Neratinib"^^xsd:string ;
		sio:hasValue	"Neratinib"^^xsd:string .

	civic-kb:Status-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-e4912a5b202adec30ad96333c48f92e9 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-e4912a5b202adec30ad96333c48f92e9 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"285"^^xsd:integer .

	civic-kb:Gene-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"P780INS"^^xsd:string .

	civic-kb:Description-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-e4912a5b202adec30ad96333c48f92e9 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In MCF10A cell lines, the in-frame insertion of a single amino acid at position 780 was shown to be sensitive to neratinib."^^xsd:string .

	civic-kb:Disease-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-e4912a5b202adec30ad96333c48f92e9 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-e4912a5b202adec30ad96333c48f92e9 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-e4912a5b202adec30ad96333c48f92e9 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-e4912a5b202adec30ad96333c48f92e9 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-e4912a5b202adec30ad96333c48f92e9 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-e4912a5b202adec30ad96333c48f92e9 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-e4912a5b202adec30ad96333c48f92e9	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-e4912a5b202adec30ad96333c48f92e9 .

}

civic-kb:provenance-e4912a5b202adec30ad96333c48f92e9 {
	civic-kb:assertion-e4912a5b202adec30ad96333c48f92e9 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-e4912a5b202adec30ad96333c48f92e9 .

	civic-kb:Status-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-e4912a5b202adec30ad96333c48f92e9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-e4912a5b202adec30ad96333c48f92e9 {
	civic-kb:nanoPub-e4912a5b202adec30ad96333c48f92e9 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-e4912a5b202adec30ad96333c48f92e9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f82f1e2df3be33ad986b32c9da71241f {
	civic-kb:nanoPub-f82f1e2df3be33ad986b32c9da71241f
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f82f1e2df3be33ad986b32c9da71241f ;
		np:hasProvenance civic-kb:provenance-f82f1e2df3be33ad986b32c9da71241f ;
		np:hasPublicationInfo civic-kb:pubInfo-f82f1e2df3be33ad986b32c9da71241f .
}

civic-kb:assertion-f82f1e2df3be33ad986b32c9da71241f {
	civic-kb:Drugs-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f82f1e2df3be33ad986b32c9da71241f .

	civic-kb:Status-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f82f1e2df3be33ad986b32c9da71241f ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f82f1e2df3be33ad986b32c9da71241f ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1123"^^xsd:integer .

	civic-kb:Gene-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17965 ;
		rdf:type	uniprot:P38398 ;
		rdfs:label	"BRCA1 Gene"^^xsd:string ;
		sio:hasValue	"BRCA1"^^xsd:string .

	civic-kb:Variant-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"P968FS"^^xsd:string .

	civic-kb:Description-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f82f1e2df3be33ad986b32c9da71241f ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A 55-year-old non-Ashkenazi Spanish female diagnosed with breast cancer (at 51 years old) and ovarian cancer. Sequencing of BRCA1 and BRCA2 revealed a 2-base frameshift insertion in BRCA1 (labeled 3020insCT/c.2901insCT in this paper, with the data shown corresponding to a GA insertion, reading left to right in the reference genome, between chr17:43092628-43092629 in GRCh38). This mutation ultimately causes a downstream premature stop codon and truncated BRCA1."^^xsd:string .

	civic-kb:Disease-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f82f1e2df3be33ad986b32c9da71241f ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f82f1e2df3be33ad986b32c9da71241f ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f82f1e2df3be33ad986b32c9da71241f ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predisposing"^^xsd:string .

	civic-kb:Evidence_Direction-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f82f1e2df3be33ad986b32c9da71241f ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Likely Pathogenic"^^xsd:string .

	civic-kb:Variant_Origin-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f82f1e2df3be33ad986b32c9da71241f ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f82f1e2df3be33ad986b32c9da71241f ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-f82f1e2df3be33ad986b32c9da71241f	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f82f1e2df3be33ad986b32c9da71241f .

}

civic-kb:provenance-f82f1e2df3be33ad986b32c9da71241f {
	civic-kb:assertion-f82f1e2df3be33ad986b32c9da71241f prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f82f1e2df3be33ad986b32c9da71241f .

	civic-kb:Status-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-f82f1e2df3be33ad986b32c9da71241f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f82f1e2df3be33ad986b32c9da71241f {
	civic-kb:nanoPub-f82f1e2df3be33ad986b32c9da71241f prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f82f1e2df3be33ad986b32c9da71241f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-6cbcd6f49c523335bbd7bd3ec0c99d15 {
	civic-kb:nanoPub-6cbcd6f49c523335bbd7bd3ec0c99d15
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		np:hasProvenance civic-kb:provenance-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		np:hasPublicationInfo civic-kb:pubInfo-6cbcd6f49c523335bbd7bd3ec0c99d15 .
}

civic-kb:assertion-6cbcd6f49c523335bbd7bd3ec0c99d15 {
	civic-kb:Drugs-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3020"^^xsd:integer .

	civic-kb:Gene-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L768S"^^xsd:string .

	civic-kb:Description-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"L768S was identified in 1/338 HER2-negative tumors (1/1248 total tumors). In vitro studies showed that MCF10A cells with HER2 L768S were sensitive to trastuzumab treatment."^^xsd:string .

	civic-kb:Disease-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-6cbcd6f49c523335bbd7bd3ec0c99d15 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-6cbcd6f49c523335bbd7bd3ec0c99d15	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-6cbcd6f49c523335bbd7bd3ec0c99d15 .

}

civic-kb:provenance-6cbcd6f49c523335bbd7bd3ec0c99d15 {
	civic-kb:assertion-6cbcd6f49c523335bbd7bd3ec0c99d15 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-6cbcd6f49c523335bbd7bd3ec0c99d15 .

	civic-kb:Status-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-6cbcd6f49c523335bbd7bd3ec0c99d15	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-6cbcd6f49c523335bbd7bd3ec0c99d15 {
	civic-kb:nanoPub-6cbcd6f49c523335bbd7bd3ec0c99d15 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-6cbcd6f49c523335bbd7bd3ec0c99d15
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c26e67445dc12a6145a7523cadc48e16 {
	civic-kb:nanoPub-c26e67445dc12a6145a7523cadc48e16
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c26e67445dc12a6145a7523cadc48e16 ;
		np:hasProvenance civic-kb:provenance-c26e67445dc12a6145a7523cadc48e16 ;
		np:hasPublicationInfo civic-kb:pubInfo-c26e67445dc12a6145a7523cadc48e16 .
}

civic-kb:assertion-c26e67445dc12a6145a7523cadc48e16 {
	civic-kb:Drugs-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c26e67445dc12a6145a7523cadc48e16 ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c26e67445dc12a6145a7523cadc48e16 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c26e67445dc12a6145a7523cadc48e16 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3021"^^xsd:integer .

	civic-kb:Gene-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L638S"^^xsd:string .

	civic-kb:Description-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c26e67445dc12a6145a7523cadc48e16 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"L768S was identified in 1/338 HER2-negative tumors (1/1248 total tumors). In vitro studies showed that MCF10A cells with HER2 L768S were sensitive to lapatinib treatment."^^xsd:string .

	civic-kb:Disease-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c26e67445dc12a6145a7523cadc48e16 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c26e67445dc12a6145a7523cadc48e16 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c26e67445dc12a6145a7523cadc48e16 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c26e67445dc12a6145a7523cadc48e16 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c26e67445dc12a6145a7523cadc48e16 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c26e67445dc12a6145a7523cadc48e16 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-c26e67445dc12a6145a7523cadc48e16	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c26e67445dc12a6145a7523cadc48e16 .

}

civic-kb:provenance-c26e67445dc12a6145a7523cadc48e16 {
	civic-kb:assertion-c26e67445dc12a6145a7523cadc48e16 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c26e67445dc12a6145a7523cadc48e16 .

	civic-kb:Status-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-c26e67445dc12a6145a7523cadc48e16	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c26e67445dc12a6145a7523cadc48e16 {
	civic-kb:nanoPub-c26e67445dc12a6145a7523cadc48e16 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c26e67445dc12a6145a7523cadc48e16
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-586579d6d91d446e778659aa5b3cb199 {
	civic-kb:nanoPub-586579d6d91d446e778659aa5b3cb199
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-586579d6d91d446e778659aa5b3cb199 ;
		np:hasProvenance civic-kb:provenance-586579d6d91d446e778659aa5b3cb199 ;
		np:hasPublicationInfo civic-kb:pubInfo-586579d6d91d446e778659aa5b3cb199 .
}

civic-kb:assertion-586579d6d91d446e778659aa5b3cb199 {
	civic-kb:Drugs-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-586579d6d91d446e778659aa5b3cb199 ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-586579d6d91d446e778659aa5b3cb199 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-586579d6d91d446e778659aa5b3cb199 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3024"^^xsd:integer .

	civic-kb:Gene-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"K753E"^^xsd:string .

	civic-kb:Description-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-586579d6d91d446e778659aa5b3cb199 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"K753E was identified in 6/338 HER2-positive tumors (2/1248 total tumors). In vitro studies showed that MCF10A cells with HER2 K753E were more resistant to lapatinib treatment in comparison to HER2 WT and other HER2 mutant (L768S, V773L, R647K, I655V, K676R, Q680R) cells."^^xsd:string .

	civic-kb:Disease-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-586579d6d91d446e778659aa5b3cb199 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-586579d6d91d446e778659aa5b3cb199 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-586579d6d91d446e778659aa5b3cb199 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-586579d6d91d446e778659aa5b3cb199 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-586579d6d91d446e778659aa5b3cb199 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-586579d6d91d446e778659aa5b3cb199 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-586579d6d91d446e778659aa5b3cb199	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-586579d6d91d446e778659aa5b3cb199 .

}

civic-kb:provenance-586579d6d91d446e778659aa5b3cb199 {
	civic-kb:assertion-586579d6d91d446e778659aa5b3cb199 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-586579d6d91d446e778659aa5b3cb199 .

	civic-kb:Status-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-586579d6d91d446e778659aa5b3cb199	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-586579d6d91d446e778659aa5b3cb199 {
	civic-kb:nanoPub-586579d6d91d446e778659aa5b3cb199 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-586579d6d91d446e778659aa5b3cb199
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-27053cc555aa6cebcfb20ff9d57114d6 {
	civic-kb:nanoPub-27053cc555aa6cebcfb20ff9d57114d6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-27053cc555aa6cebcfb20ff9d57114d6 ;
		np:hasProvenance civic-kb:provenance-27053cc555aa6cebcfb20ff9d57114d6 ;
		np:hasPublicationInfo civic-kb:pubInfo-27053cc555aa6cebcfb20ff9d57114d6 .
}

civic-kb:assertion-27053cc555aa6cebcfb20ff9d57114d6 {
	civic-kb:Drugs-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-27053cc555aa6cebcfb20ff9d57114d6 ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-27053cc555aa6cebcfb20ff9d57114d6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-27053cc555aa6cebcfb20ff9d57114d6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3023"^^xsd:integer .

	civic-kb:Gene-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"V773L"^^xsd:string .

	civic-kb:Description-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-27053cc555aa6cebcfb20ff9d57114d6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"V773L was identified in 2/338 HER2-negative tumors (2/1248 total tumors). In vitro studies showed that MCF10A cells with HER2 V773L were sensitive to lapatinib treatment."^^xsd:string .

	civic-kb:Disease-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-27053cc555aa6cebcfb20ff9d57114d6 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-27053cc555aa6cebcfb20ff9d57114d6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-27053cc555aa6cebcfb20ff9d57114d6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-27053cc555aa6cebcfb20ff9d57114d6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-27053cc555aa6cebcfb20ff9d57114d6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-27053cc555aa6cebcfb20ff9d57114d6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-27053cc555aa6cebcfb20ff9d57114d6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-27053cc555aa6cebcfb20ff9d57114d6 .

}

civic-kb:provenance-27053cc555aa6cebcfb20ff9d57114d6 {
	civic-kb:assertion-27053cc555aa6cebcfb20ff9d57114d6 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-27053cc555aa6cebcfb20ff9d57114d6 .

	civic-kb:Status-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-27053cc555aa6cebcfb20ff9d57114d6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-27053cc555aa6cebcfb20ff9d57114d6 {
	civic-kb:nanoPub-27053cc555aa6cebcfb20ff9d57114d6 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-27053cc555aa6cebcfb20ff9d57114d6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-6e504948c23a9df802dd886b1658a7e0 {
	civic-kb:nanoPub-6e504948c23a9df802dd886b1658a7e0
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-6e504948c23a9df802dd886b1658a7e0 ;
		np:hasProvenance civic-kb:provenance-6e504948c23a9df802dd886b1658a7e0 ;
		np:hasPublicationInfo civic-kb:pubInfo-6e504948c23a9df802dd886b1658a7e0 .
}

civic-kb:assertion-6e504948c23a9df802dd886b1658a7e0 {
	civic-kb:Drugs-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6e504948c23a9df802dd886b1658a7e0 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-6e504948c23a9df802dd886b1658a7e0 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-6e504948c23a9df802dd886b1658a7e0 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3025"^^xsd:integer .

	civic-kb:Gene-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L753E"^^xsd:string .

	civic-kb:Description-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-6e504948c23a9df802dd886b1658a7e0 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"K753E was identified in 6/338 HER2-positive tumors (2/1248 total tumors). In vitro studies showed that MCF10A cells with HER2 K753E were more resistant to trastuzumab treatment than HER2 WT cells. 2/18 metastatic HER2-positive breast cancers had the L753E mutation after one year of adjuvant trastuzumab. L753E was undetectable in the corresponding primary tumors."^^xsd:string .

	civic-kb:Disease-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6e504948c23a9df802dd886b1658a7e0 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-6e504948c23a9df802dd886b1658a7e0 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6e504948c23a9df802dd886b1658a7e0 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6e504948c23a9df802dd886b1658a7e0 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-6e504948c23a9df802dd886b1658a7e0 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-6e504948c23a9df802dd886b1658a7e0 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-6e504948c23a9df802dd886b1658a7e0	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-6e504948c23a9df802dd886b1658a7e0 .

}

civic-kb:provenance-6e504948c23a9df802dd886b1658a7e0 {
	civic-kb:assertion-6e504948c23a9df802dd886b1658a7e0 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-6e504948c23a9df802dd886b1658a7e0 .

	civic-kb:Status-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-6e504948c23a9df802dd886b1658a7e0	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-6e504948c23a9df802dd886b1658a7e0 {
	civic-kb:nanoPub-6e504948c23a9df802dd886b1658a7e0 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-6e504948c23a9df802dd886b1658a7e0
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f95ac27c25e34f02fbe3de26cb7cb79e {
	civic-kb:nanoPub-f95ac27c25e34f02fbe3de26cb7cb79e
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f95ac27c25e34f02fbe3de26cb7cb79e ;
		np:hasProvenance civic-kb:provenance-f95ac27c25e34f02fbe3de26cb7cb79e ;
		np:hasPublicationInfo civic-kb:pubInfo-f95ac27c25e34f02fbe3de26cb7cb79e .
}

civic-kb:assertion-f95ac27c25e34f02fbe3de26cb7cb79e {
	civic-kb:Drugs-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f95ac27c25e34f02fbe3de26cb7cb79e ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f95ac27c25e34f02fbe3de26cb7cb79e ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f95ac27c25e34f02fbe3de26cb7cb79e ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3026"^^xsd:integer .

	civic-kb:Gene-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"K755S"^^xsd:string .

	civic-kb:Description-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f95ac27c25e34f02fbe3de26cb7cb79e ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"3/18 metastatic HER2-positive breast cancers had the K755S mutation after one year of adjuvant trastuzumab. K755S was undetectable in the corresponding primary tumors. In vitro experiments showed that MCF10A cells with HER2 K755S were resistant to trastuzumab."^^xsd:string .

	civic-kb:Disease-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f95ac27c25e34f02fbe3de26cb7cb79e ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f95ac27c25e34f02fbe3de26cb7cb79e ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f95ac27c25e34f02fbe3de26cb7cb79e ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f95ac27c25e34f02fbe3de26cb7cb79e ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f95ac27c25e34f02fbe3de26cb7cb79e ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f95ac27c25e34f02fbe3de26cb7cb79e ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-f95ac27c25e34f02fbe3de26cb7cb79e	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f95ac27c25e34f02fbe3de26cb7cb79e .

}

civic-kb:provenance-f95ac27c25e34f02fbe3de26cb7cb79e {
	civic-kb:assertion-f95ac27c25e34f02fbe3de26cb7cb79e prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f95ac27c25e34f02fbe3de26cb7cb79e .

	civic-kb:Status-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-f95ac27c25e34f02fbe3de26cb7cb79e	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f95ac27c25e34f02fbe3de26cb7cb79e {
	civic-kb:nanoPub-f95ac27c25e34f02fbe3de26cb7cb79e prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f95ac27c25e34f02fbe3de26cb7cb79e
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-65fa7a56a8ed76b2c209a16df56b8449 {
	civic-kb:nanoPub-65fa7a56a8ed76b2c209a16df56b8449
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-65fa7a56a8ed76b2c209a16df56b8449 ;
		np:hasProvenance civic-kb:provenance-65fa7a56a8ed76b2c209a16df56b8449 ;
		np:hasPublicationInfo civic-kb:pubInfo-65fa7a56a8ed76b2c209a16df56b8449 .
}

civic-kb:assertion-65fa7a56a8ed76b2c209a16df56b8449 {
	civic-kb:Drugs-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-65fa7a56a8ed76b2c209a16df56b8449 .

	civic-kb:Status-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-65fa7a56a8ed76b2c209a16df56b8449 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-65fa7a56a8ed76b2c209a16df56b8449 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1318"^^xsd:integer .

	civic-kb:Gene-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C84945 ;
		rdf:type	uniprot:Q86YC2 ;
		rdfs:label	"PALB2 Gene"^^xsd:string ;
		sio:hasValue	"PALB2"^^xsd:string .

	civic-kb:Variant-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L531FS*30"^^xsd:string .

	civic-kb:Description-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-65fa7a56a8ed76b2c209a16df56b8449 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Study explored the known PALB2 variant c.1592delT (p.L531C) in the context of breast cancer. The study found that among an augmented cohort of breast cancer patients with the variant, there was a hazard ratio of 6.1 (p=.01).  Further there is weak evidence to conclude that breast cancer risk for this variant decreases with age (p=.06)."^^xsd:string .

	civic-kb:Disease-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-65fa7a56a8ed76b2c209a16df56b8449 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-65fa7a56a8ed76b2c209a16df56b8449 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-65fa7a56a8ed76b2c209a16df56b8449 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Diagnostic"^^xsd:string .

	civic-kb:Evidence_Direction-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-65fa7a56a8ed76b2c209a16df56b8449 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Positive"^^xsd:string .

	civic-kb:Variant_Origin-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-65fa7a56a8ed76b2c209a16df56b8449 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Polymorphism"^^xsd:string .

	civic-kb:Trust_Rating-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-65fa7a56a8ed76b2c209a16df56b8449 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-65fa7a56a8ed76b2c209a16df56b8449	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-65fa7a56a8ed76b2c209a16df56b8449 .

}

civic-kb:provenance-65fa7a56a8ed76b2c209a16df56b8449 {
	civic-kb:assertion-65fa7a56a8ed76b2c209a16df56b8449 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-65fa7a56a8ed76b2c209a16df56b8449 .

	civic-kb:Status-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-65fa7a56a8ed76b2c209a16df56b8449	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-65fa7a56a8ed76b2c209a16df56b8449 {
	civic-kb:nanoPub-65fa7a56a8ed76b2c209a16df56b8449 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-65fa7a56a8ed76b2c209a16df56b8449
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-9083091201a72cb9168effe63683f2e2 {
	civic-kb:nanoPub-9083091201a72cb9168effe63683f2e2
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-9083091201a72cb9168effe63683f2e2 ;
		np:hasProvenance civic-kb:provenance-9083091201a72cb9168effe63683f2e2 ;
		np:hasPublicationInfo civic-kb:pubInfo-9083091201a72cb9168effe63683f2e2 .
}

civic-kb:assertion-9083091201a72cb9168effe63683f2e2 {
	civic-kb:Drugs-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9083091201a72cb9168effe63683f2e2 ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib"^^xsd:string .

	civic-kb:Status-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-9083091201a72cb9168effe63683f2e2 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-9083091201a72cb9168effe63683f2e2 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4811"^^xsd:integer .

	civic-kb:Gene-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L536R"^^xsd:string .

	civic-kb:Description-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-9083091201a72cb9168effe63683f2e2 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase 3 clinical trial (NCT01942135) of 360 premenopausal and postmenopausal women with advanced, hormone receptor-positive breast cancer who had progressed during prior endocrine therapy, patients with ESR1 mutations (91/360), including ESR1 L536R (n=1), treated with palbociclib and fulvestrant were associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (HR:0.43; 95% CI:0.25-0.74; P=0.002). Patient without detected ESR1 mutation treated with palbociclib and fulvestrant were also associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (9.5 vs. 5.4 months; HR:0.49; 95% CI:0.35-0.70; P<0.001)."^^xsd:string .

	civic-kb:Disease-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9083091201a72cb9168effe63683f2e2 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-9083091201a72cb9168effe63683f2e2 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9083091201a72cb9168effe63683f2e2 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9083091201a72cb9168effe63683f2e2 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-9083091201a72cb9168effe63683f2e2 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-9083091201a72cb9168effe63683f2e2 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-9083091201a72cb9168effe63683f2e2	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-9083091201a72cb9168effe63683f2e2 .

}

civic-kb:provenance-9083091201a72cb9168effe63683f2e2 {
	civic-kb:assertion-9083091201a72cb9168effe63683f2e2 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-9083091201a72cb9168effe63683f2e2 .

	civic-kb:Status-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-9083091201a72cb9168effe63683f2e2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-9083091201a72cb9168effe63683f2e2 {
	civic-kb:nanoPub-9083091201a72cb9168effe63683f2e2 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-9083091201a72cb9168effe63683f2e2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-fa5319036b8af5ee1e6792a02dacb070 {
	civic-kb:nanoPub-fa5319036b8af5ee1e6792a02dacb070
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-fa5319036b8af5ee1e6792a02dacb070 ;
		np:hasProvenance civic-kb:provenance-fa5319036b8af5ee1e6792a02dacb070 ;
		np:hasPublicationInfo civic-kb:pubInfo-fa5319036b8af5ee1e6792a02dacb070 .
}

civic-kb:assertion-fa5319036b8af5ee1e6792a02dacb070 {
	civic-kb:Drugs-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fa5319036b8af5ee1e6792a02dacb070 ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib"^^xsd:string .

	civic-kb:Status-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-fa5319036b8af5ee1e6792a02dacb070 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-fa5319036b8af5ee1e6792a02dacb070 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4810"^^xsd:integer .

	civic-kb:Gene-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E380Q"^^xsd:string .

	civic-kb:Description-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-fa5319036b8af5ee1e6792a02dacb070 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-fa5319036b8af5ee1e6792a02dacb070 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-fa5319036b8af5ee1e6792a02dacb070 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fa5319036b8af5ee1e6792a02dacb070 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-fa5319036b8af5ee1e6792a02dacb070 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-fa5319036b8af5ee1e6792a02dacb070 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-fa5319036b8af5ee1e6792a02dacb070 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-fa5319036b8af5ee1e6792a02dacb070	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-fa5319036b8af5ee1e6792a02dacb070 .

}

civic-kb:provenance-fa5319036b8af5ee1e6792a02dacb070 {
	civic-kb:assertion-fa5319036b8af5ee1e6792a02dacb070 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-fa5319036b8af5ee1e6792a02dacb070 .

	civic-kb:Status-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-fa5319036b8af5ee1e6792a02dacb070	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-fa5319036b8af5ee1e6792a02dacb070 {
	civic-kb:nanoPub-fa5319036b8af5ee1e6792a02dacb070 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-fa5319036b8af5ee1e6792a02dacb070
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ac1484b9098a4e1a7a3ef27bbf10854b {
	civic-kb:nanoPub-ac1484b9098a4e1a7a3ef27bbf10854b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ac1484b9098a4e1a7a3ef27bbf10854b ;
		np:hasProvenance civic-kb:provenance-ac1484b9098a4e1a7a3ef27bbf10854b ;
		np:hasPublicationInfo civic-kb:pubInfo-ac1484b9098a4e1a7a3ef27bbf10854b .
}

civic-kb:assertion-ac1484b9098a4e1a7a3ef27bbf10854b {
	civic-kb:Drugs-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ac1484b9098a4e1a7a3ef27bbf10854b ;
		sio:hasValue	"Exemestane, Everolimus"^^xsd:string .

	civic-kb:Status-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ac1484b9098a4e1a7a3ef27bbf10854b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ac1484b9098a4e1a7a3ef27bbf10854b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"5568"^^xsd:integer .

	civic-kb:Gene-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18253 ;
		rdf:type	uniprot:Q15831 ;
		rdfs:label	"STK11 Gene"^^xsd:string ;
		sio:hasValue	"STK11"^^xsd:string .

	civic-kb:Variant-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"F354L"^^xsd:string .

	civic-kb:Description-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ac1484b9098a4e1a7a3ef27bbf10854b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"This study analyzed response to treatment of a heavily pre-treated biphenotypic breast carcinoma patient with a mutation in the gene STK11. The STK11 F354L alteration is associated with loss of heterozygosity (LOH) which suggested a potential role of this variant in mTOR inhibitor sensitivity when under LOH, regardless of its germline or somatic status.  This patient was put onto exemestane and everolimus which significantly reduced the serum levels of alkaline phosphatase and CA15-3.The patient experienced an exceptional 14-month response on this regimen."^^xsd:string .

	civic-kb:Disease-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ac1484b9098a4e1a7a3ef27bbf10854b ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ac1484b9098a4e1a7a3ef27bbf10854b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ac1484b9098a4e1a7a3ef27bbf10854b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ac1484b9098a4e1a7a3ef27bbf10854b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ac1484b9098a4e1a7a3ef27bbf10854b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Germline Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ac1484b9098a4e1a7a3ef27bbf10854b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-ac1484b9098a4e1a7a3ef27bbf10854b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ac1484b9098a4e1a7a3ef27bbf10854b .

}

civic-kb:provenance-ac1484b9098a4e1a7a3ef27bbf10854b {
	civic-kb:assertion-ac1484b9098a4e1a7a3ef27bbf10854b prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ac1484b9098a4e1a7a3ef27bbf10854b .

	civic-kb:Status-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-ac1484b9098a4e1a7a3ef27bbf10854b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ac1484b9098a4e1a7a3ef27bbf10854b {
	civic-kb:nanoPub-ac1484b9098a4e1a7a3ef27bbf10854b prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ac1484b9098a4e1a7a3ef27bbf10854b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-9a589bc3fa8db04d08383bb5cc952cb6 {
	civic-kb:nanoPub-9a589bc3fa8db04d08383bb5cc952cb6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-9a589bc3fa8db04d08383bb5cc952cb6 ;
		np:hasProvenance civic-kb:provenance-9a589bc3fa8db04d08383bb5cc952cb6 ;
		np:hasPublicationInfo civic-kb:pubInfo-9a589bc3fa8db04d08383bb5cc952cb6 .
}

civic-kb:assertion-9a589bc3fa8db04d08383bb5cc952cb6 {
	civic-kb:Drugs-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9a589bc3fa8db04d08383bb5cc952cb6 ;
		rdf:type	dron:00018224 ;
		rdf:type	db:DB01590 ;
		rdfs:label	"Everolimus"^^xsd:string ;
		sio:hasValue	"Everolimus"^^xsd:string .

	civic-kb:Status-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-9a589bc3fa8db04d08383bb5cc952cb6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-9a589bc3fa8db04d08383bb5cc952cb6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1296"^^xsd:integer .

	civic-kb:Gene-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-9a589bc3fa8db04d08383bb5cc952cb6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Archival tumor samples from 549 patients from the BOLERO-1 and -3 trials were analyzed for alterations in the PI3K pathway using next-generation sequencing, immunohistochemistry (IHC) and Sanger sequencing. In the BOLERO trials, patients with HER2-overexpressing advanced breast cancer were treated with trastuzumab, chemotherapy and randomized to receive either everolimus or placebo. In the pooled analysis of both trials, patients with PI3K mutations had longer progression-free survival with everolimus compared to placebo (HR 0.67 95%CI 0.45 to 1.00, P=0.05) whereas patients with PI3K wild type status did not benefit significantly (HR 1.1, 95%CI 0.83 to 1.46, P=0.5). The same was found when PI3K mutations, PTEN loss and AKT E17K mutations were combinedly analyzed as hyperactive PI3K pathway. Patients with PI3K hyperactive pathway had a hazard ratio of 0.67 (95%CI 0.48 to 0.93, P=0.02) compared to HR 1.19 (95%CI 0.87 to 1.62, P=0.28) in patients with PI3K normal pathway. These trends were independently confirmed in both trials but only pooled results showed consistent statistical significance."^^xsd:string .

	civic-kb:Disease-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-9a589bc3fa8db04d08383bb5cc952cb6 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-9a589bc3fa8db04d08383bb5cc952cb6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9a589bc3fa8db04d08383bb5cc952cb6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-9a589bc3fa8db04d08383bb5cc952cb6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-9a589bc3fa8db04d08383bb5cc952cb6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-9a589bc3fa8db04d08383bb5cc952cb6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-9a589bc3fa8db04d08383bb5cc952cb6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-9a589bc3fa8db04d08383bb5cc952cb6 .

}

civic-kb:provenance-9a589bc3fa8db04d08383bb5cc952cb6 {
	civic-kb:assertion-9a589bc3fa8db04d08383bb5cc952cb6 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-9a589bc3fa8db04d08383bb5cc952cb6 .

	civic-kb:Status-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-9a589bc3fa8db04d08383bb5cc952cb6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-9a589bc3fa8db04d08383bb5cc952cb6 {
	civic-kb:nanoPub-9a589bc3fa8db04d08383bb5cc952cb6 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-9a589bc3fa8db04d08383bb5cc952cb6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-17e4219d16357b628ea47479a416c3ca {
	civic-kb:nanoPub-17e4219d16357b628ea47479a416c3ca
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-17e4219d16357b628ea47479a416c3ca ;
		np:hasProvenance civic-kb:provenance-17e4219d16357b628ea47479a416c3ca ;
		np:hasPublicationInfo civic-kb:pubInfo-17e4219d16357b628ea47479a416c3ca .
}

civic-kb:assertion-17e4219d16357b628ea47479a416c3ca {
	civic-kb:Drugs-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-17e4219d16357b628ea47479a416c3ca ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-17e4219d16357b628ea47479a416c3ca ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-17e4219d16357b628ea47479a416c3ca ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1384"^^xsd:integer .

	civic-kb:Gene-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-17e4219d16357b628ea47479a416c3ca ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The HER2 overexpressing breast cancer cell line BT-474 transduced with mutant PIK3CA H1047R demonstrated essentially normal proliferation under trastuzumab, while control cells showed negligible proliferation with trastuzumab. Sequencing of 55 HER2 breast cancer samples revealed 25% PIK3CA mutation rate and Kaplan Meier curves showed decreased time to progression for mutant PIK3CA at borderline statistical significance (p=0.052). This was potentially explained by presence of PTEN loss in wild-type PIK3CA sample and combining PTEN loss with PIK3CA mutation resulted in significant differences in time to progression (p=0.007)."^^xsd:string .

	civic-kb:Disease-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-17e4219d16357b628ea47479a416c3ca ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-17e4219d16357b628ea47479a416c3ca ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-17e4219d16357b628ea47479a416c3ca ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-17e4219d16357b628ea47479a416c3ca ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-17e4219d16357b628ea47479a416c3ca ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-17e4219d16357b628ea47479a416c3ca ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-17e4219d16357b628ea47479a416c3ca	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-17e4219d16357b628ea47479a416c3ca .

}

civic-kb:provenance-17e4219d16357b628ea47479a416c3ca {
	civic-kb:assertion-17e4219d16357b628ea47479a416c3ca prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-17e4219d16357b628ea47479a416c3ca .

	civic-kb:Status-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-17e4219d16357b628ea47479a416c3ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-17e4219d16357b628ea47479a416c3ca {
	civic-kb:nanoPub-17e4219d16357b628ea47479a416c3ca prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-17e4219d16357b628ea47479a416c3ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-ecbf420adf4555c66e554590deaac323 {
	civic-kb:nanoPub-ecbf420adf4555c66e554590deaac323
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-ecbf420adf4555c66e554590deaac323 ;
		np:hasProvenance civic-kb:provenance-ecbf420adf4555c66e554590deaac323 ;
		np:hasPublicationInfo civic-kb:pubInfo-ecbf420adf4555c66e554590deaac323 .
}

civic-kb:assertion-ecbf420adf4555c66e554590deaac323 {
	civic-kb:Drugs-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ecbf420adf4555c66e554590deaac323 ;
		sio:hasValue	"Palbociclib (PD0332991), PI3K Inhibitor"^^xsd:string .

	civic-kb:Status-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-ecbf420adf4555c66e554590deaac323 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-ecbf420adf4555c66e554590deaac323 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1607"^^xsd:integer .

	civic-kb:Gene-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-ecbf420adf4555c66e554590deaac323 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Three PIK3CA mutant breast cancer cell lines were rendered resistant to PI3K inhibitors (BYL719 or GDC-0941) by chronic exposure. Co-treatment of all three cell lines with PI3K inhibitor and CDK4/6 inhibitor palbociclib resulted in synergistic reductions in cell viability which were not seen with treatment of either compound alone, and resulted in similar suppression to viability as seen in the respective PI3K inhibitor sensitive parental cell lines."^^xsd:string .

	civic-kb:Disease-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-ecbf420adf4555c66e554590deaac323 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-ecbf420adf4555c66e554590deaac323 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ecbf420adf4555c66e554590deaac323 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-ecbf420adf4555c66e554590deaac323 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-ecbf420adf4555c66e554590deaac323 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-ecbf420adf4555c66e554590deaac323 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-ecbf420adf4555c66e554590deaac323	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-ecbf420adf4555c66e554590deaac323 .

}

civic-kb:provenance-ecbf420adf4555c66e554590deaac323 {
	civic-kb:assertion-ecbf420adf4555c66e554590deaac323 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-ecbf420adf4555c66e554590deaac323 .

	civic-kb:Status-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-ecbf420adf4555c66e554590deaac323	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-ecbf420adf4555c66e554590deaac323 {
	civic-kb:nanoPub-ecbf420adf4555c66e554590deaac323 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-ecbf420adf4555c66e554590deaac323
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8b9fc6eca924889b2c74c2795b3f6ebb {
	civic-kb:nanoPub-8b9fc6eca924889b2c74c2795b3f6ebb
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8b9fc6eca924889b2c74c2795b3f6ebb ;
		np:hasProvenance civic-kb:provenance-8b9fc6eca924889b2c74c2795b3f6ebb ;
		np:hasPublicationInfo civic-kb:pubInfo-8b9fc6eca924889b2c74c2795b3f6ebb .
}

civic-kb:assertion-8b9fc6eca924889b2c74c2795b3f6ebb {
	civic-kb:Drugs-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8b9fc6eca924889b2c74c2795b3f6ebb ;
		sio:hasValue	"Ribociclib, PI3K Inhibitor"^^xsd:string .

	civic-kb:Status-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8b9fc6eca924889b2c74c2795b3f6ebb ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8b9fc6eca924889b2c74c2795b3f6ebb ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1600"^^xsd:integer .

	civic-kb:Gene-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8b9fc6eca924889b2c74c2795b3f6ebb ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Three PI3K mutant breast cancer cell lines were rendered resistant to PI3K inhibitors (BYL719 or GDC-0941), and a panel of 42 inhibitor compounds was tested on the cells for ability to resensitize the cells to PI3K inhibition. The CDK4/6 inhibitor ribociclib (LEE011) acted synergistically with PI3K inhibitor to reduce viability in all three resistant cell lines. In a panel of 12 PIK3CA mutant and 10 wild type cell lines, synergistic effects between P110alpha inhibitor BYL719 and ribociclib were significantly stronger (weighted synergy score calculation, ANOVA, p=0.012) in PIK3CA mutant cells, indicating variant specific sensitization. Mouse xenografts of 4 different PIK3CA mutant breast cancer cells resistant to PI3K inhibitor showed stronger regression under dual PI3K inhibitor and ribociclib treatment than with either treatment alone."^^xsd:string .

	civic-kb:Disease-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8b9fc6eca924889b2c74c2795b3f6ebb ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8b9fc6eca924889b2c74c2795b3f6ebb ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8b9fc6eca924889b2c74c2795b3f6ebb ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8b9fc6eca924889b2c74c2795b3f6ebb ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8b9fc6eca924889b2c74c2795b3f6ebb ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8b9fc6eca924889b2c74c2795b3f6ebb ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-8b9fc6eca924889b2c74c2795b3f6ebb	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8b9fc6eca924889b2c74c2795b3f6ebb .

}

civic-kb:provenance-8b9fc6eca924889b2c74c2795b3f6ebb {
	civic-kb:assertion-8b9fc6eca924889b2c74c2795b3f6ebb prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8b9fc6eca924889b2c74c2795b3f6ebb .

	civic-kb:Status-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-8b9fc6eca924889b2c74c2795b3f6ebb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8b9fc6eca924889b2c74c2795b3f6ebb {
	civic-kb:nanoPub-8b9fc6eca924889b2c74c2795b3f6ebb prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8b9fc6eca924889b2c74c2795b3f6ebb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-51b39d94effe12d36a532024af86f21b {
	civic-kb:nanoPub-51b39d94effe12d36a532024af86f21b
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-51b39d94effe12d36a532024af86f21b ;
		np:hasProvenance civic-kb:provenance-51b39d94effe12d36a532024af86f21b ;
		np:hasPublicationInfo civic-kb:pubInfo-51b39d94effe12d36a532024af86f21b .
}

civic-kb:assertion-51b39d94effe12d36a532024af86f21b {
	civic-kb:Drugs-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-51b39d94effe12d36a532024af86f21b ;
		rdf:type	db:DB12218 ;
		rdfs:label	"AZD-5363"^^xsd:string ;
		sio:hasValue	"AZD5363"^^xsd:string .

	civic-kb:Status-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-51b39d94effe12d36a532024af86f21b ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-51b39d94effe12d36a532024af86f21b ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1504"^^xsd:integer .

	civic-kb:Gene-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-51b39d94effe12d36a532024af86f21b ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"HER2 overexpressing breast cancer cell lines with PIK3CA mutation BT474c (K111N) and HCC-1954 (H1047R) were used to establish mouse tumor xenografts. In BT474c xenografts, three dosing schedules of AZD5363 caused significant tumor inhibition (200 mg/kg twice daily > 200 mg/kg once daily > 100 mg/kg once daily). In HCC-1954 xenografts two doses of AZD5363 induced significant tumor inhibition (150 mg/kg twice daily > 75 mg/kg twice daily) while 30 mg/kg twice weekly trastuzumab was inactive."^^xsd:string .

	civic-kb:Disease-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-51b39d94effe12d36a532024af86f21b ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-51b39d94effe12d36a532024af86f21b ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-51b39d94effe12d36a532024af86f21b ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-51b39d94effe12d36a532024af86f21b ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-51b39d94effe12d36a532024af86f21b ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-51b39d94effe12d36a532024af86f21b ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-51b39d94effe12d36a532024af86f21b	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-51b39d94effe12d36a532024af86f21b .

}

civic-kb:provenance-51b39d94effe12d36a532024af86f21b {
	civic-kb:assertion-51b39d94effe12d36a532024af86f21b prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-51b39d94effe12d36a532024af86f21b .

	civic-kb:Status-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-51b39d94effe12d36a532024af86f21b	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-51b39d94effe12d36a532024af86f21b {
	civic-kb:nanoPub-51b39d94effe12d36a532024af86f21b prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-51b39d94effe12d36a532024af86f21b
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8ae9c5b80e090076fadb31659ea94237 {
	civic-kb:nanoPub-8ae9c5b80e090076fadb31659ea94237
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8ae9c5b80e090076fadb31659ea94237 ;
		np:hasProvenance civic-kb:provenance-8ae9c5b80e090076fadb31659ea94237 ;
		np:hasPublicationInfo civic-kb:pubInfo-8ae9c5b80e090076fadb31659ea94237 .
}

civic-kb:assertion-8ae9c5b80e090076fadb31659ea94237 {
	civic-kb:Drugs-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8ae9c5b80e090076fadb31659ea94237 ;
		sio:hasValue	"Everolimus, PP242"^^xsd:string .

	civic-kb:Status-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8ae9c5b80e090076fadb31659ea94237 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8ae9c5b80e090076fadb31659ea94237 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1610"^^xsd:integer .

	civic-kb:Gene-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18093 ;
		rdfs:label	"Mutation"^^xsd:string ;
		sio:hasValue	"MUTATION"^^xsd:string .

	civic-kb:Description-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8ae9c5b80e090076fadb31659ea94237 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"A panel of 31 breast cancer cell lines was tested for sensitivity to mTORC1 inhibitor everolimus and mTORC1/mTORC2 inhibitor PP242. Inhibitor concentrations for 50% survival fraction (SF50) were measured and SF50 less than one micro molar was considered sensitive. PIK3CA mutant cell lines were significantly more sensitive to both everolimus and PP242 than PIK3CA wild type cell lines. Apoptotic indicators and cell cycle analysis indicated that the mTOR inhibitors induced G1 arrest instead of apoptosis in the cell lines."^^xsd:string .

	civic-kb:Disease-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8ae9c5b80e090076fadb31659ea94237 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8ae9c5b80e090076fadb31659ea94237 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8ae9c5b80e090076fadb31659ea94237 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8ae9c5b80e090076fadb31659ea94237 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8ae9c5b80e090076fadb31659ea94237 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8ae9c5b80e090076fadb31659ea94237 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-8ae9c5b80e090076fadb31659ea94237	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8ae9c5b80e090076fadb31659ea94237 .

}

civic-kb:provenance-8ae9c5b80e090076fadb31659ea94237 {
	civic-kb:assertion-8ae9c5b80e090076fadb31659ea94237 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8ae9c5b80e090076fadb31659ea94237 .

	civic-kb:Status-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-8ae9c5b80e090076fadb31659ea94237	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8ae9c5b80e090076fadb31659ea94237 {
	civic-kb:nanoPub-8ae9c5b80e090076fadb31659ea94237 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8ae9c5b80e090076fadb31659ea94237
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-6e8438d5b454a839e13d15675a99760d {
	civic-kb:nanoPub-6e8438d5b454a839e13d15675a99760d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-6e8438d5b454a839e13d15675a99760d ;
		np:hasProvenance civic-kb:provenance-6e8438d5b454a839e13d15675a99760d ;
		np:hasPublicationInfo civic-kb:pubInfo-6e8438d5b454a839e13d15675a99760d .
}

civic-kb:assertion-6e8438d5b454a839e13d15675a99760d {
	civic-kb:Drugs-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6e8438d5b454a839e13d15675a99760d ;
		rdf:type	db:DB11828 ;
		rdfs:label	"Neratinib"^^xsd:string ;
		sio:hasValue	"Neratinib"^^xsd:string .

	civic-kb:Status-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-6e8438d5b454a839e13d15675a99760d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-6e8438d5b454a839e13d15675a99760d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"280"^^xsd:integer .

	civic-kb:Gene-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"D769Y"^^xsd:string .

	civic-kb:Description-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-6e8438d5b454a839e13d15675a99760d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In MCF10A cell lines, the D769Y mutation was shown to be sensitive to neratinib."^^xsd:string .

	civic-kb:Disease-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-6e8438d5b454a839e13d15675a99760d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-6e8438d5b454a839e13d15675a99760d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6e8438d5b454a839e13d15675a99760d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-6e8438d5b454a839e13d15675a99760d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-6e8438d5b454a839e13d15675a99760d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-6e8438d5b454a839e13d15675a99760d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-6e8438d5b454a839e13d15675a99760d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-6e8438d5b454a839e13d15675a99760d .

}

civic-kb:provenance-6e8438d5b454a839e13d15675a99760d {
	civic-kb:assertion-6e8438d5b454a839e13d15675a99760d prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-6e8438d5b454a839e13d15675a99760d .

	civic-kb:Status-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-6e8438d5b454a839e13d15675a99760d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-6e8438d5b454a839e13d15675a99760d {
	civic-kb:nanoPub-6e8438d5b454a839e13d15675a99760d prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-6e8438d5b454a839e13d15675a99760d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-d04a771f1a440f286a33b92048784299 {
	civic-kb:nanoPub-d04a771f1a440f286a33b92048784299
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-d04a771f1a440f286a33b92048784299 ;
		np:hasProvenance civic-kb:provenance-d04a771f1a440f286a33b92048784299 ;
		np:hasPublicationInfo civic-kb:pubInfo-d04a771f1a440f286a33b92048784299 .
}

civic-kb:assertion-d04a771f1a440f286a33b92048784299 {
	civic-kb:Drugs-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d04a771f1a440f286a33b92048784299 ;
		sio:hasValue	"FGF/VEGF Receptor Tyrosine Kinase Inhibitor, PD173074, Dovitinib"^^xsd:string .

	civic-kb:Status-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-d04a771f1a440f286a33b92048784299 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-d04a771f1a440f286a33b92048784299 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"5828"^^xsd:integer .

	civic-kb:Gene-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C25859 ;
		rdf:type	uniprot:P22455 ;
		rdfs:label	"FGFR4 Gene"^^xsd:string ;
		sio:hasValue	"FGFR4"^^xsd:string .

	civic-kb:Variant-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-d04a771f1a440f286a33b92048784299 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"ERBB2-positive breast cancer cell lines including MDA-MB-361 and MDA-MB-453 were found to display outlier expression of FGFR4. Targeting FGFR4 in FGFR4 overexpressing ERBB2-positive breast cancer samples was found to confer independent as well as additive inhibitory effects upon their combined knockdown as well as pharmacological inhibition."^^xsd:string .

	civic-kb:Disease-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-d04a771f1a440f286a33b92048784299 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-d04a771f1a440f286a33b92048784299 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d04a771f1a440f286a33b92048784299 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-d04a771f1a440f286a33b92048784299 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-d04a771f1a440f286a33b92048784299 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-d04a771f1a440f286a33b92048784299 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-d04a771f1a440f286a33b92048784299	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-d04a771f1a440f286a33b92048784299 .

}

civic-kb:provenance-d04a771f1a440f286a33b92048784299 {
	civic-kb:assertion-d04a771f1a440f286a33b92048784299 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-d04a771f1a440f286a33b92048784299 .

	civic-kb:Status-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-d04a771f1a440f286a33b92048784299	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-d04a771f1a440f286a33b92048784299 {
	civic-kb:nanoPub-d04a771f1a440f286a33b92048784299 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-d04a771f1a440f286a33b92048784299
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-31a4a4a7fac263187e4f2c438a543417 {
	civic-kb:nanoPub-31a4a4a7fac263187e4f2c438a543417
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-31a4a4a7fac263187e4f2c438a543417 ;
		np:hasProvenance civic-kb:provenance-31a4a4a7fac263187e4f2c438a543417 ;
		np:hasPublicationInfo civic-kb:pubInfo-31a4a4a7fac263187e4f2c438a543417 .
}

civic-kb:assertion-31a4a4a7fac263187e4f2c438a543417 {
	civic-kb:Drugs-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-31a4a4a7fac263187e4f2c438a543417 ;
		rdf:type	db:DB12218 ;
		rdfs:label	"AZD-5363"^^xsd:string ;
		sio:hasValue	"AZD5363"^^xsd:string .

	civic-kb:Status-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-31a4a4a7fac263187e4f2c438a543417 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-31a4a4a7fac263187e4f2c438a543417 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"709"^^xsd:integer .

	civic-kb:Gene-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18350 ;
		rdf:type	uniprot:P31749 ;
		rdfs:label	"AKT1 Gene"^^xsd:string ;
		sio:hasValue	"AKT1"^^xsd:string .

	civic-kb:Variant-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E17K"^^xsd:string .

	civic-kb:Description-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-31a4a4a7fac263187e4f2c438a543417 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase-I study of AZD5363, partial response was observed in 2 patients with breast and ovarian carcinoma, respectively, and AKT1 E17K mutations. While full study results have not yet been published, this paper highlights in vitro results that further confirm the role of AKT E17K mutation."^^xsd:string .

	civic-kb:Disease-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-31a4a4a7fac263187e4f2c438a543417 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-31a4a4a7fac263187e4f2c438a543417 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-31a4a4a7fac263187e4f2c438a543417 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-31a4a4a7fac263187e4f2c438a543417 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-31a4a4a7fac263187e4f2c438a543417 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-31a4a4a7fac263187e4f2c438a543417 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-31a4a4a7fac263187e4f2c438a543417	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-31a4a4a7fac263187e4f2c438a543417 .

}

civic-kb:provenance-31a4a4a7fac263187e4f2c438a543417 {
	civic-kb:assertion-31a4a4a7fac263187e4f2c438a543417 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-31a4a4a7fac263187e4f2c438a543417 .

	civic-kb:Status-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-31a4a4a7fac263187e4f2c438a543417	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-31a4a4a7fac263187e4f2c438a543417 {
	civic-kb:nanoPub-31a4a4a7fac263187e4f2c438a543417 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-31a4a4a7fac263187e4f2c438a543417
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-7020e0a376aa54a7fb15f7287e9082d4 {
	civic-kb:nanoPub-7020e0a376aa54a7fb15f7287e9082d4
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-7020e0a376aa54a7fb15f7287e9082d4 ;
		np:hasProvenance civic-kb:provenance-7020e0a376aa54a7fb15f7287e9082d4 ;
		np:hasPublicationInfo civic-kb:pubInfo-7020e0a376aa54a7fb15f7287e9082d4 .
}

civic-kb:assertion-7020e0a376aa54a7fb15f7287e9082d4 {
	civic-kb:Drugs-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7020e0a376aa54a7fb15f7287e9082d4 ;
		rdfs:label	"MK-2206"^^xsd:string ;
		sio:hasValue	"MK-2206"^^xsd:string .

	civic-kb:Status-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-7020e0a376aa54a7fb15f7287e9082d4 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-7020e0a376aa54a7fb15f7287e9082d4 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"231"^^xsd:integer .

	civic-kb:Gene-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18350 ;
		rdf:type	uniprot:P31749 ;
		rdfs:label	"AKT1 Gene"^^xsd:string ;
		sio:hasValue	"AKT1"^^xsd:string .

	civic-kb:Variant-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"E17K"^^xsd:string .

	civic-kb:Description-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-7020e0a376aa54a7fb15f7287e9082d4 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with the AKT1 E17K mutation did not show sensitivity to AKT inhibitor MK-2206, unlike cell lines with PIK3CA mutations."^^xsd:string .

	civic-kb:Disease-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-7020e0a376aa54a7fb15f7287e9082d4 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-7020e0a376aa54a7fb15f7287e9082d4 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7020e0a376aa54a7fb15f7287e9082d4 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-7020e0a376aa54a7fb15f7287e9082d4 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-7020e0a376aa54a7fb15f7287e9082d4 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-7020e0a376aa54a7fb15f7287e9082d4 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-7020e0a376aa54a7fb15f7287e9082d4	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-7020e0a376aa54a7fb15f7287e9082d4 .

}

civic-kb:provenance-7020e0a376aa54a7fb15f7287e9082d4 {
	civic-kb:assertion-7020e0a376aa54a7fb15f7287e9082d4 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-7020e0a376aa54a7fb15f7287e9082d4 .

	civic-kb:Status-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-7020e0a376aa54a7fb15f7287e9082d4	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-7020e0a376aa54a7fb15f7287e9082d4 {
	civic-kb:nanoPub-7020e0a376aa54a7fb15f7287e9082d4 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-7020e0a376aa54a7fb15f7287e9082d4
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-1298185364bda518c868c900d91a3ba5 {
	civic-kb:nanoPub-1298185364bda518c868c900d91a3ba5
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-1298185364bda518c868c900d91a3ba5 ;
		np:hasProvenance civic-kb:provenance-1298185364bda518c868c900d91a3ba5 ;
		np:hasPublicationInfo civic-kb:pubInfo-1298185364bda518c868c900d91a3ba5 .
}

civic-kb:assertion-1298185364bda518c868c900d91a3ba5 {
	civic-kb:Drugs-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1298185364bda518c868c900d91a3ba5 .

	civic-kb:Status-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-1298185364bda518c868c900d91a3ba5 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-1298185364bda518c868c900d91a3ba5 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"363"^^xsd:integer .

	civic-kb:Gene-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21412 ;
		rdf:type	uniprot:P24864 ;
		rdfs:label	"CCNE1 Gene"^^xsd:string ;
		sio:hasValue	"CCNE1"^^xsd:string .

	civic-kb:Variant-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-1298185364bda518c868c900d91a3ba5 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Patients with high expression of total cyclin E and low-molecular weight cyclin E is strongly associated with poor prognosis in breast cancer, and the hazard ratio for these patients in 13.3 times higher than those with normal cyclin E levels."^^xsd:string .

	civic-kb:Disease-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-1298185364bda518c868c900d91a3ba5 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-1298185364bda518c868c900d91a3ba5 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1298185364bda518c868c900d91a3ba5 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-1298185364bda518c868c900d91a3ba5 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-1298185364bda518c868c900d91a3ba5 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-1298185364bda518c868c900d91a3ba5 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-1298185364bda518c868c900d91a3ba5	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-1298185364bda518c868c900d91a3ba5 .

}

civic-kb:provenance-1298185364bda518c868c900d91a3ba5 {
	civic-kb:assertion-1298185364bda518c868c900d91a3ba5 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-1298185364bda518c868c900d91a3ba5 .

	civic-kb:Status-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-1298185364bda518c868c900d91a3ba5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-1298185364bda518c868c900d91a3ba5 {
	civic-kb:nanoPub-1298185364bda518c868c900d91a3ba5 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-1298185364bda518c868c900d91a3ba5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-73d640133ba3a1919a4b2c79aea048a9 {
	civic-kb:nanoPub-73d640133ba3a1919a4b2c79aea048a9
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-73d640133ba3a1919a4b2c79aea048a9 ;
		np:hasProvenance civic-kb:provenance-73d640133ba3a1919a4b2c79aea048a9 ;
		np:hasPublicationInfo civic-kb:pubInfo-73d640133ba3a1919a4b2c79aea048a9 .
}

civic-kb:assertion-73d640133ba3a1919a4b2c79aea048a9 {
	civic-kb:Drugs-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-73d640133ba3a1919a4b2c79aea048a9 ;
		rdf:type	ncit:C15445 ;
		rdfs:label	"Hormone Therapy"^^xsd:string ;
		sio:hasValue	"Hormone Therapy"^^xsd:string .

	civic-kb:Status-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-73d640133ba3a1919a4b2c79aea048a9 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-73d640133ba3a1919a4b2c79aea048a9 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"242"^^xsd:integer .

	civic-kb:Gene-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L536Q"^^xsd:string .

	civic-kb:Description-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-73d640133ba3a1919a4b2c79aea048a9 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF7 cell lines harboring the L536Q mutation in the ligand-binding domain of ESR1 have shown resistance to hormone therapy."^^xsd:string .

	civic-kb:Disease-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-73d640133ba3a1919a4b2c79aea048a9 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-73d640133ba3a1919a4b2c79aea048a9 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-73d640133ba3a1919a4b2c79aea048a9 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-73d640133ba3a1919a4b2c79aea048a9 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-73d640133ba3a1919a4b2c79aea048a9 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-73d640133ba3a1919a4b2c79aea048a9 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-73d640133ba3a1919a4b2c79aea048a9	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-73d640133ba3a1919a4b2c79aea048a9 .

}

civic-kb:provenance-73d640133ba3a1919a4b2c79aea048a9 {
	civic-kb:assertion-73d640133ba3a1919a4b2c79aea048a9 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-73d640133ba3a1919a4b2c79aea048a9 .

	civic-kb:Status-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-73d640133ba3a1919a4b2c79aea048a9	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-73d640133ba3a1919a4b2c79aea048a9 {
	civic-kb:nanoPub-73d640133ba3a1919a4b2c79aea048a9 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-73d640133ba3a1919a4b2c79aea048a9
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-013ad1cfd75e144f9104fac50f48849f {
	civic-kb:nanoPub-013ad1cfd75e144f9104fac50f48849f
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-013ad1cfd75e144f9104fac50f48849f ;
		np:hasProvenance civic-kb:provenance-013ad1cfd75e144f9104fac50f48849f ;
		np:hasPublicationInfo civic-kb:pubInfo-013ad1cfd75e144f9104fac50f48849f .
}

civic-kb:assertion-013ad1cfd75e144f9104fac50f48849f {
	civic-kb:Drugs-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-013ad1cfd75e144f9104fac50f48849f ;
		sio:hasValue	"Tamoxifen, Fulvestrant"^^xsd:string .

	civic-kb:Status-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-013ad1cfd75e144f9104fac50f48849f ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-013ad1cfd75e144f9104fac50f48849f ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"290"^^xsd:integer .

	civic-kb:Gene-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L536Q"^^xsd:string .

	civic-kb:Description-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-013ad1cfd75e144f9104fac50f48849f ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Using an estrogen response element (ERE)-luciferase reporter system co-transfected with one of five ESR1 mutants, the L536Q ligand binding domain mutation was shown to result in constitutive activity (response in the absence of beta-estradiol ligand) and continued responsiveness (inhibition of downstream target activation) to anti-estrogen therapies (tamoxifen or fulvestrant) in HEK293T cell lines."^^xsd:string .

	civic-kb:Disease-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-013ad1cfd75e144f9104fac50f48849f ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-013ad1cfd75e144f9104fac50f48849f ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-013ad1cfd75e144f9104fac50f48849f ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-013ad1cfd75e144f9104fac50f48849f ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-013ad1cfd75e144f9104fac50f48849f ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-013ad1cfd75e144f9104fac50f48849f ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-013ad1cfd75e144f9104fac50f48849f	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-013ad1cfd75e144f9104fac50f48849f .

}

civic-kb:provenance-013ad1cfd75e144f9104fac50f48849f {
	civic-kb:assertion-013ad1cfd75e144f9104fac50f48849f prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-013ad1cfd75e144f9104fac50f48849f .

	civic-kb:Status-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-013ad1cfd75e144f9104fac50f48849f	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-013ad1cfd75e144f9104fac50f48849f {
	civic-kb:nanoPub-013ad1cfd75e144f9104fac50f48849f prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-013ad1cfd75e144f9104fac50f48849f
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c53d7c4b21a3a545209b266fe21bda19 {
	civic-kb:nanoPub-c53d7c4b21a3a545209b266fe21bda19
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c53d7c4b21a3a545209b266fe21bda19 ;
		np:hasProvenance civic-kb:provenance-c53d7c4b21a3a545209b266fe21bda19 ;
		np:hasPublicationInfo civic-kb:pubInfo-c53d7c4b21a3a545209b266fe21bda19 .
}

civic-kb:assertion-c53d7c4b21a3a545209b266fe21bda19 {
	civic-kb:Drugs-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c53d7c4b21a3a545209b266fe21bda19 ;
		rdf:type	ncit:C15445 ;
		rdfs:label	"Hormone Therapy"^^xsd:string ;
		sio:hasValue	"Hormone Therapy"^^xsd:string .

	civic-kb:Status-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c53d7c4b21a3a545209b266fe21bda19 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c53d7c4b21a3a545209b266fe21bda19 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"245"^^xsd:integer .

	civic-kb:Gene-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Y537N"^^xsd:string .

	civic-kb:Description-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c53d7c4b21a3a545209b266fe21bda19 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF7 cell lines harboring the Y537N mutation in the ligand-binding domain of ESR1 have shown resistance to hormone therapy."^^xsd:string .

	civic-kb:Disease-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c53d7c4b21a3a545209b266fe21bda19 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c53d7c4b21a3a545209b266fe21bda19 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c53d7c4b21a3a545209b266fe21bda19 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c53d7c4b21a3a545209b266fe21bda19 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c53d7c4b21a3a545209b266fe21bda19 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c53d7c4b21a3a545209b266fe21bda19 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-c53d7c4b21a3a545209b266fe21bda19	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c53d7c4b21a3a545209b266fe21bda19 .

}

civic-kb:provenance-c53d7c4b21a3a545209b266fe21bda19 {
	civic-kb:assertion-c53d7c4b21a3a545209b266fe21bda19 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c53d7c4b21a3a545209b266fe21bda19 .

	civic-kb:Status-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-c53d7c4b21a3a545209b266fe21bda19	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c53d7c4b21a3a545209b266fe21bda19 {
	civic-kb:nanoPub-c53d7c4b21a3a545209b266fe21bda19 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c53d7c4b21a3a545209b266fe21bda19
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-47055016304b2509dda46d680f684530 {
	civic-kb:nanoPub-47055016304b2509dda46d680f684530
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-47055016304b2509dda46d680f684530 ;
		np:hasProvenance civic-kb:provenance-47055016304b2509dda46d680f684530 ;
		np:hasPublicationInfo civic-kb:pubInfo-47055016304b2509dda46d680f684530 .
}

civic-kb:assertion-47055016304b2509dda46d680f684530 {
	civic-kb:Drugs-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-47055016304b2509dda46d680f684530 ;
		sio:hasValue	"Tamoxifen, Fulvestrant"^^xsd:string .

	civic-kb:Status-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-47055016304b2509dda46d680f684530 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-47055016304b2509dda46d680f684530 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"293"^^xsd:integer .

	civic-kb:Gene-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Y537N"^^xsd:string .

	civic-kb:Description-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-47055016304b2509dda46d680f684530 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Using an estrogen response element (ERE)-luciferase reporter system co-transfected with one of five ESR1 mutants, the Y537N ligand binding domain mutation was shown to result in constitutive activity (response in the absence of beta-estradiol ligand) and continued responsiveness (inhibition of downstream target activation) to anti-estrogen therapies (tamoxifen or fulvestrant) in HEK293T cell lines."^^xsd:string .

	civic-kb:Disease-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-47055016304b2509dda46d680f684530 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-47055016304b2509dda46d680f684530 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-47055016304b2509dda46d680f684530 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-47055016304b2509dda46d680f684530 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-47055016304b2509dda46d680f684530 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-47055016304b2509dda46d680f684530	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-47055016304b2509dda46d680f684530 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-47055016304b2509dda46d680f684530	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-47055016304b2509dda46d680f684530 .

}

civic-kb:provenance-47055016304b2509dda46d680f684530 {
	civic-kb:assertion-47055016304b2509dda46d680f684530 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-47055016304b2509dda46d680f684530 .

	civic-kb:Status-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-47055016304b2509dda46d680f684530	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-47055016304b2509dda46d680f684530 {
	civic-kb:nanoPub-47055016304b2509dda46d680f684530 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-47055016304b2509dda46d680f684530
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f24407b3e6cfbc54b571dc5ff97b573a {
	civic-kb:nanoPub-f24407b3e6cfbc54b571dc5ff97b573a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f24407b3e6cfbc54b571dc5ff97b573a ;
		np:hasProvenance civic-kb:provenance-f24407b3e6cfbc54b571dc5ff97b573a ;
		np:hasPublicationInfo civic-kb:pubInfo-f24407b3e6cfbc54b571dc5ff97b573a .
}

civic-kb:assertion-f24407b3e6cfbc54b571dc5ff97b573a {
	civic-kb:Drugs-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f24407b3e6cfbc54b571dc5ff97b573a ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib"^^xsd:string .

	civic-kb:Status-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f24407b3e6cfbc54b571dc5ff97b573a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f24407b3e6cfbc54b571dc5ff97b573a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4817"^^xsd:integer .

	civic-kb:Gene-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Y537N"^^xsd:string .

	civic-kb:Description-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f24407b3e6cfbc54b571dc5ff97b573a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a study of 16 metastatic breast cancer patients (NCT02142868) treated with palbociclib in combination with letrozole, patients with ESR1 mutations (5/16) detected at initial blood draw, including ESR1 Y537N (n=1), were associated with reduced progression free survival (HR=0.31; 95% CI: 0.05-0.95; P=0.047 or HR=0.25, 95% CI: 0.06-2.0, P=0.038), as compared with patients with wildtype ESR1 (n=11)."^^xsd:string .

	civic-kb:Disease-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f24407b3e6cfbc54b571dc5ff97b573a ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f24407b3e6cfbc54b571dc5ff97b573a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f24407b3e6cfbc54b571dc5ff97b573a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f24407b3e6cfbc54b571dc5ff97b573a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f24407b3e6cfbc54b571dc5ff97b573a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f24407b3e6cfbc54b571dc5ff97b573a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-f24407b3e6cfbc54b571dc5ff97b573a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f24407b3e6cfbc54b571dc5ff97b573a .

}

civic-kb:provenance-f24407b3e6cfbc54b571dc5ff97b573a {
	civic-kb:assertion-f24407b3e6cfbc54b571dc5ff97b573a prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f24407b3e6cfbc54b571dc5ff97b573a .

	civic-kb:Status-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-f24407b3e6cfbc54b571dc5ff97b573a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f24407b3e6cfbc54b571dc5ff97b573a {
	civic-kb:nanoPub-f24407b3e6cfbc54b571dc5ff97b573a prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f24407b3e6cfbc54b571dc5ff97b573a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-06db88598d9acdcae38ce8d52424ba2a {
	civic-kb:nanoPub-06db88598d9acdcae38ce8d52424ba2a
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-06db88598d9acdcae38ce8d52424ba2a ;
		np:hasProvenance civic-kb:provenance-06db88598d9acdcae38ce8d52424ba2a ;
		np:hasPublicationInfo civic-kb:pubInfo-06db88598d9acdcae38ce8d52424ba2a .
}

civic-kb:assertion-06db88598d9acdcae38ce8d52424ba2a {
	civic-kb:Drugs-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-06db88598d9acdcae38ce8d52424ba2a ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib"^^xsd:string .

	civic-kb:Status-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-06db88598d9acdcae38ce8d52424ba2a ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-06db88598d9acdcae38ce8d52424ba2a ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4816"^^xsd:integer .

	civic-kb:Gene-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Y537N"^^xsd:string .

	civic-kb:Description-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-06db88598d9acdcae38ce8d52424ba2a ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase 3 clinical trial (NCT01942135) of 360 premenopausal and postmenopausal women with advanced, hormone receptor-positive breast cancer who had progressed during prior endocrine therapy, patients with ESR1 mutations (91/360), including ESR1 Y537N (n=14), treated with palbociclib and fulvestrant were associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (HR:0.43; 95% CI:0.25-0.74; P=0.002). Patient without detected ESR1 mutation treated with palbociclib and fulvestrant were also associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (9.5 vs. 5.4 months; HR:0.49; 95% CI:0.35-0.70; P<0.001)."^^xsd:string .

	civic-kb:Disease-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-06db88598d9acdcae38ce8d52424ba2a ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-06db88598d9acdcae38ce8d52424ba2a ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-06db88598d9acdcae38ce8d52424ba2a ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-06db88598d9acdcae38ce8d52424ba2a ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-06db88598d9acdcae38ce8d52424ba2a ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-06db88598d9acdcae38ce8d52424ba2a ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-06db88598d9acdcae38ce8d52424ba2a	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-06db88598d9acdcae38ce8d52424ba2a .

}

civic-kb:provenance-06db88598d9acdcae38ce8d52424ba2a {
	civic-kb:assertion-06db88598d9acdcae38ce8d52424ba2a prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-06db88598d9acdcae38ce8d52424ba2a .

	civic-kb:Status-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-06db88598d9acdcae38ce8d52424ba2a	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-06db88598d9acdcae38ce8d52424ba2a {
	civic-kb:nanoPub-06db88598d9acdcae38ce8d52424ba2a prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-06db88598d9acdcae38ce8d52424ba2a
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f6d32b11b3af6c4d88f04f4db466bf20 {
	civic-kb:nanoPub-f6d32b11b3af6c4d88f04f4db466bf20
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f6d32b11b3af6c4d88f04f4db466bf20 ;
		np:hasProvenance civic-kb:provenance-f6d32b11b3af6c4d88f04f4db466bf20 ;
		np:hasPublicationInfo civic-kb:pubInfo-f6d32b11b3af6c4d88f04f4db466bf20 .
}

civic-kb:assertion-f6d32b11b3af6c4d88f04f4db466bf20 {
	civic-kb:Drugs-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f6d32b11b3af6c4d88f04f4db466bf20 .

	civic-kb:Status-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f6d32b11b3af6c4d88f04f4db466bf20 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f6d32b11b3af6c4d88f04f4db466bf20 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"221"^^xsd:integer .

	civic-kb:Gene-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18021 ;
		rdf:type	uniprot:P24385 ;
		rdfs:label	"CCND1 Gene"^^xsd:string ;
		sio:hasValue	"CCND1"^^xsd:string .

	civic-kb:Variant-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f6d32b11b3af6c4d88f04f4db466bf20 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Cyclin D1 overexpression is associated with the ER-positive subtype of breast cancer."^^xsd:string .

	civic-kb:Disease-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f6d32b11b3af6c4d88f04f4db466bf20 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f6d32b11b3af6c4d88f04f4db466bf20 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f6d32b11b3af6c4d88f04f4db466bf20 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Diagnostic"^^xsd:string .

	civic-kb:Evidence_Direction-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f6d32b11b3af6c4d88f04f4db466bf20 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Positive"^^xsd:string .

	civic-kb:Variant_Origin-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f6d32b11b3af6c4d88f04f4db466bf20 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f6d32b11b3af6c4d88f04f4db466bf20 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-f6d32b11b3af6c4d88f04f4db466bf20	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f6d32b11b3af6c4d88f04f4db466bf20 .

}

civic-kb:provenance-f6d32b11b3af6c4d88f04f4db466bf20 {
	civic-kb:assertion-f6d32b11b3af6c4d88f04f4db466bf20 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f6d32b11b3af6c4d88f04f4db466bf20 .

	civic-kb:Status-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-f6d32b11b3af6c4d88f04f4db466bf20	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f6d32b11b3af6c4d88f04f4db466bf20 {
	civic-kb:nanoPub-f6d32b11b3af6c4d88f04f4db466bf20 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f6d32b11b3af6c4d88f04f4db466bf20
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-4ed8e8f2bd118df29449c619093cc9ea {
	civic-kb:nanoPub-4ed8e8f2bd118df29449c619093cc9ea
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-4ed8e8f2bd118df29449c619093cc9ea ;
		np:hasProvenance civic-kb:provenance-4ed8e8f2bd118df29449c619093cc9ea ;
		np:hasPublicationInfo civic-kb:pubInfo-4ed8e8f2bd118df29449c619093cc9ea .
}

civic-kb:assertion-4ed8e8f2bd118df29449c619093cc9ea {
	civic-kb:Drugs-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4ed8e8f2bd118df29449c619093cc9ea .

	civic-kb:Status-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-4ed8e8f2bd118df29449c619093cc9ea ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-4ed8e8f2bd118df29449c619093cc9ea ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"356"^^xsd:integer .

	civic-kb:Gene-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18021 ;
		rdf:type	uniprot:P24385 ;
		rdfs:label	"CCND1 Gene"^^xsd:string ;
		sio:hasValue	"CCND1"^^xsd:string .

	civic-kb:Variant-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-4ed8e8f2bd118df29449c619093cc9ea ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In ER-positive breast cancer patients, Cyclin D1 overexpression is associated with shorter overall survival and increased metastasis."^^xsd:string .

	civic-kb:Disease-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4ed8e8f2bd118df29449c619093cc9ea ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-4ed8e8f2bd118df29449c619093cc9ea ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4ed8e8f2bd118df29449c619093cc9ea ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4ed8e8f2bd118df29449c619093cc9ea ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-4ed8e8f2bd118df29449c619093cc9ea ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-4ed8e8f2bd118df29449c619093cc9ea ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"4"^^xsd:integer .

	civic-kb:evidence-4ed8e8f2bd118df29449c619093cc9ea	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-4ed8e8f2bd118df29449c619093cc9ea .

}

civic-kb:provenance-4ed8e8f2bd118df29449c619093cc9ea {
	civic-kb:assertion-4ed8e8f2bd118df29449c619093cc9ea prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-4ed8e8f2bd118df29449c619093cc9ea .

	civic-kb:Status-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-4ed8e8f2bd118df29449c619093cc9ea	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-4ed8e8f2bd118df29449c619093cc9ea {
	civic-kb:nanoPub-4ed8e8f2bd118df29449c619093cc9ea prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-4ed8e8f2bd118df29449c619093cc9ea
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-20488e06e2e01190115c9cead47f4ba3 {
	civic-kb:nanoPub-20488e06e2e01190115c9cead47f4ba3
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-20488e06e2e01190115c9cead47f4ba3 ;
		np:hasProvenance civic-kb:provenance-20488e06e2e01190115c9cead47f4ba3 ;
		np:hasPublicationInfo civic-kb:pubInfo-20488e06e2e01190115c9cead47f4ba3 .
}

civic-kb:assertion-20488e06e2e01190115c9cead47f4ba3 {
	civic-kb:Drugs-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-20488e06e2e01190115c9cead47f4ba3 ;
		rdf:type	chebi:41774 ;
		rdf:type	db:DB00675 ;
		rdfs:label	"Tamoxifen"^^xsd:string ;
		sio:hasValue	"Tamoxifen"^^xsd:string .

	civic-kb:Status-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-20488e06e2e01190115c9cead47f4ba3 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-20488e06e2e01190115c9cead47f4ba3 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"856"^^xsd:integer .

	civic-kb:Gene-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C18021 ;
		rdf:type	uniprot:P24385 ;
		rdfs:label	"CCND1 Gene"^^xsd:string ;
		sio:hasValue	"CCND1"^^xsd:string .

	civic-kb:Variant-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C18211 ;
		rdfs:label	"Overexpression"^^xsd:string ;
		sio:hasValue	"OVEREXPRESSION"^^xsd:string .

	civic-kb:Description-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-20488e06e2e01190115c9cead47f4ba3 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The authors performed a tissue microarray analysis of 167 postmenopausal breast cancers that had been randomized to treatment with or without tamoxifen.  ER +ve patients with high CCND1 tumor expression did not show any difference in survival between tamoxifen and no treatment."^^xsd:string .

	civic-kb:Disease-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-20488e06e2e01190115c9cead47f4ba3 ;
		rdf:type	efo:1000649 ;
		rdf:type	doid:0060075 ;
		rdfs:label	"Estrogen-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Estrogen-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-20488e06e2e01190115c9cead47f4ba3 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-20488e06e2e01190115c9cead47f4ba3 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-20488e06e2e01190115c9cead47f4ba3 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-20488e06e2e01190115c9cead47f4ba3 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string .

	civic-kb:Trust_Rating-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-20488e06e2e01190115c9cead47f4ba3 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-20488e06e2e01190115c9cead47f4ba3	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-20488e06e2e01190115c9cead47f4ba3 .

}

civic-kb:provenance-20488e06e2e01190115c9cead47f4ba3 {
	civic-kb:assertion-20488e06e2e01190115c9cead47f4ba3 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-20488e06e2e01190115c9cead47f4ba3 .

	civic-kb:Status-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-20488e06e2e01190115c9cead47f4ba3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-20488e06e2e01190115c9cead47f4ba3 {
	civic-kb:nanoPub-20488e06e2e01190115c9cead47f4ba3 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-20488e06e2e01190115c9cead47f4ba3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-5cc8c2c70b915e21f18aa99b085f7691 {
	civic-kb:nanoPub-5cc8c2c70b915e21f18aa99b085f7691
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-5cc8c2c70b915e21f18aa99b085f7691 ;
		np:hasProvenance civic-kb:provenance-5cc8c2c70b915e21f18aa99b085f7691 ;
		np:hasPublicationInfo civic-kb:pubInfo-5cc8c2c70b915e21f18aa99b085f7691 .
}

civic-kb:assertion-5cc8c2c70b915e21f18aa99b085f7691 {
	civic-kb:Drugs-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5cc8c2c70b915e21f18aa99b085f7691 ;
		rdf:type	ncit:C15445 ;
		rdfs:label	"Hormone Therapy"^^xsd:string ;
		sio:hasValue	"Hormone Therapy"^^xsd:string .

	civic-kb:Status-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-5cc8c2c70b915e21f18aa99b085f7691 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-5cc8c2c70b915e21f18aa99b085f7691 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"243"^^xsd:integer .

	civic-kb:Gene-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"D538G"^^xsd:string .

	civic-kb:Description-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-5cc8c2c70b915e21f18aa99b085f7691 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF7 cell lines harboring the D538G mutation in the ligand-binding domain of ESR1 have shown resistance to hormone therapy."^^xsd:string .

	civic-kb:Disease-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5cc8c2c70b915e21f18aa99b085f7691 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-5cc8c2c70b915e21f18aa99b085f7691 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5cc8c2c70b915e21f18aa99b085f7691 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5cc8c2c70b915e21f18aa99b085f7691 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-5cc8c2c70b915e21f18aa99b085f7691 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-5cc8c2c70b915e21f18aa99b085f7691 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-5cc8c2c70b915e21f18aa99b085f7691	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-5cc8c2c70b915e21f18aa99b085f7691 .

}

civic-kb:provenance-5cc8c2c70b915e21f18aa99b085f7691 {
	civic-kb:assertion-5cc8c2c70b915e21f18aa99b085f7691 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-5cc8c2c70b915e21f18aa99b085f7691 .

	civic-kb:Status-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-5cc8c2c70b915e21f18aa99b085f7691	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-5cc8c2c70b915e21f18aa99b085f7691 {
	civic-kb:nanoPub-5cc8c2c70b915e21f18aa99b085f7691 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-5cc8c2c70b915e21f18aa99b085f7691
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-39c3a1e340675bdd66e0f51b9d22ca86 {
	civic-kb:nanoPub-39c3a1e340675bdd66e0f51b9d22ca86
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-39c3a1e340675bdd66e0f51b9d22ca86 ;
		np:hasProvenance civic-kb:provenance-39c3a1e340675bdd66e0f51b9d22ca86 ;
		np:hasPublicationInfo civic-kb:pubInfo-39c3a1e340675bdd66e0f51b9d22ca86 .
}

civic-kb:assertion-39c3a1e340675bdd66e0f51b9d22ca86 {
	civic-kb:Drugs-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-39c3a1e340675bdd66e0f51b9d22ca86 ;
		sio:hasValue	"Tamoxifen, Fulvestrant"^^xsd:string .

	civic-kb:Status-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-39c3a1e340675bdd66e0f51b9d22ca86 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-39c3a1e340675bdd66e0f51b9d22ca86 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"291"^^xsd:integer .

	civic-kb:Gene-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"D538G"^^xsd:string .

	civic-kb:Description-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-39c3a1e340675bdd66e0f51b9d22ca86 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Using an estrogen response element (ERE)-luciferase reporter system co-transfected with one of five ESR1 mutants, the N538G ligand binding domain mutation was shown to result in constitutive activity (response in the absence of beta-estradiol ligand) and continued responsiveness (inhibition of downstream target activation) to anti-estrogen therapies (tamoxifen or fulvestrant) in HEK293T cell lines."^^xsd:string .

	civic-kb:Disease-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-39c3a1e340675bdd66e0f51b9d22ca86 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-39c3a1e340675bdd66e0f51b9d22ca86 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-39c3a1e340675bdd66e0f51b9d22ca86 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-39c3a1e340675bdd66e0f51b9d22ca86 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-39c3a1e340675bdd66e0f51b9d22ca86 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-39c3a1e340675bdd66e0f51b9d22ca86 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-39c3a1e340675bdd66e0f51b9d22ca86	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-39c3a1e340675bdd66e0f51b9d22ca86 .

}

civic-kb:provenance-39c3a1e340675bdd66e0f51b9d22ca86 {
	civic-kb:assertion-39c3a1e340675bdd66e0f51b9d22ca86 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-39c3a1e340675bdd66e0f51b9d22ca86 .

	civic-kb:Status-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-39c3a1e340675bdd66e0f51b9d22ca86	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-39c3a1e340675bdd66e0f51b9d22ca86 {
	civic-kb:nanoPub-39c3a1e340675bdd66e0f51b9d22ca86 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-39c3a1e340675bdd66e0f51b9d22ca86
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-375195012d3df1ccffe242bb824ab557 {
	civic-kb:nanoPub-375195012d3df1ccffe242bb824ab557
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-375195012d3df1ccffe242bb824ab557 ;
		np:hasProvenance civic-kb:provenance-375195012d3df1ccffe242bb824ab557 ;
		np:hasPublicationInfo civic-kb:pubInfo-375195012d3df1ccffe242bb824ab557 .
}

civic-kb:assertion-375195012d3df1ccffe242bb824ab557 {
	civic-kb:Drugs-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-375195012d3df1ccffe242bb824ab557 ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib"^^xsd:string .

	civic-kb:Status-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-375195012d3df1ccffe242bb824ab557 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-375195012d3df1ccffe242bb824ab557 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4813"^^xsd:integer .

	civic-kb:Gene-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"D538G"^^xsd:string .

	civic-kb:Description-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-375195012d3df1ccffe242bb824ab557 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase 3 clinical trial (NCT01942135) of 360 premenopausal and postmenopausal women with advanced, hormone receptor-positive breast cancer who had progressed during prior endocrine therapy, patients with ESR1 mutations (91/360), including ESR1 D538G (n=51), treated with palbociclib and fulvestrant were associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (HR:0.43; 95% CI:0.25-0.74; P=0.002). Patient without detected ESR1 mutation treated with palbociclib and fulvestrant were also associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (9.5 vs. 5.4 months; HR:0.49; 95% CI:0.35-0.70; P<0.001)."^^xsd:string .

	civic-kb:Disease-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-375195012d3df1ccffe242bb824ab557 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-375195012d3df1ccffe242bb824ab557 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-375195012d3df1ccffe242bb824ab557 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-375195012d3df1ccffe242bb824ab557 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-375195012d3df1ccffe242bb824ab557 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-375195012d3df1ccffe242bb824ab557 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-375195012d3df1ccffe242bb824ab557	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-375195012d3df1ccffe242bb824ab557 .

}

civic-kb:provenance-375195012d3df1ccffe242bb824ab557 {
	civic-kb:assertion-375195012d3df1ccffe242bb824ab557 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-375195012d3df1ccffe242bb824ab557 .

	civic-kb:Status-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-375195012d3df1ccffe242bb824ab557	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-375195012d3df1ccffe242bb824ab557 {
	civic-kb:nanoPub-375195012d3df1ccffe242bb824ab557 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-375195012d3df1ccffe242bb824ab557
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-3e4607aaab299d81c048b8c892f06e97 {
	civic-kb:nanoPub-3e4607aaab299d81c048b8c892f06e97
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-3e4607aaab299d81c048b8c892f06e97 ;
		np:hasProvenance civic-kb:provenance-3e4607aaab299d81c048b8c892f06e97 ;
		np:hasPublicationInfo civic-kb:pubInfo-3e4607aaab299d81c048b8c892f06e97 .
}

civic-kb:assertion-3e4607aaab299d81c048b8c892f06e97 {
	civic-kb:Drugs-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-3e4607aaab299d81c048b8c892f06e97 ;
		sio:hasValue	"Palbociclib, Letrozole"^^xsd:string .

	civic-kb:Status-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-3e4607aaab299d81c048b8c892f06e97 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-3e4607aaab299d81c048b8c892f06e97 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4814"^^xsd:integer .

	civic-kb:Gene-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"D538G"^^xsd:string .

	civic-kb:Description-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-3e4607aaab299d81c048b8c892f06e97 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a study of 16 patients with metastatic breast cancer (NCT02142868) treated with palbociclib in combination with letrozole, patients with ESR1 mutations (5/16), including ESR1 D538G (n=2), detected at any time or at initial blood draw, were associated with reduced progression free survival (HR=0.31, 95% CI: 0.05-0.95, P=0.047), as compared with patients with wildtype ESR1 (n=11). There was no significant difference in overall survival (median; 14.1 versus
12.8 months, HR=0.40; 95% CI: 0.06-2.0, P-value=0.24)."^^xsd:string .

	civic-kb:Disease-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-3e4607aaab299d81c048b8c892f06e97 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-3e4607aaab299d81c048b8c892f06e97 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-3e4607aaab299d81c048b8c892f06e97 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-3e4607aaab299d81c048b8c892f06e97 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Does Not Support"^^xsd:string .

	civic-kb:Clinical_Significance-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-3e4607aaab299d81c048b8c892f06e97 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-3e4607aaab299d81c048b8c892f06e97 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-3e4607aaab299d81c048b8c892f06e97	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-3e4607aaab299d81c048b8c892f06e97 .

}

civic-kb:provenance-3e4607aaab299d81c048b8c892f06e97 {
	civic-kb:assertion-3e4607aaab299d81c048b8c892f06e97 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-3e4607aaab299d81c048b8c892f06e97 .

	civic-kb:Status-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-3e4607aaab299d81c048b8c892f06e97	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-3e4607aaab299d81c048b8c892f06e97 {
	civic-kb:nanoPub-3e4607aaab299d81c048b8c892f06e97 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-3e4607aaab299d81c048b8c892f06e97
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-43edfd308793db0822e98adf6033b0ce {
	civic-kb:nanoPub-43edfd308793db0822e98adf6033b0ce
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-43edfd308793db0822e98adf6033b0ce ;
		np:hasProvenance civic-kb:provenance-43edfd308793db0822e98adf6033b0ce ;
		np:hasPublicationInfo civic-kb:pubInfo-43edfd308793db0822e98adf6033b0ce .
}

civic-kb:assertion-43edfd308793db0822e98adf6033b0ce {
	civic-kb:Drugs-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-43edfd308793db0822e98adf6033b0ce ;
		rdf:type	ncit:C15445 ;
		rdfs:label	"Hormone Therapy"^^xsd:string ;
		sio:hasValue	"Hormone Therapy"^^xsd:string .

	civic-kb:Status-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-43edfd308793db0822e98adf6033b0ce ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-43edfd308793db0822e98adf6033b0ce ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"246"^^xsd:integer .

	civic-kb:Gene-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Y537S"^^xsd:string .

	civic-kb:Description-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-43edfd308793db0822e98adf6033b0ce ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF7 cell lines harboring the L537S mutation in the ligand-binding domain of ESR1 have shown resistance to hormone therapy."^^xsd:string .

	civic-kb:Disease-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-43edfd308793db0822e98adf6033b0ce ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-43edfd308793db0822e98adf6033b0ce ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-43edfd308793db0822e98adf6033b0ce ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-43edfd308793db0822e98adf6033b0ce ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-43edfd308793db0822e98adf6033b0ce ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-43edfd308793db0822e98adf6033b0ce ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-43edfd308793db0822e98adf6033b0ce	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-43edfd308793db0822e98adf6033b0ce .

}

civic-kb:provenance-43edfd308793db0822e98adf6033b0ce {
	civic-kb:assertion-43edfd308793db0822e98adf6033b0ce prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-43edfd308793db0822e98adf6033b0ce .

	civic-kb:Status-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-43edfd308793db0822e98adf6033b0ce	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-43edfd308793db0822e98adf6033b0ce {
	civic-kb:nanoPub-43edfd308793db0822e98adf6033b0ce prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-43edfd308793db0822e98adf6033b0ce
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-588c5d54987ef54073d08fcbb956d864 {
	civic-kb:nanoPub-588c5d54987ef54073d08fcbb956d864
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-588c5d54987ef54073d08fcbb956d864 ;
		np:hasProvenance civic-kb:provenance-588c5d54987ef54073d08fcbb956d864 ;
		np:hasPublicationInfo civic-kb:pubInfo-588c5d54987ef54073d08fcbb956d864 .
}

civic-kb:assertion-588c5d54987ef54073d08fcbb956d864 {
	civic-kb:Drugs-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-588c5d54987ef54073d08fcbb956d864 ;
		sio:hasValue	"Tamoxifen, Fulvestrant"^^xsd:string .

	civic-kb:Status-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-588c5d54987ef54073d08fcbb956d864 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-588c5d54987ef54073d08fcbb956d864 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"294"^^xsd:integer .

	civic-kb:Gene-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Y537S"^^xsd:string .

	civic-kb:Description-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-588c5d54987ef54073d08fcbb956d864 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Using an estrogen response element (ERE)-luciferase reporter system co-transfected with one of five ESR1 mutants, the Y537S ligand binding domain mutation was shown to result in constitutive activity (response in the absence of beta-estradiol ligand) and continued responsiveness (inhibition of downstream target activation) to anti-estrogen therapies (tamoxifen or fulvestrant) in HEK293T cell lines."^^xsd:string .

	civic-kb:Disease-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-588c5d54987ef54073d08fcbb956d864 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-588c5d54987ef54073d08fcbb956d864 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-588c5d54987ef54073d08fcbb956d864 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-588c5d54987ef54073d08fcbb956d864 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-588c5d54987ef54073d08fcbb956d864 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-588c5d54987ef54073d08fcbb956d864 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-588c5d54987ef54073d08fcbb956d864	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-588c5d54987ef54073d08fcbb956d864 .

}

civic-kb:provenance-588c5d54987ef54073d08fcbb956d864 {
	civic-kb:assertion-588c5d54987ef54073d08fcbb956d864 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-588c5d54987ef54073d08fcbb956d864 .

	civic-kb:Status-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-588c5d54987ef54073d08fcbb956d864	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-588c5d54987ef54073d08fcbb956d864 {
	civic-kb:nanoPub-588c5d54987ef54073d08fcbb956d864 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-588c5d54987ef54073d08fcbb956d864
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-4d806c9ffe0193755ef939f7f2790554 {
	civic-kb:nanoPub-4d806c9ffe0193755ef939f7f2790554
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-4d806c9ffe0193755ef939f7f2790554 ;
		np:hasProvenance civic-kb:provenance-4d806c9ffe0193755ef939f7f2790554 ;
		np:hasPublicationInfo civic-kb:pubInfo-4d806c9ffe0193755ef939f7f2790554 .
}

civic-kb:assertion-4d806c9ffe0193755ef939f7f2790554 {
	civic-kb:Drugs-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4d806c9ffe0193755ef939f7f2790554 ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib"^^xsd:string .

	civic-kb:Status-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-4d806c9ffe0193755ef939f7f2790554 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-4d806c9ffe0193755ef939f7f2790554 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4819"^^xsd:integer .

	civic-kb:Gene-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Y537S"^^xsd:string .

	civic-kb:Description-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-4d806c9ffe0193755ef939f7f2790554 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a study of 16 metastatic breast cancer patients (NCT02142868) treated with palbociclib in combination with letrozole, patients with ESR1 mutations (5/16) detected at initial blood draw, including ESR1 Y537S (n=1), were associated with reduced progression free survival (HR=0.31; 95% CI: 0.05-0.95; P=0.047 or HR=0.25, 95% CI: 0.06-2.0, P=0.038), as compared with patients with wildtype ESR1 (n=11)."^^xsd:string .

	civic-kb:Disease-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4d806c9ffe0193755ef939f7f2790554 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-4d806c9ffe0193755ef939f7f2790554 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4d806c9ffe0193755ef939f7f2790554 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4d806c9ffe0193755ef939f7f2790554 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-4d806c9ffe0193755ef939f7f2790554 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-4d806c9ffe0193755ef939f7f2790554 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-4d806c9ffe0193755ef939f7f2790554	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-4d806c9ffe0193755ef939f7f2790554 .

}

civic-kb:provenance-4d806c9ffe0193755ef939f7f2790554 {
	civic-kb:assertion-4d806c9ffe0193755ef939f7f2790554 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-4d806c9ffe0193755ef939f7f2790554 .

	civic-kb:Status-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-4d806c9ffe0193755ef939f7f2790554	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-4d806c9ffe0193755ef939f7f2790554 {
	civic-kb:nanoPub-4d806c9ffe0193755ef939f7f2790554 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-4d806c9ffe0193755ef939f7f2790554
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-5abcf2c6b3601600b794d3963ae57a5d {
	civic-kb:nanoPub-5abcf2c6b3601600b794d3963ae57a5d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-5abcf2c6b3601600b794d3963ae57a5d ;
		np:hasProvenance civic-kb:provenance-5abcf2c6b3601600b794d3963ae57a5d ;
		np:hasPublicationInfo civic-kb:pubInfo-5abcf2c6b3601600b794d3963ae57a5d .
}

civic-kb:assertion-5abcf2c6b3601600b794d3963ae57a5d {
	civic-kb:Drugs-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5abcf2c6b3601600b794d3963ae57a5d ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib"^^xsd:string .

	civic-kb:Status-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-5abcf2c6b3601600b794d3963ae57a5d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-5abcf2c6b3601600b794d3963ae57a5d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4818"^^xsd:integer .

	civic-kb:Gene-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Y537S"^^xsd:string .

	civic-kb:Description-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-5abcf2c6b3601600b794d3963ae57a5d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase 3 clinical trial (NCT01942135) of 360 premenopausal and postmenopausal women with advanced, hormone receptor-positive breast cancer who had progressed during prior endocrine therapy, patients with ESR1 mutations (91/360), including ESR1 Y537S (n=23), treated with palbociclib and fulvestrant were associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (HR:0.43; 95% CI:0.25-0.74; P=0.002). Patient without detected ESR1 mutation treated with palbociclib and fulvestrant were also associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (9.5 vs. 5.4 months; HR:0.49; 95% CI:0.35-0.70; P<0.001)."^^xsd:string .

	civic-kb:Disease-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5abcf2c6b3601600b794d3963ae57a5d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-5abcf2c6b3601600b794d3963ae57a5d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5abcf2c6b3601600b794d3963ae57a5d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5abcf2c6b3601600b794d3963ae57a5d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-5abcf2c6b3601600b794d3963ae57a5d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-5abcf2c6b3601600b794d3963ae57a5d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-5abcf2c6b3601600b794d3963ae57a5d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-5abcf2c6b3601600b794d3963ae57a5d .

}

civic-kb:provenance-5abcf2c6b3601600b794d3963ae57a5d {
	civic-kb:assertion-5abcf2c6b3601600b794d3963ae57a5d prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-5abcf2c6b3601600b794d3963ae57a5d .

	civic-kb:Status-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-5abcf2c6b3601600b794d3963ae57a5d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-5abcf2c6b3601600b794d3963ae57a5d {
	civic-kb:nanoPub-5abcf2c6b3601600b794d3963ae57a5d prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-5abcf2c6b3601600b794d3963ae57a5d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-712a0af26c21dcfd7138ac08c41524f6 {
	civic-kb:nanoPub-712a0af26c21dcfd7138ac08c41524f6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-712a0af26c21dcfd7138ac08c41524f6 ;
		np:hasProvenance civic-kb:provenance-712a0af26c21dcfd7138ac08c41524f6 ;
		np:hasPublicationInfo civic-kb:pubInfo-712a0af26c21dcfd7138ac08c41524f6 .
}

civic-kb:assertion-712a0af26c21dcfd7138ac08c41524f6 {
	civic-kb:Drugs-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-712a0af26c21dcfd7138ac08c41524f6 ;
		sio:hasValue	"MK-2206, Pictilisib"^^xsd:string .

	civic-kb:Status-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-712a0af26c21dcfd7138ac08c41524f6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-712a0af26c21dcfd7138ac08c41524f6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"710"^^xsd:integer .

	civic-kb:Gene-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C98468 ;
		rdfs:label	"E545K"^^xsd:string ;
		sio:hasValue	"E545K"^^xsd:string .

	civic-kb:Description-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-712a0af26c21dcfd7138ac08c41524f6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PIK3CA E545K mutation increased sensitivity to AKT inhibitor MK-2206 and PI3K inhibitor GDC-0941 in a breast cancer cell line model."^^xsd:string .

	civic-kb:Disease-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-712a0af26c21dcfd7138ac08c41524f6 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-712a0af26c21dcfd7138ac08c41524f6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-712a0af26c21dcfd7138ac08c41524f6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-712a0af26c21dcfd7138ac08c41524f6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-712a0af26c21dcfd7138ac08c41524f6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-712a0af26c21dcfd7138ac08c41524f6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-712a0af26c21dcfd7138ac08c41524f6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-712a0af26c21dcfd7138ac08c41524f6 .

}

civic-kb:provenance-712a0af26c21dcfd7138ac08c41524f6 {
	civic-kb:assertion-712a0af26c21dcfd7138ac08c41524f6 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-712a0af26c21dcfd7138ac08c41524f6 .

	civic-kb:Status-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-712a0af26c21dcfd7138ac08c41524f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-712a0af26c21dcfd7138ac08c41524f6 {
	civic-kb:nanoPub-712a0af26c21dcfd7138ac08c41524f6 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-712a0af26c21dcfd7138ac08c41524f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-8a09eb8d4dcdb9bc0a359c2b2a4bd369 {
	civic-kb:nanoPub-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		np:hasProvenance civic-kb:provenance-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		np:hasPublicationInfo civic-kb:pubInfo-8a09eb8d4dcdb9bc0a359c2b2a4bd369 .
}

civic-kb:assertion-8a09eb8d4dcdb9bc0a359c2b2a4bd369 {
	civic-kb:Drugs-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1453"^^xsd:integer .

	civic-kb:Gene-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C98468 ;
		rdfs:label	"E545K"^^xsd:string ;
		sio:hasValue	"E545K"^^xsd:string .

	civic-kb:Description-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"PI3K mutant E545K was overexpressed in the trastuzumab sensitive HER2 BT474 breast cancer cell line, and significant resistance to trastuzumab was induced in comparison to control cells."^^xsd:string .

	civic-kb:Disease-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		rdf:type	efo:1000294 ;
		rdf:type	ncit:C53556 ;
		rdf:type	doid:0060079 ;
		rdfs:label	"Her2-receptor Positive Breast Cancer"^^xsd:string ;
		sio:hasValue	"Her2-receptor Positive Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-8a09eb8d4dcdb9bc0a359c2b2a4bd369 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"2"^^xsd:integer .

	civic-kb:evidence-8a09eb8d4dcdb9bc0a359c2b2a4bd369	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-8a09eb8d4dcdb9bc0a359c2b2a4bd369 .

}

civic-kb:provenance-8a09eb8d4dcdb9bc0a359c2b2a4bd369 {
	civic-kb:assertion-8a09eb8d4dcdb9bc0a359c2b2a4bd369 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-8a09eb8d4dcdb9bc0a359c2b2a4bd369 .

	civic-kb:Status-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-8a09eb8d4dcdb9bc0a359c2b2a4bd369	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-8a09eb8d4dcdb9bc0a359c2b2a4bd369 {
	civic-kb:nanoPub-8a09eb8d4dcdb9bc0a359c2b2a4bd369 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-8a09eb8d4dcdb9bc0a359c2b2a4bd369
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-dbb1f0b248ee125e9ca1d5d33bb70721 {
	civic-kb:nanoPub-dbb1f0b248ee125e9ca1d5d33bb70721
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		np:hasProvenance civic-kb:provenance-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		np:hasPublicationInfo civic-kb:pubInfo-dbb1f0b248ee125e9ca1d5d33bb70721 .
}

civic-kb:assertion-dbb1f0b248ee125e9ca1d5d33bb70721 {
	civic-kb:Drugs-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		rdf:type	dron:00730818 ;
		rdf:type	db:DB05773 ;
		rdfs:label	"Ado-trastuzumab Emtansine"^^xsd:string ;
		sio:hasValue	"Ado-trastuzumab Emtansine"^^xsd:string .

	civic-kb:Status-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2036"^^xsd:integer .

	civic-kb:Gene-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C98468 ;
		rdfs:label	"E545K"^^xsd:string ;
		sio:hasValue	"E545K"^^xsd:string .

	civic-kb:Description-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase 3 clinical trial (NCT00829166), metastatic breast cancer patients with PIK3CA mutation (n=40), including patients with PIK3CA E545K, treated with ado-trastuzumab were associated with improved median progression free survival (10.9 vs. 9.8 months), as compared to patients with wild-type PIK3CA (n=93). Further, the patients harboring PIK3CA mutations (n=79) were associated with a decrease in disease progression (ado-trastuzumab relative to standard chemotherapy; HR:0.45; 95% CI:0.25-0.82), as compared to patients with wild-type PIK3CA (n=180; HR:0.74; 95% CI:0.50-1.10). In an in vitro study, MCF7 cell lines expressing PIK3CA E545K mutation was associated with increased sensitivity to ado-trastuzumab emtansine treatment compared to trastuzumab treated MCF7 cells. Sensitivity was determined by assessing cell viability. Further, in an in vivo study, MCF7 xenografts expressing PIK3CA E545K were reportedly sensitive to ado-trastuzumab emtansine, as assessed by tumor growth."^^xsd:string .

	civic-kb:Disease-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-dbb1f0b248ee125e9ca1d5d33bb70721 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-dbb1f0b248ee125e9ca1d5d33bb70721	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-dbb1f0b248ee125e9ca1d5d33bb70721 .

}

civic-kb:provenance-dbb1f0b248ee125e9ca1d5d33bb70721 {
	civic-kb:assertion-dbb1f0b248ee125e9ca1d5d33bb70721 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-dbb1f0b248ee125e9ca1d5d33bb70721 .

	civic-kb:Status-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-dbb1f0b248ee125e9ca1d5d33bb70721	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-dbb1f0b248ee125e9ca1d5d33bb70721 {
	civic-kb:nanoPub-dbb1f0b248ee125e9ca1d5d33bb70721 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-dbb1f0b248ee125e9ca1d5d33bb70721
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-5a91e173e9ec408a8ed4c5700630e6bf {
	civic-kb:nanoPub-5a91e173e9ec408a8ed4c5700630e6bf
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-5a91e173e9ec408a8ed4c5700630e6bf ;
		np:hasProvenance civic-kb:provenance-5a91e173e9ec408a8ed4c5700630e6bf ;
		np:hasPublicationInfo civic-kb:pubInfo-5a91e173e9ec408a8ed4c5700630e6bf .
}

civic-kb:assertion-5a91e173e9ec408a8ed4c5700630e6bf {
	civic-kb:Drugs-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5a91e173e9ec408a8ed4c5700630e6bf ;
		rdf:type	dron:00013025 ;
		rdf:type	db:DB0007 ;
		rdfs:label	"Trastuzumab"^^xsd:string ;
		sio:hasValue	"Trastuzumab"^^xsd:string .

	civic-kb:Status-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-5a91e173e9ec408a8ed4c5700630e6bf ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-5a91e173e9ec408a8ed4c5700630e6bf ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2035"^^xsd:integer .

	civic-kb:Gene-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C98468 ;
		rdfs:label	"E545K"^^xsd:string ;
		sio:hasValue	"E545K"^^xsd:string .

	civic-kb:Description-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-5a91e173e9ec408a8ed4c5700630e6bf ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In HER2-positive metastic breast cancer patients treated with trastuzumab-based therapy, the presence of a PIK3CA mutation was associated with an increased risk of progression (HR:2.50, 95% CI:1.35-4.61, P=0.003, univariate analysis; HR:1.86, 95% CI:1.13-3.05, P=0.014, multivariate analysis) and reduced time to progression (HR:2.50, 95% CI:1.35-4.61, P=0.003) compared to wildtype PIK3CA."^^xsd:string .

	civic-kb:Disease-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-5a91e173e9ec408a8ed4c5700630e6bf ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-5a91e173e9ec408a8ed4c5700630e6bf ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5a91e173e9ec408a8ed4c5700630e6bf ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-5a91e173e9ec408a8ed4c5700630e6bf ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-5a91e173e9ec408a8ed4c5700630e6bf ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-5a91e173e9ec408a8ed4c5700630e6bf ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-5a91e173e9ec408a8ed4c5700630e6bf	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-5a91e173e9ec408a8ed4c5700630e6bf .

}

civic-kb:provenance-5a91e173e9ec408a8ed4c5700630e6bf {
	civic-kb:assertion-5a91e173e9ec408a8ed4c5700630e6bf prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-5a91e173e9ec408a8ed4c5700630e6bf .

	civic-kb:Status-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-5a91e173e9ec408a8ed4c5700630e6bf	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-5a91e173e9ec408a8ed4c5700630e6bf {
	civic-kb:nanoPub-5a91e173e9ec408a8ed4c5700630e6bf prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-5a91e173e9ec408a8ed4c5700630e6bf
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f01862475f803d7dd35f3bb531b1fec5 {
	civic-kb:nanoPub-f01862475f803d7dd35f3bb531b1fec5
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f01862475f803d7dd35f3bb531b1fec5 ;
		np:hasProvenance civic-kb:provenance-f01862475f803d7dd35f3bb531b1fec5 ;
		np:hasPublicationInfo civic-kb:pubInfo-f01862475f803d7dd35f3bb531b1fec5 .
}

civic-kb:assertion-f01862475f803d7dd35f3bb531b1fec5 {
	civic-kb:Drugs-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f01862475f803d7dd35f3bb531b1fec5 ;
		rdf:type	db:DB11663 ;
		rdfs:label	"Pictilisib"^^xsd:string ;
		sio:hasValue	"Pictilisib"^^xsd:string .

	civic-kb:Status-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f01862475f803d7dd35f3bb531b1fec5 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f01862475f803d7dd35f3bb531b1fec5 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"2034"^^xsd:integer .

	civic-kb:Gene-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C21220 ;
		rdf:type	uniprot:P42336 ;
		rdfs:label	"PIK3CA Gene"^^xsd:string ;
		sio:hasValue	"PIK3CA"^^xsd:string .

	civic-kb:Variant-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		rdf:type	ncit:C98468 ;
		rdfs:label	"E545K"^^xsd:string ;
		sio:hasValue	"E545K"^^xsd:string .

	civic-kb:Description-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f01862475f803d7dd35f3bb531b1fec5 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer cell lines with oncogenic PIK3CA mutations had an increased sensitivity to treatment with class I PI3K inhibitor GDC-0941 compared to wildtype PIK3CA cell lines (n=54, P=0.005)."^^xsd:string .

	civic-kb:Disease-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f01862475f803d7dd35f3bb531b1fec5 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f01862475f803d7dd35f3bb531b1fec5 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f01862475f803d7dd35f3bb531b1fec5 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f01862475f803d7dd35f3bb531b1fec5 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f01862475f803d7dd35f3bb531b1fec5 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f01862475f803d7dd35f3bb531b1fec5 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-f01862475f803d7dd35f3bb531b1fec5	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f01862475f803d7dd35f3bb531b1fec5 .

}

civic-kb:provenance-f01862475f803d7dd35f3bb531b1fec5 {
	civic-kb:assertion-f01862475f803d7dd35f3bb531b1fec5 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f01862475f803d7dd35f3bb531b1fec5 .

	civic-kb:Status-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-f01862475f803d7dd35f3bb531b1fec5	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f01862475f803d7dd35f3bb531b1fec5 {
	civic-kb:nanoPub-f01862475f803d7dd35f3bb531b1fec5 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f01862475f803d7dd35f3bb531b1fec5
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-77f2b746249152b55994fbcd1c32a7a3 {
	civic-kb:nanoPub-77f2b746249152b55994fbcd1c32a7a3
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-77f2b746249152b55994fbcd1c32a7a3 ;
		np:hasProvenance civic-kb:provenance-77f2b746249152b55994fbcd1c32a7a3 ;
		np:hasPublicationInfo civic-kb:pubInfo-77f2b746249152b55994fbcd1c32a7a3 .
}

civic-kb:assertion-77f2b746249152b55994fbcd1c32a7a3 {
	civic-kb:Drugs-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-77f2b746249152b55994fbcd1c32a7a3 .

	civic-kb:Status-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-77f2b746249152b55994fbcd1c32a7a3 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-77f2b746249152b55994fbcd1c32a7a3 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"389"^^xsd:integer .

	civic-kb:Gene-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R175H"^^xsd:string .

	civic-kb:Description-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-77f2b746249152b55994fbcd1c32a7a3 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast cancer patients who harbor R175H mutation have worse overall survival than those with wild type TP53, but have better prognosis than those with R248W mutation."^^xsd:string .

	civic-kb:Disease-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-77f2b746249152b55994fbcd1c32a7a3 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-77f2b746249152b55994fbcd1c32a7a3 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"B"^^xsd:string .

	civic-kb:Evidence_Type-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-77f2b746249152b55994fbcd1c32a7a3 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Prognostic"^^xsd:string .

	civic-kb:Evidence_Direction-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-77f2b746249152b55994fbcd1c32a7a3 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Poor Outcome"^^xsd:string .

	civic-kb:Variant_Origin-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-77f2b746249152b55994fbcd1c32a7a3 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-77f2b746249152b55994fbcd1c32a7a3 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-77f2b746249152b55994fbcd1c32a7a3	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-77f2b746249152b55994fbcd1c32a7a3 .

}

civic-kb:provenance-77f2b746249152b55994fbcd1c32a7a3 {
	civic-kb:assertion-77f2b746249152b55994fbcd1c32a7a3 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-77f2b746249152b55994fbcd1c32a7a3 .

	civic-kb:Status-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-77f2b746249152b55994fbcd1c32a7a3	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-77f2b746249152b55994fbcd1c32a7a3 {
	civic-kb:nanoPub-77f2b746249152b55994fbcd1c32a7a3 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-77f2b746249152b55994fbcd1c32a7a3
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-0626ef44842f08d73c1e781329ab86ba {
	civic-kb:nanoPub-0626ef44842f08d73c1e781329ab86ba
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-0626ef44842f08d73c1e781329ab86ba ;
		np:hasProvenance civic-kb:provenance-0626ef44842f08d73c1e781329ab86ba ;
		np:hasPublicationInfo civic-kb:pubInfo-0626ef44842f08d73c1e781329ab86ba .
}

civic-kb:assertion-0626ef44842f08d73c1e781329ab86ba {
	civic-kb:Drugs-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-0626ef44842f08d73c1e781329ab86ba ;
		rdf:type	db:DB00997 ;
		rdfs:label	"Doxorubicin"^^xsd:string ;
		sio:hasValue	"Doxorubicin"^^xsd:string .

	civic-kb:Status-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-0626ef44842f08d73c1e781329ab86ba ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-0626ef44842f08d73c1e781329ab86ba ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"319"^^xsd:integer .

	civic-kb:Gene-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17359 ;
		rdf:type	uniprot:P04637 ;
		rdfs:label	"TP53 Gene"^^xsd:string ;
		sio:hasValue	"TP53"^^xsd:string .

	civic-kb:Variant-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"R175H"^^xsd:string .

	civic-kb:Description-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-0626ef44842f08d73c1e781329ab86ba ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Breast tumors in a mouse model with R175H mutation are more responsive to doxorubicin than breast tumors with wild type TP53."^^xsd:string .

	civic-kb:Disease-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-0626ef44842f08d73c1e781329ab86ba ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-0626ef44842f08d73c1e781329ab86ba ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-0626ef44842f08d73c1e781329ab86ba ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-0626ef44842f08d73c1e781329ab86ba ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-0626ef44842f08d73c1e781329ab86ba ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-0626ef44842f08d73c1e781329ab86ba ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-0626ef44842f08d73c1e781329ab86ba	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-0626ef44842f08d73c1e781329ab86ba .

}

civic-kb:provenance-0626ef44842f08d73c1e781329ab86ba {
	civic-kb:assertion-0626ef44842f08d73c1e781329ab86ba prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-0626ef44842f08d73c1e781329ab86ba .

	civic-kb:Status-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-0626ef44842f08d73c1e781329ab86ba	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-0626ef44842f08d73c1e781329ab86ba {
	civic-kb:nanoPub-0626ef44842f08d73c1e781329ab86ba prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-0626ef44842f08d73c1e781329ab86ba
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-f9dacbdc57fd1492e6db7b5cb15590f6 {
	civic-kb:nanoPub-f9dacbdc57fd1492e6db7b5cb15590f6
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		np:hasProvenance civic-kb:provenance-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		np:hasPublicationInfo civic-kb:pubInfo-f9dacbdc57fd1492e6db7b5cb15590f6 .
}

civic-kb:assertion-f9dacbdc57fd1492e6db7b5cb15590f6 {
	civic-kb:Drugs-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		rdf:type	db:DB11828 ;
		rdfs:label	"Neratinib"^^xsd:string ;
		sio:hasValue	"Neratinib"^^xsd:string .

	civic-kb:Status-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"283"^^xsd:integer .

	civic-kb:Gene-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L755S"^^xsd:string .

	civic-kb:Description-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The L755S mutation showed mild response to neratinib in MCF10A cell lines retrovirally transduced with wildtype or mutant ERBB2."^^xsd:string .

	civic-kb:Disease-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-f9dacbdc57fd1492e6db7b5cb15590f6 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-f9dacbdc57fd1492e6db7b5cb15590f6	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-f9dacbdc57fd1492e6db7b5cb15590f6 .

}

civic-kb:provenance-f9dacbdc57fd1492e6db7b5cb15590f6 {
	civic-kb:assertion-f9dacbdc57fd1492e6db7b5cb15590f6 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-f9dacbdc57fd1492e6db7b5cb15590f6 .

	civic-kb:Status-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-f9dacbdc57fd1492e6db7b5cb15590f6	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-f9dacbdc57fd1492e6db7b5cb15590f6 {
	civic-kb:nanoPub-f9dacbdc57fd1492e6db7b5cb15590f6 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-f9dacbdc57fd1492e6db7b5cb15590f6
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-4b7806b34e99274c3429d66bf9e0ba37 {
	civic-kb:nanoPub-4b7806b34e99274c3429d66bf9e0ba37
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-4b7806b34e99274c3429d66bf9e0ba37 ;
		np:hasProvenance civic-kb:provenance-4b7806b34e99274c3429d66bf9e0ba37 ;
		np:hasPublicationInfo civic-kb:pubInfo-4b7806b34e99274c3429d66bf9e0ba37 .
}

civic-kb:assertion-4b7806b34e99274c3429d66bf9e0ba37 {
	civic-kb:Drugs-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4b7806b34e99274c3429d66bf9e0ba37 ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-4b7806b34e99274c3429d66bf9e0ba37 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-4b7806b34e99274c3429d66bf9e0ba37 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"241"^^xsd:integer .

	civic-kb:Gene-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L755S"^^xsd:string .

	civic-kb:Description-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-4b7806b34e99274c3429d66bf9e0ba37 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"The L755S mutation was shown to confer resistance to lapatinib in MCF10A cell lines retrovirally transduced with wildtype or mutant ERBB2."^^xsd:string .

	civic-kb:Disease-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-4b7806b34e99274c3429d66bf9e0ba37 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-4b7806b34e99274c3429d66bf9e0ba37 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4b7806b34e99274c3429d66bf9e0ba37 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-4b7806b34e99274c3429d66bf9e0ba37 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-4b7806b34e99274c3429d66bf9e0ba37 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-4b7806b34e99274c3429d66bf9e0ba37 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-4b7806b34e99274c3429d66bf9e0ba37	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-4b7806b34e99274c3429d66bf9e0ba37 .

}

civic-kb:provenance-4b7806b34e99274c3429d66bf9e0ba37 {
	civic-kb:assertion-4b7806b34e99274c3429d66bf9e0ba37 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-4b7806b34e99274c3429d66bf9e0ba37 .

	civic-kb:Status-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-4b7806b34e99274c3429d66bf9e0ba37	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-4b7806b34e99274c3429d66bf9e0ba37 {
	civic-kb:nanoPub-4b7806b34e99274c3429d66bf9e0ba37 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-4b7806b34e99274c3429d66bf9e0ba37
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-882432c7482962512d58406454e2311d {
	civic-kb:nanoPub-882432c7482962512d58406454e2311d
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-882432c7482962512d58406454e2311d ;
		np:hasProvenance civic-kb:provenance-882432c7482962512d58406454e2311d ;
		np:hasPublicationInfo civic-kb:pubInfo-882432c7482962512d58406454e2311d .
}

civic-kb:assertion-882432c7482962512d58406454e2311d {
	civic-kb:Drugs-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-882432c7482962512d58406454e2311d ;
		rdf:type	dron:00018921 ;
		rdf:type	db:DB01259 ;
		rdfs:label	"Lapatinib"^^xsd:string ;
		sio:hasValue	"Lapatinib"^^xsd:string .

	civic-kb:Status-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-882432c7482962512d58406454e2311d ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-882432c7482962512d58406454e2311d ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"3004"^^xsd:integer .

	civic-kb:Gene-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C17756 ;
		rdf:type	uniprot:P04626 ;
		rdfs:label	"ERBB2 Gene"^^xsd:string ;
		sio:hasValue	"ERBB2"^^xsd:string .

	civic-kb:Variant-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"L755S"^^xsd:string .

	civic-kb:Description-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-882432c7482962512d58406454e2311d ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string .

	civic-kb:Disease-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-882432c7482962512d58406454e2311d ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-882432c7482962512d58406454e2311d ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-882432c7482962512d58406454e2311d ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-882432c7482962512d58406454e2311d ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-882432c7482962512d58406454e2311d ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-882432c7482962512d58406454e2311d	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-882432c7482962512d58406454e2311d ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"1"^^xsd:integer .

	civic-kb:evidence-882432c7482962512d58406454e2311d	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-882432c7482962512d58406454e2311d .

}

civic-kb:provenance-882432c7482962512d58406454e2311d {
	civic-kb:assertion-882432c7482962512d58406454e2311d prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-882432c7482962512d58406454e2311d .

	civic-kb:Status-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-882432c7482962512d58406454e2311d	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-882432c7482962512d58406454e2311d {
	civic-kb:nanoPub-882432c7482962512d58406454e2311d prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-882432c7482962512d58406454e2311d
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-61439aecae37f93e25008d88067f3250 {
	civic-kb:nanoPub-61439aecae37f93e25008d88067f3250
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-61439aecae37f93e25008d88067f3250 ;
		np:hasProvenance civic-kb:provenance-61439aecae37f93e25008d88067f3250 ;
		np:hasPublicationInfo civic-kb:pubInfo-61439aecae37f93e25008d88067f3250 .
}

civic-kb:assertion-61439aecae37f93e25008d88067f3250 {
	civic-kb:Drugs-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-61439aecae37f93e25008d88067f3250 ;
		rdf:type	ncit:C15445 ;
		rdfs:label	"Hormone Therapy"^^xsd:string ;
		sio:hasValue	"Hormone Therapy"^^xsd:string .

	civic-kb:Status-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-61439aecae37f93e25008d88067f3250 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-61439aecae37f93e25008d88067f3250 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"244"^^xsd:integer .

	civic-kb:Gene-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Y537C"^^xsd:string .

	civic-kb:Description-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-61439aecae37f93e25008d88067f3250 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"MCF7 cell lines harboring the Y537C mutation in the ligand-binding domain of ESR1 have shown resistance to hormone therapy."^^xsd:string .

	civic-kb:Disease-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-61439aecae37f93e25008d88067f3250 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-61439aecae37f93e25008d88067f3250 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-61439aecae37f93e25008d88067f3250 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-61439aecae37f93e25008d88067f3250 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Resistance or Non-Response"^^xsd:string .

	civic-kb:Variant_Origin-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-61439aecae37f93e25008d88067f3250 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-61439aecae37f93e25008d88067f3250 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"3"^^xsd:integer .

	civic-kb:evidence-61439aecae37f93e25008d88067f3250	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-61439aecae37f93e25008d88067f3250 .

}

civic-kb:provenance-61439aecae37f93e25008d88067f3250 {
	civic-kb:assertion-61439aecae37f93e25008d88067f3250 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-61439aecae37f93e25008d88067f3250 .

	civic-kb:Status-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-61439aecae37f93e25008d88067f3250	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-61439aecae37f93e25008d88067f3250 {
	civic-kb:nanoPub-61439aecae37f93e25008d88067f3250 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-61439aecae37f93e25008d88067f3250
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-599620539c2c7b186d4504de687334ca {
	civic-kb:nanoPub-599620539c2c7b186d4504de687334ca
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-599620539c2c7b186d4504de687334ca ;
		np:hasProvenance civic-kb:provenance-599620539c2c7b186d4504de687334ca ;
		np:hasPublicationInfo civic-kb:pubInfo-599620539c2c7b186d4504de687334ca .
}

civic-kb:assertion-599620539c2c7b186d4504de687334ca {
	civic-kb:Drugs-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-599620539c2c7b186d4504de687334ca ;
		sio:hasValue	"Tamoxifen, Fulvestrant"^^xsd:string .

	civic-kb:Status-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-599620539c2c7b186d4504de687334ca ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-599620539c2c7b186d4504de687334ca ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"292"^^xsd:integer .

	civic-kb:Gene-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Y537C"^^xsd:string .

	civic-kb:Description-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-599620539c2c7b186d4504de687334ca ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"Using an estrogen response element (ERE)-luciferase reporter system co-transfected with one of five ESR1 mutants, the Y537C ligand binding domain mutation was shown to result in constitutive activity (response in the absence of beta-estradiol ligand) and continued responsiveness (inhibition of downstream target activation) to anti-estrogen therapies (tamoxifen or fulvestrant) in HEK293T cell lines."^^xsd:string .

	civic-kb:Disease-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-599620539c2c7b186d4504de687334ca ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-599620539c2c7b186d4504de687334ca ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"D"^^xsd:string .

	civic-kb:Evidence_Type-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-599620539c2c7b186d4504de687334ca ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-599620539c2c7b186d4504de687334ca ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-599620539c2c7b186d4504de687334ca ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-599620539c2c7b186d4504de687334ca ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"5"^^xsd:integer .

	civic-kb:evidence-599620539c2c7b186d4504de687334ca	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-599620539c2c7b186d4504de687334ca .

}

civic-kb:provenance-599620539c2c7b186d4504de687334ca {
	civic-kb:assertion-599620539c2c7b186d4504de687334ca prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-599620539c2c7b186d4504de687334ca .

	civic-kb:Status-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-599620539c2c7b186d4504de687334ca	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-599620539c2c7b186d4504de687334ca {
	civic-kb:nanoPub-599620539c2c7b186d4504de687334ca prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-599620539c2c7b186d4504de687334ca
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-31f6a259b900fdbee19486000d698fe2 {
	civic-kb:nanoPub-31f6a259b900fdbee19486000d698fe2
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-31f6a259b900fdbee19486000d698fe2 ;
		np:hasProvenance civic-kb:provenance-31f6a259b900fdbee19486000d698fe2 ;
		np:hasPublicationInfo civic-kb:pubInfo-31f6a259b900fdbee19486000d698fe2 .
}

civic-kb:assertion-31f6a259b900fdbee19486000d698fe2 {
	civic-kb:Drugs-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-31f6a259b900fdbee19486000d698fe2 ;
		rdf:type	db:DB09073 ;
		rdfs:label	"Palbociclib"^^xsd:string ;
		sio:hasValue	"Palbociclib"^^xsd:string .

	civic-kb:Status-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-31f6a259b900fdbee19486000d698fe2 ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"submitted"^^xsd:string .

	civic-kb:Evidence_ID-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-31f6a259b900fdbee19486000d698fe2 ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"4812"^^xsd:integer .

	civic-kb:Gene-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38349 ;
		rdf:type	uniprot:P03372 ;
		rdfs:label	"ESR1 Gene"^^xsd:string ;
		sio:hasValue	"ESR1"^^xsd:string .

	civic-kb:Variant-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"Y537C"^^xsd:string .

	civic-kb:Description-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-31f6a259b900fdbee19486000d698fe2 ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"In a phase 3 clinical trial (NCT01942135) of 360 premenopausal and postmenopausal women with advanced, hormone receptor-positive breast cancer who had progressed during prior endocrine therapy, patients with ESR1 mutations (91/360), including ESR1 Y537C (n=5), treated with palbociclib and fulvestrant were associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (HR:0.43; 95% CI:0.25-0.74; P=0.002). Patient without detected ESR1 mutation treated with palbociclib and fulvestrant were also associated with improved median progression free survival, compared with patients treated with fulvestrant and placebo (9.5 vs. 5.4 months; HR:0.49; 95% CI:0.35-0.70; P<0.001)."^^xsd:string .

	civic-kb:Disease-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-31f6a259b900fdbee19486000d698fe2 ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-31f6a259b900fdbee19486000d698fe2 ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"C"^^xsd:string .

	civic-kb:Evidence_Type-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-31f6a259b900fdbee19486000d698fe2 ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-31f6a259b900fdbee19486000d698fe2 ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-31f6a259b900fdbee19486000d698fe2 ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-31f6a259b900fdbee19486000d698fe2 ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"0"^^xsd:integer .

	civic-kb:evidence-31f6a259b900fdbee19486000d698fe2	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-31f6a259b900fdbee19486000d698fe2 .

}

civic-kb:provenance-31f6a259b900fdbee19486000d698fe2 {
	civic-kb:assertion-31f6a259b900fdbee19486000d698fe2 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-31f6a259b900fdbee19486000d698fe2 .

	civic-kb:Status-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-31f6a259b900fdbee19486000d698fe2	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-31f6a259b900fdbee19486000d698fe2 {
	civic-kb:nanoPub-31f6a259b900fdbee19486000d698fe2 prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-31f6a259b900fdbee19486000d698fe2
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

civic-kb:head-c9dd35a6cdddaf165f372e31576d9feb {
	civic-kb:nanoPub-c9dd35a6cdddaf165f372e31576d9feb
		rdf:type np:Nanopublication ;
		np:hasAssertion civic-kb:assertion-c9dd35a6cdddaf165f372e31576d9feb ;
		np:hasProvenance civic-kb:provenance-c9dd35a6cdddaf165f372e31576d9feb ;
		np:hasPublicationInfo civic-kb:pubInfo-c9dd35a6cdddaf165f372e31576d9feb .
}

civic-kb:assertion-c9dd35a6cdddaf165f372e31576d9feb {
	civic-kb:Drugs-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Drugs ;
		rdf:type	sio:Drug ;
		rdfs:label "Drugs"^^xsd:string ;
		rdfs:comment "Drugs"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c9dd35a6cdddaf165f372e31576d9feb ;
		rdf:type	dron:00020139 ;
		rdf:type	db:DB08865 ;
		rdfs:label	"Crizotinib"^^xsd:string ;
		sio:hasValue	"Crizotinib"^^xsd:string .

	civic-kb:Status-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Status ;
		rdf:type	sio:StatusDescriptor ;
		sio:isAttributeOf civic-kb:evidence-c9dd35a6cdddaf165f372e31576d9feb ;
		rdfs:label "Status"^^xsd:string ;
		rdfs:comment "Status"^^xsd:string ;
		sio:hasValue	"accepted"^^xsd:string .

	civic-kb:Evidence_ID-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Evidence_ID ;
		rdf:type	sio:Identifier ;
		sio:isAttributeOf civic-kb:evidence-c9dd35a6cdddaf165f372e31576d9feb ;
		rdfs:label "Evidence ID"^^xsd:string ;
		rdfs:comment "Evidence ID"^^xsd:string ;
		sio:hasValue	"1335"^^xsd:integer .

	civic-kb:Gene-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Gene ;
		rdf:type	sio:Gene ;
		rdfs:label "Gene"^^xsd:string ;
		rdfs:comment "Gene"^^xsd:string ;
		rdf:type	ncit:C38184 ;
		rdf:type	uniprot:Q9UM73 ;
		rdfs:label	"ALK Gene"^^xsd:string ;
		sio:hasValue	"ALK"^^xsd:string .

	civic-kb:Variant-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Variant ;
		rdf:type	ncit:C97927 ;
		rdfs:label "Variant"^^xsd:string ;
		rdfs:comment "Variant"^^xsd:string ;
		sio:hasRole [ rdf:type	sio:VariantRole ;
			sio:inRelationTo civic-kb:Gene ] ;
		sio:hasValue	"ALK FUSIONS"^^xsd:string .

	civic-kb:Description-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Description ;
		rdf:type	sio:Description ;
		sio:isAttributeOf civic-kb:evidence-c9dd35a6cdddaf165f372e31576d9feb ;
		rdfs:label "Description"^^xsd:string ;
		rdfs:comment "Description"^^xsd:string ;
		sio:hasValue	"84 breast cancer samples acquired from commercial sources were assayed on Affymetrix human exon 1.0 arrays. A computational method was used to find potential gene fusions which assessed differential exon expression between the 3' and 5' ends of each gene. Two potential fusions were found and assessed using RNA ligase mediated rapid amplifiation of cDNA ends and RT-PCR. The fusions were EML4-ALK variants 1 and 2. Genomic PCR identified fusion breakpoints, and these differed from breakpoints for these EML4-ALK variants reported in NSCLC."^^xsd:string .

	civic-kb:Disease-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Disease ;
		rdf:type	sio:Disease ;
		rdfs:label "Disease"^^xsd:string ;
		rdfs:comment "Disease"^^xsd:string ;
		sio:inRelationTo	civic-kb:Gene-c9dd35a6cdddaf165f372e31576d9feb ;
		rdf:type	efo:0000305 ;
		rdf:type	ncit:C4872 ;
		rdf:type	doid:1612 ;
		rdfs:label	"Breast Cancer"^^xsd:string ;
		sio:hasValue	"Breast Cancer"^^xsd:string .

	civic-kb:Evidence_Level-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Evidence_Level ;
		rdf:type	ncit:C25554 ;
		sio:isAttributeOf civic-kb:evidence-c9dd35a6cdddaf165f372e31576d9feb ;
		rdfs:label "Evidence Level"^^xsd:string ;
		rdfs:comment "Evidence Level"^^xsd:string ;
		sio:hasValue	"E"^^xsd:string .

	civic-kb:Evidence_Type-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Evidence_Type ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c9dd35a6cdddaf165f372e31576d9feb ;
		rdfs:label "Evidence Type"^^xsd:string ;
		rdfs:comment "Evidence Type"^^xsd:string ;
		sio:hasValue	"Predictive"^^xsd:string .

	civic-kb:Evidence_Direction-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Evidence_Direction ;
		rdf:type	sio:Attribute ;
		sio:isAttributeOf civic-kb:evidence-c9dd35a6cdddaf165f372e31576d9feb ;
		rdfs:label "Evidence Direction"^^xsd:string ;
		rdfs:comment "Evidence Direction"^^xsd:string ;
		sio:hasValue	"Supports"^^xsd:string .

	civic-kb:Clinical_Significance-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Clinical_Significance ;
		rdf:type	sio:Attribute ;
		rdfs:label "Clinical Significance"^^xsd:string ;
		rdfs:comment "Clinical Significance"^^xsd:string ;
		sio:hasValue	"Sensitivity"^^xsd:string .

	civic-kb:Variant_Origin-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Variant_Origin ;
		rdf:type	ncit:C42703 ;
		sio:isAttributeOf civic-kb:Variant-c9dd35a6cdddaf165f372e31576d9feb ;
		rdfs:label "Variant Origin"^^xsd:string ;
		rdfs:comment "Variant Origin"^^xsd:string ;
		sio:hasValue	"Somatic Mutation"^^xsd:string .

	civic-kb:Trust_Rating-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:Trust_Rating ;
		rdf:type	ncit:C77538 ;
		sio:isAttributeOf civic-kb:evidence-c9dd35a6cdddaf165f372e31576d9feb ;
		rdfs:label "Trust Rating"^^xsd:string ;
		rdfs:comment "Trust Rating"^^xsd:string ;
		sio:hasValue	"1"^^xsd:integer .

	civic-kb:evidence-c9dd35a6cdddaf165f372e31576d9feb	rdf:type	civic-kb:evidence;
		rdf:type	ncit:C43583;
		sio:hasIdentifier civic-kb:Evidence_ID-c9dd35a6cdddaf165f372e31576d9feb .

}

civic-kb:provenance-c9dd35a6cdddaf165f372e31576d9feb {
	civic-kb:assertion-c9dd35a6cdddaf165f372e31576d9feb prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  ;
		prov:wasDerivedFrom	civic-kb:evidence-c9dd35a6cdddaf165f372e31576d9feb .

	civic-kb:Status-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_ID-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Gene-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Description-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Disease-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Level-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Type-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Evidence_Direction-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Clinical_Significance-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Variant_Origin-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:Trust_Rating-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

	civic-kb:evidence-c9dd35a6cdddaf165f372e31576d9feb	prov:generatedAtTime	"2018-03-05T00:00:33Z"^^xsd:dateTime  .

}

civic-kb:pubInfo-c9dd35a6cdddaf165f372e31576d9feb {
	civic-kb:nanoPub-c9dd35a6cdddaf165f372e31576d9feb prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime .

	civic-kb:Drugs-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"1"^^xsd:integer .

	civic-kb:Status-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"2"^^xsd:integer .

	civic-kb:Evidence_ID-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"3"^^xsd:integer .

	civic-kb:Gene-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"4"^^xsd:integer .

	civic-kb:Variant-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"5"^^xsd:integer .

	civic-kb:Description-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"6"^^xsd:integer .

	civic-kb:Disease-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"7"^^xsd:integer .

	civic-kb:Evidence_Level-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"8"^^xsd:integer .

	civic-kb:Evidence_Type-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"9"^^xsd:integer .

	civic-kb:Evidence_Direction-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"10"^^xsd:integer .

	civic-kb:Clinical_Significance-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"11"^^xsd:integer .

	civic-kb:Variant_Origin-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"12"^^xsd:integer .

	civic-kb:Trust_Rating-c9dd35a6cdddaf165f372e31576d9feb
		prov:generatedAtTime "2018-03-05T00:00:33Z"^^xsd:dateTime ;
		hasco:hasPosition	"13"^^xsd:integer .

}

